{"docId": "19521975", "sentence": [{"charStart": 0, "charEnd": 117, "index": 0}, {"index": 1, "charEnd": 261, "charStart": 119}, {"index": 2, "charEnd": 482, "charStart": 263}, {"index": 3, "charEnd": 789, "charStart": 484}, {"index": 4, "charEnd": 1074, "charStart": 791}, {"index": 5, "charEnd": 1364, "charStart": 1076}, {"index": 6, "charEnd": 1519, "charStart": 1366}, {"index": 7, "charEnd": 1674, "charStart": 1521}], "text": "Fluorine-18 labeling of phosphopeptides: a potential approach for the evaluation of phosphopeptide metabolism in vivo. Phosphopeptides are very useful reagents to study signal transduction pathways related with cellular protein phosphorylation/dephosphorylation. Phosphopeptides have also been identified as important drug candidates to modulate intracellular signaling mechanisms through targeting phosphotyrosine, phosphoserine, or phosphothreonine residue-binding protein domains. In this report, we describe the development of a convenient method for the mild and sufficient radiolabeling of phosphopeptides with the short-lived positron emitter fluorine-18 (18F) to allow radiopharmacological studies on phosphopeptide metabolism in vivo by means of positron emission tomography (PET). Radiolabeling was accomplished via conjugation of the N-terminus of polo-box domain (PBD)-binding phosphopeptide H-Met-Gln-Ser-pThr-Pro-Leu-OH with the bifunctional labeling agent N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) in reproducible isolated radiochemical yields of 25-28%. Radiopharmacological evaluation in vitro and in vivo of radiolabeled phosphopeptide [18F]FB-Met-Gln-Ser-pThr-Pro-Leu-OH [18F]-3 and its non-phosphorylated analog [18F]FB-Met-Gln-Ser-Thr-Pro-Leu-OH [18F]-4 involved metabolic stability, cell uptake studies, and small animal PET experiments. Radiolabeled phosphopeptide [18F]-3 showed a remarkable high metabolic stability in vivo compared to the corresponding non-phosphorylated peptide [18F]-4. The presented method indicates that radiolabeling of phosphopeptides with [18F]SFB is a promising approach for studying phosphopeptide metabolism in vivo.", "title": {"charStart": 0, "charEnd": 117}, "entity": {"RL:czVN": {"duid": "RL:czVN", "attribute": [], "entityType": "Trigger", "charEnd": 260, "source": "RLIMS-P", "charStart": 211, "entityId": [], "sentenceIndex": 1, "entityText": "cellular protein phosphorylation/dephosphorylation"}, "RL:behx": {"duid": "RL:behx", "attribute": [], "entityType": "Trigger", "charEnd": 1588, "source": "RLIMS-P", "charStart": 1574, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:r6NK": {"duid": "RL:r6NK", "attribute": [], "entityType": "Trigger", "charEnd": 902, "source": "RLIMS-P", "charStart": 889, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:8XJD": {"duid": "RL:8XJD", "attribute": [], "entityType": "SiteOther", "charEnd": 1588, "source": "RLIMS-P", "charStart": 1574, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:xPrs": {"duid": "RL:xPrs", "attribute": [], "entityType": "Trigger", "charEnd": 133, "source": "RLIMS-P", "charStart": 119, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphopeptides"}, "RL:TCRi": {"duid": "RL:TCRi", "attribute": [], "entityType": "Trigger", "charEnd": 413, "source": "RLIMS-P", "charStart": 399, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:zstj": {"duid": "RL:zstj", "attribute": [], "entityType": "SiteOther", "charEnd": 1202, "source": "RLIMS-P", "charStart": 1145, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptide [18F]FB-Met-Gln-Ser-pThr-Pro-Leu-OH [18F]-3"}, "RL:8EMo": {"duid": "RL:8EMo", "attribute": [], "entityType": "Trigger", "charEnd": 277, "source": "RLIMS-P", "charStart": 263, "entityId": [], "sentenceIndex": 2, "entityText": "Phosphopeptides"}, "RL:khsp": {"duid": "RL:khsp", "attribute": [], "entityType": "Trigger", "charEnd": 610, "source": "RLIMS-P", "charStart": 596, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:sYc6": {"duid": "RL:sYc6", "attribute": [], "entityType": "Trigger", "charEnd": 1392, "source": "RLIMS-P", "charStart": 1379, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide"}, "RL:kBxQ": {"duid": "RL:kBxQ", "attribute": [], "entityType": "Trigger", "charEnd": 1158, "source": "RLIMS-P", "charStart": 1145, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptide"}, "RL:nsmU": {"duid": "RL:nsmU", "attribute": [], "entityType": "SiteOther", "charEnd": 1400, "source": "RLIMS-P", "charStart": 1379, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide [18F]-3"}, "RL:arXw": {"duid": "RL:arXw", "attribute": [], "entityType": "Trigger", "charEnd": 38, "source": "RLIMS-P", "charStart": 24, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:KqZo": {"duid": "RL:KqZo", "attribute": [], "entityType": "SiteOther", "charEnd": 932, "source": "RLIMS-P", "charStart": 859, "entityId": [], "sentenceIndex": 4, "entityText": "polo-box domain (PBD)-binding phosphopeptide H-Met-Gln-Ser-pThr-Pro-Leu-OH"}, "RL:vPot": {"duid": "RL:vPot", "attribute": [], "entityType": "SiteOther", "charEnd": 277, "source": "RLIMS-P", "charStart": 263, "entityId": [], "sentenceIndex": 2, "entityText": "Phosphopeptides"}, "RL:AM2N": {"duid": "RL:AM2N", "attribute": [], "entityType": "SiteOther", "charEnd": 38, "source": "RLIMS-P", "charStart": 24, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:B7Ht": {"duid": "RL:B7Ht", "attribute": [], "entityType": "SiteOther", "charEnd": 133, "source": "RLIMS-P", "charStart": 119, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphopeptides"}, "RL:rnL8": {"duid": "RL:rnL8", "attribute": [], "entityType": "SiteOther", "charEnd": 610, "source": "RLIMS-P", "charStart": 596, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}}, "mesh": ["Animals", "Cell Line, Tumor", "Fluorine Radioisotopes", "Humans", "Isotope Labeling", "Male", "Oligopeptides", "Phosphoproteins", "Positron-Emission Tomography", "Rats", "Rats, Wistar"], "relation": {"RL:6BCB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TCRi"}], "duid": "RL:6BCB"}, "RL:TCC2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:zstj"}, {"role": "TRIGGER", "entity_duid": "RL:kBxQ"}], "duid": "RL:TCC2"}, "RL:jw9B": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:rnL8"}, {"role": "TRIGGER", "entity_duid": "RL:khsp"}], "duid": "RL:jw9B"}, "RL:LGEN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KqZo"}, {"role": "TRIGGER", "entity_duid": "RL:r6NK"}], "duid": "RL:LGEN"}, "RL:d6Be": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:vPot"}, {"role": "TRIGGER", "entity_duid": "RL:8EMo"}], "duid": "RL:d6Be"}, "RL:QX2a": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:czVN"}], "duid": "RL:QX2a"}, "RL:X2Dr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nsmU"}, {"role": "TRIGGER", "entity_duid": "RL:sYc6"}], "duid": "RL:X2Dr"}, "RL:Xdgo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8XJD"}, {"role": "TRIGGER", "entity_duid": "RL:behx"}], "duid": "RL:Xdgo"}, "RL:hJow": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:AM2N"}, {"role": "TRIGGER", "entity_duid": "RL:arXw"}], "duid": "RL:hJow"}, "RL:MqiP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:B7Ht"}, {"role": "TRIGGER", "entity_duid": "RL:xPrs"}], "duid": "RL:MqiP"}}, "type": ["Journal Article"]}
{"docId": "11908807", "sentence": [{"charStart": 0, "charEnd": 97, "index": 0}, {"index": 1, "charEnd": 342, "charStart": 99}, {"index": 2, "charEnd": 556, "charStart": 344}, {"index": 3, "charEnd": 750, "charStart": 558}, {"index": 4, "charEnd": 842, "charStart": 752}, {"index": 5, "charEnd": 941, "charStart": 844}, {"index": 6, "charEnd": 1221, "charStart": 943}], "text": "Fragmentation of phosphopeptides by atmospheric pressure MALDI and ESI/Ion trap mass spectrometry. An investigation of phosphate loss from phosphopeptide ions was conducted, using both atmospheric pressure matrix-assisted laser desorption/ionization (AP MALDI) and electrospray ionization (ESI) coupled to an ion trap mass spectrometer (ITMS). These experiments were carried out on a number of phosphorylated peptides in order to investigate gas phase dephosphorylation patterns associated with phosphoserine, phosphothreonine, and phosphotyrosine residues. In particular, we explored the fragmentation patterns of phosphotyrosine containing peptides, which experience a loss of 98 Da under collision induced dissociation (CID) conditions in the ITMS. The loss of 98 Da is unexpected for phosphotyrosine, given the structure of its side chain. The fragmentation of phosphoserine and phosphothreonine containing peptides was also investigated. While phosphoserine and phosphothreonine residues undergo a loss of 98 Da under CID conditions regardless of peptide amino acid composition, phosphate loss from phosphotyrosine residues seems to be dependent on the presence of arginine or lysine residues in the peptide sequence.", "title": {"charStart": 0, "charEnd": 97}, "entity": {"RL:zehb": {"duid": "RL:zehb", "attribute": [], "entityType": "Trigger", "charEnd": 961, "source": "RLIMS-P", "charStart": 949, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:8KEt": {"duid": "RL:8KEt", "attribute": [], "entityType": "Trigger", "charEnd": 877, "source": "RLIMS-P", "charStart": 865, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:jM7o": {"duid": "RL:jM7o", "attribute": [], "entityType": "Trigger", "charEnd": 31, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:B8nc": {"duid": "RL:B8nc", "attribute": [], "entityType": "Trigger", "charEnd": 1118, "source": "RLIMS-P", "charStart": 1104, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:Ckk6": {"duid": "RL:Ckk6", "attribute": [], "entityType": "Trigger", "charEnd": 507, "source": "RLIMS-P", "charStart": 495, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:t568": {"duid": "RL:t568", "attribute": [], "entityType": "Trigger", "charEnd": 407, "source": "RLIMS-P", "charStart": 394, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:2b95": {"duid": "RL:2b95", "attribute": [], "entityType": "SiteOther", "charEnd": 416, "source": "RLIMS-P", "charStart": 409, "entityId": [], "sentenceIndex": 2, "entityText": "peptides"}, "RL:5F7r": {"duid": "RL:5F7r", "attribute": [], "entityType": "Trigger", "charEnd": 629, "source": "RLIMS-P", "charStart": 615, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:ixNJ": {"duid": "RL:ixNJ", "attribute": [], "entityType": "Trigger", "charEnd": 802, "source": "RLIMS-P", "charStart": 788, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:XLPJ": {"duid": "RL:XLPJ", "attribute": [], "entityType": "SiteOther", "charEnd": 31, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acids", "Hydrolysis", "Indicators and Reagents", "Phosphates", "Phosphopeptides", "Phosphotyrosine", "Pronase", "Spectrometry, Mass, Electrospray Ionization", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization", "Trypsin"], "relation": {"RL:GJsi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zehb"}], "duid": "RL:GJsi"}, "RL:V6No": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5F7r"}], "duid": "RL:V6No"}, "RL:zYi4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:XLPJ"}, {"role": "TRIGGER", "entity_duid": "RL:jM7o"}], "duid": "RL:zYi4"}, "RL:auRT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:B8nc"}], "duid": "RL:auRT"}, "RL:3z8G": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ixNJ"}], "duid": "RL:3z8G"}, "RL:zZqg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ckk6"}], "duid": "RL:zZqg"}, "RL:bER4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:8KEt"}], "duid": "RL:bER4"}, "RL:hHzJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2b95"}, {"role": "TRIGGER", "entity_duid": "RL:t568"}], "duid": "RL:hHzJ"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "14576432", "sentence": [{"charStart": 0, "charEnd": 76, "index": 0}, {"index": 1, "charEnd": 221, "charStart": 78}, {"index": 2, "charEnd": 647, "charStart": 223}, {"index": 3, "charEnd": 830, "charStart": 649}, {"index": 4, "charEnd": 1084, "charStart": 832}], "text": "BRCT repeats as phosphopeptide-binding modules involved in protein targeting. We used a proteomic approach to identify phosphopeptide-binding modules mediating signal transduction events in the DNA damage response pathway. Using a library of partially degenerate phosphopeptides, we identified tandem BRCT (BRCA1 carboxyl-terminal) domains in PTIP (Pax transactivation domain-interacting protein) and in BRCA1 as phosphoserine- or phosphothreonine-specific binding modules that recognize substrates phosphorylated by the kinases ATM (ataxia telangiectasia-mutated) and ATR (ataxia telangiectasia- and RAD3-related) in response to gamma-irradiation. PTIP tandem BRCT domains are responsible for phosphorylation-dependent protein localization into 53BP1- and phospho-H2AX (gamma-H2AX)-containing nuclear foci, a marker of DNA damage. These findings provide a molecular basis for BRCT domain function in the DNA damage response and may help to explain why the BRCA1 BRCT domain mutation Met1775 --> Arg, which fails to bind phosphopeptides, predisposes women to breast and ovarian cancer.", "title": {"charStart": 0, "charEnd": 76}, "entity": {"RL:ACGt": {"duid": "RL:ACGt", "attribute": [], "entityType": "Protein", "charEnd": 768, "source": "RLIMS-P", "charStart": 765, "entityId": [], "sentenceIndex": 3, "entityText": "H2AX"}, "RL:bxhn": {"duid": "RL:bxhn", "attribute": [], "entityType": "Trigger", "charEnd": 768, "source": "RLIMS-P", "charStart": 757, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-H2AX"}, "RL:FUMv": {"duid": "RL:FUMv", "attribute": [], "entityType": "Trigger", "charEnd": 512, "source": "RLIMS-P", "charStart": 499, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:TXCg": {"duid": "RL:TXCg", "attribute": [], "entityType": "Trigger", "charEnd": 1035, "source": "RLIMS-P", "charStart": 1021, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:P5af": {"duid": "RL:P5af", "attribute": [], "entityType": "SiteOther", "charEnd": 672, "source": "RLIMS-P", "charStart": 649, "entityId": [], "sentenceIndex": 3, "entityText": "PTIP tandem BRCT domains"}, "RL:KNuw": {"duid": "RL:KNuw", "attribute": [], "entityType": "Trigger", "charEnd": 277, "source": "RLIMS-P", "charStart": 263, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:aq7J": {"duid": "RL:aq7J", "attribute": [], "entityType": "SiteOther", "charEnd": 1035, "source": "RLIMS-P", "charStart": 1021, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:Nh6S": {"duid": "RL:Nh6S", "attribute": [], "entityType": "Protein", "charEnd": 613, "source": "RLIMS-P", "charStart": 569, "entityId": [], "sentenceIndex": 2, "entityText": "ATR (ataxia telangiectasia- and RAD3-related)"}, "RL:d4BW": {"duid": "RL:d4BW", "attribute": [], "entityType": "SiteOther", "charEnd": 277, "source": "RLIMS-P", "charStart": 252, "entityId": [], "sentenceIndex": 2, "entityText": "degenerate phosphopeptides"}, "RL:mQaF": {"duid": "RL:mQaF", "attribute": [], "entityType": "Protein", "charEnd": 563, "source": "RLIMS-P", "charStart": 529, "entityId": [], "sentenceIndex": 2, "entityText": "ATM (ataxia telangiectasia-mutated)"}, "RL:XPJJ": {"duid": "RL:XPJJ", "attribute": [], "entityType": "Trigger", "charEnd": 446, "source": "RLIMS-P", "charStart": 431, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:eUhx": {"duid": "RL:eUhx", "attribute": [], "entityType": "Trigger", "charEnd": 425, "source": "RLIMS-P", "charStart": 413, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:o3a6": {"duid": "RL:o3a6", "attribute": [], "entityType": "Trigger", "charEnd": 708, "source": "RLIMS-P", "charStart": 694, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}}, "mesh": ["Amino Acid Motifs", "Ataxia Telangiectasia Mutated Proteins", "BRCA1 Protein", "Caffeine", "Calorimetry", "Carrier Proteins", "Cell Cycle Proteins", "Cell Nucleus", "Cytosol", "DNA Damage", "DNA-Binding Proteins", "Gamma Rays", "Humans", "Nuclear Proteins", "Peptide Library", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Protein Binding", "Protein Structure, Tertiary", "Protein-Serine-Threonine Kinases", "Proteomics", "Signal Transduction", "Tumor Cells, Cultured", "Tumor Suppressor Proteins"], "relation": {"RL:UcLk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ACGt"}, {"role": "SITE_OTHER", "entity_duid": "RL:P5af"}, {"role": "TRIGGER", "entity_duid": "RL:bxhn"}], "duid": "RL:UcLk"}, "RL:YvHj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:XPJJ"}], "duid": "RL:YvHj"}, "RL:seKU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:o3a6"}], "duid": "RL:seKU"}, "RL:zQR9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:d4BW"}, {"role": "TRIGGER", "entity_duid": "RL:KNuw"}], "duid": "RL:zQR9"}, "RL:YZae": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:eUhx"}], "duid": "RL:YZae"}, "RL:qP3A": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "KINASE", "entity_duid": "RL:Nh6S"}, {"role": "KINASE", "entity_duid": "RL:mQaF"}, {"role": "TRIGGER", "entity_duid": "RL:FUMv"}], "duid": "RL:qP3A"}, "RL:E66k": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:aq7J"}, {"role": "TRIGGER", "entity_duid": "RL:TXCg"}], "duid": "RL:E66k"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "17184134", "sentence": [{"charStart": 0, "charEnd": 78, "index": 0}, {"index": 1, "charEnd": 163, "charStart": 80}, {"index": 2, "charEnd": 362, "charStart": 165}, {"index": 3, "charEnd": 506, "charStart": 364}, {"index": 4, "charEnd": 722, "charStart": 508}, {"index": 5, "charEnd": 934, "charStart": 724}, {"index": 6, "charEnd": 1301, "charStart": 936}], "text": "Phosphopeptide modification and enrichment by oxidation-reduction condensation. Many cellular processes are regulated by the reversible phosphorylation of proteins. Despite the importance of monitoring protein phosphorylation, available methods to modify and enrich phosphopeptides from complex mixtures for subsequent mass spectrometric analysis are challenging. Here the oxidation-reduction condensation was shown for the first time to directly modify the phosphate of phosphopeptides and phosphoproteins. By coupling with a solid-phase resin, the oxidation-reduction condensation was validated for capture and recovery of phosphoserine-, phosphothreonine-, and phosphotyrosine-containing peptides from a peptide mixture. In addition, full-length phosphoproteins or phosphopeptides from a protein digestion were captured and recovered using the oxidation-reduction condensation, demonstrating its compatibility with protein mixtures. The strategy modifies all phosphopeptides, maintains high chemical selectivity, requires only two steps, and relies on commercially available reagents, suggesting that the oxidation-reduction condensation has the potential to enhance phosphopeptide enrichment methods and encourage development of efficient biochemical and proteomics tools targeting phosphorylation.", "title": {"charStart": 0, "charEnd": 78}, "entity": {"RL:FMMj": {"duid": "RL:FMMj", "attribute": [], "entityType": "Trigger", "charEnd": 485, "source": "RLIMS-P", "charStart": 471, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:hMGm": {"duid": "RL:hMGm", "attribute": [], "entityType": "SiteOther", "charEnd": 782, "source": "RLIMS-P", "charStart": 768, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:BgD8": {"duid": "RL:BgD8", "attribute": [], "entityType": "SiteOther", "charEnd": 485, "source": "RLIMS-P", "charStart": 471, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:LbgS": {"duid": "RL:LbgS", "attribute": [], "entityType": "Trigger", "charEnd": 1300, "source": "RLIMS-P", "charStart": 1286, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:UeBg": {"duid": "RL:UeBg", "attribute": [], "entityType": "Trigger", "charEnd": 637, "source": "RLIMS-P", "charStart": 625, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:stRE": {"duid": "RL:stRE", "attribute": [], "entityType": "Trigger", "charEnd": 280, "source": "RLIMS-P", "charStart": 266, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:xtAv": {"duid": "RL:xtAv", "attribute": [], "entityType": "SiteOther", "charEnd": 280, "source": "RLIMS-P", "charStart": 266, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:LN9B": {"duid": "RL:LN9B", "attribute": [], "entityType": "Trigger", "charEnd": 466, "source": "RLIMS-P", "charStart": 458, "entityId": [], "sentenceIndex": 3, "entityText": "phosphate"}, "RL:7aZg": {"duid": "RL:7aZg", "attribute": [], "entityType": "Trigger", "charEnd": 224, "source": "RLIMS-P", "charStart": 210, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:BkTZ": {"duid": "RL:BkTZ", "attribute": [], "entityType": "SiteOther", "charEnd": 976, "source": "RLIMS-P", "charStart": 962, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:RgnN": {"duid": "RL:RgnN", "attribute": [], "entityType": "Trigger", "charEnd": 976, "source": "RLIMS-P", "charStart": 962, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:vwek": {"duid": "RL:vwek", "attribute": [], "entityType": "Trigger", "charEnd": 763, "source": "RLIMS-P", "charStart": 749, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoproteins"}, "RL:Knxt": {"duid": "RL:Knxt", "attribute": [], "entityType": "Trigger", "charEnd": 150, "source": "RLIMS-P", "charStart": 136, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}}, "mesh": ["Amino Acid Sequence", "Databases, Protein", "Molecular Sequence Data", "Oxidation-Reduction", "Phosphopeptides", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"], "relation": {"RL:DWJF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Knxt"}], "duid": "RL:DWJF"}, "RL:xL4m": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:BgD8"}, {"role": "TRIGGER", "entity_duid": "RL:FMMj"}], "duid": "RL:xL4m"}, "RL:JsZm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:BkTZ"}, {"role": "TRIGGER", "entity_duid": "RL:RgnN"}], "duid": "RL:JsZm"}, "RL:UBVb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:BgD8"}, {"role": "TRIGGER", "entity_duid": "RL:LN9B"}], "duid": "RL:UBVb"}, "RL:Cv67": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UeBg"}], "duid": "RL:Cv67"}, "RL:QeVA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:hMGm"}, {"role": "TRIGGER", "entity_duid": "RL:vwek"}], "duid": "RL:QeVA"}, "RL:dtem": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:xtAv"}, {"role": "TRIGGER", "entity_duid": "RL:stRE"}], "duid": "RL:dtem"}, "RL:R8x4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LbgS"}], "duid": "RL:R8x4"}, "RL:pFoA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7aZg"}], "duid": "RL:pFoA"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "18463617", "sentence": [{"charStart": 0, "charEnd": 97, "index": 0}, {"index": 1, "charEnd": 167, "charStart": 99}, {"index": 2, "charEnd": 363, "charStart": 169}, {"index": 3, "charEnd": 530, "charStart": 365}, {"index": 4, "charEnd": 635, "charStart": 532}, {"index": 5, "charEnd": 890, "charStart": 637}, {"index": 6, "charEnd": 1013, "charStart": 892}, {"index": 7, "charEnd": 1109, "charStart": 1015}], "text": "Large-scale phosphorylation mapping reveals the extent of tyrosine phosphorylation in Arabidopsis. Protein phosphorylation regulates a wide range of cellular processes. Here, we report the proteome-wide mapping of in vivo phosphorylation sites in Arabidopsis by using complementary phosphopeptide enrichment techniques coupled with high-accuracy mass spectrometry. Using unfractionated whole cell lysates of Arabidopsis, we identified 2597 phosphopeptides with 2172 high-confidence, unique phosphorylation sites from 1346 proteins. The distribution of phosphoserine, phosphothreonine, and phosphotyrosine sites was 85.0, 10.7, and 4.3%. Although typical tyrosine-specific protein kinases are absent in Arabidopsis, the proportion of phosphotyrosines among the phospho-residues in Arabidopsis is similar to that in humans, where over 90 tyrosine-specific protein kinases have been identified. In addition, the tyrosine phosphoproteome shows features distinct from those of the serine and threonine phosphoproteomes. Taken together, we highlight the extent and contribution of tyrosine phosphorylation in plants.", "title": {"charStart": 0, "charEnd": 97}, "entity": {"RL:5Kqe": {"duid": "RL:5Kqe", "attribute": [], "entityType": "Trigger", "charEnd": 504, "source": "RLIMS-P", "charStart": 490, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:NuHF": {"duid": "RL:NuHF", "attribute": [], "entityType": "Trigger", "charEnd": 1098, "source": "RLIMS-P", "charStart": 1084, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:zWYc": {"duid": "RL:zWYc", "attribute": [], "entityType": "SiteOther", "charEnd": 454, "source": "RLIMS-P", "charStart": 440, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:5NQD": {"duid": "RL:5NQD", "attribute": [], "entityType": "Trigger", "charEnd": 121, "source": "RLIMS-P", "charStart": 107, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:tmXY": {"duid": "RL:tmXY", "attribute": [], "entityType": "Trigger", "charEnd": 26, "source": "RLIMS-P", "charStart": 12, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:UzMA": {"duid": "RL:UzMA", "attribute": [], "entityType": "SiteOther", "charEnd": 510, "source": "RLIMS-P", "charStart": 490, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation sites"}, "RL:kCJB": {"duid": "RL:kCJB", "attribute": [], "entityType": "Trigger", "charEnd": 564, "source": "RLIMS-P", "charStart": 552, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:Z3RE": {"duid": "RL:Z3RE", "attribute": [], "entityType": "Trigger", "charEnd": 236, "source": "RLIMS-P", "charStart": 222, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:6NKB": {"duid": "RL:6NKB", "attribute": [], "entityType": "Trigger", "charEnd": 748, "source": "RLIMS-P", "charStart": 733, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosines"}, "RL:PPWp": {"duid": "RL:PPWp", "attribute": [], "entityType": "Trigger", "charEnd": 81, "source": "RLIMS-P", "charStart": 67, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:M3MY": {"duid": "RL:M3MY", "attribute": [], "entityType": "SiteOther", "charEnd": 242, "source": "RLIMS-P", "charStart": 222, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation sites"}, "RL:vs5k": {"duid": "RL:vs5k", "attribute": [], "entityType": "Trigger", "charEnd": 454, "source": "RLIMS-P", "charStart": 440, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acid Motifs", "Amino Acid Sequence", "Arabidopsis", "Conserved Sequence", "Phosphoproteins", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Plant Proteins", "Protein Structure, Tertiary", "Proteome", "Sequence Homology, Amino Acid"], "relation": {"RL:moXb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PPWp"}], "duid": "RL:moXb"}, "RL:NM3d": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kCJB"}], "duid": "RL:NM3d"}, "RL:QnTL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:M3MY"}, {"role": "TRIGGER", "entity_duid": "RL:Z3RE"}], "duid": "RL:QnTL"}, "RL:TdZA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:6NKB"}], "duid": "RL:TdZA"}, "RL:iFN8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tmXY"}], "duid": "RL:iFN8"}, "RL:o75J": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NuHF"}], "duid": "RL:o75J"}, "RL:cxGJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:UzMA"}, {"role": "TRIGGER", "entity_duid": "RL:5Kqe"}], "duid": "RL:cxGJ"}, "RL:uAvR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5NQD"}], "duid": "RL:uAvR"}, "RL:dyHC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:zWYc"}, {"role": "TRIGGER", "entity_duid": "RL:vs5k"}], "duid": "RL:dyHC"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "24646179", "sentence": [{"charStart": 0, "charEnd": 98, "index": 0}, {"index": 1, "charEnd": 227, "charStart": 100}, {"index": 2, "charEnd": 424, "charStart": 229}, {"index": 3, "charEnd": 611, "charStart": 426}, {"index": 4, "charEnd": 729, "charStart": 613}, {"index": 5, "charEnd": 899, "charStart": 731}, {"index": 6, "charEnd": 983, "charStart": 901}, {"index": 7, "charEnd": 1271, "charStart": 985}, {"index": 8, "charEnd": 1395, "charStart": 1273}], "text": "Expanded cellular amino acid pools containing phosphoserine, phosphothreonine, and phosphotyrosine. Adding nonstandard amino acids to the genetic code of E. coli expands the chemical and biological functional space for proteins. This is accomplished with engineered, orthogonal aminoacyl-tRNA synthetase and tRNA pairs that require a nonstandard amino acid in sufficient intracellular quantities to support protein synthesis. While cotranslational insertion of phosphoserine into proteins has been accomplished, conditions that modulate intracellular phosphoamino acid concentrations are still poorly understood. Here we used genetic and metabolic engineering to increase the free intracellular levels of phosphoserine in E. coli. We show that deletion of the phosphoserine phosphatase serB elevates the intracellular levels of phosphoserine within ranges comparable to those of standard amino acids. These new conditions improved insertion of phosphoserine into recombinant proteins. Surprisingly, we also observed dramatic increases in intracellular levels of phosphothreonine and phosphotyrosine when WT cells were grown in LB with supplemented phosphothreonine and serB deficient cells were grown in low phosphate media with supplemented phosphotyrosine, respectively. These findings remove a major barrier for further expansion of the genetic code with additional phosphorylated amino acids.", "title": {"charStart": 0, "charEnd": 98}, "entity": {"RL:97bz": {"duid": "RL:97bz", "attribute": [], "entityType": "Trigger", "charEnd": 1163, "source": "RLIMS-P", "charStart": 1148, "entityId": [], "sentenceIndex": 7, "entityText": "phosphothreonine"}, "RL:Mnmm": {"duid": "RL:Mnmm", "attribute": [], "entityType": "Trigger", "charEnd": 1077, "source": "RLIMS-P", "charStart": 1062, "entityId": [], "sentenceIndex": 7, "entityText": "phosphothreonine"}, "RL:R3Bz": {"duid": "RL:R3Bz", "attribute": [], "entityType": "Trigger", "charEnd": 717, "source": "RLIMS-P", "charStart": 705, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:Vcoc": {"duid": "RL:Vcoc", "attribute": [], "entityType": "Trigger", "charEnd": 840, "source": "RLIMS-P", "charStart": 828, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:sH9j": {"duid": "RL:sH9j", "attribute": [], "entityType": "Trigger", "charEnd": 473, "source": "RLIMS-P", "charStart": 461, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:LgHp": {"duid": "RL:LgHp", "attribute": [], "entityType": "Trigger", "charEnd": 58, "source": "RLIMS-P", "charStart": 46, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:QqeQ": {"duid": "RL:QqeQ", "attribute": [], "entityType": "SiteOther", "charEnd": 1394, "source": "RLIMS-P", "charStart": 1384, "entityId": [], "sentenceIndex": 8, "entityText": "amino acids"}, "RL:i6P3": {"duid": "RL:i6P3", "attribute": [], "entityType": "Trigger", "charEnd": 1382, "source": "RLIMS-P", "charStart": 1369, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylated"}, "RL:kKWG": {"duid": "RL:kKWG", "attribute": [], "entityType": "Trigger", "charEnd": 1256, "source": "RLIMS-P", "charStart": 1242, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosine"}, "RL:yGW3": {"duid": "RL:yGW3", "attribute": [], "entityType": "Trigger", "charEnd": 772, "source": "RLIMS-P", "charStart": 760, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:2CQC": {"duid": "RL:2CQC", "attribute": [], "entityType": "Trigger", "charEnd": 956, "source": "RLIMS-P", "charStart": 944, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}}, "mesh": ["Amino Acyl-tRNA Synthetases", "Escherichia coli", "Escherichia coli Proteins", "Gene Deletion", "Genetic Engineering", "Phosphoric Monoester Hydrolases", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Recombinant Proteins"], "relation": {"RL:97zQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:97bz"}], "duid": "RL:97zQ"}, "RL:Lyze": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Mnmm"}], "duid": "RL:Lyze"}, "RL:9mya": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yGW3"}], "duid": "RL:9mya"}, "RL:3uV9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:QqeQ"}, {"role": "TRIGGER", "entity_duid": "RL:i6P3"}], "duid": "RL:3uV9"}, "RL:TGct": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kKWG"}], "duid": "RL:TGct"}, "RL:DkWP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2CQC"}], "duid": "RL:DkWP"}, "RL:xHF6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LgHp"}], "duid": "RL:xHF6"}, "RL:XBEg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:R3Bz"}], "duid": "RL:XBEg"}, "RL:eyhJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sH9j"}], "duid": "RL:eyhJ"}, "RL:7h5b": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Vcoc"}], "duid": "RL:7h5b"}}, "type": ["Letter", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "18228327", "sentence": [{"charStart": 0, "charEnd": 26, "index": 0}, {"index": 1, "charEnd": 93, "charStart": 28}, {"index": 2, "charEnd": 204, "charStart": 95}, {"index": 3, "charEnd": 428, "charStart": 206}, {"index": 4, "charEnd": 523, "charStart": 430}], "text": "Phosphoamino acid analysis. Proteins involved in signal transduction are often phosphorylated. Determination of the specific amino acid residue(s) involved is used in characterizing the particular pathway. Partial acid hydrolysis of phosphorylated proteins followed by two-dimensional thin layer chromatography is used to identify the phosphorylated residues of the protein as phosphoserine, phosphothreonine, or phosphotyrosine. Mild alkaline hydrolysis is used to enhance detection of phosphothreonine and phosphotyrosine.", "title": {"charStart": 0, "charEnd": 26}, "entity": {"RL:VNrb": {"duid": "RL:VNrb", "attribute": [], "entityType": "Trigger", "charEnd": 348, "source": "RLIMS-P", "charStart": 335, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:UhVS": {"duid": "RL:UhVS", "attribute": [], "entityType": "Trigger", "charEnd": 389, "source": "RLIMS-P", "charStart": 377, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:EivT": {"duid": "RL:EivT", "attribute": [], "entityType": "Trigger", "charEnd": 246, "source": "RLIMS-P", "charStart": 233, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:TWkf": {"duid": "RL:TWkf", "attribute": [], "entityType": "Trigger", "charEnd": 92, "source": "RLIMS-P", "charStart": 79, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:Ybdw": {"duid": "RL:Ybdw", "attribute": [], "entityType": "Trigger", "charEnd": 502, "source": "RLIMS-P", "charStart": 487, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}}, "mesh": ["Animals", "Electrophoresis, Gel, Two-Dimensional", "Humans", "Hydrolysis", "Phosphoamino Acids", "Proteins"], "relation": {"RL:SF9F": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:EivT"}], "duid": "RL:SF9F"}, "RL:TVyW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UhVS"}], "duid": "RL:TVyW"}, "RL:7p8E": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ybdw"}], "duid": "RL:7p8E"}, "RL:gQsu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:VNrb"}], "duid": "RL:gQsu"}, "RL:StnY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TWkf"}], "duid": "RL:StnY"}}, "type": ["Journal Article"]}
{"docId": "15273693", "sentence": [{"charStart": 0, "charEnd": 100, "index": 0}, {"index": 1, "charEnd": 338, "charStart": 102}, {"index": 2, "charEnd": 462, "charStart": 340}, {"index": 3, "charEnd": 703, "charStart": 464}, {"index": 4, "charEnd": 799, "charStart": 705}, {"index": 5, "charEnd": 1082, "charStart": 801}, {"index": 6, "charEnd": 1291, "charStart": 1084}], "text": "Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint function. Using classical genetics to study modular phosphopeptide-binding domains within a family of proteins that are functionally redundant is difficult when other members of the domain family compensate for the product of the knocked-out gene. Here we describe a chemical genetics approach that overcomes this limitation by using UV-activatable caged phosphopeptides. By incorporating a caged phosphoserine residue within a consensus motif, these reagents simultaneously and synchronously inactivate all phosphoserine/phosphothreonine-binding domain family members in a rapid and temporally regulated manner. We applied this approach to study the global function of 14-3-3 proteins in cell cycle control. Activation of the caged phosphopeptides by UV irradiation displaced endogenous proteins from 14-3-3-binding, causing premature cell cycle entry, release of G1 cells from interphase arrest and loss of the S-phase checkpoint after DNA damage, accompanied by high levels of cell death. This class of reagents will greatly facilitate molecular dissection of kinase-dependent signaling pathways when applied to other phosphopeptide-binding domains including SH2, Polo-box and tandem BRCT domains.", "title": {"charStart": 0, "charEnd": 100}, "entity": {"RL:RwRJ": {"duid": "RL:RwRJ", "attribute": [], "entityType": "SiteOther", "charEnd": 461, "source": "RLIMS-P", "charStart": 447, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:nY2y": {"duid": "RL:nY2y", "attribute": [], "entityType": "SiteOther", "charEnd": 173, "source": "RLIMS-P", "charStart": 144, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide-binding domains"}, "RL:qD54": {"duid": "RL:qD54", "attribute": [], "entityType": "Trigger", "charEnd": 1226, "source": "RLIMS-P", "charStart": 1213, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide"}, "RL:ovzj": {"duid": "RL:ovzj", "attribute": [], "entityType": "SiteOther", "charEnd": 20, "source": "RLIMS-P", "charStart": 6, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:QYRv": {"duid": "RL:QYRv", "attribute": [], "entityType": "SiteOther", "charEnd": 839, "source": "RLIMS-P", "charStart": 825, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:JDpJ": {"duid": "RL:JDpJ", "attribute": [], "entityType": "Trigger", "charEnd": 461, "source": "RLIMS-P", "charStart": 447, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:YDBc": {"duid": "RL:YDBc", "attribute": [], "entityType": "Trigger", "charEnd": 157, "source": "RLIMS-P", "charStart": 144, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:FufL": {"duid": "RL:FufL", "attribute": [], "entityType": "Trigger", "charEnd": 501, "source": "RLIMS-P", "charStart": 489, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:oTPA": {"duid": "RL:oTPA", "attribute": [], "entityType": "Trigger", "charEnd": 612, "source": "RLIMS-P", "charStart": 600, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:hYxW": {"duid": "RL:hYxW", "attribute": [], "entityType": "Trigger", "charEnd": 839, "source": "RLIMS-P", "charStart": 825, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:ApmY": {"duid": "RL:ApmY", "attribute": [], "entityType": "SiteOther", "charEnd": 1242, "source": "RLIMS-P", "charStart": 1213, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide-binding domains"}, "RL:Ni8R": {"duid": "RL:Ni8R", "attribute": [], "entityType": "Trigger", "charEnd": 20, "source": "RLIMS-P", "charStart": 6, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:v3oJ": {"duid": "RL:v3oJ", "attribute": [], "entityType": "Protein", "charEnd": 1256, "source": "RLIMS-P", "charStart": 1254, "entityId": [], "sentenceIndex": 6, "entityText": "SH2"}}, "mesh": ["14-3-3 Proteins", "Apoptosis", "Cell Line, Tumor", "Cell Survival", "G1 Phase", "Humans", "Osteosarcoma", "Phosphopeptides", "Photochemistry", "Recombinant Proteins", "S Phase", "Signal Transduction", "Structure-Activity Relationship", "Time Factors", "Ultraviolet Rays"], "relation": {"RL:N5a7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nY2y"}, {"role": "TRIGGER", "entity_duid": "RL:YDBc"}], "duid": "RL:N5a7"}, "RL:7vb8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:RwRJ"}, {"role": "TRIGGER", "entity_duid": "RL:JDpJ"}], "duid": "RL:7vb8"}, "RL:sioA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:oTPA"}], "duid": "RL:sioA"}, "RL:8sHH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ovzj"}, {"role": "TRIGGER", "entity_duid": "RL:Ni8R"}], "duid": "RL:8sHH"}, "RL:TVKL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:QYRv"}, {"role": "TRIGGER", "entity_duid": "RL:hYxW"}], "duid": "RL:TVKL"}, "RL:cB4i": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:FufL"}], "duid": "RL:cB4i"}, "RL:LSgX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:v3oJ"}, {"role": "SITE_OTHER", "entity_duid": "RL:ApmY"}, {"role": "TRIGGER", "entity_duid": "RL:qD54"}], "duid": "RL:LSgX"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "1782219", "sentence": [{"charStart": 0, "charEnd": 230, "index": 0}, {"index": 1, "charEnd": 470, "charStart": 232}, {"index": 2, "charEnd": 666, "charStart": 472}, {"index": 3, "charEnd": 822, "charStart": 668}], "text": "Monovalent cation-dependent reversible phosphorylation of ribosomal protein S8 in growth arrested Tetrahymena: kinetics of formation, phosphoamino acids, and phosphopeptides of mono-, and diphosphorylated derivatives of protein S8. The kinetics of formation of mono-, and diphosphorylated derivatives of ribosomal protein S8 in Tetrahymena starving in the presence of Na+ have been determined, and the phosphoamino acids present in these derivatives have been identified. The mono-phosphorylated product, S8', contains only phosphoserine, and behaves kinetically as the precursor of the diphosphorylated product S8\" which contains phosphoserine, and phosphothreonine. Tryptic digestion release a single major phosphoserine containing peptide from both S8' and S8\", and a single phosphothreonine containing peptide from S8\".", "title": {"charStart": 0, "charEnd": 230}, "entity": {"RL:AawY": {"duid": "RL:AawY", "attribute": [], "entityType": "Trigger", "charEnd": 665, "source": "RLIMS-P", "charStart": 650, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:PzJ4": {"duid": "RL:PzJ4", "attribute": [], "entityType": "Trigger", "charEnd": 287, "source": "RLIMS-P", "charStart": 272, "entityId": [], "sentenceIndex": 1, "entityText": "diphosphorylated"}, "RL:CDbx": {"duid": "RL:CDbx", "attribute": [], "entityType": "Trigger", "charEnd": 53, "source": "RLIMS-P", "charStart": 39, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:wVEv": {"duid": "RL:wVEv", "attribute": [], "entityType": "Trigger", "charEnd": 536, "source": "RLIMS-P", "charStart": 524, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:RLxr": {"duid": "RL:RLxr", "attribute": [{"key": "std_site", "value": "Ser-8"}], "entityType": "Site", "charEnd": 77, "source": "RLIMS-P", "charStart": 76, "entityId": [], "sentenceIndex": 0, "entityText": "S8"}, "RL:GBhE": {"duid": "RL:GBhE", "attribute": [{"key": "std_site", "value": "Ser-8"}], "entityType": "Site", "charEnd": 323, "source": "RLIMS-P", "charStart": 322, "entityId": [], "sentenceIndex": 1, "entityText": "S8"}, "RL:SXNF": {"duid": "RL:SXNF", "attribute": [], "entityType": "Trigger", "charEnd": 721, "source": "RLIMS-P", "charStart": 709, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:5Pvq": {"duid": "RL:5Pvq", "attribute": [], "entityType": "Trigger", "charEnd": 793, "source": "RLIMS-P", "charStart": 778, "entityId": [], "sentenceIndex": 3, "entityText": "phosphothreonine"}, "RL:huwv": {"duid": "RL:huwv", "attribute": [], "entityType": "Trigger", "charEnd": 643, "source": "RLIMS-P", "charStart": 631, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:6bZw": {"duid": "RL:6bZw", "attribute": [], "entityType": "Trigger", "charEnd": 203, "source": "RLIMS-P", "charStart": 188, "entityId": [], "sentenceIndex": 0, "entityText": "diphosphorylated"}, "RL:MuZb": {"duid": "RL:MuZb", "attribute": [{"key": "std_site", "value": "Ser-8"}], "entityType": "Site", "charEnd": 229, "source": "RLIMS-P", "charStart": 228, "entityId": [], "sentenceIndex": 0, "entityText": "S8"}, "RL:ZnsL": {"duid": "RL:ZnsL", "attribute": [], "entityType": "SiteOther", "charEnd": 172, "source": "RLIMS-P", "charStart": 158, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:HA9r": {"duid": "RL:HA9r", "attribute": [], "entityType": "Trigger", "charEnd": 172, "source": "RLIMS-P", "charStart": 158, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "Animals", "Cations, Monovalent", "Kinetics", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Ribosomal Proteins", "Tetrahymena thermophila"], "relation": {"RL:We7w": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ZnsL"}, {"role": "TRIGGER", "entity_duid": "RL:HA9r"}], "duid": "RL:We7w"}, "RL:NK9r": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wVEv"}], "duid": "RL:NK9r"}, "RL:yAxT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5Pvq"}], "duid": "RL:yAxT"}, "RL:oquh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:GBhE"}, {"role": "TRIGGER", "entity_duid": "RL:PzJ4"}], "duid": "RL:oquh"}, "RL:RzPb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:RLxr"}, {"role": "TRIGGER", "entity_duid": "RL:CDbx"}], "duid": "RL:RzPb"}, "RL:BXUk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:AawY"}], "duid": "RL:BXUk"}, "RL:hm67": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:SXNF"}], "duid": "RL:hm67"}, "RL:q6i7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:huwv"}], "duid": "RL:q6i7"}, "RL:P8ZX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:MuZb"}, {"role": "TRIGGER", "entity_duid": "RL:6bZw"}], "duid": "RL:P8ZX"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "2431747", "sentence": [{"charStart": 0, "charEnd": 211, "index": 0}, {"index": 1, "charEnd": 380, "charStart": 213}, {"index": 2, "charEnd": 545, "charStart": 382}, {"index": 3, "charEnd": 640, "charStart": 547}, {"index": 4, "charEnd": 747, "charStart": 642}], "text": "Resolution and identification of O-phosphoserine, O-phosphothreonine, O-phosphotyrosine, and gamma-carboxyglutamic acid as their fluorescent o-phthalaldehyde derivatives by high performance liquid chromatography. High performance liquid chromatography was used to resolve O-phosphoserine, O-phosphothreonine, and O-phosphotyrosine as their fluorescent o-phthalaldehyde derivatives. By adjusting the buffer system, very small amounts of O-phosphothreonine could be detected and quantitated in the presence of very large amounts of O-phosphoserine. In addition, gamma-carboxyglutamic acid and glutamic acid were also separated and quantitated. Depending on the buffer used, various combinations of these amino acids could be resolved in a single run.", "title": {"charStart": 0, "charEnd": 211}, "entity": {"RL:C8JX": {"duid": "RL:C8JX", "attribute": [], "entityType": "Trigger", "charEnd": 47, "source": "RLIMS-P", "charStart": 33, "entityId": [], "sentenceIndex": 0, "entityText": "O-phosphoserine"}, "RL:vxAy": {"duid": "RL:vxAy", "attribute": [], "entityType": "Trigger", "charEnd": 286, "source": "RLIMS-P", "charStart": 272, "entityId": [], "sentenceIndex": 1, "entityText": "O-phosphoserine"}, "RL:V43G": {"duid": "RL:V43G", "attribute": [], "entityType": "Trigger", "charEnd": 453, "source": "RLIMS-P", "charStart": 436, "entityId": [], "sentenceIndex": 2, "entityText": "O-phosphothreonine"}, "RL:N8PF": {"duid": "RL:N8PF", "attribute": [], "entityType": "Trigger", "charEnd": 544, "source": "RLIMS-P", "charStart": 530, "entityId": [], "sentenceIndex": 2, "entityText": "O-phosphoserine"}}, "mesh": ["1-Carboxyglutamic Acid", "Animals", "Chromatography, High Pressure Liquid", "Fluorescent Dyes", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Serine", "Threonine", "Tyrosine", "o-Phthalaldehyde"], "relation": {"RL:tSee": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:C8JX"}], "duid": "RL:tSee"}, "RL:bqNy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:N8PF"}], "duid": "RL:bqNy"}, "RL:tTEa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:vxAy"}], "duid": "RL:tTEa"}, "RL:8BVm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:V43G"}], "duid": "RL:8BVm"}}, "type": ["Journal Article"]}
{"docId": "2989019", "sentence": [{"charStart": 0, "charEnd": 84, "index": 0}, {"index": 1, "charEnd": 263, "charStart": 86}, {"index": 2, "charEnd": 376, "charStart": 265}, {"index": 3, "charEnd": 746, "charStart": 378}, {"index": 4, "charEnd": 845, "charStart": 748}, {"index": 5, "charEnd": 1073, "charStart": 847}, {"index": 6, "charEnd": 1410, "charStart": 1075}, {"index": 7, "charEnd": 1634, "charStart": 1412}], "text": "Acid phosphatase and phosphoamino acid phosphatases in murine erythroleukaemic cells. The activities of acid and alkaline phosphatases and phosphotyrosine, phosphoserine and phosphothreonine phosphatases were measured in Friend murine erythroleukaemic (MEL) cells. The effects of treating the cells with dimethyl sulphoxide (DMSO), an inducer of differentiation, were examined. In untreated cells alkaline phosphatase activity was undetectable, though there were significant amounts of acid phosphatase (76 +/- 15 mU/mg protein) and phosphotyrosine phosphatase (16 +/- 0.9mU/mg protein); phosphoserine and phosphothreonine phosphatase activities (9 +/- 0.4 and 7 +/- 0.6mU/mg protein, respectively) were lower than for phosphotyrosine phosphatase. Addition of 1 or 2% DMSO to the culture medium resulted in the expected cell death within 2 weeks. With 0.5% DMSO, cells remained viable for at least 8 weeks, but while some appeared to have smaller nuclei and retained their rounded appearance, others became fibroblastic within several days and adhered to the culture vessel. The treated cells which had kept their morphology showed no difference in acid phosphatase activities as compared with untreated controls; phosphotyrosine phosphatase was lower (9 +/- 0.8mU/mg protein) and phosphoserine and phosphothreonine phophatases higher (11 +/- 0.5 and 10 +/- 0.4mU/mg protein, respectively) than in the controls. The Km values for p-nitrophenyl phosphate were similar in untreated and treated cells (0.069 and 0.068mM, respectively); for phosphotyrosine the Km value was lower in the treated cells (0.97mM) than in the controls (1.9mM).", "title": {"charStart": 0, "charEnd": 84}, "entity": {"RL:Gj7w": {"duid": "RL:Gj7w", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 168, "source": "RLIMS-P", "charStart": 163, "entityId": [], "sentenceIndex": 1, "entityText": "serine"}, "RL:umbB": {"duid": "RL:umbB", "attribute": [], "entityType": "Trigger", "charEnd": 1293, "source": "RLIMS-P", "charStart": 1281, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:aidZ": {"duid": "RL:aidZ", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 189, "source": "RLIMS-P", "charStart": 181, "entityId": [], "sentenceIndex": 1, "entityText": "threonine"}, "RL:KjsU": {"duid": "RL:KjsU", "attribute": [], "entityType": "Trigger", "charEnd": 547, "source": "RLIMS-P", "charStart": 533, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:3dQT": {"duid": "RL:3dQT", "attribute": [], "entityType": "Trigger", "charEnd": 733, "source": "RLIMS-P", "charStart": 719, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:hgXM": {"duid": "RL:hgXM", "attribute": [], "entityType": "Trigger", "charEnd": 153, "source": "RLIMS-P", "charStart": 139, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:KDhT": {"duid": "RL:KDhT", "attribute": [], "entityType": "Protein", "charEnd": 202, "source": "RLIMS-P", "charStart": 174, "entityId": [], "sentenceIndex": 1, "entityText": "phosphothreonine phosphatases"}, "RL:MDNU": {"duid": "RL:MDNU", "attribute": [], "entityType": "Trigger", "charEnd": 1551, "source": "RLIMS-P", "charStart": 1537, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosine"}, "RL:Ykuz": {"duid": "RL:Ykuz", "attribute": [], "entityType": "Trigger", "charEnd": 1228, "source": "RLIMS-P", "charStart": 1214, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:pn4N": {"duid": "RL:pn4N", "attribute": [], "entityType": "Trigger", "charEnd": 600, "source": "RLIMS-P", "charStart": 588, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:nMak": {"duid": "RL:nMak", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 153, "source": "RLIMS-P", "charStart": 146, "entityId": [], "sentenceIndex": 1, "entityText": "tyrosine"}, "RL:ySu9": {"duid": "RL:ySu9", "attribute": [], "entityType": "Trigger", "charEnd": 32, "source": "RLIMS-P", "charStart": 21, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoamino"}, "RL:hvQT": {"duid": "RL:hvQT", "attribute": [], "entityType": "Trigger", "charEnd": 168, "source": "RLIMS-P", "charStart": 156, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}}, "mesh": ["Acid Phosphatase", "Animals", "Cell Line", "Cell Survival", "Dimethyl Sulfoxide", "Friend murine leukemia virus", "Kinetics", "Leukemia, Erythroblastic, Acute", "Mice", "Phosphoprotein Phosphatases", "Phosphoric Monoester Hydrolases", "Protein Tyrosine Phosphatases"], "relation": {"RL:ieJk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:KDhT"}, {"role": "SITE", "entity_duid": "RL:nMak"}, {"role": "SITE", "entity_duid": "RL:aidZ"}, {"role": "SITE", "entity_duid": "RL:Gj7w"}, {"role": "TRIGGER", "entity_duid": "RL:hgXM"}], "duid": "RL:ieJk"}, "RL:qSDk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:KjsU"}], "duid": "RL:qSDk"}, "RL:7pnZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:pn4N"}], "duid": "RL:7pnZ"}, "RL:toP4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ySu9"}], "duid": "RL:toP4"}, "RL:2Gkn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:umbB"}], "duid": "RL:2Gkn"}, "RL:ndiB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:KDhT"}, {"role": "SITE", "entity_duid": "RL:Gj7w"}, {"role": "TRIGGER", "entity_duid": "RL:hvQT"}], "duid": "RL:ndiB"}, "RL:5j7T": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:3dQT"}], "duid": "RL:5j7T"}, "RL:dU84": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:MDNU"}], "duid": "RL:dU84"}, "RL:iGh8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ykuz"}], "duid": "RL:iGh8"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "18429115", "sentence": [{"charStart": 0, "charEnd": 26, "index": 0}, {"index": 1, "charEnd": 100, "charStart": 28}, {"index": 2, "charEnd": 309, "charStart": 102}, {"index": 3, "charEnd": 418, "charStart": 311}, {"index": 4, "charEnd": 585, "charStart": 420}], "text": "Phosphoamino acid analysis. It is often valuable to identify the phosphorylated residue in a protein. This unit presents a protocol for partial acid hydrolysis of proteins phosphorylated at serine, threonine, or tyrosine, followed by two-dimensional thin-layer electrophoresis of the labeled phosphoamino acid. Phosphothreonine and phosphotyrosine are more stable to hydrolysis in alkali than are RNA and phosphoserine. Therefore, an alternate procedure using mild alkaline hydrolysis of protein samples to enhance the detection of phosphothreonine and phosphotyrosine is also provided.", "title": {"charStart": 0, "charEnd": 26}, "entity": {"RL:N4jk": {"duid": "RL:N4jk", "attribute": [], "entityType": "Trigger", "charEnd": 185, "source": "RLIMS-P", "charStart": 172, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:5T7X": {"duid": "RL:5T7X", "attribute": [], "entityType": "Trigger", "charEnd": 547, "source": "RLIMS-P", "charStart": 532, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:Hbrk": {"duid": "RL:Hbrk", "attribute": [], "entityType": "SiteOther", "charEnd": 86, "source": "RLIMS-P", "charStart": 80, "entityId": [], "sentenceIndex": 1, "entityText": "residue"}, "RL:jiFK": {"duid": "RL:jiFK", "attribute": [], "entityType": "Trigger", "charEnd": 417, "source": "RLIMS-P", "charStart": 405, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:hXZY": {"duid": "RL:hXZY", "attribute": [], "entityType": "Trigger", "charEnd": 78, "source": "RLIMS-P", "charStart": 65, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:7vj4": {"duid": "RL:7vj4", "attribute": [], "entityType": "Trigger", "charEnd": 326, "source": "RLIMS-P", "charStart": 311, "entityId": [], "sentenceIndex": 3, "entityText": "Phosphothreonine"}}, "mesh": ["Alkalies", "Blotting, Western", "Electrophoresis, Gel, Two-Dimensional", "Hydrogen-Ion Concentration", "Hydrolysis", "Phosphoamino Acids", "Phosphothreonine", "Phosphotyrosine"], "relation": {"RL:avsu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jiFK"}], "duid": "RL:avsu"}, "RL:HxPH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7vj4"}], "duid": "RL:HxPH"}, "RL:NQjd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Hbrk"}, {"role": "TRIGGER", "entity_duid": "RL:hXZY"}], "duid": "RL:NQjd"}, "RL:hiTP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:N4jk"}], "duid": "RL:hiTP"}, "RL:XhC9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5T7X"}], "duid": "RL:XhC9"}}, "type": ["Journal Article"]}
{"docId": "24768166", "sentence": [{"charStart": 0, "charEnd": 173, "index": 0}, {"index": 1, "charEnd": 449, "charStart": 175}, {"index": 2, "charEnd": 688, "charStart": 451}, {"index": 3, "charEnd": 853, "charStart": 690}], "text": "Development of caged non-hydrolyzable phosphoamino acids and application to photo-control of binding affinity of phosphopeptide mimetic to phosphopeptide-recognizing protein. The design and synthesis of caged non-hydrolyzable phospho-serine, -threonine, and -tyrosine derivatives that generate parent non-hydrolyzable phosphoamino acids, containing a difluoromethylene unit instead of the oxygen of a phosphoester, after UV-irradiation are described. The caged non-hydrolyzable amino acids were incorporated into peptides by standard Fmoc solid-phase peptide synthesis, and the obtained peptides were successfully converted to the parent non-hydrolyzable phosphopeptides by UV-irradiation. Application of the caged non-hydrolyzable phosphoserine-containing peptide to photo-control the binding affinity of the peptide to 14-3-3\u03b2 protein is also reported.", "title": {"charStart": 0, "charEnd": 173}, "entity": {"RL:kbXa": {"duid": "RL:kbXa", "attribute": [], "entityType": "SiteOther", "charEnd": 152, "source": "RLIMS-P", "charStart": 139, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptide"}, "RL:itAD": {"duid": "RL:itAD", "attribute": [], "entityType": "SiteOther", "charEnd": 669, "source": "RLIMS-P", "charStart": 655, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:7V2n": {"duid": "RL:7V2n", "attribute": [], "entityType": "Trigger", "charEnd": 744, "source": "RLIMS-P", "charStart": 732, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:6T89": {"duid": "RL:6T89", "attribute": [], "entityType": "Trigger", "charEnd": 126, "source": "RLIMS-P", "charStart": 113, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptide"}, "RL:PbcZ": {"duid": "RL:PbcZ", "attribute": [], "entityType": "Trigger", "charEnd": 152, "source": "RLIMS-P", "charStart": 139, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptide"}, "RL:J8fD": {"duid": "RL:J8fD", "attribute": [], "entityType": "SiteOther", "charEnd": 126, "source": "RLIMS-P", "charStart": 113, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptide"}, "RL:BbVA": {"duid": "RL:BbVA", "attribute": [], "entityType": "Trigger", "charEnd": 669, "source": "RLIMS-P", "charStart": 655, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:5s6p": {"duid": "RL:5s6p", "attribute": [], "entityType": "Trigger", "charEnd": 239, "source": "RLIMS-P", "charStart": 226, "entityId": [], "sentenceIndex": 1, "entityText": "phospho-serine"}}, "mesh": ["14-3-3 Proteins", "Phosphoamino Acids", "Phosphopeptides", "Photochemical Processes", "Ultraviolet Rays"], "relation": {"RL:rdA6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5s6p"}], "duid": "RL:rdA6"}, "RL:ojvy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:J8fD"}, {"role": "TRIGGER", "entity_duid": "RL:6T89"}], "duid": "RL:ojvy"}, "RL:w2wk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kbXa"}, {"role": "TRIGGER", "entity_duid": "RL:PbcZ"}], "duid": "RL:w2wk"}, "RL:mQk6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:itAD"}, {"role": "TRIGGER", "entity_duid": "RL:BbVA"}], "duid": "RL:mQk6"}, "RL:U24m": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7V2n"}], "duid": "RL:U24m"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "19819166", "sentence": [{"charStart": 0, "charEnd": 116, "index": 0}, {"index": 1, "charEnd": 448, "charStart": 118}, {"index": 2, "charEnd": 606, "charStart": 450}, {"index": 3, "charEnd": 707, "charStart": 608}, {"index": 4, "charEnd": 849, "charStart": 709}, {"index": 5, "charEnd": 962, "charStart": 851}], "text": "Time-resolved observation of product ions generated by 157 nm photodissociation of singly protonated phosphopeptides. Vacuum UV photodissociation tandem mass spectra of singly charged arginine-terminated phosphopeptides were recorded at times ranging from 300 ns to ms after photoexcitation, to investigate when the phosphate group falls off from the precursor and product ions and whether loss of phosphate can be eliminated in tandem mass spectra. For peptide ions containing phosphoserine and phosphothreonine, little loss of 98 Da from the product ions was observed up to 1 micros after photoexcitation. However, neutral losses from the precursor ions were considerable just 300 ns after photoactivation. Loss of 98 Da from product ions first appears about 1 micros after laser irradiation and becomes more common 13 micros after photoexcitation. Consistent with previous reports, phosphotyrosine was more stable than either phosphoserine or phosphothreonine.", "title": {"charStart": 0, "charEnd": 116}, "entity": {"RL:3Bvt": {"duid": "RL:3Bvt", "attribute": [], "entityType": "Trigger", "charEnd": 899, "source": "RLIMS-P", "charStart": 885, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:tKiQ": {"duid": "RL:tKiQ", "attribute": [], "entityType": "Trigger", "charEnd": 941, "source": "RLIMS-P", "charStart": 929, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:qaYn": {"duid": "RL:qaYn", "attribute": [], "entityType": "SiteOther", "charEnd": 218, "source": "RLIMS-P", "charStart": 204, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:5993": {"duid": "RL:5993", "attribute": [], "entityType": "Trigger", "charEnd": 115, "source": "RLIMS-P", "charStart": 101, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:oYed": {"duid": "RL:oYed", "attribute": [], "entityType": "Trigger", "charEnd": 218, "source": "RLIMS-P", "charStart": 204, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:zTf6": {"duid": "RL:zTf6", "attribute": [], "entityType": "Trigger", "charEnd": 490, "source": "RLIMS-P", "charStart": 478, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:aeLU": {"duid": "RL:aeLU", "attribute": [], "entityType": "SiteOther", "charEnd": 115, "source": "RLIMS-P", "charStart": 101, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Ions", "Models, Chemical", "Phosphopeptides", "Protons", "Radiation Dosage", "Spectrometry, Mass, Electrospray Ionization", "Ultraviolet Rays"], "relation": {"RL:Axzk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zTf6"}], "duid": "RL:Axzk"}, "RL:nvJZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:3Bvt"}], "duid": "RL:nvJZ"}, "RL:K8mE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:qaYn"}, {"role": "TRIGGER", "entity_duid": "RL:oYed"}], "duid": "RL:K8mE"}, "RL:xsHs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tKiQ"}], "duid": "RL:xsHs"}, "RL:bwEb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:aeLU"}, {"role": "TRIGGER", "entity_duid": "RL:5993"}], "duid": "RL:bwEb"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "8394059", "sentence": [{"charStart": 0, "charEnd": 72, "index": 0}, {"index": 1, "charEnd": 206, "charStart": 74}, {"index": 2, "charEnd": 301, "charStart": 208}, {"index": 3, "charEnd": 554, "charStart": 303}, {"index": 4, "charEnd": 706, "charStart": 556}, {"index": 5, "charEnd": 919, "charStart": 708}, {"index": 6, "charEnd": 1136, "charStart": 921}, {"index": 7, "charEnd": 1335, "charStart": 1138}], "text": "Phosphopeptides as substrates for thylakoid protein phosphatase activity. Lack of a suitable substrate has been a major obstacle in studying the chloroplastic thylakoid membrane protein phosphatase activity. In this study, the suitability of synthetic phosphopeptides for this purpose was investigated. Phosphothreonine-containing phosphopeptides mimicking the N-terminal phosphorylation site of the major thylakoid phosphoprotein, the light-harvesting chlorophyll a/b-binding protein (LHCP-II), were dephosphorylated by isolated peak thylakoid membranes. Phosphopeptides representing unrelated sequences or in which the target phosphothreonine had been changed to a phosphoserine were not dephosphorylated. The dephosphorylation of phosphopeptides by thylakoid membranes was similar to the dephosphorylation of endogenous LHCP-II in its pH-dependence profile, sensitivity to inhibitors, and bivalent cation requirement. The same phosphopeptide analogs of the LHCP-II phosphorylation site inhibited endogenous LHCP-II dephosphorylation in isolated thylakoids, whereas the dephospho-analogs and nonsubstrate phosphopeptides had no effect. Collectively, these results suggest that phosphopeptides mimicking a thylakoid phosphoprotein dephosphorylation site can be exploited for further study of the thylakoid protein phosphatase activity.", "title": {"charStart": 0, "charEnd": 72}, "entity": {"RL:ThjL": {"duid": "RL:ThjL", "attribute": [], "entityType": "Trigger", "charEnd": 429, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoprotein"}, "RL:xaga": {"duid": "RL:xaga", "attribute": [], "entityType": "SiteOther", "charEnd": 370, "source": "RLIMS-P", "charStart": 361, "entityId": [], "sentenceIndex": 3, "entityText": "N-terminal"}, "RL:VEKa": {"duid": "RL:VEKa", "attribute": [], "entityType": "Trigger", "charEnd": 747, "source": "RLIMS-P", "charStart": 733, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:ta4S": {"duid": "RL:ta4S", "attribute": [], "entityType": "Trigger", "charEnd": 1121, "source": "RLIMS-P", "charStart": 1107, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:7Jck": {"duid": "RL:7Jck", "attribute": [], "entityType": "Protein", "charEnd": 493, "source": "RLIMS-P", "charStart": 436, "entityId": [], "sentenceIndex": 3, "entityText": "light-harvesting chlorophyll a/b-binding protein (LHCP-II)"}, "RL:dvGa": {"duid": "RL:dvGa", "attribute": [], "entityType": "Trigger", "charEnd": 266, "source": "RLIMS-P", "charStart": 252, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:xDz5": {"duid": "RL:xDz5", "attribute": [], "entityType": "SiteOther", "charEnd": 391, "source": "RLIMS-P", "charStart": 361, "entityId": [], "sentenceIndex": 3, "entityText": "N-terminal phosphorylation site"}, "RL:4tye": {"duid": "RL:4tye", "attribute": [], "entityType": "Trigger", "charEnd": 982, "source": "RLIMS-P", "charStart": 968, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:2sBD": {"duid": "RL:2sBD", "attribute": [], "entityType": "SiteOther", "charEnd": 570, "source": "RLIMS-P", "charStart": 556, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}, "RL:wWYZ": {"duid": "RL:wWYZ", "attribute": [], "entityType": "SiteOther", "charEnd": 747, "source": "RLIMS-P", "charStart": 733, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:S78t": {"duid": "RL:S78t", "attribute": [], "entityType": "Trigger", "charEnd": 1193, "source": "RLIMS-P", "charStart": 1179, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:4uCs": {"duid": "RL:4uCs", "attribute": [], "entityType": "Trigger", "charEnd": 345, "source": "RLIMS-P", "charStart": 331, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:g5wo": {"duid": "RL:g5wo", "attribute": [], "entityType": "Trigger", "charEnd": 626, "source": "RLIMS-P", "charStart": 621, "entityId": [], "sentenceIndex": 4, "entityText": "target"}, "RL:q2f7": {"duid": "RL:q2f7", "attribute": [], "entityType": "SiteOther", "charEnd": 14, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptides"}, "RL:bX5T": {"duid": "RL:bX5T", "attribute": [], "entityType": "SiteOther", "charEnd": 266, "source": "RLIMS-P", "charStart": 252, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:tpaA": {"duid": "RL:tpaA", "attribute": [], "entityType": "Trigger", "charEnd": 386, "source": "RLIMS-P", "charStart": 372, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:QNe3": {"duid": "RL:QNe3", "attribute": [], "entityType": "SiteOther", "charEnd": 345, "source": "RLIMS-P", "charStart": 331, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:DvvP": {"duid": "RL:DvvP", "attribute": [], "entityType": "SiteOther", "charEnd": 1121, "source": "RLIMS-P", "charStart": 1107, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:C3pP": {"duid": "RL:C3pP", "attribute": [], "entityType": "Trigger", "charEnd": 14, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptides"}, "RL:UuGj": {"duid": "RL:UuGj", "attribute": [], "entityType": "Trigger", "charEnd": 679, "source": "RLIMS-P", "charStart": 667, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:kRFa": {"duid": "RL:kRFa", "attribute": [], "entityType": "SiteOther", "charEnd": 987, "source": "RLIMS-P", "charStart": 960, "entityId": [], "sentenceIndex": 6, "entityText": "LHCP-II phosphorylation site"}, "RL:SLvK": {"duid": "RL:SLvK", "attribute": [], "entityType": "SiteOther", "charEnd": 1193, "source": "RLIMS-P", "charStart": 1179, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Htco": {"duid": "RL:Htco", "attribute": [], "entityType": "Trigger", "charEnd": 1230, "source": "RLIMS-P", "charStart": 1217, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoprotein"}, "RL:SX9n": {"duid": "RL:SX9n", "attribute": [], "entityType": "Trigger", "charEnd": 570, "source": "RLIMS-P", "charStart": 556, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "Cations, Divalent", "Cell Compartmentation", "Chloroplasts", "Fabaceae", "Hydrogen-Ion Concentration", "Intracellular Membranes", "Light-Harvesting Protein Complexes", "Molecular Sequence Data", "Phosphopeptides", "Phosphoprotein Phosphatases", "Phosphorylation", "Photosynthetic Reaction Center Complex Proteins", "Plants, Medicinal", "Substrate Specificity"], "relation": {"RL:BkeC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:SLvK"}, {"role": "TRIGGER", "entity_duid": "RL:S78t"}], "duid": "RL:BkeC"}, "RL:TFbx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UuGj"}], "duid": "RL:TFbx"}, "RL:igKb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:7Jck"}, {"role": "SITE_OTHER", "entity_duid": "RL:xDz5"}, {"role": "TRIGGER", "entity_duid": "RL:ThjL"}], "duid": "RL:igKb"}, "RL:zF8d": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:xDz5"}, {"role": "SITE_OTHER", "entity_duid": "RL:xaga"}, {"role": "TRIGGER", "entity_duid": "RL:tpaA"}], "duid": "RL:zF8d"}, "RL:soYk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2sBD"}, {"role": "TRIGGER", "entity_duid": "RL:SX9n"}], "duid": "RL:soYk"}, "RL:benm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:QNe3"}, {"role": "TRIGGER", "entity_duid": "RL:4uCs"}], "duid": "RL:benm"}, "RL:dmgk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:bX5T"}, {"role": "TRIGGER", "entity_duid": "RL:dvGa"}], "duid": "RL:dmgk"}, "RL:qBhe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:DvvP"}, {"role": "TRIGGER", "entity_duid": "RL:ta4S"}], "duid": "RL:qBhe"}, "RL:DAXv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:q2f7"}, {"role": "TRIGGER", "entity_duid": "RL:C3pP"}], "duid": "RL:DAXv"}, "RL:xsyR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:g5wo"}], "duid": "RL:xsyR"}, "RL:veUq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Htco"}], "duid": "RL:veUq"}, "RL:Q8mx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:wWYZ"}, {"role": "TRIGGER", "entity_duid": "RL:VEKa"}], "duid": "RL:Q8mx"}, "RL:Y2fm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kRFa"}, {"role": "TRIGGER", "entity_duid": "RL:4tye"}], "duid": "RL:Y2fm"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "17073441", "sentence": [{"charStart": 0, "charEnd": 101, "index": 0}, {"index": 1, "charEnd": 305, "charStart": 103}, {"index": 2, "charEnd": 407, "charStart": 307}, {"index": 3, "charEnd": 501, "charStart": 409}, {"index": 4, "charEnd": 611, "charStart": 503}, {"index": 5, "charEnd": 837, "charStart": 613}, {"index": 6, "charEnd": 1017, "charStart": 839}, {"index": 7, "charEnd": 1087, "charStart": 1019}, {"index": 8, "charEnd": 1250, "charStart": 1089}, {"index": 9, "charEnd": 1430, "charStart": 1252}, {"index": 10, "charEnd": 1598, "charStart": 1432}], "text": "Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1. The wild-type p53-induced phosphatase, Wip1 (PP2Cdelta or PPM1D) is a member of the protein phosphatase 2C (PP2C) family and functions as a negative regulator of the p38 MAP kinase-p53 signaling pathway. PPM1D is amplified or Wip1 is overexpressed in several human cancers, and it acts as a weak oncogene. Although inhibition of Wip1 may have therapeutic value, no specific inhibitors are available. In this study, we designed phosphopeptide inhibitors for Wip1 on the basis of its optimal substrate sequence. We found that phosphoserine-containing diphosphorylated peptides with the sequence pSXpY inhibited Wip1 phosphatase activity, whereas phosphothreonine-containing peptides with the sequence pTXpY were physiological substrates. Moreover, the X residue in the pSXpY sequence modulated inhibitor activity, and beta-branched amino acid-substituted (Ile or Val) phosphopeptides showed high inhibitory potencies. A thioether cyclic phosphopeptide c(MpSIpYVA) had a K(i) <1.0 microM. Two serine/threonine phosphatases, PP2Calpha and PP2A, were not significantly inhibited by the cyclic phosphopeptide with a nonhydrolyzable phosphoserine mimetic. A homology model of Wip1 bound to a cyclic phosphopeptide and site-directed mutagenesis helped to identify residues important for Wip1 inhibitor selectivity among the PP2C family. These results provide the first proof of concept of a specific inhibitor of the catalytic site of Wip1 and should be useful for developing potential anti-cancer drugs.", "title": {"charStart": 0, "charEnd": 101}, "entity": {"RL:Wghi": {"duid": "RL:Wghi", "attribute": [], "entityType": "Trigger", "charEnd": 983, "source": "RLIMS-P", "charStart": 969, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:kDzg": {"duid": "RL:kDzg", "attribute": [], "entityType": "Trigger", "charEnd": 1241, "source": "RLIMS-P", "charStart": 1229, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:xD3J": {"duid": "RL:xD3J", "attribute": [], "entityType": "Protein", "charEnd": 727, "source": "RLIMS-P", "charStart": 712, "entityId": [], "sentenceIndex": 5, "entityText": "Wip1 phosphatase"}, "RL:mGXf": {"duid": "RL:mGXf", "attribute": [], "entityType": "Trigger", "charEnd": 1204, "source": "RLIMS-P", "charStart": 1191, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:QznB": {"duid": "RL:QznB", "attribute": [], "entityType": "SiteOther", "charEnd": 983, "source": "RLIMS-P", "charStart": 969, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:wiph": {"duid": "RL:wiph", "attribute": [], "entityType": "SiteOther", "charEnd": 1204, "source": "RLIMS-P", "charStart": 1191, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:74hp": {"duid": "RL:74hp", "attribute": [], "entityType": "Trigger", "charEnd": 543, "source": "RLIMS-P", "charStart": 530, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:4Qen": {"duid": "RL:4Qen", "attribute": [], "entityType": "Trigger", "charEnd": 639, "source": "RLIMS-P", "charStart": 627, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:Mm65": {"duid": "RL:Mm65", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 639, "source": "RLIMS-P", "charStart": 634, "entityId": [], "sentenceIndex": 5, "entityText": "serine"}, "RL:Ncr7": {"duid": "RL:Ncr7", "attribute": [], "entityType": "SiteOther", "charEnd": 959, "source": "RLIMS-P", "charStart": 957, "entityId": [], "sentenceIndex": 6, "entityText": "Ile"}, "RL:6SsA": {"duid": "RL:6SsA", "attribute": [], "entityType": "Trigger", "charEnd": 762, "source": "RLIMS-P", "charStart": 747, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:8bzL": {"duid": "RL:8bzL", "attribute": [], "entityType": "Trigger", "charEnd": 53, "source": "RLIMS-P", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptide"}, "RL:vnHq": {"duid": "RL:vnHq", "attribute": [], "entityType": "SiteOther", "charEnd": 966, "source": "RLIMS-P", "charStart": 964, "entityId": [], "sentenceIndex": 6, "entityText": "Val"}}, "mesh": ["Amino Acid Sequence", "Catalytic Domain", "Circular Dichroism", "Enzyme Inhibitors", "Humans", "Models, Molecular", "Molecular Sequence Data", "Nuclear Magnetic Resonance, Biomolecular", "Phosphopeptides", "Phosphoprotein Phosphatases", "Protein Phosphatase 2C", "Substrate Specificity"], "relation": {"RL:N8pH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:74hp"}], "duid": "RL:N8pH"}, "RL:Spfq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:6SsA"}], "duid": "RL:Spfq"}, "RL:gi3Q": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kDzg"}], "duid": "RL:gi3Q"}, "RL:4diY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:wiph"}, {"role": "TRIGGER", "entity_duid": "RL:mGXf"}], "duid": "RL:4diY"}, "RL:UNeg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:8bzL"}], "duid": "RL:UNeg"}, "RL:Qmtk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Ncr7"}, {"role": "SITE_OTHER", "entity_duid": "RL:QznB"}, {"role": "SITE_OTHER", "entity_duid": "RL:vnHq"}, {"role": "TRIGGER", "entity_duid": "RL:Wghi"}], "duid": "RL:Qmtk"}, "RL:xCTE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:xD3J"}, {"role": "SITE", "entity_duid": "RL:Mm65"}, {"role": "TRIGGER", "entity_duid": "RL:4Qen"}], "duid": "RL:xCTE"}}, "type": ["Journal Article", "Research Support, N.I.H., Intramural", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "11006587", "sentence": [{"charStart": 0, "charEnd": 76, "index": 0}, {"index": 1, "charEnd": 329, "charStart": 78}, {"index": 2, "charEnd": 503, "charStart": 331}, {"index": 3, "charEnd": 579, "charStart": 505}, {"index": 4, "charEnd": 613, "charStart": 580}, {"index": 5, "charEnd": 723, "charStart": 615}, {"index": 6, "charEnd": 778, "charStart": 725}, {"index": 7, "charEnd": 959, "charStart": 780}, {"index": 8, "charEnd": 1146, "charStart": 961}], "text": "Electron capture dissociation of singly and multiply phosphorylated peptides. Analysis of phosphotyrosine and phosphoserine containing peptides by nano-electrospray Fourier transform ion cyclotron resonance (FTICR) mass spectrometry established electron capture dissociation (ECD) as a viable method for phosphopeptide sequencing. In general, ECD spectra of synthetic and native phosphopeptides appeared less complex than conventional collision activated dissociation (CAD) mass spectra of these species. ECD of multiply protonated phosphopeptide ions generated mainly c- and z(.)-type peptide fragment ion series. No loss of water, phosphate groups or phosphoric acid from intact phosphopeptide ions nor from the c and z(.) fragment ion products was observed in the ECD spectra. ECD enabled complete or near-complete amino acid sequencing of phosphopeptides for the assignment of up to four phosphorylation sites in peptides in the mass range 1400 to 3500 Da. Nano-scale Fe(III)-affinity chromatography combined with nano-electrospray FTMS/ECD facilitated phosphopeptide analysis and amino acid sequencing from crude proteolytic peptide mixtures.", "title": {"charStart": 0, "charEnd": 76}, "entity": {"RL:RW4N": {"duid": "RL:RW4N", "attribute": [], "entityType": "Trigger", "charEnd": 1070, "source": "RLIMS-P", "charStart": 1057, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:Dkxd": {"duid": "RL:Dkxd", "attribute": [], "entityType": "Trigger", "charEnd": 317, "source": "RLIMS-P", "charStart": 304, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:3zjZ": {"duid": "RL:3zjZ", "attribute": [], "entityType": "Trigger", "charEnd": 393, "source": "RLIMS-P", "charStart": 379, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:cSqs": {"duid": "RL:cSqs", "attribute": [], "entityType": "SiteOther", "charEnd": 912, "source": "RLIMS-P", "charStart": 892, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation sites"}, "RL:tDF7": {"duid": "RL:tDF7", "attribute": [], "entityType": "Trigger", "charEnd": 906, "source": "RLIMS-P", "charStart": 892, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:UVpe": {"duid": "RL:UVpe", "attribute": [], "entityType": "SiteOther", "charEnd": 75, "source": "RLIMS-P", "charStart": 68, "entityId": [], "sentenceIndex": 0, "entityText": "peptides"}, "RL:M9qc": {"duid": "RL:M9qc", "attribute": [], "entityType": "SiteOther", "charEnd": 924, "source": "RLIMS-P", "charStart": 917, "entityId": [], "sentenceIndex": 7, "entityText": "peptides"}, "RL:9Bej": {"duid": "RL:9Bej", "attribute": [], "entityType": "SiteOther", "charEnd": 857, "source": "RLIMS-P", "charStart": 843, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:bWZ7": {"duid": "RL:bWZ7", "attribute": [], "entityType": "Trigger", "charEnd": 857, "source": "RLIMS-P", "charStart": 843, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:WkBc": {"duid": "RL:WkBc", "attribute": [], "entityType": "SiteOther", "charEnd": 393, "source": "RLIMS-P", "charStart": 379, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:mMAW": {"duid": "RL:mMAW", "attribute": [], "entityType": "SiteOther", "charEnd": 1070, "source": "RLIMS-P", "charStart": 1057, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:4gwo": {"duid": "RL:4gwo", "attribute": [], "entityType": "Trigger", "charEnd": 66, "source": "RLIMS-P", "charStart": 53, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:v6Hm": {"duid": "RL:v6Hm", "attribute": [], "entityType": "SiteOther", "charEnd": 1094, "source": "RLIMS-P", "charStart": 1085, "entityId": [], "sentenceIndex": 8, "entityText": "amino acid"}, "RL:yNDo": {"duid": "RL:yNDo", "attribute": [], "entityType": "Trigger", "charEnd": 104, "source": "RLIMS-P", "charStart": 90, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:EXPC": {"duid": "RL:EXPC", "attribute": [], "entityType": "SiteOther", "charEnd": 317, "source": "RLIMS-P", "charStart": 304, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}}, "mesh": ["Amino Acid Sequence", "Animals", "Caseins", "Cattle", "Chromatography, Affinity", "Fourier Analysis", "Mass Spectrometry", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphotyrosine"], "relation": {"RL:QEmC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:EXPC"}, {"role": "TRIGGER", "entity_duid": "RL:Dkxd"}], "duid": "RL:QEmC"}, "RL:XTGm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:UVpe"}, {"role": "TRIGGER", "entity_duid": "RL:4gwo"}], "duid": "RL:XTGm"}, "RL:w5BV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:9Bej"}, {"role": "TRIGGER", "entity_duid": "RL:bWZ7"}], "duid": "RL:w5BV"}, "RL:YFq6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:WkBc"}, {"role": "TRIGGER", "entity_duid": "RL:3zjZ"}], "duid": "RL:YFq6"}, "RL:MNGG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yNDo"}], "duid": "RL:MNGG"}, "RL:ZdgY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mMAW"}, {"role": "SITE_OTHER", "entity_duid": "RL:v6Hm"}, {"role": "TRIGGER", "entity_duid": "RL:RW4N"}], "duid": "RL:ZdgY"}, "RL:gADe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:cSqs"}, {"role": "SITE_OTHER", "entity_duid": "RL:M9qc"}, {"role": "TRIGGER", "entity_duid": "RL:tDF7"}], "duid": "RL:gADe"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "12237455", "sentence": [{"charStart": 0, "charEnd": 94, "index": 0}, {"index": 1, "charEnd": 195, "charStart": 96}, {"index": 2, "charEnd": 371, "charStart": 197}, {"index": 3, "charEnd": 518, "charStart": 373}, {"index": 4, "charEnd": 651, "charStart": 520}, {"index": 5, "charEnd": 779, "charStart": 653}, {"index": 6, "charEnd": 867, "charStart": 781}, {"index": 7, "charEnd": 969, "charStart": 869}, {"index": 8, "charEnd": 1187, "charStart": 971}, {"index": 9, "charEnd": 1388, "charStart": 1189}, {"index": 10, "charEnd": 1514, "charStart": 1390}], "text": "The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. The activity of protein tyrosine phosphatases (PTPs) is restricted by their substrate specificities. The analysis of PTP specificity was greatly helped by the discovery that \"substrate-trapping\" PTP mutants, such as PTP-1B D181A, stably and specifically bind their substrates. We have set up a PTP substrate specificity assay based on the SPOT technique, which involves the microsynthesis of (phospho)peptides on membranes. To validate this approach, substrate trapping PTP-1B was tested on its cognate ligand, the autophosphorylated insulin receptor (IR). On SPOT membranes, IR peptides with phosphotyrosine 1163 were efficiently bound by PTP1B D181A, and dephosphorylated by PTP-1B. Phosphotyrosine 1163 was preferred over the neighboring 1158 and 1162 phosphotyrosines. PTP-1B also recognized IR-like motifs in Trk autophosphorylation domains, and STAT 5 phosphopeptides. Using a gridded 20-by-20 SPOT library, we show that peptides with the YZM motif (Z: phosphotyrosine) are the strongest ligands for PTP-1B D181A, but not the optimal substrates for dephosphorylation by wild-type PTP1B. In addition we show that PTP-1B and PTP-beta dephosphorylation efficiency is strongly modulated by the introduction of phospho-serine or phospho-threonine in their cognate phospho-tyrosine substrates. Altogether our data illustrate that the SPOT technique is a highly efficient tool for the study of PTP substrate specificity.", "title": {"charStart": 0, "charEnd": 94}, "entity": {"RL:mAGu": {"duid": "RL:mAGu", "attribute": [], "entityType": "Protein", "charEnd": 650, "source": "RLIMS-P", "charStart": 630, "entityId": [], "sentenceIndex": 4, "entityText": "insulin receptor (IR)"}, "RL:VKQo": {"duid": "RL:VKQo", "attribute": [], "entityType": "Protein", "charEnd": 912, "source": "RLIMS-P", "charStart": 910, "entityId": [], "sentenceIndex": 7, "entityText": "Trk"}, "RL:k39r": {"duid": "RL:k39r", "attribute": [], "entityType": "SiteOther", "charEnd": 940, "source": "RLIMS-P", "charStart": 910, "entityId": [], "sentenceIndex": 7, "entityText": "Trk autophosphorylation domains"}, "RL:dQRk": {"duid": "RL:dQRk", "attribute": [], "entityType": "Trigger", "charEnd": 703, "source": "RLIMS-P", "charStart": 689, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:iZUF": {"duid": "RL:iZUF", "attribute": [], "entityType": "Trigger", "charEnd": 628, "source": "RLIMS-P", "charStart": 611, "entityId": [], "sentenceIndex": 4, "entityText": "autophosphorylated"}, "RL:LuB2": {"duid": "RL:LuB2", "attribute": [], "entityType": "Trigger", "charEnd": 1321, "source": "RLIMS-P", "charStart": 1308, "entityId": [], "sentenceIndex": 9, "entityText": "phospho-serine"}, "RL:TdXT": {"duid": "RL:TdXT", "attribute": [], "entityType": "SiteOther", "charEnd": 968, "source": "RLIMS-P", "charStart": 954, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Qh7S": {"duid": "RL:Qh7S", "attribute": [], "entityType": "Trigger", "charEnd": 1069, "source": "RLIMS-P", "charStart": 1055, "entityId": [], "sentenceIndex": 8, "entityText": "phosphotyrosine"}, "RL:JEsn": {"duid": "RL:JEsn", "attribute": [], "entityType": "Trigger", "charEnd": 795, "source": "RLIMS-P", "charStart": 781, "entityId": [], "sentenceIndex": 6, "entityText": "Phosphotyrosine"}, "RL:HZ6w": {"duid": "RL:HZ6w", "attribute": [], "entityType": "Trigger", "charEnd": 932, "source": "RLIMS-P", "charStart": 914, "entityId": [], "sentenceIndex": 7, "entityText": "autophosphorylation"}, "RL:GYEn": {"duid": "RL:GYEn", "attribute": [], "entityType": "Trigger", "charEnd": 866, "source": "RLIMS-P", "charStart": 851, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosines"}}, "mesh": ["Amino Acid Motifs", "Peptide Library", "Phosphopeptides", "Phosphorylation", "Protein Tyrosine Phosphatases", "Receptor, Insulin", "Substrate Specificity"], "relation": {"RL:uk53": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dQRk"}], "duid": "RL:uk53"}, "RL:go2v": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JEsn"}], "duid": "RL:go2v"}, "RL:mCjf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LuB2"}], "duid": "RL:mCjf"}, "RL:Hbmp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:mAGu"}, {"role": "KINASE", "entity_duid": "RL:mAGu"}, {"role": "TRIGGER", "entity_duid": "RL:iZUF"}], "duid": "RL:Hbmp"}, "RL:ePr5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Qh7S"}], "duid": "RL:ePr5"}, "RL:W7Vf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:VKQo"}, {"role": "KINASE", "entity_duid": "RL:VKQo"}, {"role": "SITE_OTHER", "entity_duid": "RL:k39r"}, {"role": "SITE_OTHER", "entity_duid": "RL:TdXT"}, {"role": "TRIGGER", "entity_duid": "RL:HZ6w"}], "duid": "RL:W7Vf"}, "RL:U9B4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GYEn"}], "duid": "RL:U9B4"}}, "type": ["Journal Article"]}
{"docId": "23994561", "sentence": [{"charStart": 0, "charEnd": 146, "index": 0}, {"index": 1, "charEnd": 260, "charStart": 148}, {"index": 2, "charEnd": 347, "charStart": 262}, {"index": 3, "charEnd": 606, "charStart": 349}, {"index": 4, "charEnd": 782, "charStart": 608}, {"index": 5, "charEnd": 992, "charStart": 784}, {"index": 6, "charEnd": 1185, "charStart": 994}, {"index": 7, "charEnd": 1393, "charStart": 1187}, {"index": 8, "charEnd": 1553, "charStart": 1395}, {"index": 9, "charEnd": 1648, "charStart": 1555}], "text": "Determination of phosphoserine/threonine by nano ultra-performance liquid chromatography-tandem mass spectrometry coupled with microscale labeling. Protein phosphorylation is an important regulatory post-translational modification in many biochemical processes. The phosphopeptide analysis strategies developed in this study were all at microscale. After using a standard microwave oven to assist protein digestion, phosphoserine and phosphothreonine were tagged with chemical analogues, such as 2-mercaptoethanol and 3-mercapto-1-propanol, to enable simultaneously relative quantitation and identification. This method enabled the use of thio alcohols for direct labeling of phosphorylated sites (not labeled at the mercapto, amino, hydroxyl, or carboxyl groups) of phosphopeptides. Various digestion parameters (e.g., microwave power, reaction time, NH4HCO3 concentration) and derivatization efficiency parameters (e.g., reaction time, labeling tag concentration) were studied and optimized. In both control and experimental samples, microwave-assisted digestion coupled with relative quantitation using analogue tags enabled calculation of phosphopeptide ratios in the same sequence. A non-labeling method was also established for quantifying phosphopeptides in human plasma by using the abundant protein albumin as an internal control for normalizing relative quantities of phosphopeptides. Nano ultra-performance liquid chromatography (nanoUPLC) was combined with LTQ Orbitrap to enable simultaneous protein relative quantitation and identification. These strategies proved to be effective for quantifying phosphopeptides in biological samples.", "title": {"charStart": 0, "charEnd": 146}, "entity": {"RL:qjFF": {"duid": "RL:qjFF", "attribute": [], "entityType": "Trigger", "charEnd": 29, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:cQ4R": {"duid": "RL:cQ4R", "attribute": [], "entityType": "Trigger", "charEnd": 781, "source": "RLIMS-P", "charStart": 767, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:U7Gh": {"duid": "RL:U7Gh", "attribute": [], "entityType": "Trigger", "charEnd": 428, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:ceZv": {"duid": "RL:ceZv", "attribute": [], "entityType": "Trigger", "charEnd": 689, "source": "RLIMS-P", "charStart": 676, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:EpCy": {"duid": "RL:EpCy", "attribute": [], "entityType": "SiteOther", "charEnd": 695, "source": "RLIMS-P", "charStart": 691, "entityId": [], "sentenceIndex": 4, "entityText": "sites"}, "RL:9Wx5": {"duid": "RL:9Wx5", "attribute": [], "entityType": "SiteOther", "charEnd": 781, "source": "RLIMS-P", "charStart": 767, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:nZKD": {"duid": "RL:nZKD", "attribute": [], "entityType": "SiteOther", "charEnd": 1260, "source": "RLIMS-P", "charStart": 1234, "entityId": [], "sentenceIndex": 7, "entityText": "quantifying phosphopeptides"}, "RL:WkWm": {"duid": "RL:WkWm", "attribute": [], "entityType": "Trigger", "charEnd": 1392, "source": "RLIMS-P", "charStart": 1378, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:PzsN": {"duid": "RL:PzsN", "attribute": [], "entityType": "SiteOther", "charEnd": 1625, "source": "RLIMS-P", "charStart": 1599, "entityId": [], "sentenceIndex": 9, "entityText": "quantifying phosphopeptides"}, "RL:zMP6": {"duid": "RL:zMP6", "attribute": [], "entityType": "SiteOther", "charEnd": 1392, "source": "RLIMS-P", "charStart": 1378, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:26v8": {"duid": "RL:26v8", "attribute": [], "entityType": "Trigger", "charEnd": 1260, "source": "RLIMS-P", "charStart": 1246, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:jzRt": {"duid": "RL:jzRt", "attribute": [], "entityType": "Trigger", "charEnd": 170, "source": "RLIMS-P", "charStart": 156, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:tqfo": {"duid": "RL:tqfo", "attribute": [], "entityType": "Trigger", "charEnd": 1625, "source": "RLIMS-P", "charStart": 1611, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}}, "mesh": ["Alcohols", "Amino Acid Sequence", "Animals", "Cell Line", "Chickens", "Chromatography, High Pressure Liquid", "Eggs", "Food Analysis", "Humans", "Milk", "Molecular Sequence Data", "Phosphoserine", "Rats", "Sulfhydryl Compounds", "Tandem Mass Spectrometry", "Threonine"], "relation": {"RL:buKT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:PzsN"}, {"role": "TRIGGER", "entity_duid": "RL:tqfo"}], "duid": "RL:buKT"}, "RL:KCxz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:zMP6"}, {"role": "TRIGGER", "entity_duid": "RL:WkWm"}], "duid": "RL:KCxz"}, "RL:JdbQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qjFF"}], "duid": "RL:JdbQ"}, "RL:QvJd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:EpCy"}, {"role": "TRIGGER", "entity_duid": "RL:ceZv"}], "duid": "RL:QvJd"}, "RL:Fjq9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nZKD"}, {"role": "TRIGGER", "entity_duid": "RL:26v8"}], "duid": "RL:Fjq9"}, "RL:ezDH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jzRt"}], "duid": "RL:ezDH"}, "RL:DKPz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:9Wx5"}, {"role": "TRIGGER", "entity_duid": "RL:cQ4R"}], "duid": "RL:DKPz"}, "RL:s86f": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:U7Gh"}], "duid": "RL:s86f"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "14578343", "sentence": [{"charStart": 0, "charEnd": 74, "index": 0}, {"index": 1, "charEnd": 164, "charStart": 76}, {"index": 2, "charEnd": 249, "charStart": 166}, {"index": 3, "charEnd": 457, "charStart": 251}, {"index": 4, "charEnd": 463, "charStart": 459}, {"index": 5, "charEnd": 474, "charStart": 465}, {"index": 6, "charEnd": 565, "charStart": 476}, {"index": 7, "charEnd": 740, "charStart": 567}, {"index": 8, "charEnd": 747, "charStart": 742}, {"index": 9, "charEnd": 761, "charStart": 749}, {"index": 10, "charEnd": 875, "charStart": 763}, {"index": 11, "charEnd": 944, "charStart": 877}, {"index": 12, "charEnd": 1107, "charStart": 946}, {"index": 13, "charEnd": 1230, "charStart": 1109}, {"index": 14, "charEnd": 1415, "charStart": 1232}, {"index": 15, "charEnd": 1491, "charStart": 1417}, {"index": 16, "charEnd": 1616, "charStart": 1493}, {"index": 17, "charEnd": 1715, "charStart": 1618}], "text": "Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. Protein phosphorylation by protein kinases may generate docking sites for other proteins. It thus allows the assembly of signaling complexes in response to kinase activation. Several protein domains that bind phosphoserine or phosphothreonine residues have been identified, including the 14-3-3, PIN1, FHA, KIX, WD-40 domain, and polo box (Yaffe, M. B., and Elia, A. E. (2001) Curr. Opin. Cell Biol. 13, 131-138; Elia, A. E., Cantley, L. C., and Yaffe, M. B. (2003) Science 299, 1228-1231). The BRCA1 COOH-terminal (BRCT) domains are protein modules found in many proteins that regulate DNA damage responses (Koonin, E. V., Altschul, S. F., and Bork, P. (1996) Nat. Genet. 13, 266-268). Whether BRCT domains can mediate phosphorylation-dependent interactions has not been systematically investigated. We report here that the BRCT domains also recognize phosphopeptides. Oriented peptide library analysis indicated that the BRCT domains from BRCA1, MDC1, BARD1, and DNA Ligase IV preferred distinct phosphoserine-containing peptides. In addition, the interaction between BRCA1 and the BRCT binding motif of BACH1 was required for BACH1 checkpoint activity. Furthermore, BRCT domains of the yeast DNA repair protein Rad9 could bind phosphopeptides, suggesting that the BRCT domains represent a class of ancient phosphopeptide-binding modules. Potential targets of BRCT domains were identified through data base search. Structural analysis of BRCA1 BRCT repeats also predicted conserved residues that may form the phosphopeptide-binding pocket. Thus, the BRCT repeats are a new family of phosphopeptide-binding domains in DNA damage responses.", "title": {"charStart": 0, "charEnd": 74}, "entity": {"RL:yXbR": {"duid": "RL:yXbR", "attribute": [], "entityType": "Trigger", "charEnd": 1086, "source": "RLIMS-P", "charStart": 1074, "entityId": [], "sentenceIndex": 12, "entityText": "phosphoserine"}, "RL:TNmN": {"duid": "RL:TNmN", "attribute": [], "entityType": "Trigger", "charEnd": 810, "source": "RLIMS-P", "charStart": 796, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:KLMC": {"duid": "RL:KLMC", "attribute": [], "entityType": "SiteOther", "charEnd": 1320, "source": "RLIMS-P", "charStart": 1306, "entityId": [], "sentenceIndex": 14, "entityText": "phosphopeptides"}, "RL:Yd6D": {"duid": "RL:Yd6D", "attribute": [], "entityType": "Trigger", "charEnd": 943, "source": "RLIMS-P", "charStart": 929, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:7ufA": {"duid": "RL:7ufA", "attribute": [], "entityType": "Trigger", "charEnd": 98, "source": "RLIMS-P", "charStart": 84, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:NJg4": {"duid": "RL:NJg4", "attribute": [], "entityType": "Trigger", "charEnd": 1320, "source": "RLIMS-P", "charStart": 1306, "entityId": [], "sentenceIndex": 14, "entityText": "phosphopeptides"}, "RL:YcN5": {"duid": "RL:YcN5", "attribute": [], "entityType": "Trigger", "charEnd": 297, "source": "RLIMS-P", "charStart": 285, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:Nby9": {"duid": "RL:Nby9", "attribute": [], "entityType": "SiteOther", "charEnd": 943, "source": "RLIMS-P", "charStart": 929, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:V8rS": {"duid": "RL:V8rS", "attribute": [], "entityType": "SiteOther", "charEnd": 1639, "source": "RLIMS-P", "charStart": 1624, "entityId": [], "sentenceIndex": 17, "entityText": "the BRCT repeats"}, "RL:B6ye": {"duid": "RL:B6ye", "attribute": [], "entityType": "SiteOther", "charEnd": 1690, "source": "RLIMS-P", "charStart": 1661, "entityId": [], "sentenceIndex": 17, "entityText": "phosphopeptide-binding domains"}, "RL:5TsF": {"duid": "RL:5TsF", "attribute": [], "entityType": "SiteOther", "charEnd": 144, "source": "RLIMS-P", "charStart": 140, "entityId": [], "sentenceIndex": 1, "entityText": "sites"}, "RL:wEmn": {"duid": "RL:wEmn", "attribute": [], "entityType": "Trigger", "charEnd": 1674, "source": "RLIMS-P", "charStart": 1661, "entityId": [], "sentenceIndex": 17, "entityText": "phosphopeptide"}}, "mesh": ["Amino Acid Motifs", "BRCA1 Protein", "Basic-Leucine Zipper Transcription Factors", "Carrier Proteins", "Cell Cycle Proteins", "DNA Damage", "DNA Ligase ATP", "DNA Ligases", "DNA Repair", "DNA-Binding Proteins", "Dose-Response Relationship, Drug", "Dose-Response Relationship, Radiation", "Fanconi Anemia Complementation Group Proteins", "G2 Phase", "Gene Library", "Genes, BRCA1", "HeLa Cells", "Humans", "Microscopy, Fluorescence", "Mitosis", "Mutation", "Nuclear Proteins", "Peptides", "Phosphorylation", "Phosphoserine", "Protein Binding", "Protein Structure, Tertiary", "RNA, Small Interfering", "Signal Transduction", "Trans-Activators", "Transcription Factors", "Tumor Suppressor Proteins", "Ubiquitin-Protein Ligases"], "relation": {"RL:LCSr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TNmN"}], "duid": "RL:LCSr"}, "RL:S8tK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:B6ye"}, {"role": "SITE_OTHER", "entity_duid": "RL:V8rS"}, {"role": "TRIGGER", "entity_duid": "RL:wEmn"}], "duid": "RL:S8tK"}, "RL:M33n": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:5TsF"}, {"role": "TRIGGER", "entity_duid": "RL:7ufA"}], "duid": "RL:M33n"}, "RL:A4zk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yXbR"}], "duid": "RL:A4zk"}, "RL:fUiu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Nby9"}, {"role": "TRIGGER", "entity_duid": "RL:Yd6D"}], "duid": "RL:fUiu"}, "RL:2DKY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KLMC"}, {"role": "TRIGGER", "entity_duid": "RL:NJg4"}], "duid": "RL:2DKY"}, "RL:pNfQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:YcN5"}], "duid": "RL:pNfQ"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "7539777", "sentence": [{"charStart": 0, "charEnd": 105, "index": 0}, {"index": 1, "charEnd": 204, "charStart": 107}, {"index": 2, "charEnd": 343, "charStart": 206}, {"index": 3, "charEnd": 562, "charStart": 345}, {"index": 4, "charEnd": 753, "charStart": 564}, {"index": 5, "charEnd": 901, "charStart": 755}, {"index": 6, "charEnd": 1073, "charStart": 903}], "text": "A new approach to phosphoserine, phosphothreonine and phosphotyrosine synthons and to thiophospho analogs. Stepwise synthesis of mono- and multiphosphorylated phosphopeptides related to src-protein kinase. Several phosphoserine, phosphothreonine and phosphotyrosine synthons suitable for the stepwise synthesis of phosphopeptides were prepared. Treatment of methylthiomethyl (MTM) esters of either Z-, Boc-, Allocserine and threonine with phosphochloridate in pyridine followed by MgBr2 cleavage of MTM in diethyl ether afforded the title compounds in good yield. Thiophosphoserine and phosphotyrosine synthons were also obtained by the phosphoramidite method using di-(2,2,2-trichloroethyl)-N,N-diisopropylphosphoramidite and MCPBA as oxidizing reagent. Trichloroethyl proved valuable as phosphate protecting group especially in phosphotyrosine derivatives owing to its stability in acidic conditions. These synthons were involved in the liquid-phase synthesis of several phospho and/or thiophosphopeptides related to either src-protein kinase or rat liver pyruvate kinase.", "title": {"charStart": 0, "charEnd": 204}, "entity": {"RL:umMW": {"duid": "RL:umMW", "attribute": [], "entityType": "SiteOther", "charEnd": 173, "source": "RLIMS-P", "charStart": 159, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:TKb3": {"duid": "RL:TKb3", "attribute": [], "entityType": "Trigger", "charEnd": 328, "source": "RLIMS-P", "charStart": 314, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:9ND5": {"duid": "RL:9ND5", "attribute": [], "entityType": "SiteOther", "charEnd": 1006, "source": "RLIMS-P", "charStart": 973, "entityId": [], "sentenceIndex": 6, "entityText": "phospho and/or thiophosphopeptides"}, "RL:werU": {"duid": "RL:werU", "attribute": [], "entityType": "Trigger", "charEnd": 30, "source": "RLIMS-P", "charStart": 18, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:6iQq": {"duid": "RL:6iQq", "attribute": [], "entityType": "Trigger", "charEnd": 157, "source": "RLIMS-P", "charStart": 139, "entityId": [], "sentenceIndex": 1, "entityText": "multiphosphorylated"}, "RL:vM2M": {"duid": "RL:vM2M", "attribute": [], "entityType": "Trigger", "charEnd": 1006, "source": "RLIMS-P", "charStart": 988, "entityId": [], "sentenceIndex": 6, "entityText": "thiophosphopeptides"}, "RL:pzUg": {"duid": "RL:pzUg", "attribute": [], "entityType": "SiteOther", "charEnd": 328, "source": "RLIMS-P", "charStart": 314, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:knaH": {"duid": "RL:knaH", "attribute": [], "entityType": "Trigger", "charEnd": 844, "source": "RLIMS-P", "charStart": 830, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:EhyG": {"duid": "RL:EhyG", "attribute": [], "entityType": "Trigger", "charEnd": 226, "source": "RLIMS-P", "charStart": 214, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:UnH7": {"duid": "RL:UnH7", "attribute": [], "entityType": "Trigger", "charEnd": 580, "source": "RLIMS-P", "charStart": 564, "entityId": [], "sentenceIndex": 4, "entityText": "Thiophosphoserine"}, "RL:D8Yv": {"duid": "RL:D8Yv", "attribute": [], "entityType": "Trigger", "charEnd": 173, "source": "RLIMS-P", "charStart": 159, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "CSK Tyrosine-Protein Kinase", "Molecular Sequence Data", "Organothiophosphates", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Protein-Tyrosine Kinases", "Tyrosine", "src-Family Kinases"], "relation": {"RL:8MAB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:EhyG"}], "duid": "RL:8MAB"}, "RL:muBr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UnH7"}], "duid": "RL:muBr"}, "RL:AaAH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:pzUg"}, {"role": "TRIGGER", "entity_duid": "RL:TKb3"}], "duid": "RL:AaAH"}, "RL:6TBz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:umMW"}, {"role": "TRIGGER", "entity_duid": "RL:6iQq"}], "duid": "RL:6TBz"}, "RL:CGVe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:werU"}], "duid": "RL:CGVe"}, "RL:DWpP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:knaH"}], "duid": "RL:DWpP"}, "RL:BKvS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:umMW"}, {"role": "TRIGGER", "entity_duid": "RL:D8Yv"}], "duid": "RL:BKvS"}, "RL:tYLV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:9ND5"}, {"role": "TRIGGER", "entity_duid": "RL:vM2M"}], "duid": "RL:tYLV"}}, "type": ["Comparative Study", "Journal Article"]}
{"docId": "2307228", "sentence": [{"charStart": 0, "charEnd": 61, "index": 0}, {"index": 1, "charEnd": 165, "charStart": 63}, {"index": 2, "charEnd": 309, "charStart": 167}, {"index": 3, "charEnd": 562, "charStart": 311}, {"index": 4, "charEnd": 651, "charStart": 564}, {"index": 5, "charEnd": 748, "charStart": 653}, {"index": 6, "charEnd": 864, "charStart": 750}], "text": "Synthetic phosphopeptides are substrates for casein kinase II. Casein kinase II is a protein serine/threonine kinase that exhibits a preference for acidic substrates. Previous studies have demonstrated that a glutamic acid 3 amino acids C-terminal (+3) to a serine or threonine is required for phosphorylation. To examine the ability of phosphoserine and phosphothreonine residues to serve as specificity determinants for casein kinase II, phosphopeptides containing either of these phosphoamino acids in the +3 position were synthesized and tested as substrates. Phosphopeptides containing phosphoserine in the +3 position were readily phosphorylated. In contrast, corresponding phosphothreonine-containing peptides were very poorly phosphorylated. These results imply that prior phosphorylation of substrate proteins on serine, but not threonine residues, may II.", "title": {"charStart": 0, "charEnd": 61}, "entity": {"RL:6XRG": {"duid": "RL:6XRG", "attribute": [], "entityType": "SiteOther", "charEnd": 454, "source": "RLIMS-P", "charStart": 440, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:Ldph": {"duid": "RL:Ldph", "attribute": [], "entityType": "Trigger", "charEnd": 603, "source": "RLIMS-P", "charStart": 591, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:TdQL": {"duid": "RL:TdQL", "attribute": [], "entityType": "Trigger", "charEnd": 578, "source": "RLIMS-P", "charStart": 564, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}, "RL:FjDX": {"duid": "RL:FjDX", "attribute": [], "entityType": "SiteOther", "charEnd": 578, "source": "RLIMS-P", "charStart": 564, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}, "RL:2dFJ": {"duid": "RL:2dFJ", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 603, "source": "RLIMS-P", "charStart": 598, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:wVM4": {"duid": "RL:wVM4", "attribute": [], "entityType": "Trigger", "charEnd": 454, "source": "RLIMS-P", "charStart": 440, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:pWsi": {"duid": "RL:pWsi", "attribute": [], "entityType": "Protein", "charEnd": 437, "source": "RLIMS-P", "charStart": 422, "entityId": [], "sentenceIndex": 3, "entityText": "casein kinase II"}, "RL:A4WZ": {"duid": "RL:A4WZ", "attribute": [], "entityType": "Trigger", "charEnd": 747, "source": "RLIMS-P", "charStart": 734, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:xeEh": {"duid": "RL:xeEh", "attribute": [], "entityType": "Trigger", "charEnd": 695, "source": "RLIMS-P", "charStart": 680, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:Bhco": {"duid": "RL:Bhco", "attribute": [], "entityType": "Trigger", "charEnd": 650, "source": "RLIMS-P", "charStart": 637, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:bG4W": {"duid": "RL:bG4W", "attribute": [], "entityType": "Trigger", "charEnd": 308, "source": "RLIMS-P", "charStart": 294, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:RH5d": {"duid": "RL:RH5d", "attribute": [], "entityType": "Trigger", "charEnd": 349, "source": "RLIMS-P", "charStart": 337, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:nQnm": {"duid": "RL:nQnm", "attribute": [], "entityType": "Trigger", "charEnd": 24, "source": "RLIMS-P", "charStart": 10, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:KKPu": {"duid": "RL:KKPu", "attribute": [], "entityType": "SiteOther", "charEnd": 24, "source": "RLIMS-P", "charStart": 10, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:zyeq": {"duid": "RL:zyeq", "attribute": [], "entityType": "Trigger", "charEnd": 795, "source": "RLIMS-P", "charStart": 781, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}}, "mesh": ["Amino Acid Sequence", "Casein Kinases", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Protein Kinases", "Substrate Specificity"], "relation": {"RL:H7Lb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:pWsi"}, {"role": "SITE", "entity_duid": "RL:2dFJ"}, {"role": "TRIGGER", "entity_duid": "RL:Bhco"}], "duid": "RL:H7Lb"}, "RL:nWgC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:6XRG"}, {"role": "TRIGGER", "entity_duid": "RL:wVM4"}], "duid": "RL:nWgC"}, "RL:REoH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zyeq"}], "duid": "RL:REoH"}, "RL:RzL9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:A4WZ"}], "duid": "RL:RzL9"}, "RL:ipG2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KKPu"}, {"role": "TRIGGER", "entity_duid": "RL:nQnm"}], "duid": "RL:ipG2"}, "RL:Rcq7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:FjDX"}, {"role": "TRIGGER", "entity_duid": "RL:TdQL"}], "duid": "RL:Rcq7"}, "RL:EjRe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:bG4W"}], "duid": "RL:EjRe"}, "RL:Bx7G": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RH5d"}], "duid": "RL:Bx7G"}, "RL:UDGQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xeEh"}], "duid": "RL:UDGQ"}, "RL:WGQt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ldph"}], "duid": "RL:WGQt"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "2506143", "sentence": [{"charStart": 0, "charEnd": 77, "index": 0}, {"index": 1, "charEnd": 172, "charStart": 79}, {"index": 2, "charEnd": 330, "charStart": 174}, {"index": 3, "charEnd": 519, "charStart": 332}, {"index": 4, "charEnd": 641, "charStart": 521}, {"index": 5, "charEnd": 805, "charStart": 643}], "text": "Synthesis of phosphopeptides containing O-phosphoserine or O-phosphothreonine. Peptides containing phosphoserine or phosphothreonine were synthesized by solid phase methods. Phosphoserine and phosphothreonine were incorporated into peptides using Boc-diphenylphosphono esters of serine and threonine and standard DCC/HOBt coupling. The phenylphosphoesters were not removed when the peptides were cleaved from the resin by HF or by trifluoromethane sulfonic acid, but were subsequently removed by catalytic hydrogenation. Phosphopeptides were purified by HPLC and by Fe+3-Chelex chromatography and their identity verified by mass spectrometry. Two peptides, Leu-Arg-Arg-Ala-Ser(P)-Leu-Gly and Leu-Arg-Arg-Ala-Thr(P)-Leu-Gly, were prepared by both enzymatic and chemical methods and had identical properties.", "title": {"charStart": 0, "charEnd": 77}, "entity": {"RL:fFip": {"duid": "RL:fFip", "attribute": [], "entityType": "Trigger", "charEnd": 535, "source": "RLIMS-P", "charStart": 521, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}, "RL:RKoJ": {"duid": "RL:RKoJ", "attribute": [], "entityType": "Trigger", "charEnd": 27, "source": "RLIMS-P", "charStart": 13, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:7JaS": {"duid": "RL:7JaS", "attribute": [], "entityType": "SiteOther", "charEnd": 27, "source": "RLIMS-P", "charStart": 13, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:5TaV": {"duid": "RL:5TaV", "attribute": [], "entityType": "Trigger", "charEnd": 54, "source": "RLIMS-P", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "O-phosphoserine"}, "RL:wnup": {"duid": "RL:wnup", "attribute": [], "entityType": "SiteOther", "charEnd": 535, "source": "RLIMS-P", "charStart": 521, "entityId": [], "sentenceIndex": 4, "entityText": "Phosphopeptides"}, "RL:RfuJ": {"duid": "RL:RfuJ", "attribute": [], "entityType": "Trigger", "charEnd": 186, "source": "RLIMS-P", "charStart": 174, "entityId": [], "sentenceIndex": 2, "entityText": "Phosphoserine"}, "RL:79Rv": {"duid": "RL:79Rv", "attribute": [], "entityType": "Trigger", "charEnd": 111, "source": "RLIMS-P", "charStart": 99, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}}, "mesh": ["Amino Acids", "Chemical Phenomena", "Chemistry", "Chromatography, Affinity", "Mass Spectrometry", "Phosphopeptides", "Phosphoserine", "Phosphothreonine", "Serine", "Threonine"], "relation": {"RL:z2hG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7JaS"}, {"role": "TRIGGER", "entity_duid": "RL:RKoJ"}], "duid": "RL:z2hG"}, "RL:pxnF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:79Rv"}], "duid": "RL:pxnF"}, "RL:zS9K": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5TaV"}], "duid": "RL:zS9K"}, "RL:oGGK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RfuJ"}], "duid": "RL:oGGK"}, "RL:UW48": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:wnup"}, {"role": "TRIGGER", "entity_duid": "RL:fFip"}], "duid": "RL:UW48"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "19426863", "sentence": [{"charStart": 0, "charEnd": 103, "index": 0}, {"index": 1, "charEnd": 315, "charStart": 105}, {"index": 2, "charEnd": 487, "charStart": 317}, {"index": 3, "charEnd": 689, "charStart": 489}, {"index": 4, "charEnd": 871, "charStart": 691}, {"index": 5, "charEnd": 1024, "charStart": 873}, {"index": 6, "charEnd": 1141, "charStart": 1026}, {"index": 7, "charEnd": 1417, "charStart": 1143}, {"index": 8, "charEnd": 1701, "charStart": 1419}], "text": "Selective enrichment in phosphopeptides for the identification of phosphorylated mitochondrial proteins. In vivo protein phosphorylation is a reversible and dynamic process controlled by protein kinases and phosphatases for the addition and removal of the phosphate group to serine, threonine, and tyrosine residues. In addition to other regulation events, increasing evidence indicates that reversible protein phosphorylation plays an important role in regulating mitochondrial function. Detecting changes in the state of protein phosphorylation is a difficult task since phosphorylation on a specific protein is typically transient and usually presents in substoichiometric concentration. Moreover, what makes mass spectrometry (MS)-based phosphopeptide analysis difficult is that ionization efficiency of phosphopeptides is lower than their nonphosphorylated analogues. Different strategies have been proposed for the selective enrichment of low abundance phosphoproteins and phosphopeptides present in biological samples. As a result of recent advances, phosphoproteomics has become one of the most rapidly developing areas of proteomics. In the last few years, a number of studies have focused on the analysis of phosphoproteome purified from yeast, liver and heart mitochondria, as well as on the identification of endogenously phosphorylated subunits of mitochondrial oxidative phosphorylation system complexes. This chapter describes methods for the selective enrichment of phosphoserine, phosphothreonine, and phosphotyrosine containing peptides and proteins and phosphate-specific MS strategy generally applicable to phosphoprotein analysis but focusing specifically on mitochondrial samples.", "title": {"charStart": 0, "charEnd": 103}, "entity": {"RL:nKSJ": {"duid": "RL:nKSJ", "attribute": [], "entityType": "SiteOther", "charEnd": 993, "source": "RLIMS-P", "charStart": 979, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:wQks": {"duid": "RL:wQks", "attribute": [], "entityType": "Trigger", "charEnd": 79, "source": "RLIMS-P", "charStart": 66, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:twJU": {"duid": "RL:twJU", "attribute": [], "entityType": "Trigger", "charEnd": 545, "source": "RLIMS-P", "charStart": 531, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:KE6m": {"duid": "RL:KE6m", "attribute": [], "entityType": "Trigger", "charEnd": 587, "source": "RLIMS-P", "charStart": 573, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:Fpn7": {"duid": "RL:Fpn7", "attribute": [], "entityType": "Trigger", "charEnd": 973, "source": "RLIMS-P", "charStart": 959, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoproteins"}, "RL:GoDS": {"duid": "RL:GoDS", "attribute": [], "entityType": "Trigger", "charEnd": 1347, "source": "RLIMS-P", "charStart": 1334, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylated"}, "RL:JdF4": {"duid": "RL:JdF4", "attribute": [], "entityType": "Trigger", "charEnd": 135, "source": "RLIMS-P", "charStart": 121, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:VMTR": {"duid": "RL:VMTR", "attribute": [], "entityType": "SiteOther", "charEnd": 822, "source": "RLIMS-P", "charStart": 808, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:zPBx": {"duid": "RL:zPBx", "attribute": [], "entityType": "Trigger", "charEnd": 270, "source": "RLIMS-P", "charStart": 256, "entityId": [], "sentenceIndex": 1, "entityText": "phosphate group"}, "RL:9rzN": {"duid": "RL:9rzN", "attribute": [], "entityType": "SiteOther", "charEnd": 38, "source": "RLIMS-P", "charStart": 24, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:ocmy": {"duid": "RL:ocmy", "attribute": [], "entityType": "Trigger", "charEnd": 1494, "source": "RLIMS-P", "charStart": 1482, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:ScHy": {"duid": "RL:ScHy", "attribute": [], "entityType": "Trigger", "charEnd": 425, "source": "RLIMS-P", "charStart": 411, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:LrVj": {"duid": "RL:LrVj", "attribute": [], "entityType": "Trigger", "charEnd": 38, "source": "RLIMS-P", "charStart": 24, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:LCyr": {"duid": "RL:LCyr", "attribute": [], "entityType": "Trigger", "charEnd": 822, "source": "RLIMS-P", "charStart": 808, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}}, "mesh": ["Animals", "Humans", "Mass Spectrometry", "Mitochondrial Proteins", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine"], "relation": {"RL:nSTT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wQks"}], "duid": "RL:nSTT"}, "RL:6EAq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:twJU"}], "duid": "RL:6EAq"}, "RL:Ts6k": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GoDS"}], "duid": "RL:Ts6k"}, "RL:keEx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:KE6m"}], "duid": "RL:keEx"}, "RL:RPsD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:9rzN"}, {"role": "TRIGGER", "entity_duid": "RL:LrVj"}], "duid": "RL:RPsD"}, "RL:miWz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:VMTR"}, {"role": "TRIGGER", "entity_duid": "RL:LCyr"}], "duid": "RL:miWz"}, "RL:n2Ny": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ScHy"}], "duid": "RL:n2Ny"}, "RL:sDSf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JdF4"}], "duid": "RL:sDSf"}, "RL:9DUA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nKSJ"}, {"role": "TRIGGER", "entity_duid": "RL:Fpn7"}], "duid": "RL:9DUA"}, "RL:7SeC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zPBx"}], "duid": "RL:7SeC"}, "RL:dDSX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ocmy"}], "duid": "RL:dDSX"}}, "type": ["Journal Article"]}
{"docId": "24225996", "sentence": [{"charStart": 0, "charEnd": 114, "index": 0}, {"index": 1, "charEnd": 272, "charStart": 116}, {"index": 2, "charEnd": 493, "charStart": 274}, {"index": 3, "charEnd": 664, "charStart": 495}, {"index": 4, "charEnd": 906, "charStart": 666}, {"index": 5, "charEnd": 1007, "charStart": 908}, {"index": 6, "charEnd": 1121, "charStart": 1009}, {"index": 7, "charEnd": 1511, "charStart": 1123}, {"index": 8, "charEnd": 1690, "charStart": 1513}, {"index": 9, "charEnd": 1873, "charStart": 1692}], "text": "Selective detection of phosphopeptides in complex mixtures by electrospray liquid chromatography/mass spectrometry. A mass spectrometry-based method that does not involve the use of radiolabeling was developed for selective detection of phosphopeptides in complex mixtures. Mixtures of phosphorylated and nonphosphorylated peptides at the low picomole level are analyzed by negative ion electrospray liquid chromatography/mass spectrometry using C-18 packed fused-silica columns (\u2264320-\u03bcm i.d.). Peptides and phosphopeptides in the chromatographic eluant undergo collision-induced dissociation in the free-jet expansion region prior to the mass analyzing quadrupole. Using relatively high collisional excitation potentials, phospho|peptides containing phosphoserine, phosphothreonine, and phosphotyrosine fragment to yield diagnostic ions at m/z 63 and 79 corresponding to PO2 (-); and PO3 (-), respectively. Chromatographic peaks containing phosphopeptides are indicated where these diagnostic ions maximize. The highest sensitivity for phosphopeptide detection is obtained using selected-ion monitoring for m/z 63 and 79. Full-scan mass spectra that exhibit the diagnostic phosphopeptide fragment ions, together with pseudomolecular ions, may be obtained by stepping the collisional excitation potential from a high value during the portion of each scan in which the low-mass-to-charge ratio diagnostic marker ions are being detected to a lower value while the upper mass-to-charge ratio range is being scanned. Good sensitivity for phosphopeptide detection was achieved using standard trifluoroacetic acid containing mobile phases for reversed-phase high-performance liquid chromatography. Data illustrating the selectivity and sensitivity of the approach are presented for mixtures of peptides and phosphopeptides containing the three commonly phosphorylated amino acids.", "title": {"charStart": 0, "charEnd": 114}, "entity": {"RL:Vj7g": {"duid": "RL:Vj7g", "attribute": [], "entityType": "SiteOther", "charEnd": 738, "source": "RLIMS-P", "charStart": 723, "entityId": [], "sentenceIndex": 4, "entityText": "phospho|peptides"}, "RL:Amzy": {"duid": "RL:Amzy", "attribute": [], "entityType": "SiteOther", "charEnd": 1872, "source": "RLIMS-P", "charStart": 1862, "entityId": [], "sentenceIndex": 9, "entityText": "amino acids"}, "RL:dJRP": {"duid": "RL:dJRP", "attribute": [], "entityType": "Trigger", "charEnd": 1860, "source": "RLIMS-P", "charStart": 1847, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylated"}, "RL:mr2R": {"duid": "RL:mr2R", "attribute": [], "entityType": "SiteOther", "charEnd": 251, "source": "RLIMS-P", "charStart": 237, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:LsUu": {"duid": "RL:LsUu", "attribute": [], "entityType": "Trigger", "charEnd": 522, "source": "RLIMS-P", "charStart": 508, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:RZBv": {"duid": "RL:RZBv", "attribute": [], "entityType": "SiteOther", "charEnd": 502, "source": "RLIMS-P", "charStart": 495, "entityId": [], "sentenceIndex": 3, "entityText": "Peptides"}, "RL:9oza": {"duid": "RL:9oza", "attribute": [], "entityType": "SiteOther", "charEnd": 37, "source": "RLIMS-P", "charStart": 23, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:8Yxt": {"duid": "RL:8Yxt", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 781, "source": "RLIMS-P", "charStart": 773, "entityId": [], "sentenceIndex": 4, "entityText": "threonine"}, "RL:6etC": {"duid": "RL:6etC", "attribute": [], "entityType": "Trigger", "charEnd": 1815, "source": "RLIMS-P", "charStart": 1801, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:yWww": {"duid": "RL:yWww", "attribute": [], "entityType": "Trigger", "charEnd": 37, "source": "RLIMS-P", "charStart": 23, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:5ohV": {"duid": "RL:5ohV", "attribute": [], "entityType": "SiteOther", "charEnd": 1795, "source": "RLIMS-P", "charStart": 1788, "entityId": [], "sentenceIndex": 9, "entityText": "peptides"}, "RL:P9Kc": {"duid": "RL:P9Kc", "attribute": [], "entityType": "Trigger", "charEnd": 763, "source": "RLIMS-P", "charStart": 751, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:JCNq": {"duid": "RL:JCNq", "attribute": [], "entityType": "Trigger", "charEnd": 955, "source": "RLIMS-P", "charStart": 941, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:5jR2": {"duid": "RL:5jR2", "attribute": [], "entityType": "Trigger", "charEnd": 251, "source": "RLIMS-P", "charStart": 237, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:68uE": {"duid": "RL:68uE", "attribute": [], "entityType": "SiteOther", "charEnd": 955, "source": "RLIMS-P", "charStart": 941, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:nyU8": {"duid": "RL:nyU8", "attribute": [], "entityType": "Protein", "charEnd": 1606, "source": "RLIMS-P", "charStart": 1587, "entityId": [], "sentenceIndex": 8, "entityText": "trifluoroacetic acid"}, "RL:d8EB": {"duid": "RL:d8EB", "attribute": [], "entityType": "SiteOther", "charEnd": 1815, "source": "RLIMS-P", "charStart": 1801, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:J8qk": {"duid": "RL:J8qk", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 763, "source": "RLIMS-P", "charStart": 758, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:9zfc": {"duid": "RL:9zfc", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 802, "source": "RLIMS-P", "charStart": 795, "entityId": [], "sentenceIndex": 4, "entityText": "tyrosine"}, "RL:j6dr": {"duid": "RL:j6dr", "attribute": [], "entityType": "SiteOther", "charEnd": 522, "source": "RLIMS-P", "charStart": 508, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}}, "relation": {"RL:yLkg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:d8EB"}, {"role": "SITE_OTHER", "entity_duid": "RL:5ohV"}, {"role": "TRIGGER", "entity_duid": "RL:6etC"}], "duid": "RL:yLkg"}, "RL:aFtx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:68uE"}, {"role": "TRIGGER", "entity_duid": "RL:JCNq"}], "duid": "RL:aFtx"}, "RL:taDD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:P9Kc"}], "duid": "RL:taDD"}, "RL:Mekm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mr2R"}, {"role": "TRIGGER", "entity_duid": "RL:5jR2"}], "duid": "RL:Mekm"}, "RL:Thfr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:j6dr"}, {"role": "SITE_OTHER", "entity_duid": "RL:RZBv"}, {"role": "TRIGGER", "entity_duid": "RL:LsUu"}], "duid": "RL:Thfr"}, "RL:aof7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:9oza"}, {"role": "TRIGGER", "entity_duid": "RL:yWww"}], "duid": "RL:aof7"}, "RL:FzRg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:nyU8"}, {"role": "SITE", "entity_duid": "RL:J8qk"}, {"role": "SITE", "entity_duid": "RL:9zfc"}, {"role": "SITE", "entity_duid": "RL:8Yxt"}, {"role": "SITE_OTHER", "entity_duid": "RL:Amzy"}, {"role": "SITE_OTHER", "entity_duid": "RL:Vj7g"}, {"role": "TRIGGER", "entity_duid": "RL:dJRP"}], "duid": "RL:FzRg"}}, "type": ["Journal Article"]}
{"docId": "16478119", "sentence": [{"charStart": 0, "charEnd": 78, "index": 0}, {"index": 1, "charEnd": 215, "charStart": 80}, {"index": 2, "charEnd": 399, "charStart": 217}, {"index": 3, "charEnd": 637, "charStart": 401}, {"index": 4, "charEnd": 918, "charStart": 639}, {"index": 5, "charEnd": 1190, "charStart": 920}, {"index": 6, "charEnd": 1414, "charStart": 1192}, {"index": 7, "charEnd": 1538, "charStart": 1416}, {"index": 8, "charEnd": 1683, "charStart": 1540}, {"index": 9, "charEnd": 1877, "charStart": 1685}, {"index": 10, "charEnd": 1978, "charStart": 1879}], "text": "Phosphate group-driven fragmentation of multiply charged phosphopeptide anions. Improved recognition of peptides phosphorylated at serine, threonine, or tyrosine by negative ion electrospray tandem mass spectrometry. The nanoelectrospray product ion spectra of multiply charged phosphopeptide anions reveal the occurrence of phosphate-specific high-mass fragment ions of the type [M - nH - 79](n-1)-. These so far unrecognized fragments, which are observed for phosphoserine-, phosphothreonine-, and phosphotyrosine-containing peptides, are the counterparts of the established inorganic phosphopeptide marker ion found at m/z 79 = [PO3]-. The high-mass marker ions are formed with high efficiency at moderate collision offset values and are particularly useful for sensitive recognition of pSer-, pThr-, and pTyr-peptides due to the low background level in MS/MS spectra at m/z values above those of the precursor ions. By virtue of this feature, the detection of the new phosphorylation-specific fragment ions appears to be more sensitive than the detection of the low-mass phosphate marker ion at m/z 79, where a higher interference by nonspecific background signals is generally observed. The number of phosphate groups within a phosphopeptide can also be estimated on the basis of the [M - nH - 79](n-1)- ions, since these exhibit an effective, sequential neutral loss of H3PO4 of the residing phosphate groups. A mechanistic explanation for the formation of the [M - nH - 79](n-1)- ions from multiply charged phosphopeptides is given. The high-mass marker ions are proposed to originate from phosphopeptide anions, which carry two negative charges located at the phosphate group. A new search tool denominated \"variable m/z gain analysis\", which utilizes these newly recognized high-mass fragments for spotting of phosphopeptides in a negative ion parent scan, is proposed. The findings strengthen the value of negative ion ESI-MS/MS for analysis of protein phosphorylation.", "title": {"charStart": 0, "charEnd": 215}, "entity": {"RL:v4B2": {"duid": "RL:v4B2", "attribute": [], "entityType": "Trigger", "charEnd": 1833, "source": "RLIMS-P", "charStart": 1819, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:aJsi": {"duid": "RL:aJsi", "attribute": [], "entityType": "Trigger", "charEnd": 1977, "source": "RLIMS-P", "charStart": 1963, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:evzF": {"duid": "RL:evzF", "attribute": [], "entityType": "Trigger", "charEnd": 1528, "source": "RLIMS-P", "charStart": 1514, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:XKh7": {"duid": "RL:XKh7", "attribute": [], "entityType": "Trigger", "charEnd": 473, "source": "RLIMS-P", "charStart": 461, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:Cpy7": {"duid": "RL:Cpy7", "attribute": [], "entityType": "SiteOther", "charEnd": 1528, "source": "RLIMS-P", "charStart": 1514, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:ZuRF": {"duid": "RL:ZuRF", "attribute": [], "entityType": "SiteOther", "charEnd": 1833, "source": "RLIMS-P", "charStart": 1819, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:eWTr": {"duid": "RL:eWTr", "attribute": [], "entityType": "Trigger", "charEnd": 986, "source": "RLIMS-P", "charStart": 972, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:ey5X": {"duid": "RL:ey5X", "attribute": [], "entityType": "Trigger", "charEnd": 126, "source": "RLIMS-P", "charStart": 113, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:pqVf": {"duid": "RL:pqVf", "attribute": [], "entityType": "SiteOther", "charEnd": 1245, "source": "RLIMS-P", "charStart": 1230, "entityId": [], "sentenceIndex": 6, "entityText": "a phosphopeptide"}, "RL:RdTF": {"duid": "RL:RdTF", "attribute": [], "entityType": "Trigger", "charEnd": 1245, "source": "RLIMS-P", "charStart": 1232, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide"}}, "mesh": ["Amino Acid Sequence", "Anions", "Phosphates", "Phosphopeptides", "Phosphorylation", "Serine", "Spectrometry, Mass, Electrospray Ionization", "Tandem Mass Spectrometry", "Threonine", "Tyrosine"], "relation": {"RL:UfpR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Cpy7"}, {"role": "TRIGGER", "entity_duid": "RL:evzF"}], "duid": "RL:UfpR"}, "RL:T5Hj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aJsi"}], "duid": "RL:T5Hj"}, "RL:urCi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ZuRF"}, {"role": "TRIGGER", "entity_duid": "RL:v4B2"}], "duid": "RL:urCi"}, "RL:Aa62": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ey5X"}], "duid": "RL:Aa62"}, "RL:CmQv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:XKh7"}], "duid": "RL:CmQv"}, "RL:5UNX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:pqVf"}, {"role": "TRIGGER", "entity_duid": "RL:RdTF"}], "duid": "RL:5UNX"}, "RL:QcU8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:eWTr"}], "duid": "RL:QcU8"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "12923550", "sentence": [{"charStart": 0, "charEnd": 72, "index": 0}, {"index": 1, "charEnd": 287, "charStart": 74}, {"index": 2, "charEnd": 389, "charStart": 289}, {"index": 3, "charEnd": 514, "charStart": 391}, {"index": 4, "charEnd": 694, "charStart": 516}, {"index": 5, "charEnd": 897, "charStart": 696}, {"index": 6, "charEnd": 1016, "charStart": 899}, {"index": 7, "charEnd": 1181, "charStart": 1018}], "text": "Phosphospecific proteolysis for mapping sites of protein phosphorylation. Protein phosphorylation is a dominant mechanism of information transfer in cells, and a major goal of current proteomic efforts is to generate a system-level map describing all the sites of protein phosphorylation. Recent efforts have focused on developing technologies for enriching and quantifying phosphopeptides. Identification of the sites of phosphorylation typically relies on tandem mass spectrometry to sequence individual peptides. Here we describe an approach for phosphopeptide mapping that makes it possible to interrogate a protein sequence directly with a protease that recognizes sites of phosphorylation. The key to this approach is the selective chemical transformation of phosphoserine and phosphothreonine residues into lysine analogs (aminoethylcysteine and beta-methylaminoethylcysteine, respectively). Aminoethylcysteine-modified peptides are then cleaved with a lysine-specific protease to map sites of phosphorylation. A blocking step enables single-site cleavage, and adaptation of this reaction to the solid phase facilitates phosphopeptide enrichment and modification in one step.", "title": {"charStart": 0, "charEnd": 72}, "entity": {"RL:Vm8D": {"duid": "RL:Vm8D", "attribute": [], "entityType": "SiteOther", "charEnd": 388, "source": "RLIMS-P", "charStart": 362, "entityId": [], "sentenceIndex": 2, "entityText": "quantifying phosphopeptides"}, "RL:Hj36": {"duid": "RL:Hj36", "attribute": [], "entityType": "Trigger", "charEnd": 286, "source": "RLIMS-P", "charStart": 272, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:YgjR": {"duid": "RL:YgjR", "attribute": [], "entityType": "SiteOther", "charEnd": 674, "source": "RLIMS-P", "charStart": 670, "entityId": [], "sentenceIndex": 4, "entityText": "sites"}, "RL:tEtf": {"duid": "RL:tEtf", "attribute": [], "entityType": "SiteOther", "charEnd": 996, "source": "RLIMS-P", "charStart": 992, "entityId": [], "sentenceIndex": 6, "entityText": "sites"}, "RL:MrHL": {"duid": "RL:MrHL", "attribute": [], "entityType": "Trigger", "charEnd": 777, "source": "RLIMS-P", "charStart": 765, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:N8q4": {"duid": "RL:N8q4", "attribute": [], "entityType": "Trigger", "charEnd": 436, "source": "RLIMS-P", "charStart": 422, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:FAph": {"duid": "RL:FAph", "attribute": [], "entityType": "SiteOther", "charEnd": 417, "source": "RLIMS-P", "charStart": 413, "entityId": [], "sentenceIndex": 3, "entityText": "sites"}, "RL:D7nS": {"duid": "RL:D7nS", "attribute": [], "entityType": "Trigger", "charEnd": 388, "source": "RLIMS-P", "charStart": 374, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:jKhn": {"duid": "RL:jKhn", "attribute": [], "entityType": "Trigger", "charEnd": 71, "source": "RLIMS-P", "charStart": 57, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:NLYJ": {"duid": "RL:NLYJ", "attribute": [], "entityType": "SiteOther", "charEnd": 259, "source": "RLIMS-P", "charStart": 255, "entityId": [], "sentenceIndex": 1, "entityText": "sites"}, "RL:E3P7": {"duid": "RL:E3P7", "attribute": [], "entityType": "Trigger", "charEnd": 96, "source": "RLIMS-P", "charStart": 82, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:zNPs": {"duid": "RL:zNPs", "attribute": [], "entityType": "Trigger", "charEnd": 1015, "source": "RLIMS-P", "charStart": 1001, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:3jFD": {"duid": "RL:3jFD", "attribute": [], "entityType": "Trigger", "charEnd": 693, "source": "RLIMS-P", "charStart": 679, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:kcBx": {"duid": "RL:kcBx", "attribute": [], "entityType": "SiteOther", "charEnd": 44, "source": "RLIMS-P", "charStart": 32, "entityId": [], "sentenceIndex": 0, "entityText": "mapping sites"}}, "mesh": ["Cyclic AMP-Dependent Protein Kinases", "Endopeptidases", "Enzyme-Linked Immunosorbent Assay", "Peptide Hydrolases", "Phosphoamino Acids", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotransferases", "Protein Interaction Mapping", "Proteome", "Proteomics", "Tubulin", "beta-Adrenergic Receptor Kinases"], "relation": {"RL:mAmT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:MrHL"}], "duid": "RL:mAmT"}, "RL:is6u": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:tEtf"}, {"role": "TRIGGER", "entity_duid": "RL:zNPs"}], "duid": "RL:is6u"}, "RL:cqLs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Vm8D"}, {"role": "TRIGGER", "entity_duid": "RL:D7nS"}], "duid": "RL:cqLs"}, "RL:JV9D": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:NLYJ"}, {"role": "TRIGGER", "entity_duid": "RL:E3P7"}], "duid": "RL:JV9D"}, "RL:V3mi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:FAph"}, {"role": "TRIGGER", "entity_duid": "RL:N8q4"}], "duid": "RL:V3mi"}, "RL:KrWF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:YgjR"}, {"role": "TRIGGER", "entity_duid": "RL:3jFD"}], "duid": "RL:KrWF"}, "RL:PRxv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:NLYJ"}, {"role": "TRIGGER", "entity_duid": "RL:Hj36"}], "duid": "RL:PRxv"}, "RL:LpZv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kcBx"}, {"role": "TRIGGER", "entity_duid": "RL:jKhn"}], "duid": "RL:LpZv"}}, "type": ["Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "1705399", "sentence": [{"charStart": 0, "charEnd": 87, "index": 0}, {"index": 1, "charEnd": 215, "charStart": 89}, {"index": 2, "charEnd": 416, "charStart": 217}, {"index": 3, "charEnd": 551, "charStart": 418}, {"index": 4, "charEnd": 750, "charStart": 553}, {"index": 5, "charEnd": 903, "charStart": 752}], "text": "Synthesis of phosphotyrosyl-containing phosphopeptides by solid-phase peptide synthesis. The synthesis of phosphotyrosine-containing phosphopeptides using solid-phase peptide synthesis (SPPS) techniques is described. We present the synthesis of a Boc-phosphotyrosine derivative, which when used with modifications of the conventional SPPS protocol permits the incorporation of phosphotyrosine into synthetic peptides. The resulting phosphopeptides were authenticated by fast atom bombardment mass spectrometry, amino acid analysis, and phosphate assay. Alkaline phosphatase was found to dephosphorylate synthetic phosphopeptides at different rates, supporting the potential use of these synthetic substrates for studies of phosphoprotein phosphatases. Synthesis of a phosphopeptide using the described protocol has several advantages over the preparation of phosphopeptides via enzymatic phosphorylation.", "title": {"charStart": 0, "charEnd": 87}, "entity": {"RL:oM4o": {"duid": "RL:oM4o", "attribute": [], "entityType": "Trigger", "charEnd": 26, "source": "RLIMS-P", "charStart": 13, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosyl"}, "RL:NUHB": {"duid": "RL:NUHB", "attribute": [], "entityType": "SiteOther", "charEnd": 627, "source": "RLIMS-P", "charStart": 613, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:S725": {"duid": "RL:S725", "attribute": [], "entityType": "Trigger", "charEnd": 446, "source": "RLIMS-P", "charStart": 432, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:DPCk": {"duid": "RL:DPCk", "attribute": [], "entityType": "Trigger", "charEnd": 780, "source": "RLIMS-P", "charStart": 767, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptide"}, "RL:VSrw": {"duid": "RL:VSrw", "attribute": [], "entityType": "Trigger", "charEnd": 902, "source": "RLIMS-P", "charStart": 888, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:Z7XR": {"duid": "RL:Z7XR", "attribute": [], "entityType": "Trigger", "charEnd": 265, "source": "RLIMS-P", "charStart": 247, "entityId": [], "sentenceIndex": 2, "entityText": "Boc-phosphotyrosine"}, "RL:KUYD": {"duid": "RL:KUYD", "attribute": [], "entityType": "SiteOther", "charEnd": 780, "source": "RLIMS-P", "charStart": 765, "entityId": [], "sentenceIndex": 5, "entityText": "a phosphopeptide"}, "RL:KvbE": {"duid": "RL:KvbE", "attribute": [], "entityType": "Trigger", "charEnd": 627, "source": "RLIMS-P", "charStart": 613, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:xqVR": {"duid": "RL:xqVR", "attribute": [], "entityType": "Trigger", "charEnd": 391, "source": "RLIMS-P", "charStart": 377, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:fmgz": {"duid": "RL:fmgz", "attribute": [], "entityType": "SiteOther", "charEnd": 872, "source": "RLIMS-P", "charStart": 858, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:uWmD": {"duid": "RL:uWmD", "attribute": [], "entityType": "Trigger", "charEnd": 120, "source": "RLIMS-P", "charStart": 106, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:XArh": {"duid": "RL:XArh", "attribute": [], "entityType": "SiteOther", "charEnd": 446, "source": "RLIMS-P", "charStart": 432, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:8cqn": {"duid": "RL:8cqn", "attribute": [], "entityType": "Trigger", "charEnd": 872, "source": "RLIMS-P", "charStart": 858, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:tPpb": {"duid": "RL:tPpb", "attribute": [], "entityType": "Trigger", "charEnd": 736, "source": "RLIMS-P", "charStart": 723, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoprotein"}, "RL:hYu6": {"duid": "RL:hYu6", "attribute": [], "entityType": "Protein", "charEnd": 749, "source": "RLIMS-P", "charStart": 723, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoprotein phosphatases"}}, "mesh": ["Alkaline Phosphatase", "Amino Acids", "Phosphopeptides", "Phosphorylation", "Phosphotyrosine", "Spectrometry, Mass, Fast Atom Bombardment", "Tyrosine"], "relation": {"RL:DZnk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:XArh"}, {"role": "TRIGGER", "entity_duid": "RL:S725"}], "duid": "RL:DZnk"}, "RL:CTGT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KUYD"}, {"role": "TRIGGER", "entity_duid": "RL:DPCk"}], "duid": "RL:CTGT"}, "RL:M4tN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xqVR"}], "duid": "RL:M4tN"}, "RL:bWEN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:fmgz"}, {"role": "TRIGGER", "entity_duid": "RL:VSrw"}], "duid": "RL:bWEN"}, "RL:Vmn3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:hYu6"}, {"role": "TRIGGER", "entity_duid": "RL:tPpb"}], "duid": "RL:Vmn3"}, "RL:gP8D": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:oM4o"}], "duid": "RL:gP8D"}, "RL:FMh7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:uWmD"}], "duid": "RL:FMh7"}, "RL:eVa3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:fmgz"}, {"role": "TRIGGER", "entity_duid": "RL:8cqn"}], "duid": "RL:eVa3"}, "RL:YSqu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Z7XR"}], "duid": "RL:YSqu"}, "RL:P9YG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:NUHB"}, {"role": "TRIGGER", "entity_duid": "RL:KvbE"}], "duid": "RL:P9YG"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "7894600", "sentence": [{"charStart": 0, "charEnd": 78, "index": 0}], "text": "Synthesis of phosphopeptides containing O-phosphoserine and O-phosphothreonine.", "title": {"charStart": 0, "charEnd": 78}, "entity": {"RL:8Xsj": {"duid": "RL:8Xsj", "attribute": [], "entityType": "Trigger", "charEnd": 27, "source": "RLIMS-P", "charStart": 13, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:Dtca": {"duid": "RL:Dtca", "attribute": [], "entityType": "SiteOther", "charEnd": 27, "source": "RLIMS-P", "charStart": 13, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:rGzL": {"duid": "RL:rGzL", "attribute": [], "entityType": "Trigger", "charEnd": 54, "source": "RLIMS-P", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "O-phosphoserine"}}, "mesh": ["Amino Acid Sequence", "Indicators and Reagents", "Molecular Biology", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine"], "relation": {"RL:cxNN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:rGzL"}], "duid": "RL:cxNN"}, "RL:gAET": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Dtca"}, {"role": "TRIGGER", "entity_duid": "RL:8Xsj"}], "duid": "RL:gAET"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "11857762", "sentence": [{"charStart": 0, "charEnd": 137, "index": 0}, {"index": 1, "charEnd": 364, "charStart": 139}, {"index": 2, "charEnd": 541, "charStart": 366}, {"index": 3, "charEnd": 718, "charStart": 543}, {"index": 4, "charEnd": 829, "charStart": 720}, {"index": 5, "charEnd": 953, "charStart": 831}, {"index": 6, "charEnd": 1278, "charStart": 955}, {"index": 7, "charEnd": 1387, "charStart": 1280}, {"index": 8, "charEnd": 1476, "charStart": 1389}, {"index": 9, "charEnd": 1677, "charStart": 1478}], "text": "Phosphopeptide detection and sequencing by matrix-assisted laser desorption/ionization quadrupole time-of-flight tandem mass spectrometry. A prototype matrix-assisted laser desorption/ionization quadrupole time-of-flight (MALDI-TOF) tandem mass spectrometer was used to sequence a series of phosphotyrosine-, phosphothreonine- and phosphoserine-containing peptides. The high mass resolution and mass accuracy of the instrument allowed the localization of one, three or four phosphorylated amino acid residues in phosphopeptides up to 3.1 kDa. Tandem mass spectra of two different phosphotyrosine peptides permitted amino acid sequence determination and localization of one and three phosphorylation sites, respectively. The phosphotyrosine immonium ion at m/z 216.04 was observed in these MALDI low-energy CID tandem mass spectra. Elimination of phosphate groups was evident from the triphosphorylated peptide but not from the monophosphorylated species. The main fragmentation pathway for the synthetic phosphothreonine-containing peptide and for phosphoserine-containing peptides derived from beta-casein and ovalbumin was the beta-elimination of phosphoric acid with concomitant conversion of phosphoserine to dehydroalanine and phosphothreonine to 2-aminodehydrobutyric acid. Peptide fragment ions of the b- and y-type allowed, in all cases, the localization of phosphorylation sites. Ion signals corresponding to (b-17), (b-18) and (y-17) fragment ions were also observed. The abundant neutral loss of phosphoric acid (-98 Da) is useful for femtomole level detection of phosphoserine-peptides in crude peptide mixtures generated by gel in situ digestion of phosphoproteins.", "title": {"charStart": 0, "charEnd": 137}, "entity": {"RL:9Vqz": {"duid": "RL:9Vqz", "attribute": [], "entityType": "Trigger", "charEnd": 1019, "source": "RLIMS-P", "charStart": 1004, "entityId": [], "sentenceIndex": 6, "entityText": "phosphothreonine"}, "RL:X6RR": {"duid": "RL:X6RR", "attribute": [], "entityType": "Trigger", "charEnd": 1247, "source": "RLIMS-P", "charStart": 1232, "entityId": [], "sentenceIndex": 6, "entityText": "phosphothreonine"}, "RL:Gs77": {"duid": "RL:Gs77", "attribute": [], "entityType": "Trigger", "charEnd": 305, "source": "RLIMS-P", "charStart": 291, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:Zfn7": {"duid": "RL:Zfn7", "attribute": [], "entityType": "Trigger", "charEnd": 1208, "source": "RLIMS-P", "charStart": 1196, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:TGCZ": {"duid": "RL:TGCZ", "attribute": [], "entityType": "SiteOther", "charEnd": 703, "source": "RLIMS-P", "charStart": 683, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation sites"}, "RL:WsRU": {"duid": "RL:WsRU", "attribute": [], "entityType": "SiteOther", "charEnd": 1386, "source": "RLIMS-P", "charStart": 1366, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation sites"}, "RL:9MFu": {"duid": "RL:9MFu", "attribute": [], "entityType": "Trigger", "charEnd": 594, "source": "RLIMS-P", "charStart": 580, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:xZCY": {"duid": "RL:xZCY", "attribute": [], "entityType": "Trigger", "charEnd": 1676, "source": "RLIMS-P", "charStart": 1662, "entityId": [], "sentenceIndex": 9, "entityText": "phosphoproteins"}, "RL:4999": {"duid": "RL:4999", "attribute": [], "entityType": "Trigger", "charEnd": 1587, "source": "RLIMS-P", "charStart": 1575, "entityId": [], "sentenceIndex": 9, "entityText": "phosphoserine"}, "RL:UsHB": {"duid": "RL:UsHB", "attribute": [], "entityType": "Trigger", "charEnd": 526, "source": "RLIMS-P", "charStart": 512, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:aZrj": {"duid": "RL:aZrj", "attribute": [], "entityType": "Trigger", "charEnd": 487, "source": "RLIMS-P", "charStart": 474, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:JoBk": {"duid": "RL:JoBk", "attribute": [], "entityType": "Trigger", "charEnd": 1380, "source": "RLIMS-P", "charStart": 1366, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:VRNK": {"duid": "RL:VRNK", "attribute": [], "entityType": "Trigger", "charEnd": 1060, "source": "RLIMS-P", "charStart": 1048, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:cawP": {"duid": "RL:cawP", "attribute": [], "entityType": "Trigger", "charEnd": 900, "source": "RLIMS-P", "charStart": 884, "entityId": [], "sentenceIndex": 5, "entityText": "triphosphorylated"}, "RL:sMdx": {"duid": "RL:sMdx", "attribute": [], "entityType": "Trigger", "charEnd": 697, "source": "RLIMS-P", "charStart": 683, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:vm59": {"duid": "RL:vm59", "attribute": [], "entityType": "SiteOther", "charEnd": 908, "source": "RLIMS-P", "charStart": 902, "entityId": [], "sentenceIndex": 5, "entityText": "peptide"}, "RL:gFSz": {"duid": "RL:gFSz", "attribute": [], "entityType": "SiteOther", "charEnd": 526, "source": "RLIMS-P", "charStart": 512, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:McQX": {"duid": "RL:McQX", "attribute": [], "entityType": "SiteOther", "charEnd": 507, "source": "RLIMS-P", "charStart": 489, "entityId": [], "sentenceIndex": 2, "entityText": "amino acid residues"}, "RL:QmXo": {"duid": "RL:QmXo", "attribute": [], "entityType": "Trigger", "charEnd": 738, "source": "RLIMS-P", "charStart": 724, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:Vj5B": {"duid": "RL:Vj5B", "attribute": [], "entityType": "Trigger", "charEnd": 343, "source": "RLIMS-P", "charStart": 331, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:ZXwC": {"duid": "RL:ZXwC", "attribute": [], "entityType": "Trigger", "charEnd": 324, "source": "RLIMS-P", "charStart": 309, "entityId": [], "sentenceIndex": 1, "entityText": "phosphothreonine"}}, "mesh": ["Amino Acid Sequence", "Animals", "Caseins", "Cattle", "Chromatography, Affinity", "Molecular Sequence Data", "Ovalbumin", "Phosphopeptides", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Sequence Analysis, Protein", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"], "relation": {"RL:GCAB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4999"}], "duid": "RL:GCAB"}, "RL:Xoue": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Gs77"}], "duid": "RL:Xoue"}, "RL:mi3a": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Zfn7"}], "duid": "RL:mi3a"}, "RL:jwk3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:gFSz"}, {"role": "TRIGGER", "entity_duid": "RL:UsHB"}], "duid": "RL:jwk3"}, "RL:xbYR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:VRNK"}], "duid": "RL:xbYR"}, "RL:PKUb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZXwC"}], "duid": "RL:PKUb"}, "RL:5jy7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:X6RR"}], "duid": "RL:5jy7"}, "RL:C7pB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9Vqz"}], "duid": "RL:C7pB"}, "RL:5pHM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:WsRU"}, {"role": "TRIGGER", "entity_duid": "RL:JoBk"}], "duid": "RL:5pHM"}, "RL:ksUP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:vm59"}, {"role": "TRIGGER", "entity_duid": "RL:cawP"}], "duid": "RL:ksUP"}, "RL:Aadk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:McQX"}, {"role": "TRIGGER", "entity_duid": "RL:aZrj"}], "duid": "RL:Aadk"}, "RL:LTuZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QmXo"}], "duid": "RL:LTuZ"}, "RL:XkxY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:TGCZ"}, {"role": "TRIGGER", "entity_duid": "RL:sMdx"}], "duid": "RL:XkxY"}, "RL:FMNh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9MFu"}], "duid": "RL:FMNh"}, "RL:nY4w": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xZCY"}], "duid": "RL:nY4w"}, "RL:tZxc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Vj5B"}], "duid": "RL:tZxc"}}, "type": ["Journal Article"]}
{"docId": "19764811", "sentence": [{"charStart": 0, "charEnd": 105, "index": 0}, {"index": 1, "charEnd": 296, "charStart": 107}, {"index": 2, "charEnd": 505, "charStart": 298}, {"index": 3, "charEnd": 576, "charStart": 507}, {"index": 4, "charEnd": 714, "charStart": 578}, {"index": 5, "charEnd": 836, "charStart": 716}, {"index": 6, "charEnd": 899, "charStart": 838}, {"index": 7, "charEnd": 1112, "charStart": 901}, {"index": 8, "charEnd": 1209, "charStart": 1114}, {"index": 9, "charEnd": 1376, "charStart": 1211}, {"index": 10, "charEnd": 1545, "charStart": 1378}, {"index": 11, "charEnd": 1765, "charStart": 1547}], "text": "In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS. Protein phosphorylation plays an essential role in signal transduction pathways that regulate substrate and energy metabolism, contractile function, and muscle mass in human skeletal muscle. Abnormal phosphorylation of signaling enzymes has been identified in insulin-resistant muscle using phosphoepitope-specific antibodies, but its role in other skeletal muscle disorders remains largely unknown. This may be in part due to insufficient knowledge of relevant targets. Here, we therefore present the first large-scale in vivo phosphoproteomic study of human skeletal muscle from 3 lean, healthy volunteers. Trypsin digestion of 3-5 mg human skeletal muscle protein was followed by phosphopeptide enrichment using SCX and TiO(2). The resulting phosphopeptides were analyzed by HPLC-ESI-MS/MS. Using this unbiased approach, we identified 306 distinct in vivo phosphorylation sites in 127 proteins, including 240 phosphoserines, 53 phosphothreonines, and 13 phosphotyrosines in at least 2 out of 3 subjects. In addition, 61 ambiguous phosphorylation sites were identified in at least 2 out of 3 subjects. The majority of phosphoproteins detected are involved in sarcomeric function, excitation-contraction coupling (the Ca(2+)-cycle), glycolysis, and glycogen metabolism. Of particular interest, we identified multiple novel phosphorylation sites on several sarcomeric Z-disk proteins known to be involved in signaling and muscle disorders. These results provide numerous new targets for the investigation of human skeletal muscle phosphoproteins in health and disease and demonstrate feasibility of phosphoproteomics research of human skeletal muscle in vivo.", "title": {"charStart": 0, "charEnd": 105}, "entity": {"RL:kCit": {"duid": "RL:kCit", "attribute": [], "entityType": "SiteOther", "charEnd": 866, "source": "RLIMS-P", "charStart": 852, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:TTbv": {"duid": "RL:TTbv", "attribute": [], "entityType": "Protein", "charEnd": 1651, "source": "RLIMS-P", "charStart": 1615, "entityId": [], "sentenceIndex": 11, "entityText": "human skeletal muscle phosphoproteins"}, "RL:RUDj": {"duid": "RL:RUDj", "attribute": [], "entityType": "SiteOther", "charEnd": 1451, "source": "RLIMS-P", "charStart": 1431, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation sites"}, "RL:Eu7F": {"duid": "RL:Eu7F", "attribute": [], "entityType": "SiteOther", "charEnd": 986, "source": "RLIMS-P", "charStart": 966, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation sites"}, "RL:2qUZ": {"duid": "RL:2qUZ", "attribute": [], "entityType": "Trigger", "charEnd": 1651, "source": "RLIMS-P", "charStart": 1637, "entityId": [], "sentenceIndex": 11, "entityText": "phosphoproteins"}, "RL:4PPw": {"duid": "RL:4PPw", "attribute": [], "entityType": "Trigger", "charEnd": 1054, "source": "RLIMS-P", "charStart": 1038, "entityId": [], "sentenceIndex": 7, "entityText": "phosphothreonines"}, "RL:petT": {"duid": "RL:petT", "attribute": [], "entityType": "Trigger", "charEnd": 1445, "source": "RLIMS-P", "charStart": 1431, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:8SXS": {"duid": "RL:8SXS", "attribute": [], "entityType": "SiteOther", "charEnd": 1160, "source": "RLIMS-P", "charStart": 1140, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation sites"}, "RL:dtym": {"duid": "RL:dtym", "attribute": [], "entityType": "Trigger", "charEnd": 129, "source": "RLIMS-P", "charStart": 115, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:GqUi": {"duid": "RL:GqUi", "attribute": [], "entityType": "Trigger", "charEnd": 980, "source": "RLIMS-P", "charStart": 966, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:j8S2": {"duid": "RL:j8S2", "attribute": [], "entityType": "Trigger", "charEnd": 1079, "source": "RLIMS-P", "charStart": 1064, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosines"}, "RL:FdS6": {"duid": "RL:FdS6", "attribute": [], "entityType": "Trigger", "charEnd": 1154, "source": "RLIMS-P", "charStart": 1140, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:3N7J": {"duid": "RL:3N7J", "attribute": [], "entityType": "Trigger", "charEnd": 866, "source": "RLIMS-P", "charStart": 852, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:UTnV": {"duid": "RL:UTnV", "attribute": [], "entityType": "Protein", "charEnd": 1489, "source": "RLIMS-P", "charStart": 1475, "entityId": [], "sentenceIndex": 10, "entityText": "Z-disk proteins"}, "RL:r7Ej": {"duid": "RL:r7Ej", "attribute": [], "entityType": "Trigger", "charEnd": 1032, "source": "RLIMS-P", "charStart": 1019, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserines"}, "RL:Yfmx": {"duid": "RL:Yfmx", "attribute": [], "entityType": "Trigger", "charEnd": 1241, "source": "RLIMS-P", "charStart": 1227, "entityId": [], "sentenceIndex": 9, "entityText": "phosphoproteins"}, "RL:Dvbp": {"duid": "RL:Dvbp", "attribute": [], "entityType": "Trigger", "charEnd": 321, "source": "RLIMS-P", "charStart": 307, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}}, "mesh": ["Adult", "Amino Acid Sequence", "Chromatography, High Pressure Liquid", "Computational Biology", "Humans", "Male", "Middle Aged", "Molecular Sequence Data", "Muscle Proteins", "Muscle, Skeletal", "Phosphopeptides", "Phosphorylation", "Proteome", "Proteomics", "Spectrometry, Mass, Electrospray Ionization", "Tandem Mass Spectrometry"], "relation": {"RL:KXkr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:r7Ej"}], "duid": "RL:KXkr"}, "RL:qrm3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kCit"}, {"role": "TRIGGER", "entity_duid": "RL:3N7J"}], "duid": "RL:qrm3"}, "RL:eVYi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Eu7F"}, {"role": "TRIGGER", "entity_duid": "RL:GqUi"}], "duid": "RL:eVYi"}, "RL:75uy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dtym"}], "duid": "RL:75uy"}, "RL:6aAR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8SXS"}, {"role": "TRIGGER", "entity_duid": "RL:FdS6"}], "duid": "RL:6aAR"}, "RL:6CWM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Yfmx"}], "duid": "RL:6CWM"}, "RL:X2dV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Dvbp"}], "duid": "RL:X2dV"}, "RL:pPc6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:UTnV"}, {"role": "SITE_OTHER", "entity_duid": "RL:RUDj"}, {"role": "TRIGGER", "entity_duid": "RL:petT"}], "duid": "RL:pPc6"}, "RL:E3dS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4PPw"}], "duid": "RL:E3dS"}, "RL:uScd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:TTbv"}, {"role": "TRIGGER", "entity_duid": "RL:2qUZ"}], "duid": "RL:uScd"}, "RL:iMws": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:j8S2"}], "duid": "RL:iMws"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}
{"docId": "8504096", "sentence": [{"charStart": 0, "charEnd": 36, "index": 0}, {"index": 1, "charEnd": 40, "charStart": 38}, {"index": 2, "charEnd": 160, "charStart": 42}, {"index": 3, "charEnd": 373, "charStart": 162}, {"index": 4, "charEnd": 521, "charStart": 375}, {"index": 5, "charEnd": 696, "charStart": 523}, {"index": 6, "charEnd": 869, "charStart": 698}, {"index": 7, "charEnd": 964, "charStart": 871}, {"index": 8, "charEnd": 1032, "charStart": 966}, {"index": 9, "charEnd": 1174, "charStart": 1034}, {"index": 10, "charEnd": 1390, "charStart": 1176}], "text": "Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. Autophosphorylation sites of the human insulin receptor were identified by microsequence analysis of 19 discrete tryptic [32P]phosphopeptides, purified from the autophosphorylated cytoplasmic kinase domain (CKD). Seventeen phosphopeptides were generated by cleavage at Arg and/or Lys, but two phosphopeptides were generated reproducibly by anomalous cleavages. Two new sites were identified in the juxtamembrane region of the intact insulin receptor beta-subunit (the amino terminus of the CKD), including phosphotyrosines 965 and 972. Three sites in the central region, including phosphotyrosines 1158, 1162, and 1163, were identified from six phosphopeptides; tyrosine at 1158 was the least phosphorylated. Monophosphopeptides contained phosphotyrosine at either residue 1158 or 1163, but not at 1162. Bisphosphorylation included phosphotyrosines only at 1162 and 1163. The two autophosphorylation sites near the carboxy terminus were found in seven phosphopeptides, including phosphotyrosines at 1328 and 1334. When mapped by reverse-phase high-performance liquid chromatography, these phosphopeptides eluted in the order central domain, first; carboxy-terminal region, second; and juxtamembrane (amino-terminal) domain, last.", "title": {"charStart": 0, "charEnd": 160}, "entity": {"RL:e5Zf": {"duid": "RL:e5Zf", "attribute": [], "entityType": "SiteOther", "charEnd": 186, "source": "RLIMS-P", "charStart": 162, "entityId": [], "sentenceIndex": 3, "entityText": "Autophosphorylation sites"}, "RL:DYqd": {"duid": "RL:DYqd", "attribute": [], "entityType": "Trigger", "charEnd": 1009, "source": "RLIMS-P", "charStart": 994, "entityId": [], "sentenceIndex": 8, "entityText": "phosphotyrosines"}, "RL:mv8h": {"duid": "RL:mv8h", "attribute": [], "entityType": "Trigger", "charEnd": 1128, "source": "RLIMS-P", "charStart": 1114, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:zXK4": {"duid": "RL:zXK4", "attribute": [], "entityType": "Trigger", "charEnd": 1060, "source": "RLIMS-P", "charStart": 1042, "entityId": [], "sentenceIndex": 9, "entityText": "autophosphorylation"}, "RL:pL8J": {"duid": "RL:pL8J", "attribute": [], "entityType": "SiteOther", "charEnd": 821, "source": "RLIMS-P", "charStart": 807, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:YNh6": {"duid": "RL:YNh6", "attribute": [], "entityType": "Trigger", "charEnd": 77, "source": "RLIMS-P", "charStart": 59, "entityId": [], "sentenceIndex": 2, "entityText": "autophosphorylation"}, "RL:MPN2": {"duid": "RL:MPN2", "attribute": [], "entityType": "Trigger", "charEnd": 399, "source": "RLIMS-P", "charStart": 385, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:cpjb": {"duid": "RL:cpjb", "attribute": [], "entityType": "Trigger", "charEnd": 889, "source": "RLIMS-P", "charStart": 871, "entityId": [], "sentenceIndex": 7, "entityText": "Monophosphopeptides"}, "RL:3Nay": {"duid": "RL:3Nay", "attribute": [], "entityType": "Trigger", "charEnd": 35, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "autophosphorylation"}, "RL:zRG9": {"duid": "RL:zRG9", "attribute": [], "entityType": "Protein", "charEnd": 15, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Insulin receptor"}, "RL:CZb6": {"duid": "RL:CZb6", "attribute": [], "entityType": "Trigger", "charEnd": 180, "source": "RLIMS-P", "charStart": 162, "entityId": [], "sentenceIndex": 3, "entityText": "Autophosphorylation"}, "RL:2tu2": {"duid": "RL:2tu2", "attribute": [], "entityType": "Trigger", "charEnd": 915, "source": "RLIMS-P", "charStart": 901, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosine"}, "RL:bn9H": {"duid": "RL:bn9H", "attribute": [], "entityType": "Trigger", "charEnd": 683, "source": "RLIMS-P", "charStart": 668, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosines"}, "RL:nnny": {"duid": "RL:nnny", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 915, "source": "RLIMS-P", "charStart": 908, "entityId": [], "sentenceIndex": 7, "entityText": "tyrosine"}, "RL:C9cA": {"duid": "RL:C9cA", "attribute": [], "entityType": "Trigger", "charEnd": 340, "source": "RLIMS-P", "charStart": 323, "entityId": [], "sentenceIndex": 3, "entityText": "autophosphorylated"}, "RL:uNNY": {"duid": "RL:uNNY", "attribute": [], "entityType": "Trigger", "charEnd": 302, "source": "RLIMS-P", "charStart": 288, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:YrY8": {"duid": "RL:YrY8", "attribute": [], "entityType": "Trigger", "charEnd": 821, "source": "RLIMS-P", "charStart": 807, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:WSy2": {"duid": "RL:WSy2", "attribute": [], "entityType": "Protein", "charEnd": 216, "source": "RLIMS-P", "charStart": 201, "entityId": [], "sentenceIndex": 3, "entityText": "insulin receptor"}, "RL:yA4D": {"duid": "RL:yA4D", "attribute": [], "entityType": "Trigger", "charEnd": 1265, "source": "RLIMS-P", "charStart": 1251, "entityId": [], "sentenceIndex": 10, "entityText": "phosphopeptides"}, "RL:Vhdo": {"duid": "RL:Vhdo", "attribute": [], "entityType": "SiteOther", "charEnd": 889, "source": "RLIMS-P", "charStart": 871, "entityId": [], "sentenceIndex": 7, "entityText": "Monophosphopeptides"}, "RL:qg5C": {"duid": "RL:qg5C", "attribute": [], "entityType": "SiteOther", "charEnd": 469, "source": "RLIMS-P", "charStart": 455, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:YFtw": {"duid": "RL:YFtw", "attribute": [], "entityType": "Trigger", "charEnd": 1156, "source": "RLIMS-P", "charStart": 1141, "entityId": [], "sentenceIndex": 9, "entityText": "phosphotyrosines"}, "RL:WeeB": {"duid": "RL:WeeB", "attribute": [], "entityType": "SiteOther", "charEnd": 1128, "source": "RLIMS-P", "charStart": 1114, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:qSoN": {"duid": "RL:qSoN", "attribute": [], "entityType": "SiteOther", "charEnd": 372, "source": "RLIMS-P", "charStart": 342, "entityId": [], "sentenceIndex": 3, "entityText": "cytoplasmic kinase domain (CKD)"}, "RL:FfgY": {"duid": "RL:FfgY", "attribute": [], "entityType": "SiteOther", "charEnd": 83, "source": "RLIMS-P", "charStart": 59, "entityId": [], "sentenceIndex": 2, "entityText": "autophosphorylation sites"}, "RL:4bjo": {"duid": "RL:4bjo", "attribute": [], "entityType": "Trigger", "charEnd": 469, "source": "RLIMS-P", "charStart": 455, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:yTNw": {"duid": "RL:yTNw", "attribute": [], "entityType": "SiteOther", "charEnd": 302, "source": "RLIMS-P", "charStart": 283, "entityId": [], "sentenceIndex": 3, "entityText": "[32P]phosphopeptides"}, "RL:3Zgr": {"duid": "RL:3Zgr", "attribute": [], "entityType": "SiteOther", "charEnd": 1066, "source": "RLIMS-P", "charStart": 1042, "entityId": [], "sentenceIndex": 9, "entityText": "autophosphorylation sites"}, "RL:RSJr": {"duid": "RL:RSJr", "attribute": [], "entityType": "Trigger", "charEnd": 983, "source": "RLIMS-P", "charStart": 966, "entityId": [], "sentenceIndex": 8, "entityText": "Bisphosphorylation"}, "RL:hghV": {"duid": "RL:hghV", "attribute": [], "entityType": "SiteOther", "charEnd": 399, "source": "RLIMS-P", "charStart": 385, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:83x7": {"duid": "RL:83x7", "attribute": [], "entityType": "SiteOther", "charEnd": 946, "source": "RLIMS-P", "charStart": 920, "entityId": [], "sentenceIndex": 7, "entityText": "either residue 1158 or 1163"}}, "mesh": ["Adenosine Triphosphate", "Amino Acid Sequence", "Animals", "Baculoviridae", "Binding Sites", "Cell Line", "Cell Membrane", "Chromatography, High Pressure Liquid", "Cytoplasm", "Humans", "Molecular Sequence Data", "Moths", "Phosphates", "Phosphoproteins", "Phosphorylation", "Protein Kinases", "Receptor, Insulin", "Recombinant Proteins", "Sequence Analysis"], "relation": {"RL:m3rS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:yTNw"}, {"role": "TRIGGER", "entity_duid": "RL:uNNY"}], "duid": "RL:m3rS"}, "RL:P6Qv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:pL8J"}, {"role": "TRIGGER", "entity_duid": "RL:YrY8"}], "duid": "RL:P6Qv"}, "RL:M7nP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:zRG9"}, {"role": "KINASE", "entity_duid": "RL:zRG9"}, {"role": "TRIGGER", "entity_duid": "RL:3Nay"}], "duid": "RL:M7nP"}, "RL:v7dr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:WeeB"}, {"role": "TRIGGER", "entity_duid": "RL:mv8h"}], "duid": "RL:v7dr"}, "RL:pjsE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:bn9H"}], "duid": "RL:pjsE"}, "RL:iPBF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:FfgY"}, {"role": "TRIGGER", "entity_duid": "RL:YNh6"}], "duid": "RL:iPBF"}, "RL:iBfV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:hghV"}, {"role": "TRIGGER", "entity_duid": "RL:MPN2"}], "duid": "RL:iBfV"}, "RL:eAXZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:WSy2"}, {"role": "KINASE", "entity_duid": "RL:WSy2"}, {"role": "SITE_OTHER", "entity_duid": "RL:e5Zf"}, {"role": "TRIGGER", "entity_duid": "RL:CZb6"}], "duid": "RL:eAXZ"}, "RL:TWXi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:WSy2"}, {"role": "KINASE", "entity_duid": "RL:WSy2"}, {"role": "SITE", "entity_duid": "RL:nnny"}, {"role": "SITE_OTHER", "entity_duid": "RL:83x7"}, {"role": "SITE_OTHER", "entity_duid": "RL:3Zgr"}, {"role": "TRIGGER", "entity_duid": "RL:zXK4"}], "duid": "RL:TWXi"}, "RL:wc6E": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Vhdo"}, {"role": "TRIGGER", "entity_duid": "RL:cpjb"}], "duid": "RL:wc6E"}, "RL:zJVe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:YFtw"}], "duid": "RL:zJVe"}, "RL:yE3u": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RSJr"}], "duid": "RL:yE3u"}, "RL:yRzx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yA4D"}], "duid": "RL:yRzx"}, "RL:SpQN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2tu2"}], "duid": "RL:SpQN"}, "RL:iTic": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DYqd"}], "duid": "RL:iTic"}, "RL:w6FL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:qSoN"}, {"role": "TRIGGER", "entity_duid": "RL:C9cA"}], "duid": "RL:w6FL"}, "RL:xrog": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:qg5C"}, {"role": "TRIGGER", "entity_duid": "RL:4bjo"}], "duid": "RL:xrog"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "17288512", "sentence": [{"charStart": 0, "charEnd": 72, "index": 0}, {"index": 1, "charEnd": 233, "charStart": 74}, {"index": 2, "charEnd": 571, "charStart": 235}, {"index": 3, "charEnd": 749, "charStart": 573}, {"index": 4, "charEnd": 1008, "charStart": 751}, {"index": 5, "charEnd": 1204, "charStart": 1010}], "text": "Quantitative proteomic approaches for studying phosphotyrosine signaling. Protein tyrosine phosphorylation is a fundamental mechanism for controlling many aspects of cellular processes, as well as aspects of human health and diseases. Compared with phosphoserine and phosphothreonine, phosphotyrosine signaling is more tightly regulated, but often more challenging to characterize, due to significantly lower levels of tyrosine phosphorylation (i.e., a relative abundance of 1800:200:1 was estimated for phosphoserine/phosphothreonine/phosphotyrosine in vertebrate cells). In this review, we outline recent advances in analytical methodologies for enrichment, identification and accurate quantitation of tyrosine-phosphorylated proteins and peptides. Advances in antibody-based technologies, capillary liquid chromatography coupled with mass spectrometry, and various stable isotope labeling strategies are discussed, as well as non-mass spectrometry-based methods, such as those using protein/peptide arrays. As a result of these advances, powerful tools now have the power to crack signal transduction codes at the system level, and provide a basis for discovering novel drug targets for human diseases.", "title": {"charStart": 0, "charEnd": 72}, "entity": {"RL:BAYz": {"duid": "RL:BAYz", "attribute": [], "entityType": "Trigger", "charEnd": 516, "source": "RLIMS-P", "charStart": 504, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:W5Z8": {"duid": "RL:W5Z8", "attribute": [], "entityType": "Trigger", "charEnd": 299, "source": "RLIMS-P", "charStart": 285, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:nqYM": {"duid": "RL:nqYM", "attribute": [], "entityType": "Trigger", "charEnd": 442, "source": "RLIMS-P", "charStart": 428, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:hbyw": {"duid": "RL:hbyw", "attribute": [], "entityType": "Trigger", "charEnd": 726, "source": "RLIMS-P", "charStart": 713, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:4Vp3": {"duid": "RL:4Vp3", "attribute": [], "entityType": "Trigger", "charEnd": 61, "source": "RLIMS-P", "charStart": 47, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}, "RL:qhJn": {"duid": "RL:qhJn", "attribute": [], "entityType": "Trigger", "charEnd": 261, "source": "RLIMS-P", "charStart": 249, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:7X9k": {"duid": "RL:7X9k", "attribute": [], "entityType": "Trigger", "charEnd": 105, "source": "RLIMS-P", "charStart": 91, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}}, "mesh": ["Animals", "Chemistry Techniques, Analytical", "Humans", "Phosphoproteins", "Phosphorylation", "Phosphotyrosine", "Proteomics", "Signal Transduction"], "relation": {"RL:vaDL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:BAYz"}], "duid": "RL:vaDL"}, "RL:a9eC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4Vp3"}], "duid": "RL:a9eC"}, "RL:pp9d": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qhJn"}], "duid": "RL:pp9d"}, "RL:q93S": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:nqYM"}], "duid": "RL:q93S"}, "RL:bum6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:hbyw"}], "duid": "RL:bum6"}, "RL:EbsK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:W5Z8"}], "duid": "RL:EbsK"}, "RL:eKTr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7X9k"}], "duid": "RL:eKTr"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Review"]}
{"docId": "2109702", "sentence": [{"charStart": 0, "charEnd": 77, "index": 0}, {"index": 1, "charEnd": 249, "charStart": 79}, {"index": 2, "charEnd": 495, "charStart": 251}, {"index": 3, "charEnd": 757, "charStart": 497}, {"index": 4, "charEnd": 838, "charStart": 759}, {"index": 5, "charEnd": 1026, "charStart": 840}], "text": "Expression of c-myc gene in human ovary carcinoma cells treated with vanadate. The widely accepted hypothesis of vanadate action on cells postulates that this ion inhibits protein phosphatase(s) that dephosphorylates protein phosphotyrosine residues. This inhibition causes tyrosine hyperphosphorylation of cell proteins followed by changes in physiological action of phosphoproteins resulting in stimulation of cell proliferation, expression of protooncogenes, and transient cell transformation. We have found that treatment of human ovary carcinoma (CaOv) cells with vanadate causes the increase in total protein phosphorylation from 1.5- to 2.0-fold whereas the ratio between phosphoserine, phosphothreonine, and phosphotyrosine content remains unchanged. At the same time, enhancement of c-myc gene expression (not c-fos) was observed. Hence, the increase in the ratio of phosphotyrosine to phosphoserine and phosphothreonine is not an obligatory intermediate stage before vanadate-dependent activation of c-myc expression.", "title": {"charStart": 0, "charEnd": 77}, "entity": {"RL:HfyG": {"duid": "RL:HfyG", "attribute": [], "entityType": "Trigger", "charEnd": 890, "source": "RLIMS-P", "charStart": 876, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:W6Jm": {"duid": "RL:W6Jm", "attribute": [], "entityType": "Trigger", "charEnd": 629, "source": "RLIMS-P", "charStart": 615, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:eSc6": {"duid": "RL:eSc6", "attribute": [], "entityType": "Trigger", "charEnd": 907, "source": "RLIMS-P", "charStart": 895, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:an9d": {"duid": "RL:an9d", "attribute": [], "entityType": "Trigger", "charEnd": 691, "source": "RLIMS-P", "charStart": 679, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:NbzC": {"duid": "RL:NbzC", "attribute": [], "entityType": "Trigger", "charEnd": 239, "source": "RLIMS-P", "charStart": 225, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:6apX": {"duid": "RL:6apX", "attribute": [], "entityType": "Trigger", "charEnd": 382, "source": "RLIMS-P", "charStart": 368, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoproteins"}, "RL:ZxQ5": {"duid": "RL:ZxQ5", "attribute": [], "entityType": "Trigger", "charEnd": 302, "source": "RLIMS-P", "charStart": 283, "entityId": [], "sentenceIndex": 2, "entityText": "hyperphosphorylation"}}, "mesh": ["Cell Transformation, Neoplastic", "Female", "Gene Expression", "Humans", "Ovarian Neoplasms", "Phosphorylation", "Proto-Oncogene Proteins", "Proto-Oncogene Proteins c-fos", "Proto-Oncogene Proteins c-myc", "Tumor Cells, Cultured", "Vanadates"], "relation": {"RL:h8bL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:an9d"}], "duid": "RL:h8bL"}, "RL:Ym4w": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:W6Jm"}], "duid": "RL:Ym4w"}, "RL:gcB3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NbzC"}], "duid": "RL:gcB3"}, "RL:s9hr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:HfyG"}], "duid": "RL:s9hr"}, "RL:fq7V": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:6apX"}], "duid": "RL:fq7V"}, "RL:Xrop": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:eSc6"}], "duid": "RL:Xrop"}, "RL:b2rV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZxQ5"}], "duid": "RL:b2rV"}}, "type": ["Journal Article"]}
{"docId": "7687226", "sentence": [{"charStart": 0, "charEnd": 99, "index": 0}, {"index": 1, "charEnd": 283, "charStart": 101}, {"index": 2, "charEnd": 374, "charStart": 285}, {"index": 3, "charEnd": 531, "charStart": 376}, {"index": 4, "charEnd": 720, "charStart": 533}, {"index": 5, "charEnd": 908, "charStart": 722}, {"index": 6, "charEnd": 1048, "charStart": 910}, {"index": 7, "charEnd": 1207, "charStart": 1050}, {"index": 8, "charEnd": 1358, "charStart": 1209}, {"index": 9, "charEnd": 1439, "charStart": 1360}], "text": "Strategies for nonradioactive methods in the localization of phosphorylated amino acids in proteins. Identification of O-phosphorylated amino acids within the primary structure of regulatory proteins is important in understanding the mechanisms by which their functions are regulated. In many cases radioactive labeling with [32P]phosphate is tedious or sometimes impossible. Therefore, we have established a series of new non-radioactive methods that permit the localization of phosphoserine, phosphothreonine, and phosphotyrosine. After partial hydrolysis of a phosphopeptide or phosphoprotein, phosphoserine, phosphothreonine, or phosphotyrosine are determined by capillary electrophoresis as their dabsyl-derivatives. Chemical modification transforms phosphoserine or phosphothreonine to S-ethyl-cysteine or beta-methyl-S-ethyl-cysteine, respectively, allowing their localization during sequence analysis. We apply solid-phase sequencing to overcome the limitations of the gas-phase sequenator in the case of phosphotyrosine-containing peptides. Liquid chromatography on-line connected to an electrospray mass spectrometer is a powerful new method of increasing importance in the protein chemistry field. It is especially well suited for identification of phosphoserine- or phosphothreonine-containing peptides in a proteolytic digest of a phosphoprotein. In this article we will describe how to work with these new methods practically.", "title": {"charStart": 0, "charEnd": 99}, "entity": {"RL:Qnnx": {"duid": "RL:Qnnx", "attribute": [], "entityType": "Trigger", "charEnd": 134, "source": "RLIMS-P", "charStart": 121, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:7sQ3": {"duid": "RL:7sQ3", "attribute": [], "entityType": "SiteOther", "charEnd": 576, "source": "RLIMS-P", "charStart": 563, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:ztVN": {"duid": "RL:ztVN", "attribute": [], "entityType": "Trigger", "charEnd": 767, "source": "RLIMS-P", "charStart": 755, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:bhmp": {"duid": "RL:bhmp", "attribute": [], "entityType": "Trigger", "charEnd": 74, "source": "RLIMS-P", "charStart": 61, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:Ucho": {"duid": "RL:Ucho", "attribute": [], "entityType": "Trigger", "charEnd": 1027, "source": "RLIMS-P", "charStart": 1013, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:GQjP": {"duid": "RL:GQjP", "attribute": [], "entityType": "Trigger", "charEnd": 1357, "source": "RLIMS-P", "charStart": 1344, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoprotein"}, "RL:hvGQ": {"duid": "RL:hvGQ", "attribute": [], "entityType": "SiteOther", "charEnd": 146, "source": "RLIMS-P", "charStart": 136, "entityId": [], "sentenceIndex": 1, "entityText": "amino acids"}, "RL:guKC": {"duid": "RL:guKC", "attribute": [], "entityType": "Trigger", "charEnd": 609, "source": "RLIMS-P", "charStart": 597, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:b3di": {"duid": "RL:b3di", "attribute": [], "entityType": "Trigger", "charEnd": 1272, "source": "RLIMS-P", "charStart": 1260, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:bPiV": {"duid": "RL:bPiV", "attribute": [], "entityType": "Trigger", "charEnd": 576, "source": "RLIMS-P", "charStart": 563, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:avTV": {"duid": "RL:avTV", "attribute": [], "entityType": "Protein", "charEnd": 1357, "source": "RLIMS-P", "charStart": 1342, "entityId": [], "sentenceIndex": 8, "entityText": "a phosphoprotein"}, "RL:vvV4": {"duid": "RL:vvV4", "attribute": [], "entityType": "Trigger", "charEnd": 1293, "source": "RLIMS-P", "charStart": 1278, "entityId": [], "sentenceIndex": 8, "entityText": "phosphothreonine"}, "RL:epyB": {"duid": "RL:epyB", "attribute": [], "entityType": "SiteOther", "charEnd": 86, "source": "RLIMS-P", "charStart": 76, "entityId": [], "sentenceIndex": 0, "entityText": "amino acids"}, "RL:x67R": {"duid": "RL:x67R", "attribute": [], "entityType": "Trigger", "charEnd": 491, "source": "RLIMS-P", "charStart": 479, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}}, "mesh": ["Amino Acid Sequence", "Amino Acids", "Mass Spectrometry", "Molecular Sequence Data", "Phosphoproteins", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Tyrosine"], "relation": {"RL:UtYY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ucho"}], "duid": "RL:UtYY"}, "RL:dzQt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:avTV"}, {"role": "TRIGGER", "entity_duid": "RL:GQjP"}], "duid": "RL:dzQt"}, "RL:6uMK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:guKC"}], "duid": "RL:6uMK"}, "RL:zRTR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:epyB"}, {"role": "TRIGGER", "entity_duid": "RL:bhmp"}], "duid": "RL:zRTR"}, "RL:RC33": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:hvGQ"}, {"role": "TRIGGER", "entity_duid": "RL:Qnnx"}], "duid": "RL:RC33"}, "RL:k87K": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:b3di"}], "duid": "RL:k87K"}, "RL:FrwW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:x67R"}], "duid": "RL:FrwW"}, "RL:Tn3N": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:vvV4"}], "duid": "RL:Tn3N"}, "RL:i5VC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7sQ3"}, {"role": "TRIGGER", "entity_duid": "RL:bPiV"}], "duid": "RL:i5VC"}, "RL:c5nz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ztVN"}], "duid": "RL:c5nz"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}
{"docId": "6162272", "sentence": [{"charStart": 0, "charEnd": 109, "index": 0}], "text": "Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus.", "title": {"charStart": 0, "charEnd": 109}, "entity": {"RL:Dhze": {"duid": "RL:Dhze", "attribute": [], "entityType": "Trigger", "charEnd": 28, "source": "RLIMS-P", "charStart": 16, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}}, "mesh": ["Animals", "Cells, Cultured", "Cricetinae", "Kidney", "Mesocricetus", "Phosphoproteins", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Proteins", "Tyrosine", "Vesicular stomatitis Indiana virus", "Viral Proteins"], "relation": {"RL:hG9j": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Dhze"}], "duid": "RL:hG9j"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "24723360", "sentence": [{"charStart": 0, "charEnd": 137, "index": 0}, {"index": 1, "charEnd": 242, "charStart": 139}, {"index": 2, "charEnd": 426, "charStart": 244}, {"index": 3, "charEnd": 687, "charStart": 428}, {"index": 4, "charEnd": 885, "charStart": 689}, {"index": 5, "charEnd": 1102, "charStart": 887}, {"index": 6, "charEnd": 1213, "charStart": 1104}, {"index": 7, "charEnd": 1451, "charStart": 1215}, {"index": 8, "charEnd": 1556, "charStart": 1453}], "text": "Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer. Altered protein phosphorylation is a feature of many human cancers that can be targeted therapeutically. Phosphopeptide enrichment is a critical step for maximizing the depth of phosphoproteome coverage by MS, but remains challenging for tissue specimens because of their high complexity. We describe the first analysis of a tissue phosphoproteome using polymer-based metal ion affinity capture (PolyMAC), a nanopolymer that has excellent yield and specificity for phosphopeptide enrichment, on a transgenic mouse model of HER2-driven breast cancer. By combining phosphotyrosine immunoprecipitation with PolyMAC, 411 unique peptides with 139 phosphotyrosine, 45 phosphoserine, and 29 phosphothreonine sites were identified from five LC-MS/MS runs. Combining reverse phase liquid chromatography fractionation at pH 8.0 with PolyMAC identified 1571 unique peptides with 1279 phosphoserine, 213 phosphothreonine, and 21 phosphotyrosine sites from eight LC-MS/MS runs. Linear motif analysis indicated that many of the phosphosites correspond to well-known phosphorylation motifs. Analysis of the tyrosine phosphoproteome with the Drug Gene Interaction database uncovered a network of potential therapeutic targets centered on Src family kinases with inhibitors that are either FDA-approved or in clinical development. These results demonstrate that PolyMAC is well suited for phosphoproteomic analysis of tissue specimens.", "title": {"charStart": 0, "charEnd": 137}, "entity": {"RL:kfo4": {"duid": "RL:kfo4", "attribute": [], "entityType": "Trigger", "charEnd": 1046, "source": "RLIMS-P", "charStart": 1031, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:mQCY": {"duid": "RL:mQCY", "attribute": [], "entityType": "Trigger", "charEnd": 1024, "source": "RLIMS-P", "charStart": 1012, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:wMFM": {"duid": "RL:wMFM", "attribute": [], "entityType": "SiteOther", "charEnd": 1212, "source": "RLIMS-P", "charStart": 1191, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation motifs"}, "RL:VbE8": {"duid": "RL:VbE8", "attribute": [], "entityType": "Trigger", "charEnd": 795, "source": "RLIMS-P", "charStart": 781, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:TX5W": {"duid": "RL:TX5W", "attribute": [], "entityType": "Trigger", "charEnd": 169, "source": "RLIMS-P", "charStart": 155, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:r2nD": {"duid": "RL:r2nD", "attribute": [], "entityType": "Trigger", "charEnd": 813, "source": "RLIMS-P", "charStart": 801, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:9WXB": {"duid": "RL:9WXB", "attribute": [], "entityType": "Trigger", "charEnd": 716, "source": "RLIMS-P", "charStart": 702, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:5GXR": {"duid": "RL:5GXR", "attribute": [], "entityType": "Trigger", "charEnd": 1205, "source": "RLIMS-P", "charStart": 1191, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:7aFi": {"duid": "RL:7aFi", "attribute": [], "entityType": "Trigger", "charEnd": 838, "source": "RLIMS-P", "charStart": 823, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:jFbX": {"duid": "RL:jFbX", "attribute": [], "entityType": "Trigger", "charEnd": 1070, "source": "RLIMS-P", "charStart": 1056, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}}, "mesh": ["Animals", "Chromatography, Affinity", "Female", "Male", "Mammary Neoplasms, Experimental", "Mice", "Mice, Transgenic", "Phosphoamino Acids", "Phosphopeptides", "Proteomics", "Receptor, ErbB-2", "Tandem Mass Spectrometry", "Tissue Array Analysis"], "relation": {"RL:bDeZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9WXB"}], "duid": "RL:bDeZ"}, "RL:odfu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:wMFM"}, {"role": "TRIGGER", "entity_duid": "RL:5GXR"}], "duid": "RL:odfu"}, "RL:R7pv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mQCY"}], "duid": "RL:R7pv"}, "RL:rVcg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:r2nD"}], "duid": "RL:rVcg"}, "RL:8QbR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7aFi"}], "duid": "RL:8QbR"}, "RL:Au2t": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jFbX"}], "duid": "RL:Au2t"}, "RL:Yjyt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:VbE8"}], "duid": "RL:Yjyt"}, "RL:MAYt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kfo4"}], "duid": "RL:MAYt"}, "RL:ZcPq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TX5W"}], "duid": "RL:ZcPq"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}
{"docId": "6187758", "sentence": [{"charStart": 0, "charEnd": 159, "index": 0}], "text": "Dansylation and high-performance liquid chromatographic separation of phosphoserine, phosphothreonine and phosphotyrosine from 32P-labeled protein hydrolyzates.", "title": {"charStart": 0, "charEnd": 159}, "entity": {"RL:XP2V": {"duid": "RL:XP2V", "attribute": [], "entityType": "Trigger", "charEnd": 82, "source": "RLIMS-P", "charStart": 70, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}}, "mesh": ["Animals", "Binding Sites", "Chromatography, High Pressure Liquid", "Dansyl Compounds", "Hydrolysis", "In Vitro Techniques", "Isotope Labeling", "Phosphorus Radioisotopes", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Proteins", "Rats", "Serine", "Threonine", "Tyrosine"], "relation": {"RL:nZSx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:XP2V"}], "duid": "RL:nZSx"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "21134632", "sentence": [{"charStart": 0, "charEnd": 54, "index": 0}, {"index": 1, "charEnd": 240, "charStart": 56}, {"index": 2, "charEnd": 405, "charStart": 242}], "text": "FHA domain pThr binding specificity: it's all about me. The FHA domain is a phospho-peptide binding module involved in a wide range of cellular pathways, with a striking specificity for phospho-threonine over phospho-serine binding partners. Biochemical, structural, and dynamic simulations analysis allowed Pennell and colleagues to unravel the molecular basis of FHA domain phospho-threonine specificity.", "title": {"charStart": 0, "charEnd": 54}, "entity": {"RL:L4Rt": {"duid": "RL:L4Rt", "attribute": [], "entityType": "Trigger", "charEnd": 202, "source": "RLIMS-P", "charStart": 186, "entityId": [], "sentenceIndex": 1, "entityText": "phospho-threonine"}, "RL:P9wM": {"duid": "RL:P9wM", "attribute": [], "entityType": "Trigger", "charEnd": 222, "source": "RLIMS-P", "charStart": 209, "entityId": [], "sentenceIndex": 1, "entityText": "phospho-serine"}, "RL:XafZ": {"duid": "RL:XafZ", "attribute": [], "entityType": "SiteOther", "charEnd": 90, "source": "RLIMS-P", "charStart": 84, "entityId": [], "sentenceIndex": 1, "entityText": "peptide"}, "RL:3HWq": {"duid": "RL:3HWq", "attribute": [], "entityType": "Trigger", "charEnd": 90, "source": "RLIMS-P", "charStart": 76, "entityId": [], "sentenceIndex": 1, "entityText": "phospho-peptide"}, "RL:tZxJ": {"duid": "RL:tZxJ", "attribute": [], "entityType": "Trigger", "charEnd": 392, "source": "RLIMS-P", "charStart": 376, "entityId": [], "sentenceIndex": 2, "entityText": "phospho-threonine"}}, "relation": {"RL:pJyo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:P9wM"}], "duid": "RL:pJyo"}, "RL:VNX8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:L4Rt"}], "duid": "RL:VNX8"}, "RL:C5XJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tZxJ"}], "duid": "RL:C5XJ"}, "RL:iFyd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:XafZ"}, {"role": "TRIGGER", "entity_duid": "RL:3HWq"}], "duid": "RL:iFyd"}}, "type": ["Comment", "Journal Article"]}
{"docId": "31707662", "sentence": [{"charStart": 0, "charEnd": 107, "index": 0}, {"index": 1, "charEnd": 355, "charStart": 109}, {"index": 2, "charEnd": 598, "charStart": 357}, {"index": 3, "charEnd": 788, "charStart": 600}, {"index": 4, "charEnd": 930, "charStart": 790}, {"index": 5, "charEnd": 1214, "charStart": 932}, {"index": 6, "charEnd": 1402, "charStart": 1216}, {"index": 7, "charEnd": 1646, "charStart": 1404}, {"index": 8, "charEnd": 1848, "charStart": 1648}], "text": "High-Throughput Characterization of Histidine Phosphorylation Sites Using UPAX and Tandem Mass Spectrometry. Liquid chromatography (LC)-tandem mass spectrometry (MS/MS) is key for the characterization of phosphorylation sites in a high-throughput manner, and its application has proven essential to elucidate the phosphoproteome of many biological systems. Following proteolytic digestion of proteins extracted from tissues or cells, phosphopeptides are typically enriched by affinity chromatography using TiO2 or metal-ions (e.g., Fe3+) coupled to solid-phase materials, prior to LC-MS/MS analysis. Separation of relatively low abundance phosphopeptides from nonphosphorylated peptides in these types of extremely complex mixtures is essential to maximize coverage of the phosphoproteome. Maintaining acidic conditions during these IMAC or TiO2-based enrichment minimizes the concurrent unwanted binding of highly acidic peptides. However, while peptides containing phosphomonoesters, namely, phosphoserine (pSer), phosphothreonine (pThr), and phosphotyrosine (pTyr), are stable under these acidic binding conditions, phosphopeptides containing acid-labile phosphate group such as phosphohistidine (pHis), are not. Consequently, hydrolysis of these types of phosphopeptides occurs during standard phosphopeptide enrichment, and subsequent phosphosite identification by LC-MS/MS is severely compromised. Here we describe UPAX, unbiased phosphopeptide enrichment using strong anion exchange, for the separation of both acid-stable (pSer, pThr, pTyr) and acid-labile phosphopeptides (including those containing pHis) from nonphosphorylated peptides. We outline how implementation of UPAX prior to a minimally modified standard proteomics workflow can be used to identify sites of pHis as well as other acid-labile, as well as acid-stable phosphosites.", "title": {"charStart": 0, "charEnd": 107}, "entity": {"RL:pKQs": {"duid": "RL:pKQs", "attribute": [], "entityType": "Trigger", "charEnd": 1579, "source": "RLIMS-P", "charStart": 1565, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:txyM": {"duid": "RL:txyM", "attribute": [], "entityType": "Trigger", "charEnd": 1133, "source": "RLIMS-P", "charStart": 1119, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:wgC6": {"duid": "RL:wgC6", "attribute": [], "entityType": "Trigger", "charEnd": 1006, "source": "RLIMS-P", "charStart": 994, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:yvKd": {"duid": "RL:yvKd", "attribute": [], "entityType": "SiteOther", "charEnd": 1133, "source": "RLIMS-P", "charStart": 1119, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:m4ky": {"duid": "RL:m4ky", "attribute": [], "entityType": "Trigger", "charEnd": 448, "source": "RLIMS-P", "charStart": 434, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:mhv5": {"duid": "RL:mhv5", "attribute": [], "entityType": "SiteOther", "charEnd": 1579, "source": "RLIMS-P", "charStart": 1565, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Bv58": {"duid": "RL:Bv58", "attribute": [], "entityType": "Trigger", "charEnd": 653, "source": "RLIMS-P", "charStart": 639, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:k6AC": {"duid": "RL:k6AC", "attribute": [], "entityType": "Trigger", "charEnd": 218, "source": "RLIMS-P", "charStart": 204, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:LdmV": {"duid": "RL:LdmV", "attribute": [], "entityType": "Trigger", "charEnd": 1273, "source": "RLIMS-P", "charStart": 1259, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:T3tV": {"duid": "RL:T3tV", "attribute": [], "entityType": "SiteOther", "charEnd": 653, "source": "RLIMS-P", "charStart": 639, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:H7Cw": {"duid": "RL:H7Cw", "attribute": [], "entityType": "Trigger", "charEnd": 1172, "source": "RLIMS-P", "charStart": 1158, "entityId": [], "sentenceIndex": 5, "entityText": "phosphate group"}, "RL:oqpH": {"duid": "RL:oqpH", "attribute": [], "entityType": "Trigger", "charEnd": 60, "source": "RLIMS-P", "charStart": 46, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphorylation"}, "RL:CidC": {"duid": "RL:CidC", "attribute": [], "entityType": "SiteOther", "charEnd": 1273, "source": "RLIMS-P", "charStart": 1259, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:hZqS": {"duid": "RL:hZqS", "attribute": [], "entityType": "SiteOther", "charEnd": 448, "source": "RLIMS-P", "charStart": 434, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:8AcT": {"duid": "RL:8AcT", "attribute": [], "entityType": "SiteOther", "charEnd": 224, "source": "RLIMS-P", "charStart": 204, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation sites"}}, "relation": {"RL:4x58": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:T3tV"}, {"role": "TRIGGER", "entity_duid": "RL:Bv58"}], "duid": "RL:4x58"}, "RL:P4rA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wgC6"}], "duid": "RL:P4rA"}, "RL:8Bm3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mhv5"}, {"role": "TRIGGER", "entity_duid": "RL:pKQs"}], "duid": "RL:8Bm3"}, "RL:EZ3M": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8AcT"}, {"role": "TRIGGER", "entity_duid": "RL:k6AC"}], "duid": "RL:EZ3M"}, "RL:aAyA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:yvKd"}, {"role": "TRIGGER", "entity_duid": "RL:txyM"}], "duid": "RL:aAyA"}, "RL:DBjk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:yvKd"}, {"role": "TRIGGER", "entity_duid": "RL:H7Cw"}], "duid": "RL:DBjk"}, "RL:KBX2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:oqpH"}], "duid": "RL:KBX2"}, "RL:6mBa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:CidC"}, {"role": "TRIGGER", "entity_duid": "RL:LdmV"}], "duid": "RL:6mBa"}, "RL:uPoQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:hZqS"}, {"role": "TRIGGER", "entity_duid": "RL:m4ky"}], "duid": "RL:uPoQ"}}, "type": ["Journal Article"]}
{"docId": "6189415", "sentence": [{"charStart": 0, "charEnd": 161, "index": 0}, {"index": 1, "charEnd": 351, "charStart": 163}, {"index": 2, "charEnd": 501, "charStart": 353}, {"index": 3, "charEnd": 631, "charStart": 503}, {"index": 4, "charEnd": 713, "charStart": 633}, {"index": 5, "charEnd": 906, "charStart": 715}, {"index": 6, "charEnd": 1022, "charStart": 908}], "text": "A rapid microdetermination of phosphoserine, phosphothreonine, and phosphotyrosine in proteins by automatic cation exchange on a conventional amino acid analyzer. A cation-exchange chromatographic method for the separation and determination of phosphoserine, phosphothreonine, and phosphotyrosine in proteins after partial acid hydrolysis is described. The short column (0.6 X 8 cm) of an automatic amino acid analyzer was used and elution was carried out isocratically with 10 mM trifluoroacetic acid. The method is highly sensitive and each of the three O-phosphoamino acids can be accurately determined down to the 50-pmol level. Higher sensitivity may be obtained by the use of [32P]phosphate-labeled proteins. A correction factor for the decomposition of phosphoserine or phosphothreonine during acid hydrolysis can be deduced from the amount of inorganic phosphate recovered at the column void volume. The method is sensitive enough to be used for 32P-labeled proteins isolated by two-dimensional gel electrophoresis.", "title": {"charStart": 0, "charEnd": 161}, "entity": {"RL:wAaE": {"duid": "RL:wAaE", "attribute": [], "entityType": "Trigger", "charEnd": 772, "source": "RLIMS-P", "charStart": 760, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:ugkX": {"duid": "RL:ugkX", "attribute": [], "entityType": "Trigger", "charEnd": 256, "source": "RLIMS-P", "charStart": 244, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:yAJi": {"duid": "RL:yAJi", "attribute": [], "entityType": "Trigger", "charEnd": 42, "source": "RLIMS-P", "charStart": 30, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}}, "mesh": ["Animals", "Chromatography, High Pressure Liquid", "Chromatography, Ion Exchange", "Hydrolysis", "Myocardium", "Phosphoproteins", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Rats", "Serine", "Threonine", "Tyrosine"], "relation": {"RL:Xf99": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ugkX"}], "duid": "RL:Xf99"}, "RL:wxwm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yAJi"}], "duid": "RL:wxwm"}, "RL:9p69": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wAaE"}], "duid": "RL:9p69"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "10037602", "sentence": [{"charStart": 0, "charEnd": 76, "index": 0}, {"index": 1, "charEnd": 271, "charStart": 78}, {"index": 2, "charEnd": 418, "charStart": 273}, {"index": 3, "charEnd": 531, "charStart": 420}, {"index": 4, "charEnd": 732, "charStart": 533}, {"index": 5, "charEnd": 878, "charStart": 734}, {"index": 6, "charEnd": 1040, "charStart": 880}], "text": "Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Protein-interacting modules help determine the specificity of signal transduction events, and protein phosphorylation can modulate the assembly of such modules into specific signaling complexes. Although phosphotyrosine-binding modules have been well-characterized, phosphoserine- or phosphothreonine-binding modules have not been described. WW domains are small protein modules found in various proteins that participate in cell signaling or regulation. WW domains of the essential mitotic prolyl isomerase Pin1 and the ubiquitin ligase Nedd4 bound to phosphoproteins, including physiological substrates of enzymes, in a phosphorylation-dependent manner. The Pin1 WW domain functioned as a phosphoserine- or phosphothreonine-binding module, with properties similar to those of SRC homology 2 domains. Phosphoserine- or phosphothreonine-binding activity was required for Pin1 to interact with its substrates in vitro and to perform its essential function in vivo.", "title": {"charStart": 0, "charEnd": 76}, "entity": {"RL:wWsV": {"duid": "RL:wWsV", "attribute": [], "entityType": "Trigger", "charEnd": 296, "source": "RLIMS-P", "charStart": 282, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:m2Gg": {"duid": "RL:m2Gg", "attribute": [], "entityType": "Trigger", "charEnd": 714, "source": "RLIMS-P", "charStart": 700, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:AViU": {"duid": "RL:AViU", "attribute": [], "entityType": "Trigger", "charEnd": 194, "source": "RLIMS-P", "charStart": 180, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:aLzD": {"duid": "RL:aLzD", "attribute": [], "entityType": "Trigger", "charEnd": 356, "source": "RLIMS-P", "charStart": 344, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:gNC3": {"duid": "RL:gNC3", "attribute": [], "entityType": "Trigger", "charEnd": 38, "source": "RLIMS-P", "charStart": 26, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:9B4Q": {"duid": "RL:9B4Q", "attribute": [], "entityType": "Trigger", "charEnd": 892, "source": "RLIMS-P", "charStart": 880, "entityId": [], "sentenceIndex": 6, "entityText": "Phosphoserine"}, "RL:qw6G": {"duid": "RL:qw6G", "attribute": [], "entityType": "Trigger", "charEnd": 781, "source": "RLIMS-P", "charStart": 769, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:b6Fz": {"duid": "RL:b6Fz", "attribute": [], "entityType": "Trigger", "charEnd": 645, "source": "RLIMS-P", "charStart": 631, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoproteins"}, "RL:VvKc": {"duid": "RL:VvKc", "attribute": [], "entityType": "Trigger", "charEnd": 802, "source": "RLIMS-P", "charStart": 787, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:dE2G": {"duid": "RL:dE2G", "attribute": [], "entityType": "SiteOther", "charEnd": 542, "source": "RLIMS-P", "charStart": 533, "entityId": [], "sentenceIndex": 4, "entityText": "WW domains"}}, "mesh": ["Amino Acid Sequence", "Amino Acid Substitution", "Calcium-Binding Proteins", "Cell Cycle Proteins", "Endosomal Sorting Complexes Required for Transport", "HeLa Cells", "Humans", "Ligases", "NIMA-Interacting Peptidylprolyl Isomerase", "Nedd4 Ubiquitin Protein Ligases", "Peptidylprolyl Isomerase", "Phosphopeptides", "Phosphoproteins", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Point Mutation", "Signal Transduction", "Ubiquitin-Protein Ligases", "cdc25 Phosphatases"], "relation": {"RL:viuU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:m2Gg"}], "duid": "RL:viuU"}, "RL:4Sqq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:VvKc"}], "duid": "RL:4Sqq"}, "RL:ZhvH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:gNC3"}], "duid": "RL:ZhvH"}, "RL:EsGf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wWsV"}], "duid": "RL:EsGf"}, "RL:U5nZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aLzD"}], "duid": "RL:U5nZ"}, "RL:fvcu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qw6G"}], "duid": "RL:fvcu"}, "RL:Dpq4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9B4Q"}], "duid": "RL:Dpq4"}, "RL:4wbp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:AViU"}], "duid": "RL:4wbp"}, "RL:Uoy6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:dE2G"}, {"role": "TRIGGER", "entity_duid": "RL:b6Fz"}], "duid": "RL:Uoy6"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "29406695", "sentence": [{"charStart": 0, "charEnd": 125, "index": 0}, {"index": 1, "charEnd": 408, "charStart": 127}, {"index": 2, "charEnd": 537, "charStart": 410}, {"index": 3, "charEnd": 772, "charStart": 539}, {"index": 4, "charEnd": 988, "charStart": 774}, {"index": 5, "charEnd": 1149, "charStart": 990}, {"index": 6, "charEnd": 1269, "charStart": 1151}, {"index": 7, "charEnd": 1417, "charStart": 1271}], "text": "Neutralizing the Detrimental Effect of an N-Hydroxysuccinimide Quenching Reagent on Phosphopeptide in Quantitative Proteomics. One of the most common chemistries used to label primary amines utilizes N-hydroxysuccinimide (NHS), which is also structurally incorporated in various quantitative proteomic reagents such as isobaric tags for relative and absolute quantification (iTRAQ) and tandem mass tags (TMT). In this paper we report detrimental effect of hydroxylamine, a widely used quenching reagent for excess NHS, on phosphopeptides. We found an impairment in the degree of phosphopeptide identification when hydroxylamine-quenched TMT-labeled samples were vacuum-dried and desalted compared to the nondried (just diluted) and desalted ones prior to phosphoenrichment. We have also demonstrated that vacuum-drying in the presence of hydroxylamine promotes \u03b2-elimination of phosphate groups from phosphoserine and phosphothreonine while having a minimalistic effect on phosphotyrosine. Additionally, we herein report that this negative impact of hydroxylamine could be minimized by direct desalting after appropriate dilution of quenched samples. We also found a 1.6-fold increase in the number of phosphopeptide identifications after employing our optimized method. The above method was also successfully applied to human tumor tissues to quantify over 15000 phosphopeptides from 3 mg TMT 6-plex labeled-peptides.", "title": {"charStart": 0, "charEnd": 125}, "entity": {"RL:Gbyf": {"duid": "RL:Gbyf", "attribute": [], "entityType": "Trigger", "charEnd": 536, "source": "RLIMS-P", "charStart": 522, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:A89x": {"duid": "RL:A89x", "attribute": [], "entityType": "Trigger", "charEnd": 97, "source": "RLIMS-P", "charStart": 84, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptide"}, "RL:psvZ": {"duid": "RL:psvZ", "attribute": [], "entityType": "SiteOther", "charEnd": 536, "source": "RLIMS-P", "charStart": 522, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:oYRy": {"duid": "RL:oYRy", "attribute": [], "entityType": "SiteOther", "charEnd": 1378, "source": "RLIMS-P", "charStart": 1364, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:DhxS": {"duid": "RL:DhxS", "attribute": [], "entityType": "Trigger", "charEnd": 912, "source": "RLIMS-P", "charStart": 900, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:kgq4": {"duid": "RL:kgq4", "attribute": [], "entityType": "SiteOther", "charEnd": 97, "source": "RLIMS-P", "charStart": 84, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptide"}, "RL:Xb4G": {"duid": "RL:Xb4G", "attribute": [], "entityType": "Trigger", "charEnd": 1378, "source": "RLIMS-P", "charStart": 1364, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Qyib": {"duid": "RL:Qyib", "attribute": [], "entityType": "Trigger", "charEnd": 987, "source": "RLIMS-P", "charStart": 973, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}}, "mesh": ["Humans", "Hydroxylamine", "Indicators and Reagents", "Phosphopeptides", "Phosphoserine", "Phosphothreonine", "Proteomics", "Succinimides"], "relation": {"RL:9jaD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:psvZ"}, {"role": "TRIGGER", "entity_duid": "RL:Gbyf"}], "duid": "RL:9jaD"}, "RL:hu5W": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kgq4"}, {"role": "TRIGGER", "entity_duid": "RL:A89x"}], "duid": "RL:hu5W"}, "RL:8aT5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Qyib"}], "duid": "RL:8aT5"}, "RL:jGRk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DhxS"}], "duid": "RL:jGRk"}, "RL:8LoS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:oYRy"}, {"role": "TRIGGER", "entity_duid": "RL:Xb4G"}], "duid": "RL:8LoS"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "1719344", "sentence": [{"charStart": 0, "charEnd": 108, "index": 0}], "text": "Separation of phosphotyrosine, phosphoserine, and phosphothreonine by high-performance liquid chromatography.", "title": {"charStart": 0, "charEnd": 108}, "entity": {"RL:GLWV": {"duid": "RL:GLWV", "attribute": [], "entityType": "Trigger", "charEnd": 28, "source": "RLIMS-P", "charStart": 14, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}}, "mesh": ["Chromatography, High Pressure Liquid", "Chromatography, Ion Exchange", "Hydrolysis", "Indicators and Reagents", "Phosphoproteins", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Tyrosine"], "relation": {"RL:2YoN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GLWV"}], "duid": "RL:2YoN"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "1692212", "sentence": [{"charStart": 0, "charEnd": 85, "index": 0}, {"index": 1, "charEnd": 279, "charStart": 87}, {"index": 2, "charEnd": 347, "charStart": 281}, {"index": 3, "charEnd": 439, "charStart": 349}, {"index": 4, "charEnd": 569, "charStart": 441}, {"index": 5, "charEnd": 771, "charStart": 571}, {"index": 6, "charEnd": 967, "charStart": 773}, {"index": 7, "charEnd": 1113, "charStart": 969}], "text": "Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets. Arginine vasopressin administration (10(-10)-10(-6) M) to isolated human platelets induces an increase in the specific immunoblotting of a 38 kDa protein revealed by a phosphotyrosine antibody. This signal is biphasic with maximal stimulation within one minute. Neither forskolin (10(-5) M) nor phorbol ester (10(-6) M) produces a similar 38 kDa signal. The specific immunoblotted signals are competitively abolished by 1 mM phosphotyrosine but not phosphoserine or phosphothreonine. Electrophoretic separation at pH 3.5 of the acid hydrolysates of the 38 kDa proteins reveals a vasopressin dependent increase in levels of phosphotyrosine as well as phosphoserine and phosphothreonine. The 38 kDa phosphorylation is also induced by the specific arginine vasopressin V1 receptor agonist (Phe2Orn8Vastocina) and blocked by the V1 receptor antagonist [desGly(NH2)d(CH2)5Tyr(Me) AVPb]. These observations suggest that arginine vasopressin signal transduction may be associated with the tyrosine phosphorylation of a 38 kDa protein.", "title": {"charStart": 0, "charEnd": 85}, "entity": {"RL:jnys": {"duid": "RL:jnys", "attribute": [], "entityType": "Trigger", "charEnd": 798, "source": "RLIMS-P", "charStart": 784, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:JhCu": {"duid": "RL:JhCu", "attribute": [], "entityType": "Protein", "charEnd": 1112, "source": "RLIMS-P", "charStart": 1097, "entityId": [], "sentenceIndex": 7, "entityText": "a 38 kDa protein"}, "RL:nLi4": {"duid": "RL:nLi4", "attribute": [], "entityType": "Trigger", "charEnd": 548, "source": "RLIMS-P", "charStart": 536, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:yv86": {"duid": "RL:yv86", "attribute": [], "entityType": "Trigger", "charEnd": 724, "source": "RLIMS-P", "charStart": 710, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:Y6RF": {"duid": "RL:Y6RF", "attribute": [], "entityType": "Trigger", "charEnd": 749, "source": "RLIMS-P", "charStart": 737, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:Z54H": {"duid": "RL:Z54H", "attribute": [], "entityType": "Protein", "charEnd": 65, "source": "RLIMS-P", "charStart": 50, "entityId": [], "sentenceIndex": 0, "entityText": "a 38 kDa protein"}, "RL:V4NZ": {"duid": "RL:V4NZ", "attribute": [], "entityType": "Protein", "charEnd": 782, "source": "RLIMS-P", "charStart": 780, "entityId": [], "sentenceIndex": 6, "entityText": "kDa"}, "RL:cRsN": {"duid": "RL:cRsN", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 29, "source": "RLIMS-P", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "tyrosine"}, "RL:CVbX": {"duid": "RL:CVbX", "attribute": [], "entityType": "Protein", "charEnd": 851, "source": "RLIMS-P", "charStart": 832, "entityId": [], "sentenceIndex": 6, "entityText": "arginine vasopressin"}, "RL:zuGK": {"duid": "RL:zuGK", "attribute": [], "entityType": "Trigger", "charEnd": 1092, "source": "RLIMS-P", "charStart": 1078, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:pdxT": {"duid": "RL:pdxT", "attribute": [], "entityType": "Trigger", "charEnd": 45, "source": "RLIMS-P", "charStart": 31, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:dfwm": {"duid": "RL:dfwm", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 1076, "source": "RLIMS-P", "charStart": 1069, "entityId": [], "sentenceIndex": 7, "entityText": "tyrosine"}}, "mesh": ["Angiotensin Receptor Antagonists", "Animals", "Arginine Vasopressin", "Blood Platelets", "Blotting, Western", "Colforsin", "Dose-Response Relationship, Drug", "Electrophoresis", "Humans", "In Vitro Techniques", "Phorbol Esters", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Protein-Tyrosine Kinases", "Receptors, Vasopressin", "Time Factors", "Tyrosine"], "relation": {"RL:yFxN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:JhCu"}, {"role": "SITE", "entity_duid": "RL:dfwm"}, {"role": "TRIGGER", "entity_duid": "RL:zuGK"}], "duid": "RL:yFxN"}, "RL:M5Yn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Y6RF"}], "duid": "RL:M5Yn"}, "RL:oZZT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Z54H"}, {"role": "SITE", "entity_duid": "RL:cRsN"}, {"role": "TRIGGER", "entity_duid": "RL:pdxT"}], "duid": "RL:oZZT"}, "RL:DxaB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yv86"}], "duid": "RL:DxaB"}, "RL:BxpR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:nLi4"}], "duid": "RL:BxpR"}, "RL:kitj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:V4NZ"}, {"role": "INDUCER", "entity_duid": "RL:CVbX"}, {"role": "TRIGGER", "entity_duid": "RL:jnys"}], "duid": "RL:kitj"}}, "type": ["Journal Article"]}
{"docId": "1111592", "sentence": [{"charStart": 0, "charEnd": 53, "index": 0}, {"index": 1, "charEnd": 256, "charStart": 55}, {"index": 2, "charEnd": 337, "charStart": 258}, {"index": 3, "charEnd": 431, "charStart": 339}, {"index": 4, "charEnd": 513, "charStart": 433}, {"index": 5, "charEnd": 607, "charStart": 515}, {"index": 6, "charEnd": 711, "charStart": 609}, {"index": 7, "charEnd": 789, "charStart": 713}], "text": "Phosphopeptide and phosphoprotein metabolism in brain. Phosphopeptide and phosphoprotein phosphorylation was studied in rat brain microsomes and rat brain slices which were incubated in the presence of [gamma-32 P] ATP under various experimental conditions. Radioactive phosphoserine was isolated from phosphopeptides and phosphoproteins. Naplus, K+, Mg2+ and cyclic AMP had a stimulating effect on the labelling of phosphopeptides. Ouabain and Ca2+ lowered the level of 32P incorporation into the phosphopeptides. The phosphoproteins behaved similarly to the phosphopeptides except for the potassium effect. Chase experiments showed a faster decrease in the labelling of phosphopeptides than in phosphoproteins. We suggest that both compounds may be involved in active transport phenomena.", "title": {"charStart": 0, "charEnd": 53}, "entity": {"RL:PF7E": {"duid": "RL:PF7E", "attribute": [], "entityType": "Trigger", "charEnd": 430, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:Ffq9": {"duid": "RL:Ffq9", "attribute": [], "entityType": "Trigger", "charEnd": 710, "source": "RLIMS-P", "charStart": 696, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoproteins"}, "RL:Xkqz": {"duid": "RL:Xkqz", "attribute": [], "entityType": "Trigger", "charEnd": 574, "source": "RLIMS-P", "charStart": 560, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:8tWU": {"duid": "RL:8tWU", "attribute": [], "entityType": "SiteOther", "charEnd": 686, "source": "RLIMS-P", "charStart": 672, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:2ibz": {"duid": "RL:2ibz", "attribute": [], "entityType": "Trigger", "charEnd": 316, "source": "RLIMS-P", "charStart": 302, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:vML7": {"duid": "RL:vML7", "attribute": [], "entityType": "Trigger", "charEnd": 686, "source": "RLIMS-P", "charStart": 672, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:4nHh": {"duid": "RL:4nHh", "attribute": [], "entityType": "SiteOther", "charEnd": 316, "source": "RLIMS-P", "charStart": 302, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:Gaoi": {"duid": "RL:Gaoi", "attribute": [], "entityType": "SiteOther", "charEnd": 512, "source": "RLIMS-P", "charStart": 498, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:qKsw": {"duid": "RL:qKsw", "attribute": [], "entityType": "Trigger", "charEnd": 282, "source": "RLIMS-P", "charStart": 270, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:SUZg": {"duid": "RL:SUZg", "attribute": [], "entityType": "Trigger", "charEnd": 533, "source": "RLIMS-P", "charStart": 519, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoproteins"}, "RL:VNzA": {"duid": "RL:VNzA", "attribute": [], "entityType": "Trigger", "charEnd": 512, "source": "RLIMS-P", "charStart": 498, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:DQoQ": {"duid": "RL:DQoQ", "attribute": [], "entityType": "SiteOther", "charEnd": 574, "source": "RLIMS-P", "charStart": 560, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:htwq": {"duid": "RL:htwq", "attribute": [], "entityType": "Trigger", "charEnd": 68, "source": "RLIMS-P", "charStart": 55, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphopeptide"}, "RL:uBss": {"duid": "RL:uBss", "attribute": [], "entityType": "SiteOther", "charEnd": 430, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}}, "mesh": ["Adenosine Triphosphate", "Animals", "Biological Transport, Active", "Brain", "Cerebral Cortex", "Microsomes", "Organophosphorus Compounds", "Ouabain", "Oxidative Phosphorylation", "Phosphopeptides", "Phosphoproteins", "Phosphorus Radioisotopes", "Rats", "Serine"], "relation": {"RL:RvUD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ffq9"}], "duid": "RL:RvUD"}, "RL:EgJn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8tWU"}, {"role": "TRIGGER", "entity_duid": "RL:vML7"}], "duid": "RL:EgJn"}, "RL:ycmx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:4nHh"}, {"role": "TRIGGER", "entity_duid": "RL:2ibz"}], "duid": "RL:ycmx"}, "RL:ET5Z": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:SUZg"}], "duid": "RL:ET5Z"}, "RL:xheV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Gaoi"}, {"role": "TRIGGER", "entity_duid": "RL:VNzA"}], "duid": "RL:xheV"}, "RL:Q7gm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:uBss"}, {"role": "TRIGGER", "entity_duid": "RL:PF7E"}], "duid": "RL:Q7gm"}, "RL:XUFt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:DQoQ"}, {"role": "TRIGGER", "entity_duid": "RL:Xkqz"}], "duid": "RL:XUFt"}, "RL:dvc9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qKsw"}], "duid": "RL:dvc9"}, "RL:fFCN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:htwq"}], "duid": "RL:fFCN"}}, "type": ["Journal Article"]}
{"docId": "2193799", "sentence": [{"charStart": 0, "charEnd": 77, "index": 0}, {"index": 1, "charEnd": 237, "charStart": 79}, {"index": 2, "charEnd": 373, "charStart": 239}, {"index": 3, "charEnd": 588, "charStart": 375}, {"index": 4, "charEnd": 658, "charStart": 590}, {"index": 5, "charEnd": 860, "charStart": 660}, {"index": 6, "charEnd": 939, "charStart": 862}, {"index": 7, "charEnd": 1018, "charStart": 941}, {"index": 8, "charEnd": 1204, "charStart": 1020}, {"index": 9, "charEnd": 1431, "charStart": 1206}, {"index": 10, "charEnd": 1825, "charStart": 1433}, {"index": 11, "charEnd": 1975, "charStart": 1827}, {"index": 12, "charEnd": 2085, "charStart": 1977}], "text": "The effect of protein kinase-C inhibition on insulin receptor phosphorylation. The effect of protein kinase-C (PKC) inhibition on insulin receptor phosphorylation in HepG2 cells was analyzed by two-dimensional tryptic phosphopeptide maps. In basal cells, there was one major insulin receptor-derived tryptic phosphothreonine peptide and at least four phosphoserine peptides. Phorbol 12,13-dibutyrate (PDBU) stimulated phosphorylation of the phosphothreonine peptide, some of the basal phosphoserine peptides, and at least one phosphoserine peptide that was not detected in the basal state. Staurosporine completely inhibited the PDBU-mediated phosphorylation. Although staurosporine also inhibited basal phosphorylation of the phosphothreonine peptide, down-regulation of PKC did not, suggesting that PKC does not mediate basal insulin receptor phosphorylation. Insulin treatment resulted in the appearance of four phosphotyrosine peptides. It also stimulated the phosphorylation of at least two phosphoserine peptides. One of these may have been a complex of two or more distinct but poorly resolved phosphopeptides, which was seen in basal cells and a component of which seemed to be stimulated by PDBU. However, neither staurosporine nor down-regulation of PKC diminished insulin-stimulated serine phosphorylation of these peptides, indicating that insulin-stimulated receptor serine phosphorylation did not involve PKC activity. The addition of staurosporine to cells that had been incubated with PDBU resulted in the very rapid decay of phosphorylation of the phosphothreonine-containing peptide, indicating that this site of phosphorylation turns over very rapidly, while some of the other phosphoserine-containing peptides, including the major unique site of phosphorylation stimulated by PDBU, turned over more slowly. Thus, the insulin receptor contains several sites of serine/threonine phosphorylation, some of which are substrates for more than one protein kinase. This may permit complex modulation of insulin receptor functions in response to multiple signalling pathways.", "title": {"charStart": 0, "charEnd": 77}, "entity": {"RL:cCuJ": {"duid": "RL:cCuJ", "attribute": [], "entityType": "Trigger", "charEnd": 1645, "source": "RLIMS-P", "charStart": 1631, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:Yj22": {"duid": "RL:Yj22", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1008, "source": "RLIMS-P", "charStart": 1003, "entityId": [], "sentenceIndex": 7, "entityText": "serine"}, "RL:65gr": {"duid": "RL:65gr", "attribute": [], "entityType": "Trigger", "charEnd": 1401, "source": "RLIMS-P", "charStart": 1387, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:UNKp": {"duid": "RL:UNKp", "attribute": [], "entityType": "Trigger", "charEnd": 497, "source": "RLIMS-P", "charStart": 485, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:prjf": {"duid": "RL:prjf", "attribute": [], "entityType": "Trigger", "charEnd": 231, "source": "RLIMS-P", "charStart": 218, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:WHUr": {"duid": "RL:WHUr", "attribute": [], "entityType": "Trigger", "charEnd": 742, "source": "RLIMS-P", "charStart": 727, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:TU6t": {"duid": "RL:TU6t", "attribute": [], "entityType": "Trigger", "charEnd": 978, "source": "RLIMS-P", "charStart": 964, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:ZSfj": {"duid": "RL:ZSfj", "attribute": [], "entityType": "Trigger", "charEnd": 538, "source": "RLIMS-P", "charStart": 526, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:wftG": {"duid": "RL:wftG", "attribute": [], "entityType": "Protein", "charEnd": 60, "source": "RLIMS-P", "charStart": 45, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptor"}, "RL:jM7m": {"duid": "RL:jM7m", "attribute": [], "entityType": "Protein", "charEnd": 290, "source": "RLIMS-P", "charStart": 275, "entityId": [], "sentenceIndex": 2, "entityText": "insulin receptor"}, "RL:aqje": {"duid": "RL:aqje", "attribute": [], "entityType": "Trigger", "charEnd": 1556, "source": "RLIMS-P", "charStart": 1542, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:EKNa": {"duid": "RL:EKNa", "attribute": [], "entityType": "Trigger", "charEnd": 1580, "source": "RLIMS-P", "charStart": 1565, "entityId": [], "sentenceIndex": 10, "entityText": "phosphothreonine"}, "RL:2sBq": {"duid": "RL:2sBq", "attribute": [], "entityType": "Trigger", "charEnd": 1780, "source": "RLIMS-P", "charStart": 1766, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:2y6D": {"duid": "RL:2y6D", "attribute": [], "entityType": "Trigger", "charEnd": 929, "source": "RLIMS-P", "charStart": 915, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:2juk": {"duid": "RL:2juk", "attribute": [], "entityType": "Trigger", "charEnd": 1708, "source": "RLIMS-P", "charStart": 1696, "entityId": [], "sentenceIndex": 10, "entityText": "phosphoserine"}, "RL:ryzz": {"duid": "RL:ryzz", "attribute": [], "entityType": "Trigger", "charEnd": 323, "source": "RLIMS-P", "charStart": 308, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:CCCY": {"duid": "RL:CCCY", "attribute": [], "entityType": "Protein", "charEnd": 1852, "source": "RLIMS-P", "charStart": 1837, "entityId": [], "sentenceIndex": 11, "entityText": "insulin receptor"}, "RL:5ZzU": {"duid": "RL:5ZzU", "attribute": [], "entityType": "Trigger", "charEnd": 432, "source": "RLIMS-P", "charStart": 418, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:VgQV": {"duid": "RL:VgQV", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 456, "source": "RLIMS-P", "charStart": 448, "entityId": [], "sentenceIndex": 3, "entityText": "threonine"}, "RL:WdkH": {"duid": "RL:WdkH", "attribute": [], "entityType": "Protein", "charEnd": 145, "source": "RLIMS-P", "charStart": 130, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}, "RL:ZrPr": {"duid": "RL:ZrPr", "attribute": [], "entityType": "Trigger", "charEnd": 1315, "source": "RLIMS-P", "charStart": 1301, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:BRk8": {"duid": "RL:BRk8", "attribute": [], "entityType": "Trigger", "charEnd": 859, "source": "RLIMS-P", "charStart": 845, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:irFP": {"duid": "RL:irFP", "attribute": [], "entityType": "Trigger", "charEnd": 1911, "source": "RLIMS-P", "charStart": 1897, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation"}, "RL:MBkD": {"duid": "RL:MBkD", "attribute": [], "entityType": "SiteOther", "charEnd": 231, "source": "RLIMS-P", "charStart": 218, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:w5MX": {"duid": "RL:w5MX", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1895, "source": "RLIMS-P", "charStart": 1887, "entityId": [], "sentenceIndex": 11, "entityText": "threonine"}, "RL:csGB": {"duid": "RL:csGB", "attribute": [], "entityType": "SiteOther", "charEnd": 1875, "source": "RLIMS-P", "charStart": 1871, "entityId": [], "sentenceIndex": 11, "entityText": "sites"}, "RL:DzTo": {"duid": "RL:DzTo", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 742, "source": "RLIMS-P", "charStart": 734, "entityId": [], "sentenceIndex": 5, "entityText": "threonine"}, "RL:K7H2": {"duid": "RL:K7H2", "attribute": [], "entityType": "Trigger", "charEnd": 718, "source": "RLIMS-P", "charStart": 704, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:V6sW": {"duid": "RL:V6sW", "attribute": [], "entityType": "Trigger", "charEnd": 363, "source": "RLIMS-P", "charStart": 351, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:pEAs": {"duid": "RL:pEAs", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1885, "source": "RLIMS-P", "charStart": 1880, "entityId": [], "sentenceIndex": 11, "entityText": "serine"}, "RL:2wy4": {"duid": "RL:2wy4", "attribute": [], "entityType": "SiteOther", "charEnd": 1115, "source": "RLIMS-P", "charStart": 1101, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptides"}, "RL:qCQh": {"duid": "RL:qCQh", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1580, "source": "RLIMS-P", "charStart": 1572, "entityId": [], "sentenceIndex": 10, "entityText": "threonine"}, "RL:TVn4": {"duid": "RL:TVn4", "attribute": [], "entityType": "Trigger", "charEnd": 657, "source": "RLIMS-P", "charStart": 643, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:87MQ": {"duid": "RL:87MQ", "attribute": [], "entityType": "Protein", "charEnd": 843, "source": "RLIMS-P", "charStart": 828, "entityId": [], "sentenceIndex": 5, "entityText": "insulin receptor"}, "RL:rBBJ": {"duid": "RL:rBBJ", "attribute": [], "entityType": "Trigger", "charEnd": 161, "source": "RLIMS-P", "charStart": 147, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:4Mec": {"duid": "RL:4Mec", "attribute": [], "entityType": "SiteOther", "charEnd": 1626, "source": "RLIMS-P", "charStart": 1623, "entityId": [], "sentenceIndex": 10, "entityText": "site"}, "RL:k6rm": {"duid": "RL:k6rm", "attribute": [], "entityType": "Trigger", "charEnd": 1008, "source": "RLIMS-P", "charStart": 996, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}, "RL:gFzV": {"duid": "RL:gFzV", "attribute": [], "entityType": "Trigger", "charEnd": 76, "source": "RLIMS-P", "charStart": 62, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:C8Te": {"duid": "RL:C8Te", "attribute": [], "entityType": "SiteOther", "charEnd": 1761, "source": "RLIMS-P", "charStart": 1758, "entityId": [], "sentenceIndex": 10, "entityText": "site"}, "RL:cRrm": {"duid": "RL:cRrm", "attribute": [], "entityType": "Trigger", "charEnd": 1115, "source": "RLIMS-P", "charStart": 1101, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptides"}, "RL:U25u": {"duid": "RL:U25u", "attribute": [], "entityType": "Trigger", "charEnd": 456, "source": "RLIMS-P", "charStart": 441, "entityId": [], "sentenceIndex": 3, "entityText": "phosphothreonine"}}, "mesh": ["Alkaloids", "Cell Line", "Down-Regulation", "Electrophoresis, Gel, Two-Dimensional", "Insulin", "Peptide Mapping", "Phorbol 12,13-Dibutyrate", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Protein Kinase C", "Receptor, Insulin", "Staurosporine", "Tetradecanoylphorbol Acetate", "Trypsin"], "relation": {"RL:haF6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:WdkH"}, {"role": "TRIGGER", "entity_duid": "RL:rBBJ"}], "duid": "RL:haF6"}, "RL:L93S": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:87MQ"}, {"role": "SITE", "entity_duid": "RL:qCQh"}, {"role": "SITE_OTHER", "entity_duid": "RL:4Mec"}, {"role": "TRIGGER", "entity_duid": "RL:cCuJ"}], "duid": "RL:L93S"}, "RL:5ssq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TVn4"}], "duid": "RL:5ssq"}, "RL:jGTN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:MBkD"}, {"role": "TRIGGER", "entity_duid": "RL:prjf"}], "duid": "RL:jGTN"}, "RL:r4CV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:WHUr"}], "duid": "RL:r4CV"}, "RL:6vYE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:87MQ"}, {"role": "SITE", "entity_duid": "RL:Yj22"}, {"role": "TRIGGER", "entity_duid": "RL:TU6t"}], "duid": "RL:6vYE"}, "RL:xLDc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:U25u"}], "duid": "RL:xLDc"}, "RL:JFaJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:87MQ"}, {"role": "SITE", "entity_duid": "RL:qCQh"}, {"role": "TRIGGER", "entity_duid": "RL:aqje"}], "duid": "RL:JFaJ"}, "RL:NWiV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ryzz"}], "duid": "RL:NWiV"}, "RL:aWrc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:87MQ"}, {"role": "SITE", "entity_duid": "RL:DzTo"}, {"role": "TRIGGER", "entity_duid": "RL:K7H2"}], "duid": "RL:aWrc"}, "RL:Ni86": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZrPr"}], "duid": "RL:Ni86"}, "RL:m5JG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:wftG"}, {"role": "TRIGGER", "entity_duid": "RL:gFzV"}], "duid": "RL:m5JG"}, "RL:r8Wn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:jM7m"}, {"role": "SITE", "entity_duid": "RL:VgQV"}, {"role": "TRIGGER", "entity_duid": "RL:5ZzU"}], "duid": "RL:r8Wn"}, "RL:h5tG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:CCCY"}, {"role": "SITE", "entity_duid": "RL:pEAs"}, {"role": "SITE", "entity_duid": "RL:w5MX"}, {"role": "SITE_OTHER", "entity_duid": "RL:csGB"}, {"role": "TRIGGER", "entity_duid": "RL:irFP"}], "duid": "RL:h5tG"}, "RL:nomc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2juk"}], "duid": "RL:nomc"}, "RL:5fCC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:C8Te"}, {"role": "TRIGGER", "entity_duid": "RL:2sBq"}], "duid": "RL:5fCC"}, "RL:CpTE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:V6sW"}], "duid": "RL:CpTE"}, "RL:E5vd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UNKp"}], "duid": "RL:E5vd"}, "RL:CtCc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:65gr"}], "duid": "RL:CtCc"}, "RL:7y3Y": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:87MQ"}, {"role": "TRIGGER", "entity_duid": "RL:BRk8"}], "duid": "RL:7y3Y"}, "RL:4P8T": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZSfj"}], "duid": "RL:4P8T"}, "RL:CKTR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:k6rm"}], "duid": "RL:CKTR"}, "RL:gA37": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2wy4"}, {"role": "TRIGGER", "entity_duid": "RL:cRrm"}], "duid": "RL:gA37"}, "RL:H6vu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2y6D"}], "duid": "RL:H6vu"}, "RL:y4ut": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:EKNa"}], "duid": "RL:y4ut"}}, "type": ["Journal Article"]}
{"docId": "6208480", "sentence": [{"charStart": 0, "charEnd": 157, "index": 0}, {"index": 1, "charEnd": 297, "charStart": 159}, {"index": 2, "charEnd": 439, "charStart": 299}, {"index": 3, "charEnd": 513, "charStart": 441}, {"index": 4, "charEnd": 777, "charStart": 515}, {"index": 5, "charEnd": 904, "charStart": 779}, {"index": 6, "charEnd": 980, "charStart": 906}, {"index": 7, "charEnd": 1080, "charStart": 982}, {"index": 8, "charEnd": 1226, "charStart": 1082}, {"index": 9, "charEnd": 1420, "charStart": 1228}, {"index": 10, "charEnd": 1525, "charStart": 1422}, {"index": 11, "charEnd": 1620, "charStart": 1527}, {"index": 12, "charEnd": 1682, "charStart": 1622}], "text": "Effects of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on metabolism of the epidermal growth factor receptor in normal human fibroblasts. The biosynthesis, phosphorylation, and degradation of the epidermal growth factor (EGF) receptor were examined in normal human fibroblasts. The receptor was initially synthesized as an Mr = 160,000 immature form which matured to an Mr = 170,000 form in a monensin-sensitive manner. Tunicamycin treatment led to the accumulation of an Mr = 130,000 protein. The receptor was phosphorylated on serine and threonine residues in normally growing and quiescent cells, and treatment with EGF or the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) resulted in a two- to threefold increase in receptor-bound phosphate. EGF increased the amount of phosphoserine and phosphothreonine and caused the appearance of a minor amount of phosphotyrosine. TPA increased the levels of phosphoserine and phosphothreonine exclusively. Prior treatment with TPA inhibited the EGF-dependent appearance of phosphotyrosine in the receptor. Analysis of tryptic phosphopeptides revealed that six of the seven major peptides were common to the receptor from cells treated with EGF or TPA. EGF strongly stimulated [3H]thymidine incorporation in confluent cells, increased final saturation density three to fourfold, and increased whole-cell levels of phosphotyrosine about threefold. Treatment of cells with TPA before addition of EGF inhibited all three of these EGF-dependent responses. EGF also decreased the receptor half-life from 15 h to 1 h, but this was not inhibited by TPA. TPA alone had no detectable effect on the receptor half-life.", "title": {"charStart": 0, "charEnd": 157}, "entity": {"RL:p2uB": {"duid": "RL:p2uB", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 555, "source": "RLIMS-P", "charStart": 550, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:dzqS": {"duid": "RL:dzqS", "attribute": [], "entityType": "Trigger", "charEnd": 903, "source": "RLIMS-P", "charStart": 889, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:z7hP": {"duid": "RL:z7hP", "attribute": [], "entityType": "Trigger", "charEnd": 1403, "source": "RLIMS-P", "charStart": 1389, "entityId": [], "sentenceIndex": 9, "entityText": "phosphotyrosine"}, "RL:suki": {"duid": "RL:suki", "attribute": [], "entityType": "Trigger", "charEnd": 946, "source": "RLIMS-P", "charStart": 934, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:AYu2": {"duid": "RL:AYu2", "attribute": [], "entityType": "Protein", "charEnd": 254, "source": "RLIMS-P", "charStart": 217, "entityId": [], "sentenceIndex": 1, "entityText": "epidermal growth factor (EGF) receptor"}, "RL:v8hc": {"duid": "RL:v8hc", "attribute": [], "entityType": "Trigger", "charEnd": 545, "source": "RLIMS-P", "charStart": 532, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:Wa4v": {"duid": "RL:Wa4v", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 1063, "source": "RLIMS-P", "charStart": 1056, "entityId": [], "sentenceIndex": 7, "entityText": "tyrosine"}, "RL:JS2j": {"duid": "RL:JS2j", "attribute": [], "entityType": "Trigger", "charEnd": 819, "source": "RLIMS-P", "charStart": 807, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:kbFP": {"duid": "RL:kbFP", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 569, "source": "RLIMS-P", "charStart": 561, "entityId": [], "sentenceIndex": 4, "entityText": "threonine"}, "RL:Zti8": {"duid": "RL:Zti8", "attribute": [], "entityType": "Trigger", "charEnd": 1116, "source": "RLIMS-P", "charStart": 1102, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptides"}, "RL:vj8j": {"duid": "RL:vj8j", "attribute": [], "entityType": "Trigger", "charEnd": 1063, "source": "RLIMS-P", "charStart": 1049, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosine"}, "RL:GEir": {"duid": "RL:GEir", "attribute": [], "entityType": "SiteOther", "charEnd": 1116, "source": "RLIMS-P", "charStart": 1102, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptides"}, "RL:yQ3i": {"duid": "RL:yQ3i", "attribute": [], "entityType": "Trigger", "charEnd": 191, "source": "RLIMS-P", "charStart": 177, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}}, "mesh": ["Cells, Cultured", "DNA Replication", "Epidermal Growth Factor", "ErbB Receptors", "Fibroblasts", "Humans", "Kinetics", "Male", "Phorbols", "Phosphorylation", "Phosphotyrosine", "Receptors, Cell Surface", "Skin", "Tetradecanoylphorbol Acetate", "Tyrosine"], "relation": {"RL:hTyo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:AYu2"}, {"role": "TRIGGER", "entity_duid": "RL:yQ3i"}], "duid": "RL:hTyo"}, "RL:3rSv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:AYu2"}, {"role": "SITE", "entity_duid": "RL:Wa4v"}, {"role": "TRIGGER", "entity_duid": "RL:vj8j"}], "duid": "RL:3rSv"}, "RL:jCQZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:z7hP"}], "duid": "RL:jCQZ"}, "RL:iUPa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:GEir"}, {"role": "TRIGGER", "entity_duid": "RL:Zti8"}], "duid": "RL:iUPa"}, "RL:c6ee": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dzqS"}], "duid": "RL:c6ee"}, "RL:RpkF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:suki"}], "duid": "RL:RpkF"}, "RL:QMVE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:AYu2"}, {"role": "SITE", "entity_duid": "RL:p2uB"}, {"role": "SITE", "entity_duid": "RL:kbFP"}, {"role": "TRIGGER", "entity_duid": "RL:v8hc"}], "duid": "RL:QMVE"}, "RL:Y8CN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JS2j"}], "duid": "RL:Y8CN"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "9794085", "sentence": [{"charStart": 0, "charEnd": 65, "index": 0}, {"index": 1, "charEnd": 198, "charStart": 67}, {"index": 2, "charEnd": 310, "charStart": 200}, {"index": 3, "charEnd": 469, "charStart": 312}, {"index": 4, "charEnd": 549, "charStart": 471}, {"index": 5, "charEnd": 683, "charStart": 551}, {"index": 6, "charEnd": 798, "charStart": 685}, {"index": 7, "charEnd": 844, "charStart": 800}, {"index": 8, "charEnd": 961, "charStart": 846}], "text": "Fragmentation of phosphopeptides in an ion trap mass spectrometer. A systematic study of the fragmentation pattern of phosphopeptides in an electrospray (ESI) ion trap mass spectrometer is presented. We show that phosphotyrosine- and phosphothreonine-containing peptides show complicated fragmentation patterns. These phosphopeptides were observed to lose the phosphate moiety in the form of H3PO4 and/or HPO3, but were also detected with no loss of the phosphate group. The tendency to lose the phosphate moiety depends strongly on the charge state. Thus, the highest observed charge state tends to retain the phosphate moiety with extensive fragmentation along the peptide backbone. We also show that phosphoserine-containing peptides have relatively simple fragmentation patterns of losing H3PO4. This loss is independent of the charge state. We suggest strategies for the accurate identification of phosphorylation sites using the ion trap mass spectrometer.", "title": {"charStart": 0, "charEnd": 65}, "entity": {"RL:Mn9c": {"duid": "RL:Mn9c", "attribute": [], "entityType": "SiteOther", "charEnd": 31, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:2TXc": {"duid": "RL:2TXc", "attribute": [], "entityType": "SiteOther", "charEnd": 132, "source": "RLIMS-P", "charStart": 118, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:2DZp": {"duid": "RL:2DZp", "attribute": [], "entityType": "Trigger", "charEnd": 332, "source": "RLIMS-P", "charStart": 318, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:mZF8": {"duid": "RL:mZF8", "attribute": [], "entityType": "Trigger", "charEnd": 249, "source": "RLIMS-P", "charStart": 234, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:a9bV": {"duid": "RL:a9bV", "attribute": [], "entityType": "Trigger", "charEnd": 917, "source": "RLIMS-P", "charStart": 903, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:FhRj": {"duid": "RL:FhRj", "attribute": [], "entityType": "Trigger", "charEnd": 227, "source": "RLIMS-P", "charStart": 213, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:sMYB": {"duid": "RL:sMYB", "attribute": [], "entityType": "SiteOther", "charEnd": 923, "source": "RLIMS-P", "charStart": 903, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation sites"}, "RL:Y43C": {"duid": "RL:Y43C", "attribute": [], "entityType": "SiteOther", "charEnd": 332, "source": "RLIMS-P", "charStart": 318, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:HrUb": {"duid": "RL:HrUb", "attribute": [], "entityType": "Trigger", "charEnd": 715, "source": "RLIMS-P", "charStart": 703, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:aUub": {"duid": "RL:aUub", "attribute": [], "entityType": "Trigger", "charEnd": 132, "source": "RLIMS-P", "charStart": 118, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:zXcN": {"duid": "RL:zXcN", "attribute": [], "entityType": "Trigger", "charEnd": 31, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "Chromatography, Liquid", "Gas Chromatography-Mass Spectrometry", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine"], "relation": {"RL:Rn4M": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2TXc"}, {"role": "TRIGGER", "entity_duid": "RL:aUub"}], "duid": "RL:Rn4M"}, "RL:qgNa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2TXc"}, {"role": "SITE_OTHER", "entity_duid": "RL:Y43C"}, {"role": "TRIGGER", "entity_duid": "RL:2DZp"}], "duid": "RL:qgNa"}, "RL:TWqQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:sMYB"}, {"role": "TRIGGER", "entity_duid": "RL:a9bV"}], "duid": "RL:TWqQ"}, "RL:9E4m": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mZF8"}], "duid": "RL:9E4m"}, "RL:icdA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Mn9c"}, {"role": "TRIGGER", "entity_duid": "RL:zXcN"}], "duid": "RL:icdA"}, "RL:2ZUu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:FhRj"}], "duid": "RL:2ZUu"}, "RL:maup": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:HrUb"}], "duid": "RL:maup"}}, "type": ["Journal Article"]}
{"docId": "12595692", "sentence": [{"charStart": 0, "charEnd": 85, "index": 0}, {"index": 1, "charEnd": 222, "charStart": 87}, {"index": 2, "charEnd": 445, "charStart": 224}, {"index": 3, "charEnd": 711, "charStart": 447}, {"index": 4, "charEnd": 900, "charStart": 713}, {"index": 5, "charEnd": 1116, "charStart": 902}], "text": "Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. We have developed a proteomic approach for identifying phosphopeptide binding domains that modulate kinase-dependent signaling pathways. An immobilized library of partially degenerate phosphopeptides biased toward a particular protein kinase phosphorylation motif is used to isolate phospho-binding domains that bind to proteins phosphorylated by that kinase. Applying this approach to cyclin-dependent kinases (Cdks), we identified the polo-box domain (PBD) of the mitotic kinase polo-like kinase 1 (Plk1) as a specific phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined its optimal binding motif. This motif is present in known Plk1 substrates such as Cdc25, and an optimal phosphopeptide containing the motif disrupted PBD-substrate binding and localization of the PBD to centrosomes. This finding reveals how Plk1 can localize to specific sites within cells in response to Cdk phosphorylation at those sites and provides a structural mechanism for targeting the Plk1 kinase domain to its substrates.", "title": {"charStart": 0, "charEnd": 85}, "entity": {"RL:r97N": {"duid": "RL:r97N", "attribute": [], "entityType": "Trigger", "charEnd": 620, "source": "RLIMS-P", "charStart": 608, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:WrLa": {"duid": "RL:WrLa", "attribute": [], "entityType": "Trigger", "charEnd": 1009, "source": "RLIMS-P", "charStart": 995, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:bGdw": {"duid": "RL:bGdw", "attribute": [], "entityType": "SiteOther", "charEnd": 349, "source": "RLIMS-P", "charStart": 314, "entityId": [], "sentenceIndex": 2, "entityText": "protein kinase phosphorylation motif"}, "RL:mGBw": {"duid": "RL:mGBw", "attribute": [], "entityType": "Trigger", "charEnd": 343, "source": "RLIMS-P", "charStart": 329, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:c5vf": {"duid": "RL:c5vf", "attribute": [], "entityType": "SiteOther", "charEnd": 171, "source": "RLIMS-P", "charStart": 142, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide binding domains"}, "RL:Ybs7": {"duid": "RL:Ybs7", "attribute": [], "entityType": "SiteOther", "charEnd": 285, "source": "RLIMS-P", "charStart": 260, "entityId": [], "sentenceIndex": 2, "entityText": "degenerate phosphopeptides"}, "RL:J7uj": {"duid": "RL:J7uj", "attribute": [], "entityType": "SiteOther", "charEnd": 1024, "source": "RLIMS-P", "charStart": 1020, "entityId": [], "sentenceIndex": 5, "entityText": "sites"}, "RL:bryR": {"duid": "RL:bryR", "attribute": [], "entityType": "Trigger", "charEnd": 155, "source": "RLIMS-P", "charStart": 142, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:enaZ": {"duid": "RL:enaZ", "attribute": [], "entityType": "Trigger", "charEnd": 285, "source": "RLIMS-P", "charStart": 271, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:eSFd": {"duid": "RL:eSFd", "attribute": [], "entityType": "Protein", "charEnd": 993, "source": "RLIMS-P", "charStart": 991, "entityId": [], "sentenceIndex": 5, "entityText": "Cdk"}, "RL:cmi5": {"duid": "RL:cmi5", "attribute": [], "entityType": "Trigger", "charEnd": 803, "source": "RLIMS-P", "charStart": 790, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:sVrt": {"duid": "RL:sVrt", "attribute": [], "entityType": "SiteOther", "charEnd": 961, "source": "RLIMS-P", "charStart": 948, "entityId": [], "sentenceIndex": 5, "entityText": "specific sites"}, "RL:Y3DL": {"duid": "RL:Y3DL", "attribute": [], "entityType": "Trigger", "charEnd": 429, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:y7Gw": {"duid": "RL:y7Gw", "attribute": [], "entityType": "SiteOther", "charEnd": 803, "source": "RLIMS-P", "charStart": 790, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}}, "mesh": ["Amino Acid Motifs", "Binding Sites", "Calorimetry", "Cell Cycle Proteins", "Centrosome", "HeLa Cells", "Humans", "Ligands", "Mitosis", "Peptide Library", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Point Mutation", "Protein Binding", "Protein Kinases", "Protein Structure, Tertiary", "Protein-Serine-Threonine Kinases", "Proteomics", "Proto-Oncogene Proteins", "Signal Transduction", "cdc25 Phosphatases"], "relation": {"RL:uKfU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Ybs7"}, {"role": "TRIGGER", "entity_duid": "RL:enaZ"}], "duid": "RL:uKfU"}, "RL:exuJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:eSFd"}, {"role": "SITE_OTHER", "entity_duid": "RL:J7uj"}, {"role": "SITE_OTHER", "entity_duid": "RL:sVrt"}, {"role": "TRIGGER", "entity_duid": "RL:WrLa"}], "duid": "RL:exuJ"}, "RL:j6PM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Y3DL"}], "duid": "RL:j6PM"}, "RL:JVyx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:y7Gw"}, {"role": "TRIGGER", "entity_duid": "RL:cmi5"}], "duid": "RL:JVyx"}, "RL:KXmz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:bGdw"}, {"role": "TRIGGER", "entity_duid": "RL:mGBw"}], "duid": "RL:KXmz"}, "RL:d7dy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:c5vf"}, {"role": "TRIGGER", "entity_duid": "RL:bryR"}], "duid": "RL:d7dy"}, "RL:sHLQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:r97N"}], "duid": "RL:sHLQ"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "17935722", "sentence": [{"charStart": 0, "charEnd": 68, "index": 0}, {"index": 1, "charEnd": 414, "charStart": 70}, {"index": 2, "charEnd": 549, "charStart": 416}, {"index": 3, "charEnd": 760, "charStart": 551}, {"index": 4, "charEnd": 928, "charStart": 762}, {"index": 5, "charEnd": 1224, "charStart": 930}, {"index": 6, "charEnd": 1439, "charStart": 1226}], "text": "Phosphopeptide elution times in reversed-phase liquid chromatography. Elution time shifts between 33 different peptides and their corresponding phosphopeptides ranging from 4 amino acid residues to 35 amino acids in length were systematically investigated using high-resolution reversed-phase liquid chromatography (RPLC)-tandem mass spectrometry (MS/MS) analysis with trifluoroacetic acid as the ion pairing agent. Observed peptide elution time shifts for a single phosphorylation ranged from -5.28 min (for pYVPML) to +0.59 min (for HRDpSGLLDSLGR). Peptides containing a phosphotyrosine residue displayed a significant decrease in elution time following phosphorylation compared to their similar-sized peptides with phosphoserine or phosphothreonine residues. While peptide phosphorylation generally led to a decrease in the observed elution time, five peptides displayed increased elution times as a result of phosphorylation. For large peptides (> or =18 amino acids), the elution time shifts due to single phosphorylation were limited (ranging between -0.48 and +0.03 min), while the elution time shifts for small peptides (<18 amino acids) were characterized by a larger deviation (ranging between -5.28 and +0.59 min). The predictive capability for the observed RPLC elution time change due to phosphorylation has been suggested, which will aid in assigning confident phosphopeptide identifications and their subsequent confirmation.", "title": {"charStart": 0, "charEnd": 68}, "entity": {"RL:2PxE": {"duid": "RL:2PxE", "attribute": [], "entityType": "Trigger", "charEnd": 927, "source": "RLIMS-P", "charStart": 913, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:VFz3": {"duid": "RL:VFz3", "attribute": [], "entityType": "Trigger", "charEnd": 1025, "source": "RLIMS-P", "charStart": 1011, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:dGiH": {"duid": "RL:dGiH", "attribute": [], "entityType": "Trigger", "charEnd": 730, "source": "RLIMS-P", "charStart": 718, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:5wvM": {"duid": "RL:5wvM", "attribute": [], "entityType": "Trigger", "charEnd": 480, "source": "RLIMS-P", "charStart": 466, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:2KhM": {"duid": "RL:2KhM", "attribute": [], "entityType": "Trigger", "charEnd": 158, "source": "RLIMS-P", "charStart": 144, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:Ttr4": {"duid": "RL:Ttr4", "attribute": [], "entityType": "Trigger", "charEnd": 670, "source": "RLIMS-P", "charStart": 656, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:Uyvb": {"duid": "RL:Uyvb", "attribute": [], "entityType": "SiteOther", "charEnd": 774, "source": "RLIMS-P", "charStart": 768, "entityId": [], "sentenceIndex": 4, "entityText": "peptide"}, "RL:hdEY": {"duid": "RL:hdEY", "attribute": [], "entityType": "Trigger", "charEnd": 1315, "source": "RLIMS-P", "charStart": 1301, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:Ymya": {"duid": "RL:Ymya", "attribute": [], "entityType": "SiteOther", "charEnd": 158, "source": "RLIMS-P", "charStart": 130, "entityId": [], "sentenceIndex": 1, "entityText": "corresponding phosphopeptides"}, "RL:DwYW": {"duid": "RL:DwYW", "attribute": [], "entityType": "Trigger", "charEnd": 587, "source": "RLIMS-P", "charStart": 573, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:yEVA": {"duid": "RL:yEVA", "attribute": [], "entityType": "Trigger", "charEnd": 790, "source": "RLIMS-P", "charStart": 776, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}}, "mesh": ["Amino Acid Sequence", "Chromatography, Liquid", "Hydrophobic and Hydrophilic Interactions", "Molecular Sequence Data", "Peptide Fragments", "Peptides", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Predictive Value of Tests", "Proteome", "Sensitivity and Specificity", "Spectrometry, Mass, Electrospray Ionization", "Tandem Mass Spectrometry", "Time Factors", "Trifluoroacetic Acid", "Trypsin"], "relation": {"RL:6LQb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DwYW"}], "duid": "RL:6LQb"}, "RL:fZTY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5wvM"}], "duid": "RL:fZTY"}, "RL:bN6W": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Uyvb"}, {"role": "TRIGGER", "entity_duid": "RL:yEVA"}], "duid": "RL:bN6W"}, "RL:xhrM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:VFz3"}], "duid": "RL:xhrM"}, "RL:x6n5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2PxE"}], "duid": "RL:x6n5"}, "RL:UEYz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:hdEY"}], "duid": "RL:UEYz"}, "RL:MmVV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Ymya"}, {"role": "TRIGGER", "entity_duid": "RL:2KhM"}], "duid": "RL:MmVV"}, "RL:ykav": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dGiH"}], "duid": "RL:ykav"}, "RL:xE4s": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ttr4"}], "duid": "RL:xE4s"}}, "type": ["Comparative Study", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "8567164", "sentence": [{"charStart": 0, "charEnd": 158, "index": 0}, {"index": 1, "charEnd": 454, "charStart": 160}, {"index": 2, "charEnd": 605, "charStart": 456}, {"index": 3, "charEnd": 716, "charStart": 607}], "text": "Chemical synthesis of phosphopeptides using the arylthio group for protection of phosphate: application to identification of cdc2 kinase phosphorylation sites. Synthesis of two O-phosphorylated dipeptides, N-Boc-O[S,S-bis(p-methoxyphenyl)phosphorodithioyl] -serylproline and N-Boc-O-[S,S-bis(p-methoxyphenyl) phosphorodithioyl]threonylproline, as new O-phosphorylated dipeptide building blocks for the synthesis of O-phosphorylated peptides, is described. Peptides containing phosphoserine or phosphothreonine were prepared by use of these building blocks in the Boc mode of liquid-phase peptide synthesis. Sites phosphorylated by cdc2 kinase were easily identified using these chemically synthesized phosphopeptides.", "title": {"charStart": 0, "charEnd": 158}, "entity": {"RL:Ruo3": {"duid": "RL:Ruo3", "attribute": [], "entityType": "Trigger", "charEnd": 366, "source": "RLIMS-P", "charStart": 353, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:W34e": {"duid": "RL:W34e", "attribute": [], "entityType": "SiteOther", "charEnd": 341, "source": "RLIMS-P", "charStart": 286, "entityId": [], "sentenceIndex": 1, "entityText": "S-bis(p-methoxyphenyl) phosphorodithioyl]threonylproline"}, "RL:NaXF": {"duid": "RL:NaXF", "attribute": [], "entityType": "SiteOther", "charEnd": 36, "source": "RLIMS-P", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:JzPH": {"duid": "RL:JzPH", "attribute": [], "entityType": "SiteOther", "charEnd": 157, "source": "RLIMS-P", "charStart": 125, "entityId": [], "sentenceIndex": 0, "entityText": "cdc2 kinase phosphorylation sites"}, "RL:9saQ": {"duid": "RL:9saQ", "attribute": [], "entityType": "Trigger", "charEnd": 36, "source": "RLIMS-P", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:GTVf": {"duid": "RL:GTVf", "attribute": [], "entityType": "Protein", "charEnd": 641, "source": "RLIMS-P", "charStart": 631, "entityId": [], "sentenceIndex": 3, "entityText": "cdc2 kinase"}, "RL:CqEs": {"duid": "RL:CqEs", "attribute": [], "entityType": "Trigger", "charEnd": 430, "source": "RLIMS-P", "charStart": 417, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:G96A": {"duid": "RL:G96A", "attribute": [], "entityType": "Trigger", "charEnd": 715, "source": "RLIMS-P", "charStart": 701, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:FsLy": {"duid": "RL:FsLy", "attribute": [], "entityType": "SiteOther", "charEnd": 611, "source": "RLIMS-P", "charStart": 607, "entityId": [], "sentenceIndex": 3, "entityText": "Sites"}, "RL:jeTr": {"duid": "RL:jeTr", "attribute": [], "entityType": "Trigger", "charEnd": 488, "source": "RLIMS-P", "charStart": 476, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:vmNh": {"duid": "RL:vmNh", "attribute": [], "entityType": "SiteOther", "charEnd": 439, "source": "RLIMS-P", "charStart": 432, "entityId": [], "sentenceIndex": 1, "entityText": "peptides"}, "RL:Lp2G": {"duid": "RL:Lp2G", "attribute": [], "entityType": "SiteOther", "charEnd": 715, "source": "RLIMS-P", "charStart": 701, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:DttN": {"duid": "RL:DttN", "attribute": [], "entityType": "Trigger", "charEnd": 192, "source": "RLIMS-P", "charStart": 179, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:DpsK": {"duid": "RL:DpsK", "attribute": [], "entityType": "Trigger", "charEnd": 626, "source": "RLIMS-P", "charStart": 613, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:nbvg": {"duid": "RL:nbvg", "attribute": [], "entityType": "Protein", "charEnd": 135, "source": "RLIMS-P", "charStart": 125, "entityId": [], "sentenceIndex": 0, "entityText": "cdc2 kinase"}, "RL:hcxW": {"duid": "RL:hcxW", "attribute": [], "entityType": "Trigger", "charEnd": 151, "source": "RLIMS-P", "charStart": 137, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}}, "mesh": ["Amino Acid Sequence", "Binding Sites", "CDC2 Protein Kinase", "Chromatography, High Pressure Liquid", "Humans", "Magnetic Resonance Spectroscopy", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Retinoblastoma Protein"], "relation": {"RL:RRTr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jeTr"}], "duid": "RL:RRTr"}, "RL:6LFU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:W34e"}, {"role": "TRIGGER", "entity_duid": "RL:DttN"}], "duid": "RL:6LFU"}, "RL:R3HK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:NaXF"}, {"role": "TRIGGER", "entity_duid": "RL:9saQ"}], "duid": "RL:R3HK"}, "RL:6tm7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "KINASE", "entity_duid": "RL:GTVf"}, {"role": "SITE_OTHER", "entity_duid": "RL:FsLy"}, {"role": "TRIGGER", "entity_duid": "RL:DpsK"}], "duid": "RL:6tm7"}, "RL:a7AN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ruo3"}], "duid": "RL:a7AN"}, "RL:5b6B": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "KINASE", "entity_duid": "RL:nbvg"}, {"role": "SITE_OTHER", "entity_duid": "RL:JzPH"}, {"role": "TRIGGER", "entity_duid": "RL:hcxW"}], "duid": "RL:5b6B"}, "RL:bivS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:vmNh"}, {"role": "TRIGGER", "entity_duid": "RL:CqEs"}], "duid": "RL:bivS"}, "RL:N2g8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:NaXF"}, {"role": "SITE_OTHER", "entity_duid": "RL:Lp2G"}, {"role": "TRIGGER", "entity_duid": "RL:G96A"}], "duid": "RL:N2g8"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "18578522", "sentence": [{"charStart": 0, "charEnd": 112, "index": 0}, {"index": 1, "charEnd": 256, "charStart": 114}, {"index": 2, "charEnd": 461, "charStart": 258}, {"index": 3, "charEnd": 717, "charStart": 463}, {"index": 4, "charEnd": 1007, "charStart": 719}, {"index": 5, "charEnd": 1215, "charStart": 1009}, {"index": 6, "charEnd": 1517, "charStart": 1217}, {"index": 7, "charEnd": 1709, "charStart": 1519}], "text": "TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. Phosphorylation of plasma membrane proteins frequently initiates signal transduction pathways or attenuate plasma membrane transport processes. Because of the low abundance and hydrophobic features of many plasma membrane proteins and the low stoichiometry of protein phosphorylation, studies of the plasma membrane phosphoproteome are challenging. We present an optimized analytical strategy for plasma membrane phosphoproteomics that combines efficient plasma membrane protein preparation with TiO(2)-based phosphopeptide enrichment and high-performance mass spectrometry for phosphopeptide sequencing. We used sucrose centrifugation in combination with sodium carbonate extraction to achieve efficient and reproducible purification of low microgram levels of plasma membrane proteins from human mesenchymal stem cells (hMSCs, 10(7) cells), achieving more than 70% yield of membrane proteins. Phosphopeptide enrichment by titanium dioxide chromatography followed by capillary liquid chromatography-tandem mass spectrometry allowed us to assign 703 unique phosphorylation sites in 376 phosphoproteins. Our experiments revealed that treatment of cell cultures with three different types of protein phosphatase inhibitors produces distinct phosphopeptide populations and an increase of 10-40% of the number of detected and sequenced phosphoserine, phosphothreonine and phosphotyrosine containing peptides. In summary, our analytical strategy enables functional phosphoproteomic analysis of stem cell differentiation and cell surface biomarker discovery using very low amounts of starting material.", "title": {"charStart": 0, "charEnd": 112}, "entity": {"RL:ym9p": {"duid": "RL:ym9p", "attribute": [], "entityType": "Trigger", "charEnd": 128, "source": "RLIMS-P", "charStart": 114, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphorylation"}, "RL:E2mY": {"duid": "RL:E2mY", "attribute": [], "entityType": "Trigger", "charEnd": 1458, "source": "RLIMS-P", "charStart": 1446, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:GgVT": {"duid": "RL:GgVT", "attribute": [], "entityType": "Trigger", "charEnd": 1214, "source": "RLIMS-P", "charStart": 1200, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoproteins"}, "RL:yehv": {"duid": "RL:yehv", "attribute": [], "entityType": "SiteOther", "charEnd": 1191, "source": "RLIMS-P", "charStart": 1171, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation sites"}, "RL:2sTn": {"duid": "RL:2sTn", "attribute": [], "entityType": "SiteOther", "charEnd": 705, "source": "RLIMS-P", "charStart": 692, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}, "RL:gTXw": {"duid": "RL:gTXw", "attribute": [], "entityType": "Trigger", "charEnd": 1185, "source": "RLIMS-P", "charStart": 1171, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:GCCB": {"duid": "RL:GCCB", "attribute": [], "entityType": "Trigger", "charEnd": 396, "source": "RLIMS-P", "charStart": 382, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:XRBs": {"duid": "RL:XRBs", "attribute": [], "entityType": "Trigger", "charEnd": 705, "source": "RLIMS-P", "charStart": 692, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}}, "mesh": ["Cell Line", "Cell Membrane", "Chromatography", "Humans", "Membrane Proteins", "Mesenchymal Stem Cells", "Phosphopeptides", "Phosphoric Monoester Hydrolases", "Tandem Mass Spectrometry", "Titanium"], "relation": {"RL:QND8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GgVT"}], "duid": "RL:QND8"}, "RL:kqDh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:yehv"}, {"role": "TRIGGER", "entity_duid": "RL:gTXw"}], "duid": "RL:kqDh"}, "RL:e6TF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2sTn"}, {"role": "TRIGGER", "entity_duid": "RL:XRBs"}], "duid": "RL:e6TF"}, "RL:7aJr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ym9p"}], "duid": "RL:7aJr"}, "RL:wmpj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GCCB"}], "duid": "RL:wmpj"}, "RL:979M": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:E2mY"}], "duid": "RL:979M"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "17297928", "sentence": [{"charStart": 0, "charEnd": 79, "index": 0}, {"index": 1, "charEnd": 231, "charStart": 81}, {"index": 2, "charEnd": 369, "charStart": 233}, {"index": 3, "charEnd": 483, "charStart": 371}, {"index": 4, "charEnd": 563, "charStart": 485}, {"index": 5, "charEnd": 669, "charStart": 565}, {"index": 6, "charEnd": 839, "charStart": 671}, {"index": 7, "charEnd": 992, "charStart": 841}, {"index": 8, "charEnd": 1077, "charStart": 994}, {"index": 9, "charEnd": 1170, "charStart": 1079}, {"index": 10, "charEnd": 1305, "charStart": 1172}, {"index": 11, "charEnd": 1467, "charStart": 1307}, {"index": 12, "charEnd": 1638, "charStart": 1469}, {"index": 13, "charEnd": 1832, "charStart": 1640}, {"index": 14, "charEnd": 1911, "charStart": 1834}, {"index": 15, "charEnd": 2013, "charStart": 1913}], "text": "Automatic validation of phosphopeptide identifications from tandem mass spectra. We developed and compared two approaches for automated validation of phosphopeptide tandem mass spectra identified using database searching algorithms. Phosphopeptide identifications were obtained through SEQUEST searches of a protein database appended with its decoy (reversed sequences). Statistical evaluation and iterative searches were employed to create a high-quality data set of phosphopeptides. Automation of postsearch validation was approached by two different strategies. By using statistical multiple testing, we calculate a p value for each tentative peptide phosphorylation. In a second method, we use a support vector machine (SVM; a machine learning algorithm) binary classifier to predict whether a tentative peptide phosphorylation is true. We show good agreement (85%) between postsearch validation of phosphopeptide/spectrum matches by multiple testing and that from support vector machines. Automatic methods conform very well with manual expert validation in a blinded test. Additionally, the algorithms were tested on the identification of synthetic phosphopeptides. We show that phosphate neutral losses in tandem mass spectra can be used to assess the correctness of phosphopeptide/spectrum matches. An SVM classifier with a radial basis function provided classification accuracy from 95.7% to 96.8% of the positive data set, depending on search algorithm used. Establishing the efficacy of an identification is a necessary step for further postsearch interrogation of the spectra for complete localization of phosphorylation sites. Our current implementation performs validation of phosphoserine/phosphothreonine-containing peptides having one or two phosphorylation sites from data gathered on an ion trap mass spectrometer. The SVM-based algorithm has been implemented in the software package DeBunker. We illustrate the application of the SVM-based software DeBunker on a large phosphorylation data set.", "title": {"charStart": 0, "charEnd": 79}, "entity": {"RL:HvXV": {"duid": "RL:HvXV", "attribute": [], "entityType": "Trigger", "charEnd": 1631, "source": "RLIMS-P", "charStart": 1617, "entityId": [], "sentenceIndex": 12, "entityText": "phosphorylation"}, "RL:hUZB": {"duid": "RL:hUZB", "attribute": [], "entityType": "Trigger", "charEnd": 1169, "source": "RLIMS-P", "charStart": 1155, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:KpHe": {"duid": "RL:KpHe", "attribute": [], "entityType": "Trigger", "charEnd": 830, "source": "RLIMS-P", "charStart": 816, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:o9gz": {"duid": "RL:o9gz", "attribute": [], "entityType": "Trigger", "charEnd": 668, "source": "RLIMS-P", "charStart": 654, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:mYQC": {"duid": "RL:mYQC", "attribute": [], "entityType": "SiteOther", "charEnd": 814, "source": "RLIMS-P", "charStart": 808, "entityId": [], "sentenceIndex": 6, "entityText": "peptide"}, "RL:c2rP": {"duid": "RL:c2rP", "attribute": [], "entityType": "Trigger", "charEnd": 1773, "source": "RLIMS-P", "charStart": 1759, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation"}, "RL:QbgX": {"duid": "RL:QbgX", "attribute": [], "entityType": "Trigger", "charEnd": 482, "source": "RLIMS-P", "charStart": 468, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:YakK": {"duid": "RL:YakK", "attribute": [], "entityType": "SiteOther", "charEnd": 1779, "source": "RLIMS-P", "charStart": 1759, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation sites"}, "RL:agUx": {"duid": "RL:agUx", "attribute": [], "entityType": "SiteOther", "charEnd": 652, "source": "RLIMS-P", "charStart": 646, "entityId": [], "sentenceIndex": 5, "entityText": "peptide"}, "RL:7fJ2": {"duid": "RL:7fJ2", "attribute": [], "entityType": "SiteOther", "charEnd": 1169, "source": "RLIMS-P", "charStart": 1155, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:rc2N": {"duid": "RL:rc2N", "attribute": [], "entityType": "SiteOther", "charEnd": 1637, "source": "RLIMS-P", "charStart": 1617, "entityId": [], "sentenceIndex": 12, "entityText": "phosphorylation sites"}, "RL:7Fgg": {"duid": "RL:7Fgg", "attribute": [], "entityType": "SiteOther", "charEnd": 482, "source": "RLIMS-P", "charStart": 468, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:mqoa": {"duid": "RL:mqoa", "attribute": [], "entityType": "Trigger", "charEnd": 1702, "source": "RLIMS-P", "charStart": 1690, "entityId": [], "sentenceIndex": 13, "entityText": "phosphoserine"}, "RL:ZYXR": {"duid": "RL:ZYXR", "attribute": [], "entityType": "Trigger", "charEnd": 2003, "source": "RLIMS-P", "charStart": 1989, "entityId": [], "sentenceIndex": 15, "entityText": "phosphorylation"}}, "mesh": ["Algorithms", "Animals", "Brain", "Databases, Protein", "HeLa Cells", "Humans", "Phosphopeptides", "Rats", "Sensitivity and Specificity", "Tandem Mass Spectrometry"], "relation": {"RL:dqfm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:agUx"}, {"role": "TRIGGER", "entity_duid": "RL:o9gz"}], "duid": "RL:dqfm"}, "RL:qJm7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7fJ2"}, {"role": "TRIGGER", "entity_duid": "RL:hUZB"}], "duid": "RL:qJm7"}, "RL:yGkm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZYXR"}], "duid": "RL:yGkm"}, "RL:hXbw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7Fgg"}, {"role": "TRIGGER", "entity_duid": "RL:QbgX"}], "duid": "RL:hXbw"}, "RL:ud4r": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:rc2N"}, {"role": "TRIGGER", "entity_duid": "RL:HvXV"}], "duid": "RL:ud4r"}, "RL:JFYb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mqoa"}], "duid": "RL:JFYb"}, "RL:3v7h": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mYQC"}, {"role": "TRIGGER", "entity_duid": "RL:KpHe"}], "duid": "RL:3v7h"}, "RL:UgDB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:YakK"}, {"role": "TRIGGER", "entity_duid": "RL:c2rP"}], "duid": "RL:UgDB"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Validation Study"]}
{"docId": "19585040", "sentence": [{"charStart": 0, "charEnd": 35, "index": 0}, {"index": 1, "charEnd": 321, "charStart": 37}], "text": "Phosphate-assisted peptide ligation. A novel ligation method for the synthesis of phosphopeptides and peptides is described, which utilises the inherent reactivity of a peptide bearing an N-terminal phosphoserine or phosphothreonine residue to facilitate amide bond formation with a range of C-terminal peptide thioesters.", "title": {"charStart": 0, "charEnd": 35}, "entity": {"RL:ydd8": {"duid": "RL:ydd8", "attribute": [], "entityType": "Trigger", "charEnd": 96, "source": "RLIMS-P", "charStart": 82, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:kVX6": {"duid": "RL:kVX6", "attribute": [], "entityType": "Trigger", "charEnd": 211, "source": "RLIMS-P", "charStart": 199, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:Yf78": {"duid": "RL:Yf78", "attribute": [], "entityType": "SiteOther", "charEnd": 96, "source": "RLIMS-P", "charStart": 82, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:WpYD": {"duid": "RL:WpYD", "attribute": [], "entityType": "SiteOther", "charEnd": 109, "source": "RLIMS-P", "charStart": 102, "entityId": [], "sentenceIndex": 1, "entityText": "peptides"}}, "mesh": ["Chromatography, High Pressure Liquid", "Kinetics", "Mass Spectrometry", "Nuclear Magnetic Resonance, Biomolecular", "Peptides", "Phosphates", "Spectroscopy, Fourier Transform Infrared"], "relation": {"RL:jdXP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Yf78"}, {"role": "SITE_OTHER", "entity_duid": "RL:WpYD"}, {"role": "TRIGGER", "entity_duid": "RL:ydd8"}], "duid": "RL:jdXP"}, "RL:y8Wx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kVX6"}], "duid": "RL:y8Wx"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "6286990", "sentence": [{"charStart": 0, "charEnd": 107, "index": 0}, {"index": 1, "charEnd": 237, "charStart": 109}, {"index": 2, "charEnd": 472, "charStart": 239}, {"index": 3, "charEnd": 602, "charStart": 474}, {"index": 4, "charEnd": 837, "charStart": 604}, {"index": 5, "charEnd": 1010, "charStart": 839}, {"index": 6, "charEnd": 1179, "charStart": 1012}, {"index": 7, "charEnd": 1380, "charStart": 1181}, {"index": 8, "charEnd": 1538, "charStart": 1382}, {"index": 9, "charEnd": 1632, "charStart": 1540}, {"index": 10, "charEnd": 1741, "charStart": 1634}], "text": "Site-specific phosphorylation regulates the transcriptive activity of vesicular stomatitis virus NS protein. In vitro transcription by vesicular stomatitis virus nucleocapsids is inhibited by enzymatic dephosphorylation of the NS protein. We provide evidence that specific, partial dephosphorylation of NS molecules is the only detectable change in nucleocapsids treated with bacterial alkaline phosphatase under conditions that prevent the action of adventitious protease. Dephosphorylation appeared to affect only the rate of transcription; there were no changes in sedimentation rates of transcripts. To identify the sites of phosphorylation required for NS activity in transcription, we examined phosphopeptides produced by chymotrypsin digestion of the two electrophoretic classes of NS molecules found in virions and infected cells. The electrophoretically slower class, NS1, abundant in the intracellular soluble pool, has a lower activity in transcription; it contained six chymotryptic phosphopeptides. Five of these peptides contained both phosphoserine and phosphothreonine, indicating that this peptide cluster represents at least 11 separate sites of phosphorylation. In the electrophoretically faster nucleocapsid-associated NS2 class of molecules, which support a higher rate of transcription, another group of eight phosphopeptides was superimposed on this pattern. Two of these peptides contained both phosphoserine and phosphothreonine, so this cluster of peptides represents at least 10 additional phosphorylation sites. These sites were especially sensitive to dephosphorylation by bacterial alkaline phosphatase. One or more of them appears to be responsible for the higher transcription rates medicated by NS2 molecules.", "title": {"charStart": 0, "charEnd": 107}, "entity": {"RL:wXkD": {"duid": "RL:wXkD", "attribute": [], "entityType": "Trigger", "charEnd": 714, "source": "RLIMS-P", "charStart": 700, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:KFRs": {"duid": "RL:KFRs", "attribute": [], "entityType": "SiteOther", "charEnd": 714, "source": "RLIMS-P", "charStart": 700, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:SQRS": {"duid": "RL:SQRS", "attribute": [], "entityType": "SiteOther", "charEnd": 1346, "source": "RLIMS-P", "charStart": 1332, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:jmMN": {"duid": "RL:jmMN", "attribute": [], "entityType": "Trigger", "charEnd": 1431, "source": "RLIMS-P", "charStart": 1419, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:Gw3k": {"duid": "RL:Gw3k", "attribute": [], "entityType": "Trigger", "charEnd": 1178, "source": "RLIMS-P", "charStart": 1164, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:2HGt": {"duid": "RL:2HGt", "attribute": [], "entityType": "SiteOther", "charEnd": 624, "source": "RLIMS-P", "charStart": 620, "entityId": [], "sentenceIndex": 4, "entityText": "sites"}, "RL:H4Yu": {"duid": "RL:H4Yu", "attribute": [], "entityType": "Trigger", "charEnd": 1062, "source": "RLIMS-P", "charStart": 1050, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:wauK": {"duid": "RL:wauK", "attribute": [], "entityType": "SiteOther", "charEnd": 1402, "source": "RLIMS-P", "charStart": 1389, "entityId": [], "sentenceIndex": 8, "entityText": "these peptides"}, "RL:sW3D": {"duid": "RL:sW3D", "attribute": [], "entityType": "Protein", "charEnd": 106, "source": "RLIMS-P", "charStart": 70, "entityId": [], "sentenceIndex": 0, "entityText": "vesicular stomatitis virus NS protein"}, "RL:bdQe": {"duid": "RL:bdQe", "attribute": [], "entityType": "SiteOther", "charEnd": 3, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Site"}, "RL:Nm7p": {"duid": "RL:Nm7p", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1083, "source": "RLIMS-P", "charStart": 1075, "entityId": [], "sentenceIndex": 6, "entityText": "threonine"}, "RL:6uhT": {"duid": "RL:6uhT", "attribute": [], "entityType": "Trigger", "charEnd": 1531, "source": "RLIMS-P", "charStart": 1517, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:aNko": {"duid": "RL:aNko", "attribute": [], "entityType": "Trigger", "charEnd": 490, "source": "RLIMS-P", "charStart": 474, "entityId": [], "sentenceIndex": 3, "entityText": "Dephosphorylation"}, "RL:N22n": {"duid": "RL:N22n", "attribute": [], "entityType": "SiteOther", "charEnd": 1159, "source": "RLIMS-P", "charStart": 1146, "entityId": [], "sentenceIndex": 6, "entityText": "separate sites"}, "RL:ovrd": {"duid": "RL:ovrd", "attribute": [], "entityType": "Trigger", "charEnd": 1009, "source": "RLIMS-P", "charStart": 995, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:kB7i": {"duid": "RL:kB7i", "attribute": [], "entityType": "Trigger", "charEnd": 28, "source": "RLIMS-P", "charStart": 14, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:WSNb": {"duid": "RL:WSNb", "attribute": [], "entityType": "SiteOther", "charEnd": 1009, "source": "RLIMS-P", "charStart": 995, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:JC7f": {"duid": "RL:JC7f", "attribute": [], "entityType": "Protein", "charEnd": 790, "source": "RLIMS-P", "charStart": 789, "entityId": [], "sentenceIndex": 4, "entityText": "NS"}, "RL:sPZm": {"duid": "RL:sPZm", "attribute": [], "entityType": "SiteOther", "charEnd": 1537, "source": "RLIMS-P", "charStart": 1517, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation sites"}, "RL:Q6Uz": {"duid": "RL:Q6Uz", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1062, "source": "RLIMS-P", "charStart": 1057, "entityId": [], "sentenceIndex": 6, "entityText": "serine"}, "RL:jVrX": {"duid": "RL:jVrX", "attribute": [], "entityType": "Trigger", "charEnd": 643, "source": "RLIMS-P", "charStart": 629, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:gXv6": {"duid": "RL:gXv6", "attribute": [], "entityType": "Trigger", "charEnd": 1346, "source": "RLIMS-P", "charStart": 1332, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}}, "mesh": ["Alkaline Phosphatase", "Kinetics", "Phosphoproteins", "Phosphorylation", "Protein Conformation", "Transcription, Genetic", "Vesicular stomatitis Indiana virus", "Viral Proteins"], "relation": {"RL:SQ5A": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:SQRS"}, {"role": "TRIGGER", "entity_duid": "RL:gXv6"}], "duid": "RL:SQ5A"}, "RL:G2zv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:JC7f"}, {"role": "SITE", "entity_duid": "RL:Q6Uz"}, {"role": "SITE", "entity_duid": "RL:Nm7p"}, {"role": "SITE_OTHER", "entity_duid": "RL:wauK"}, {"role": "SITE_OTHER", "entity_duid": "RL:sPZm"}, {"role": "TRIGGER", "entity_duid": "RL:6uhT"}], "duid": "RL:G2zv"}, "RL:ryZX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:2HGt"}, {"role": "TRIGGER", "entity_duid": "RL:jVrX"}], "duid": "RL:ryZX"}, "RL:vmno": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:sW3D"}, {"role": "SITE_OTHER", "entity_duid": "RL:bdQe"}, {"role": "TRIGGER", "entity_duid": "RL:kB7i"}], "duid": "RL:vmno"}, "RL:394Q": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KFRs"}, {"role": "TRIGGER", "entity_duid": "RL:wXkD"}], "duid": "RL:394Q"}, "RL:ksbv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aNko"}], "duid": "RL:ksbv"}, "RL:47Kg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:H4Yu"}], "duid": "RL:47Kg"}, "RL:puPX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jmMN"}], "duid": "RL:puPX"}, "RL:b5N4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:N22n"}, {"role": "TRIGGER", "entity_duid": "RL:Gw3k"}], "duid": "RL:b5N4"}, "RL:SnMV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:WSNb"}, {"role": "TRIGGER", "entity_duid": "RL:ovrd"}], "duid": "RL:SnMV"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "12463352", "sentence": [{"charStart": 0, "charEnd": 157, "index": 0}, {"index": 1, "charEnd": 262, "charStart": 159}, {"index": 2, "charEnd": 491, "charStart": 264}, {"index": 3, "charEnd": 682, "charStart": 493}, {"index": 4, "charEnd": 984, "charStart": 684}, {"index": 5, "charEnd": 1195, "charStart": 986}, {"index": 6, "charEnd": 1271, "charStart": 1197}, {"index": 7, "charEnd": 1487, "charStart": 1273}], "text": "Identification of phosphoserine and phosphothreonine as cysteic acid and beta-methylcysteic acid residues in peptides by tandem mass spectrometric sequencing. Tandem mass spectrometry has long been an intrinsic tool to determine phosphorylation sites in proteins. However, loss of the phosphate moiety from both phosphoserine and phosphothreonine residues in low-energy collision-induced dissociation is a common phenomenon, which makes identification of P-Ser and P-Thr residues complicated. A method for direct sequencing of the Ser and Thr phosphorylation sites by ESI tandem mass spectrometry following beta-elimination/sulfite addition to convert -HPO4 to -SO3 has been studied. Five model phosphopeptides, including three synthetic P-Ser-, P-Thr-, or P-Ser- and P-Thr-containing peptides; a protein kinases C-phosphorylated peptide; and a phosphopeptide derived from beta-casein trypsin digests were modified and then sequenced using an ESI-quadrupole ion trap mass spectrometer. Following incubation of P-Ser- or P-Thr-containing peptides with Na2SO3/NaOH, 90% P-Ser and 80% P-Thr was converted to cysteic acid and beta-methylcysteic acid, respectively, as revealed by amino acid analysis. The conversion can be carried out at 1 microM concentration of the peptide. Both cysteic acid and beta-methylcysteic acid residues in the sequence were shown to be stable and easily identifiable under general conditions for tandem mass spectrometric sequencing applicable to common peptides.", "title": {"charStart": 0, "charEnd": 157}, "entity": {"RL:v8UQ": {"duid": "RL:v8UQ", "attribute": [], "entityType": "Protein", "charEnd": 570, "source": "RLIMS-P", "charStart": 568, "entityId": [], "sentenceIndex": 3, "entityText": "ESI"}, "RL:natS": {"duid": "RL:natS", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 533, "source": "RLIMS-P", "charStart": 531, "entityId": [], "sentenceIndex": 3, "entityText": "Ser"}, "RL:RFDM": {"duid": "RL:RFDM", "attribute": [], "entityType": "Trigger", "charEnd": 30, "source": "RLIMS-P", "charStart": 18, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:HJmG": {"duid": "RL:HJmG", "attribute": [], "entityType": "Trigger", "charEnd": 828, "source": "RLIMS-P", "charStart": 815, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:6t2M": {"duid": "RL:6t2M", "attribute": [], "entityType": "Trigger", "charEnd": 709, "source": "RLIMS-P", "charStart": 695, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:TW3R": {"duid": "RL:TW3R", "attribute": [], "entityType": "Trigger", "charEnd": 557, "source": "RLIMS-P", "charStart": 543, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:mpDp": {"duid": "RL:mpDp", "attribute": [], "entityType": "SiteOther", "charEnd": 709, "source": "RLIMS-P", "charStart": 695, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:Yo4H": {"duid": "RL:Yo4H", "attribute": [], "entityType": "SiteOther", "charEnd": 858, "source": "RLIMS-P", "charStart": 843, "entityId": [], "sentenceIndex": 4, "entityText": "a phosphopeptide"}, "RL:yCzi": {"duid": "RL:yCzi", "attribute": [], "entityType": "Trigger", "charEnd": 324, "source": "RLIMS-P", "charStart": 312, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:LSQx": {"duid": "RL:LSQx", "attribute": [], "entityType": "SiteOther", "charEnd": 249, "source": "RLIMS-P", "charStart": 229, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation sites"}, "RL:YEjc": {"duid": "RL:YEjc", "attribute": [], "entityType": "Trigger", "charEnd": 243, "source": "RLIMS-P", "charStart": 229, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:So8D": {"duid": "RL:So8D", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 541, "source": "RLIMS-P", "charStart": 539, "entityId": [], "sentenceIndex": 3, "entityText": "Thr"}, "RL:YYu8": {"duid": "RL:YYu8", "attribute": [], "entityType": "Trigger", "charEnd": 858, "source": "RLIMS-P", "charStart": 845, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:J9kC": {"duid": "RL:J9kC", "attribute": [], "entityType": "Protein", "charEnd": 67, "source": "RLIMS-P", "charStart": 56, "entityId": [], "sentenceIndex": 0, "entityText": "cysteic acid"}, "RL:THjv": {"duid": "RL:THjv", "attribute": [], "entityType": "SiteOther", "charEnd": 836, "source": "RLIMS-P", "charStart": 830, "entityId": [], "sentenceIndex": 4, "entityText": "peptide"}}, "mesh": ["Amino Acid Sequence", "Amino Acids", "Caseins", "Cysteic Acid", "Indicators and Reagents", "Mass Spectrometry", "Peptides", "Phosphoserine", "Phosphothreonine", "Protein Hydrolysates", "Protein Kinases", "Sequence Analysis", "Trypsin"], "relation": {"RL:QeWv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RFDM"}], "duid": "RL:QeWv"}, "RL:jtFH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Yo4H"}, {"role": "TRIGGER", "entity_duid": "RL:YYu8"}], "duid": "RL:jtFH"}, "RL:rcVL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:THjv"}, {"role": "TRIGGER", "entity_duid": "RL:HJmG"}], "duid": "RL:rcVL"}, "RL:9whh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:LSQx"}, {"role": "TRIGGER", "entity_duid": "RL:YEjc"}], "duid": "RL:9whh"}, "RL:Y4AG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:J9kC"}, {"role": "INDUCER", "entity_duid": "RL:v8UQ"}, {"role": "SITE", "entity_duid": "RL:So8D"}, {"role": "SITE", "entity_duid": "RL:natS"}, {"role": "TRIGGER", "entity_duid": "RL:TW3R"}], "duid": "RL:Y4AG"}, "RL:3FqD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mpDp"}, {"role": "TRIGGER", "entity_duid": "RL:6t2M"}], "duid": "RL:3FqD"}, "RL:TFM9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yCzi"}], "duid": "RL:TFM9"}}, "type": ["Journal Article"]}
{"docId": "6434347", "sentence": [{"charStart": 0, "charEnd": 102, "index": 0}, {"index": 1, "charEnd": 195, "charStart": 104}, {"index": 2, "charEnd": 341, "charStart": 197}, {"index": 3, "charEnd": 469, "charStart": 343}, {"index": 4, "charEnd": 671, "charStart": 471}, {"index": 5, "charEnd": 804, "charStart": 673}], "text": "Glycogen synthase in rat adipocytes and skeletal muscle is phosphorylated on both serine and threonine. Glycogen synthase is phosphorylated both in vivo and in vitro on multiple sites per subunit. All phosphorylations of the enzyme thus far identified occur on serines which are found in two cyanogen bromide fragments, denoted CB-1 and CB-2. We have immunoprecipitated [32P]glycogen synthase from rat adipocytes and epitrochlearis muscles incubated with [32P]phosphate. Phosphoamino acid analyses by two-dimensional electrophoresis after acid hydrolysis revealed no [32P]phosphotyrosine, but significant levels of [32P]phosphothreonine (6-14% of the [32P](phosphoserine). The [32P]phosphothreonine was recovered in the large CNBr-fragment (CB-2), indicative of a hitherto unknown phosphorylation site(s).", "title": {"charStart": 0, "charEnd": 102}, "entity": {"RL:pGRQ": {"duid": "RL:pGRQ", "attribute": [], "entityType": "Trigger", "charEnd": 586, "source": "RLIMS-P", "charStart": 572, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:5hGQ": {"duid": "RL:5hGQ", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 87, "source": "RLIMS-P", "charStart": 82, "entityId": [], "sentenceIndex": 0, "entityText": "serine"}, "RL:B8W8": {"duid": "RL:B8W8", "attribute": [], "entityType": "Protein", "charEnd": 120, "source": "RLIMS-P", "charStart": 104, "entityId": [], "sentenceIndex": 1, "entityText": "Glycogen synthase"}, "RL:TPPr": {"duid": "RL:TPPr", "attribute": [], "entityType": "Trigger", "charEnd": 697, "source": "RLIMS-P", "charStart": 682, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:aatJ": {"duid": "RL:aatJ", "attribute": [], "entityType": "Trigger", "charEnd": 72, "source": "RLIMS-P", "charStart": 59, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:EnmR": {"duid": "RL:EnmR", "attribute": [], "entityType": "Trigger", "charEnd": 138, "source": "RLIMS-P", "charStart": 125, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:54uz": {"duid": "RL:54uz", "attribute": [], "entityType": "SiteOther", "charEnd": 182, "source": "RLIMS-P", "charStart": 178, "entityId": [], "sentenceIndex": 1, "entityText": "sites"}, "RL:4gFo": {"duid": "RL:4gFo", "attribute": [], "entityType": "Trigger", "charEnd": 795, "source": "RLIMS-P", "charStart": 781, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:dzsq": {"duid": "RL:dzsq", "attribute": [], "entityType": "Trigger", "charEnd": 635, "source": "RLIMS-P", "charStart": 620, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:Ahyr": {"duid": "RL:Ahyr", "attribute": [], "entityType": "Protein", "charEnd": 16, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Glycogen synthase"}, "RL:cgJV": {"duid": "RL:cgJV", "attribute": [], "entityType": "Trigger", "charEnd": 669, "source": "RLIMS-P", "charStart": 657, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:LuwQ": {"duid": "RL:LuwQ", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 101, "source": "RLIMS-P", "charStart": 93, "entityId": [], "sentenceIndex": 0, "entityText": "threonine"}, "RL:sGWP": {"duid": "RL:sGWP", "attribute": [], "entityType": "Trigger", "charEnd": 216, "source": "RLIMS-P", "charStart": 201, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylations"}}, "mesh": ["Adipose Tissue", "Animals", "Chromatography, Thin Layer", "Glycogen Synthase", "Macromolecular Substances", "Male", "Muscles", "Phosphorus Radioisotopes", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Rats", "Serine", "Threonine"], "relation": {"RL:Mvh2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Ahyr"}, {"role": "SITE", "entity_duid": "RL:5hGQ"}, {"role": "SITE", "entity_duid": "RL:LuwQ"}, {"role": "TRIGGER", "entity_duid": "RL:aatJ"}], "duid": "RL:Mvh2"}, "RL:2Zyw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:cgJV"}], "duid": "RL:2Zyw"}, "RL:Gkte": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TPPr"}], "duid": "RL:Gkte"}, "RL:hMQo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:pGRQ"}], "duid": "RL:hMQo"}, "RL:j9zv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:B8W8"}, {"role": "SITE_OTHER", "entity_duid": "RL:54uz"}, {"role": "TRIGGER", "entity_duid": "RL:EnmR"}], "duid": "RL:j9zv"}, "RL:222x": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4gFo"}], "duid": "RL:222x"}, "RL:DAW6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dzsq"}], "duid": "RL:DAW6"}, "RL:Ay8k": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sGWP"}], "duid": "RL:Ay8k"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "22233074", "sentence": [{"charStart": 0, "charEnd": 47, "index": 0}, {"index": 1, "charEnd": 135, "charStart": 49}, {"index": 2, "charEnd": 318, "charStart": 137}, {"index": 3, "charEnd": 397, "charStart": 320}, {"index": 4, "charEnd": 480, "charStart": 399}, {"index": 5, "charEnd": 620, "charStart": 482}, {"index": 6, "charEnd": 776, "charStart": 622}, {"index": 7, "charEnd": 995, "charStart": 778}, {"index": 8, "charEnd": 1198, "charStart": 997}, {"index": 9, "charEnd": 1366, "charStart": 1200}], "text": "Chemical enrichment of tyrosine phosphopeptides. Tyrosine phosphorylation of proteins plays a vital role in signal transduction pathway. Currently, antibody-based method dominates the tyrosine phosphopeptide enrichment and there is a lack of other general approaches for selective isolation of tyrosine phosphopeptides. However, antibody-based methods are of high cost and biased to certain motifs. Here we developed a chemistry-based method for tyrosine phosphopeptide enrichment. This method utilized the beta-elimination, which only occurs on phospho-serine/threonine residues, to achieve the reverse selection effect. After the dephosphorylation of serine/threonine phosphopeptides a sensitive phosphopeptide isolation method was applied to enrich tyrosine phosphopeptides. In this proof-of-concept study, it showed that the beta-elimination for several standard serine phosphopeptides was completed over 99% while the recovery of tyrosine phosphopeptide remained at around 70% within 20 min. In the further test with 6-protein digests monitored by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis, only tyrosine phosphopeptides were detected. Due to the low-cost and unbiased properties, the method has potential applications in tyrosine signaling pathway analysis as an alternative to antibody-based approach.", "title": {"charStart": 0, "charEnd": 47}, "entity": {"RL:RGAt": {"duid": "RL:RGAt", "attribute": [], "entityType": "Trigger", "charEnd": 1183, "source": "RLIMS-P", "charStart": 1169, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptides"}, "RL:4EcY": {"duid": "RL:4EcY", "attribute": [], "entityType": "Trigger", "charEnd": 317, "source": "RLIMS-P", "charStart": 303, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:QVyT": {"duid": "RL:QVyT", "attribute": [], "entityType": "Trigger", "charEnd": 775, "source": "RLIMS-P", "charStart": 761, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:tkLH": {"duid": "RL:tkLH", "attribute": [], "entityType": "Trigger", "charEnd": 888, "source": "RLIMS-P", "charStart": 874, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:iwLj": {"duid": "RL:iwLj", "attribute": [], "entityType": "Trigger", "charEnd": 46, "source": "RLIMS-P", "charStart": 32, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:8ZrE": {"duid": "RL:8ZrE", "attribute": [], "entityType": "Trigger", "charEnd": 684, "source": "RLIMS-P", "charStart": 670, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:rWy8": {"duid": "RL:rWy8", "attribute": [], "entityType": "Trigger", "charEnd": 72, "source": "RLIMS-P", "charStart": 58, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:9dUb": {"duid": "RL:9dUb", "attribute": [], "entityType": "Trigger", "charEnd": 957, "source": "RLIMS-P", "charStart": 944, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptide"}, "RL:Ngzc": {"duid": "RL:Ngzc", "attribute": [], "entityType": "Trigger", "charEnd": 578, "source": "RLIMS-P", "charStart": 546, "entityId": [], "sentenceIndex": 5, "entityText": "phospho-serine/threonine residues"}}, "mesh": ["Humans", "Mass Spectrometry", "Phosphopeptides", "Phosphorylation", "Tyrosine"], "relation": {"RL:73YK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9dUb"}], "duid": "RL:73YK"}, "RL:WRBs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:8ZrE"}], "duid": "RL:WRBs"}, "RL:P38v": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tkLH"}], "duid": "RL:P38v"}, "RL:FkhU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QVyT"}], "duid": "RL:FkhU"}, "RL:cMmX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4EcY"}], "duid": "RL:cMmX"}, "RL:5YKJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:iwLj"}], "duid": "RL:5YKJ"}, "RL:HEcX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RGAt"}], "duid": "RL:HEcX"}, "RL:4XNw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:rWy8"}], "duid": "RL:4XNw"}, "RL:D9HK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ngzc"}], "duid": "RL:D9HK"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}
{"docId": "3001088", "sentence": [{"charStart": 0, "charEnd": 113, "index": 0}, {"index": 1, "charEnd": 420, "charStart": 115}, {"index": 2, "charEnd": 473, "charStart": 422}, {"index": 3, "charEnd": 684, "charStart": 475}, {"index": 4, "charEnd": 810, "charStart": 686}, {"index": 5, "charEnd": 1104, "charStart": 812}, {"index": 6, "charEnd": 1209, "charStart": 1106}, {"index": 7, "charEnd": 1328, "charStart": 1211}, {"index": 8, "charEnd": 1467, "charStart": 1330}, {"index": 9, "charEnd": 1849, "charStart": 1469}], "text": "Phosphorylation of receptors for insulin and insulin-like growth factor I. Effects of hormones and phorbol esters. The phosphorylation of receptors for insulin and insulin-like growth factor I was studied by phosphoamino acid analysis and tryptic phosphopeptide maps in an attempt to determine if protein kinase C is involved in their phosphorylation in response to insulin and insulin-like growth factor I, respectively. Two cell lines were utilized, Hep G2 and IM-9 cells. sn-1,2-Dioctanoylglycerol and 12-O-tetradecanoylphorbol 13-acetate (TPA), agents known to activate protein kinase C, stimulated the phosphorylation of the beta subunits of both receptors, as did their hormones. In unstimulated cells, phosphorylation of the insulin receptor occurred on seryl and to a lesser extent on threonyl residues. TPA stimulated seryl and threonyl phosphorylation that resulted in the appearance of four major phosphoserine-containing phosphopeptides which were not detected in the basal state and an increase in phosphorylation of a phosphothreonine-containing peptide which was present in the basal state. Insulin treatment resulted in the appearance of three major phosphotyrosine-containing tryptic peptides. In IM-9 cells, insulin also increased the phosphoserine and possibly the phosphothreonine content of the beta subunit. In both cells, the major phosphoserine-containing peptides that were stimulated by TPA were not detected following treatment with insulin. Very similar results, including similar peptide maps, were obtained for the insulin-like growth factor I receptor from cells treated with TPA and insulin-like growth factor I. Although not entirely conclusive, these results suggest that the insulin- and insulin-like growth factor I-stimulated phosphorylation of their receptors does not result from activation of protein kinase C.", "title": {"charStart": 0, "charEnd": 113}, "entity": {"RL:ridJ": {"duid": "RL:ridJ", "attribute": [], "entityType": "Trigger", "charEnd": 1367, "source": "RLIMS-P", "charStart": 1355, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:NSNK": {"duid": "RL:NSNK", "attribute": [], "entityType": "Trigger", "charEnd": 133, "source": "RLIMS-P", "charStart": 119, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:DcB6": {"duid": "RL:DcB6", "attribute": [], "entityType": "Trigger", "charEnd": 920, "source": "RLIMS-P", "charStart": 908, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:ReQK": {"duid": "RL:ReQK", "attribute": [], "entityType": "Trigger", "charEnd": 1047, "source": "RLIMS-P", "charStart": 1032, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}, "RL:p8DQ": {"duid": "RL:p8DQ", "attribute": [], "entityType": "SiteOther", "charEnd": 765, "source": "RLIMS-P", "charStart": 761, "entityId": [], "sentenceIndex": 4, "entityText": "seryl"}, "RL:XvmF": {"duid": "RL:XvmF", "attribute": [], "entityType": "Protein", "charEnd": 158, "source": "RLIMS-P", "charStart": 152, "entityId": [], "sentenceIndex": 1, "entityText": "insulin"}, "RL:qC2t": {"duid": "RL:qC2t", "attribute": [], "entityType": "Protein", "charEnd": 747, "source": "RLIMS-P", "charStart": 732, "entityId": [], "sentenceIndex": 4, "entityText": "insulin receptor"}, "RL:UmS3": {"duid": "RL:UmS3", "attribute": [], "entityType": "SiteOther", "charEnd": 260, "source": "RLIMS-P", "charStart": 247, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:pABN": {"duid": "RL:pABN", "attribute": [], "entityType": "Trigger", "charEnd": 1025, "source": "RLIMS-P", "charStart": 1011, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:ghWb": {"duid": "RL:ghWb", "attribute": [], "entityType": "Trigger", "charEnd": 349, "source": "RLIMS-P", "charStart": 335, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:2fi2": {"duid": "RL:2fi2", "attribute": [], "entityType": "Trigger", "charEnd": 860, "source": "RLIMS-P", "charStart": 846, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:2PyX": {"duid": "RL:2PyX", "attribute": [], "entityType": "Trigger", "charEnd": 723, "source": "RLIMS-P", "charStart": 709, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:FvQP": {"duid": "RL:FvQP", "attribute": [], "entityType": "Trigger", "charEnd": 621, "source": "RLIMS-P", "charStart": 607, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:tUDN": {"duid": "RL:tUDN", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1047, "source": "RLIMS-P", "charStart": 1039, "entityId": [], "sentenceIndex": 5, "entityText": "threonine"}, "RL:pTgF": {"duid": "RL:pTgF", "attribute": [], "entityType": "Trigger", "charEnd": 1777, "source": "RLIMS-P", "charStart": 1763, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:JLPo": {"duid": "RL:JLPo", "attribute": [], "entityType": "Trigger", "charEnd": 1265, "source": "RLIMS-P", "charStart": 1253, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}, "RL:VPBu": {"duid": "RL:VPBu", "attribute": [], "entityType": "Trigger", "charEnd": 260, "source": "RLIMS-P", "charStart": 247, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:3tFL": {"duid": "RL:3tFL", "attribute": [], "entityType": "Protein", "charEnd": 191, "source": "RLIMS-P", "charStart": 184, "entityId": [], "sentenceIndex": 1, "entityText": "factor I"}, "RL:c93u": {"duid": "RL:c93u", "attribute": [], "entityType": "Trigger", "charEnd": 1180, "source": "RLIMS-P", "charStart": 1166, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:YGn5": {"duid": "RL:YGn5", "attribute": [], "entityType": "Trigger", "charEnd": 14, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphorylation"}, "RL:pdkw": {"duid": "RL:pdkw", "attribute": [], "entityType": "Trigger", "charEnd": 1299, "source": "RLIMS-P", "charStart": 1284, "entityId": [], "sentenceIndex": 7, "entityText": "phosphothreonine"}, "RL:E4To": {"duid": "RL:E4To", "attribute": [], "entityType": "Protein", "charEnd": 372, "source": "RLIMS-P", "charStart": 366, "entityId": [], "sentenceIndex": 1, "entityText": "insulin"}}, "mesh": ["Carcinoma, Hepatocellular", "Cell Line", "Electrophoresis, Polyacrylamide Gel", "Humans", "Liver Neoplasms", "Phorbol Esters", "Phosphoproteins", "Phosphorylation", "Protein Kinase C", "Receptor, Insulin", "Receptors, Cell Surface", "Receptors, Somatomedin", "Tetradecanoylphorbol Acetate", "Trypsin"], "relation": {"RL:jssG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ghWb"}], "duid": "RL:jssG"}, "RL:vpXS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:c93u"}], "duid": "RL:vpXS"}, "RL:95kk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:E4To"}, {"role": "SITE", "entity_duid": "RL:tUDN"}, {"role": "TRIGGER", "entity_duid": "RL:pABN"}], "duid": "RL:95kk"}, "RL:QitZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:UmS3"}, {"role": "TRIGGER", "entity_duid": "RL:VPBu"}], "duid": "RL:QitZ"}, "RL:4MfD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2fi2"}], "duid": "RL:4MfD"}, "RL:qGxs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DcB6"}], "duid": "RL:qGxs"}, "RL:PLuk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:YGn5"}], "duid": "RL:PLuk"}, "RL:RD4q": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JLPo"}], "duid": "RL:RD4q"}, "RL:tD9T": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XvmF"}, {"role": "TRIGGER", "entity_duid": "RL:FvQP"}], "duid": "RL:tD9T"}, "RL:Qsrx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:pTgF"}], "duid": "RL:Qsrx"}, "RL:Frhk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:qC2t"}, {"role": "SITE_OTHER", "entity_duid": "RL:p8DQ"}, {"role": "TRIGGER", "entity_duid": "RL:2PyX"}], "duid": "RL:Frhk"}, "RL:daTs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ReQK"}], "duid": "RL:daTs"}, "RL:kT67": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NSNK"}], "duid": "RL:kT67"}, "RL:dzdM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:pdkw"}], "duid": "RL:dzdM"}, "RL:XCDA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ridJ"}], "duid": "RL:XCDA"}, "RL:vsRm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:3tFL"}, {"role": "TRIGGER", "entity_duid": "RL:FvQP"}], "duid": "RL:vsRm"}}, "type": ["Journal Article"]}
{"docId": "1691639", "sentence": [{"charStart": 0, "charEnd": 55, "index": 0}, {"index": 1, "charEnd": 187, "charStart": 57}, {"index": 2, "charEnd": 434, "charStart": 189}, {"index": 3, "charEnd": 667, "charStart": 436}, {"index": 4, "charEnd": 929, "charStart": 669}, {"index": 5, "charEnd": 1082, "charStart": 931}], "text": "Fluorescence of phosphotyrosine--terbium(III) complexes. Phosphotyrosine, a biologically important protein residue, was investigated for the ability to enhance terbium (Tb3+) fluorescence. Spectroscopic analysis of the Tb3+: phosphotyrosine interaction indicated the development of a new excitation peak at 275 nm and strong Tb+ fluorescence enhancement at 488 and 540 nm that was linear over a range from 0.5 to 100 microM amino acid. Subsequent experiments comparing the ability of phosphotyrosine, phosphothreonine, phosphoserine and 20 other common non-phosphorylated amino acids showed that only phosphotyrosine produced significant Tb3+ fluorescence enhancement. Analysis of various phospho-sugars and nucleotides showed (with the expected exception of GMP) that they produced little or no significant fluorescence enhancement, indicating a further selectiveness for the phosphotyrosine: Tb3+ fluorescence enhancement event. These results establish a basis for the future use of Tb3+ fluorescence enhancement as a unique probe for the investigation of phosphotyrosine residues.", "title": {"charStart": 0, "charEnd": 55}, "entity": {"RL:Ufps": {"duid": "RL:Ufps", "attribute": [], "entityType": "Trigger", "charEnd": 891, "source": "RLIMS-P", "charStart": 877, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:T2e5": {"duid": "RL:T2e5", "attribute": [], "entityType": "Trigger", "charEnd": 498, "source": "RLIMS-P", "charStart": 484, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:PwK5": {"duid": "RL:PwK5", "attribute": [], "entityType": "Trigger", "charEnd": 71, "source": "RLIMS-P", "charStart": 57, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphotyrosine"}, "RL:Tc3g": {"duid": "RL:Tc3g", "attribute": [], "entityType": "Trigger", "charEnd": 30, "source": "RLIMS-P", "charStart": 16, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}, "RL:wt3B": {"duid": "RL:wt3B", "attribute": [], "entityType": "Trigger", "charEnd": 615, "source": "RLIMS-P", "charStart": 601, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:Saf7": {"duid": "RL:Saf7", "attribute": [], "entityType": "Trigger", "charEnd": 1072, "source": "RLIMS-P", "charStart": 1058, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:xCeC": {"duid": "RL:xCeC", "attribute": [], "entityType": "Trigger", "charEnd": 239, "source": "RLIMS-P", "charStart": 225, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}}, "mesh": ["In Vitro Techniques", "Phosphorylation", "Phosphotyrosine", "Protein Binding", "Spectrometry, Fluorescence", "Terbium", "Tyrosine"], "relation": {"RL:N7mK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:T2e5"}], "duid": "RL:N7mK"}, "RL:ievh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PwK5"}], "duid": "RL:ievh"}, "RL:SBg3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wt3B"}], "duid": "RL:SBg3"}, "RL:6PTp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Ufps"}], "duid": "RL:6PTp"}, "RL:Z7gN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Saf7"}], "duid": "RL:Z7gN"}, "RL:LJRF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Tc3g"}], "duid": "RL:LJRF"}, "RL:mQ4N": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xCeC"}], "duid": "RL:mQ4N"}}, "type": ["Journal Article"]}
{"docId": "19890956", "sentence": [{"charStart": 0, "charEnd": 73, "index": 0}, {"index": 1, "charEnd": 240, "charStart": 75}, {"index": 2, "charEnd": 401, "charStart": 242}, {"index": 3, "charEnd": 591, "charStart": 403}, {"index": 4, "charEnd": 814, "charStart": 593}, {"index": 5, "charEnd": 971, "charStart": 816}, {"index": 6, "charEnd": 1050, "charStart": 973}, {"index": 7, "charEnd": 1296, "charStart": 1052}, {"index": 8, "charEnd": 1548, "charStart": 1298}, {"index": 9, "charEnd": 1707, "charStart": 1550}], "text": "Ultraviolet photodissociation at 266 nm of phosphorylated peptide cations. Ultraviolet (UV) photodissociation (PD) experiments using 266 nm light were performed for a series of phosphopeptide cations in a Fourier transform mass spectrometer. The objective of the experiments was to determine whether 266 nm UV irradiation on the phosphopeptide cations would induce unique peptide backbone dissociation. In addition, the general behavior of the phosphate loss (-80 or -98 Da) was monitored, particularly for those phosphopeptides with a phosphotyrosine residue that itself is a UV chromophore. For phosphopeptides with a UV chromophore, their photodissociation behavior was very similar to that of low-energy sustained off-resonance irradiation collisionally activated dissociation (SORI-CAD), with a few exceptions. For example, b- and y-type peptide backbone fragments were prevalent, and their dephosphorylation behavior was consistent with that of the SORI-CAD results. For phosphoserine peptides, the loss of a phosphate group was always observed. On the other hand, for phosphotyrosine peptides, the phosphate loss was found to be dependent on the presence of a basic amino group in the sequence and the charge state of the precursor ions, in agreement with the CAD results in the literature. However, hydrogen atom loss or aromatic side chain loss, which is known to be the excited state specific fragmentation pathway, was rarely observed in our 266 nm UV PD experiments, in contrast to the previous UV PD literature (particularly at 220 nm). The mechanism for these observations is described in terms of dominant internal conversion followed by intramolecular vibrational energy redistribution (IVR).", "title": {"charStart": 0, "charEnd": 73}, "entity": {"RL:LsSh": {"duid": "RL:LsSh", "attribute": [], "entityType": "Trigger", "charEnd": 989, "source": "RLIMS-P", "charStart": 977, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:oDxK": {"duid": "RL:oDxK", "attribute": [], "entityType": "Trigger", "charEnd": 527, "source": "RLIMS-P", "charStart": 513, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:dvtJ": {"duid": "RL:dvtJ", "attribute": [], "entityType": "SiteOther", "charEnd": 527, "source": "RLIMS-P", "charStart": 513, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:6jfg": {"duid": "RL:6jfg", "attribute": [], "entityType": "Trigger", "charEnd": 611, "source": "RLIMS-P", "charStart": 597, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:knZ9": {"duid": "RL:knZ9", "attribute": [], "entityType": "SiteOther", "charEnd": 611, "source": "RLIMS-P", "charStart": 597, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:6Rdt": {"duid": "RL:6Rdt", "attribute": [], "entityType": "Trigger", "charEnd": 550, "source": "RLIMS-P", "charStart": 536, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:f6LE": {"duid": "RL:f6LE", "attribute": [], "entityType": "Trigger", "charEnd": 1089, "source": "RLIMS-P", "charStart": 1075, "entityId": [], "sentenceIndex": 7, "entityText": "phosphotyrosine"}}, "mesh": ["Cations", "Mass Spectrometry", "Phosphopeptides", "Phosphoserine", "Phosphotyrosine", "Photochemical Processes", "Spectroscopy, Fourier Transform Infrared", "Ultraviolet Rays"], "relation": {"RL:k2D4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LsSh"}], "duid": "RL:k2D4"}, "RL:pRmP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:f6LE"}], "duid": "RL:pRmP"}, "RL:L5ni": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:dvtJ"}, {"role": "TRIGGER", "entity_duid": "RL:oDxK"}], "duid": "RL:L5ni"}, "RL:iWe6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:knZ9"}, {"role": "TRIGGER", "entity_duid": "RL:6jfg"}], "duid": "RL:iWe6"}, "RL:wBn7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:6Rdt"}], "duid": "RL:wBn7"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "6194716", "sentence": [{"charStart": 0, "charEnd": 85, "index": 0}, {"index": 1, "charEnd": 209, "charStart": 87}, {"index": 2, "charEnd": 324, "charStart": 211}, {"index": 3, "charEnd": 456, "charStart": 326}], "text": "Polyamide thin-layer chromatography of phosphorylated tyrosine, threonine, and serine. One-dimensional thin-layer chromatography on polyamide plates offers an easy and rapid identification of O-phosphotyrosine. The thin-layer plate is developed for 30 min in 5% propionic acid containing 0.013%-0.025% sodium dodecyl sulfate. O-Phosphotyrosine, with Rf = 0.54, can be well separated from O-phosphothreonine and O-phosphoserine, which comigrate at Rf = 0.72.", "title": {"charStart": 0, "charEnd": 85}, "entity": {"RL:LSeY": {"duid": "RL:LSeY", "attribute": [], "entityType": "Trigger", "charEnd": 52, "source": "RLIMS-P", "charStart": 39, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:5XYZ": {"duid": "RL:5XYZ", "attribute": [], "entityType": "Trigger", "charEnd": 405, "source": "RLIMS-P", "charStart": 388, "entityId": [], "sentenceIndex": 3, "entityText": "O-phosphothreonine"}, "RL:mVXD": {"duid": "RL:mVXD", "attribute": [], "entityType": "Trigger", "charEnd": 342, "source": "RLIMS-P", "charStart": 326, "entityId": [], "sentenceIndex": 3, "entityText": "O-Phosphotyrosine"}, "RL:poPk": {"duid": "RL:poPk", "attribute": [], "entityType": "Trigger", "charEnd": 208, "source": "RLIMS-P", "charStart": 192, "entityId": [], "sentenceIndex": 1, "entityText": "O-phosphotyrosine"}}, "mesh": ["Chromatography, Thin Layer", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Serine", "Threonine", "Tyrosine"], "relation": {"RL:xtby": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:poPk"}], "duid": "RL:xtby"}, "RL:wiiN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5XYZ"}], "duid": "RL:wiiN"}, "RL:BXWP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mVXD"}], "duid": "RL:BXWP"}, "RL:mcqB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LSeY"}], "duid": "RL:mcqB"}}, "type": ["Journal Article"]}
{"docId": "19526547", "sentence": [{"charStart": 0, "charEnd": 239, "index": 0}, {"index": 1, "charEnd": 305, "charStart": 241}, {"index": 2, "charEnd": 630, "charStart": 307}, {"index": 3, "charEnd": 947, "charStart": 632}, {"index": 4, "charEnd": 1190, "charStart": 949}, {"index": 5, "charEnd": 1559, "charStart": 1192}], "text": "A sensitive magnetic bead method for the detection and identification of tyrosine phosphorylation in proteins by MALDI-TOF/TOF MS. Phosphorylation is one of the most important PTMs and is estimated to occur on 30% of the mammalian proteome. Its perturbed regulation has been implicated in many pathologies. The rarity of phosphotyrosine compared with phosphoserine or phosphothreonine is prompting the development of more sensitive approaches because proteomic technologies that are currently used to assess tyrosine phosphorylation in proteins are inadequate, identifying only a fraction of the predicted tyrosine phosphoproteome. Here we describe the development of a reproducible, high-sensitivity methodology for the detection and mapping of phosphotyrosine residues by MS. The anti-phosphotyrosine antibody 4G10 was coupled covalently to super para-magnetic beads or by affinity to super para-magnetic beads with protein G covalently attached. Using this approach, we successfully enriched phosphotyrosine peptides mixed with non-phosphorylated peptides at a ratio of up to 1:200, enabling detection at a level representing the highest sensitivity reported for tyrosine phosphorylation. The beads were subsequently used to enrich tyrosine phosphopeptides from a digest of the in vitro-phosphorylated recombinant beta-intracellular region of the granulocyte-macrophage colony-stimulating factor receptor, which was subsequently analysed by MALDI-TOF/TOF MS. Our results define this methodology as a sensitive approach for tyrosine phosphoproteome analysis.", "title": {"charStart": 0, "charEnd": 129}, "entity": {"RL:ZWkJ": {"duid": "RL:ZWkJ", "attribute": [], "entityType": "Trigger", "charEnd": 760, "source": "RLIMS-P", "charStart": 746, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:QcMa": {"duid": "RL:QcMa", "attribute": [], "entityType": "Protein", "charEnd": 1406, "source": "RLIMS-P", "charStart": 1350, "entityId": [], "sentenceIndex": 5, "entityText": "granulocyte-macrophage colony-stimulating factor receptor"}, "RL:XZne": {"duid": "RL:XZne", "attribute": [], "entityType": "Trigger", "charEnd": 335, "source": "RLIMS-P", "charStart": 321, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:j9bw": {"duid": "RL:j9bw", "attribute": [], "entityType": "Trigger", "charEnd": 145, "source": "RLIMS-P", "charStart": 131, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphorylation"}, "RL:yKNV": {"duid": "RL:yKNV", "attribute": [], "entityType": "Trigger", "charEnd": 1009, "source": "RLIMS-P", "charStart": 995, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:365T": {"duid": "RL:365T", "attribute": [], "entityType": "Trigger", "charEnd": 1303, "source": "RLIMS-P", "charStart": 1284, "entityId": [], "sentenceIndex": 5, "entityText": "vitro-phosphorylated"}, "RL:Agag": {"duid": "RL:Agag", "attribute": [], "entityType": "SiteOther", "charEnd": 1341, "source": "RLIMS-P", "charStart": 1317, "entityId": [], "sentenceIndex": 5, "entityText": "beta-intracellular region"}, "RL:Rh4f": {"duid": "RL:Rh4f", "attribute": [], "entityType": "Trigger", "charEnd": 96, "source": "RLIMS-P", "charStart": 82, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:SFE3": {"duid": "RL:SFE3", "attribute": [], "entityType": "Trigger", "charEnd": 1258, "source": "RLIMS-P", "charStart": 1244, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:Pqjc": {"duid": "RL:Pqjc", "attribute": [], "entityType": "Trigger", "charEnd": 531, "source": "RLIMS-P", "charStart": 517, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:dtPV": {"duid": "RL:dtPV", "attribute": [], "entityType": "Trigger", "charEnd": 363, "source": "RLIMS-P", "charStart": 351, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:evwx": {"duid": "RL:evwx", "attribute": [], "entityType": "Trigger", "charEnd": 1189, "source": "RLIMS-P", "charStart": 1175, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}}, "mesh": ["Granulocyte-Macrophage Colony-Stimulating Factor", "Immunosorbent Techniques", "Magnetics", "Microspheres", "Phosphoproteins", "Phosphorylation", "Phosphotyrosine", "Proteomics", "Reproducibility of Results", "Sensitivity and Specificity", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"], "relation": {"RL:4Rnw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:QcMa"}, {"role": "SITE_OTHER", "entity_duid": "RL:Agag"}, {"role": "TRIGGER", "entity_duid": "RL:365T"}], "duid": "RL:4Rnw"}, "RL:qUPv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:j9bw"}], "duid": "RL:qUPv"}, "RL:XHLb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yKNV"}], "duid": "RL:XHLb"}, "RL:SuxQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:SFE3"}], "duid": "RL:SuxQ"}, "RL:KyxD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Rh4f"}], "duid": "RL:KyxD"}, "RL:BARg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:XZne"}], "duid": "RL:BARg"}, "RL:hwRR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:evwx"}], "duid": "RL:hwRR"}, "RL:tGrc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dtPV"}], "duid": "RL:tGrc"}, "RL:VLWZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZWkJ"}], "duid": "RL:VLWZ"}, "RL:cecy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Pqjc"}], "duid": "RL:cecy"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "16240095", "sentence": [{"charStart": 0, "charEnd": 163, "index": 0}, {"index": 1, "charEnd": 374, "charStart": 165}, {"index": 2, "charEnd": 671, "charStart": 376}, {"index": 3, "charEnd": 889, "charStart": 673}, {"index": 4, "charEnd": 983, "charStart": 891}, {"index": 5, "charEnd": 1113, "charStart": 985}, {"index": 6, "charEnd": 1133, "charStart": 1115}], "text": "AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine. We report a consistent set of AMBER force-field parameters for the most common phosphorylated amino acids, phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine in different protonation states. The calculation of atomic charges followed the original restrained electrostatic potential fitting procedure used to determine the charges for the parm94/99 parameter set, taking alpha-helical and beta-strand conformations of the corresponding ACE-/NME-capped model peptide backbone into account. Missing force-field parameters were taken directly from the general AMBER force field (gaff) and the parm99 data set with minor modifications, or were newly generated based on ab initio calculations for model systems. Final parameters were validated by geometry optimizations and molecular-dynamics simulations. Template libraries for the phosphorylated amino acids in Leap format and corresponding frcmod parameter files are made available. [Figure: see text].", "title": {"charStart": 0, "charEnd": 163}, "entity": {"RL:58Jm": {"duid": "RL:58Jm", "attribute": [], "entityType": "Trigger", "charEnd": 46, "source": "RLIMS-P", "charStart": 33, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:A2SW": {"duid": "RL:A2SW", "attribute": [], "entityType": "Trigger", "charEnd": 257, "source": "RLIMS-P", "charStart": 244, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:2tJ4": {"duid": "RL:2tJ4", "attribute": [], "entityType": "Trigger", "charEnd": 1025, "source": "RLIMS-P", "charStart": 1012, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:d2Cs": {"duid": "RL:d2Cs", "attribute": [], "entityType": "SiteOther", "charEnd": 1037, "source": "RLIMS-P", "charStart": 1027, "entityId": [], "sentenceIndex": 5, "entityText": "amino acids"}, "RL:kjjo": {"duid": "RL:kjjo", "attribute": [], "entityType": "SiteOther", "charEnd": 58, "source": "RLIMS-P", "charStart": 48, "entityId": [], "sentenceIndex": 0, "entityText": "amino acids"}, "RL:TpeN": {"duid": "RL:TpeN", "attribute": [], "entityType": "Trigger", "charEnd": 105, "source": "RLIMS-P", "charStart": 93, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}}, "mesh": ["Acids", "Computational Biology", "Computer Simulation", "Hydrogen", "Molecular Structure", "Phosphoamino Acids", "Protons"], "relation": {"RL:exrH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TpeN"}], "duid": "RL:exrH"}, "RL:QAWk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:d2Cs"}, {"role": "TRIGGER", "entity_duid": "RL:2tJ4"}], "duid": "RL:QAWk"}, "RL:Uejz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kjjo"}, {"role": "TRIGGER", "entity_duid": "RL:58Jm"}], "duid": "RL:Uejz"}, "RL:izi3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:A2SW"}], "duid": "RL:izi3"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "30414067", "sentence": [{"charStart": 0, "charEnd": 119, "index": 0}, {"index": 1, "charEnd": 352, "charStart": 121}, {"index": 2, "charEnd": 595, "charStart": 354}, {"index": 3, "charEnd": 767, "charStart": 597}, {"index": 4, "charEnd": 1048, "charStart": 769}, {"index": 5, "charEnd": 1207, "charStart": 1050}, {"index": 6, "charEnd": 1227, "charStart": 1209}], "text": "Free Radical-Initiated Peptide Sequencing Mass Spectrometry for Phosphopeptide Post-translational Modification Analysis. Free radical-initiated peptide sequencing mass spectrometry (FRIPS MS) was employed to analyze a number of representative singly or doubly protonated phosphopeptides (phosphoserine and phosphotyrosine peptides) in positive ion mode. In contrast to collision-activated dissociation (CAD) results, a loss of a phosphate group occurred to a limited degree for both phosphoserine and phosphotyrosine peptides, and thus, localization of a phosphorylated site was readily achieved. Considering that FRIPS MS supplies a substantial amount of collisional energy to peptides, this result was quite unexpected because a labile phosphate group was conserved. Analysis of the resulting peptide fragments revealed the extensive production of a-, c-, x-, and z-type fragments (with some minor b- and y-type fragments), suggesting that radical-driven peptide fragmentation was the primary mechanism involved in the FRIPS MS of phosphopeptides. Results of this study clearly indicate that FRIPS MS is a promising tool for the characterization of post-translational modifications such as phosphorylation. Graphical Abstract.", "title": {"charStart": 0, "charEnd": 119}, "entity": {"RL:aLQb": {"duid": "RL:aLQb", "attribute": [], "entityType": "SiteOther", "charEnd": 1047, "source": "RLIMS-P", "charStart": 1033, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:VS8q": {"duid": "RL:VS8q", "attribute": [], "entityType": "Trigger", "charEnd": 1047, "source": "RLIMS-P", "charStart": 1033, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:mv86": {"duid": "RL:mv86", "attribute": [], "entityType": "Trigger", "charEnd": 285, "source": "RLIMS-P", "charStart": 271, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:KV7X": {"duid": "RL:KV7X", "attribute": [], "entityType": "Trigger", "charEnd": 568, "source": "RLIMS-P", "charStart": 555, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:vTkB": {"duid": "RL:vTkB", "attribute": [], "entityType": "SiteOther", "charEnd": 573, "source": "RLIMS-P", "charStart": 570, "entityId": [], "sentenceIndex": 2, "entityText": "site"}, "RL:ywfQ": {"duid": "RL:ywfQ", "attribute": [], "entityType": "Trigger", "charEnd": 495, "source": "RLIMS-P", "charStart": 483, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:iiVD": {"duid": "RL:iiVD", "attribute": [], "entityType": "Trigger", "charEnd": 1206, "source": "RLIMS-P", "charStart": 1192, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}}, "mesh": ["Cyclic N-Oxides", "Free Radicals", "Mass Spectrometry", "Peptide Fragments", "Phosphopeptides", "Phosphoserine", "Phosphotyrosine", "Protein Processing, Post-Translational", "Protons"], "relation": {"RL:LCvk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ywfQ"}], "duid": "RL:LCvk"}, "RL:7NNa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:vTkB"}, {"role": "TRIGGER", "entity_duid": "RL:KV7X"}], "duid": "RL:7NNa"}, "RL:4rnD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:iiVD"}], "duid": "RL:4rnD"}, "RL:q2ok": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mv86"}], "duid": "RL:q2ok"}, "RL:SgsQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:aLQb"}, {"role": "TRIGGER", "entity_duid": "RL:VS8q"}], "duid": "RL:SgsQ"}}, "type": ["Comparative Study", "Journal Article"]}
{"docId": "1705393", "sentence": [{"charStart": 0, "charEnd": 62, "index": 0}, {"index": 1, "charEnd": 232, "charStart": 64}, {"index": 2, "charEnd": 464, "charStart": 234}, {"index": 3, "charEnd": 597, "charStart": 466}, {"index": 4, "charEnd": 732, "charStart": 599}], "text": "An alternative method for a fast separation of phosphotyrosine. A simple and rapid procedure is described for fully separating phosphotyrosine from phosphoserine and phosphothreonine through one-dimensional thin-layer chromatography. The migration properties of these phosphoamino acids are compared with those of CMP, UMP, ATP, ribose phosphate, and inorganic orthophosphate, considered the most frequent comigrating products derived from 32P-labeling experiments. We demonstrate that Rf values for the three phosphoamino acids differ from those displayed by the mentioned contaminating compounds. One of the most relevant advantages of this procedure is that a complete separation of phosphotyrosine can be achieved in only 90 min.", "title": {"charStart": 0, "charEnd": 62}, "entity": {"RL:7WQn": {"duid": "RL:7WQn", "attribute": [], "entityType": "Trigger", "charEnd": 61, "source": "RLIMS-P", "charStart": 47, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}, "RL:aK74": {"duid": "RL:aK74", "attribute": [], "entityType": "Trigger", "charEnd": 141, "source": "RLIMS-P", "charStart": 127, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:qTtE": {"duid": "RL:qTtE", "attribute": [], "entityType": "Trigger", "charEnd": 160, "source": "RLIMS-P", "charStart": 148, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:7zU5": {"duid": "RL:7zU5", "attribute": [], "entityType": "Trigger", "charEnd": 700, "source": "RLIMS-P", "charStart": 686, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}}, "mesh": ["Adenosine Triphosphate", "Animals", "Chromatography, Thin Layer", "Cytidine Monophosphate", "Humans", "Liver", "Lymphocytes", "Mice", "Phosphorus Radioisotopes", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Tyrosine", "Uridine Monophosphate"], "relation": {"RL:yTww": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qTtE"}], "duid": "RL:yTww"}, "RL:BGFh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aK74"}], "duid": "RL:BGFh"}, "RL:y3so": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7zU5"}], "duid": "RL:y3so"}, "RL:oUiF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7WQn"}], "duid": "RL:oUiF"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "2545474", "sentence": [{"charStart": 0, "charEnd": 93, "index": 0}, {"index": 1, "charEnd": 96, "charStart": 95}, {"index": 2, "charEnd": 264, "charStart": 98}, {"index": 3, "charEnd": 267, "charStart": 266}, {"index": 4, "charEnd": 388, "charStart": 269}, {"index": 5, "charEnd": 391, "charStart": 390}, {"index": 6, "charEnd": 709, "charStart": 393}, {"index": 7, "charEnd": 712, "charStart": 711}, {"index": 8, "charEnd": 911, "charStart": 714}, {"index": 9, "charEnd": 914, "charStart": 913}, {"index": 10, "charEnd": 1058, "charStart": 916}], "text": "Temporal changes in phosphoamino acid phosphatase activities in murine erythroleukaemic cells. 1. The activities of phosphotyrosine, phosphothreonine and phosphoserine phosphatases were measured at various time periods in Friend murine erythroleukaemic (MEL) cells. 2. Effects of DMSO (dimethyl sulphoxide) and HMBA (hexamethylene bisacetamide), inducers of differentiation, were examined. 3. The activities of all three enzymes showed cyclic variation when measured on a daily basis over a period of several days; this was also the case when phosphothreonine phosphatase was determined in cells treated with DMSO or HMBA and when phosphoserine phosphatase was assayed after stimulation of the cells with HMBA. 4. Evidence for rhythmic variation in phosphotyrosine phosphatase activities was also obtained when the activities were determined at hourly intervals both in control cells and those treated with HMBA. 5. The time-dependent changes observed could be significant in that control of dephosphorylation may possibly be achieved by altering the rhythms.", "title": {"charStart": 0, "charEnd": 93}, "entity": {"RL:PMDZ": {"duid": "RL:PMDZ", "attribute": [], "entityType": "Trigger", "charEnd": 763, "source": "RLIMS-P", "charStart": 749, "entityId": [], "sentenceIndex": 8, "entityText": "phosphotyrosine"}, "RL:NuHE": {"duid": "RL:NuHE", "attribute": [], "entityType": "Trigger", "charEnd": 643, "source": "RLIMS-P", "charStart": 631, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:N3Tu": {"duid": "RL:N3Tu", "attribute": [], "entityType": "Trigger", "charEnd": 130, "source": "RLIMS-P", "charStart": 116, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:bfr3": {"duid": "RL:bfr3", "attribute": [], "entityType": "Trigger", "charEnd": 558, "source": "RLIMS-P", "charStart": 543, "entityId": [], "sentenceIndex": 6, "entityText": "phosphothreonine"}}, "mesh": ["Animals", "Cell Line", "Friend murine leukemia virus", "Leukemia, Erythroblastic, Acute", "Mice", "Phosphoprotein Phosphatases", "Phosphoric Monoester Hydrolases", "Phosphorylation", "Protein Tyrosine Phosphatases", "Tumor Cells, Cultured"], "relation": {"RL:HYB8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PMDZ"}], "duid": "RL:HYB8"}, "RL:5dd7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:N3Tu"}], "duid": "RL:5dd7"}, "RL:Nxuv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NuHE"}], "duid": "RL:Nxuv"}, "RL:s6pQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:bfr3"}], "duid": "RL:s6pQ"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "10453998", "sentence": [{"charStart": 0, "charEnd": 110, "index": 0}, {"index": 1, "charEnd": 187, "charStart": 112}, {"index": 2, "charEnd": 378, "charStart": 189}, {"index": 3, "charEnd": 459, "charStart": 380}], "text": "Modulatory effect of divalent metal cations on the phosphotyrosine activity of the frog liver acid phosphatase. Frog liver acid phosphatase hydrolyzes phosphotyrosine at acidic pH optimum. Mn2+, Ca2+ and Mg2+ (but not Zn2+) ions modulate this activity by shifting its pH optimum to physiological pH. This effect is not observed when p-nitrophenylphosphate is used as a substrate. Phosphoserine and phosphothreonine are not hydrolyzed under the same conditions.", "title": {"charStart": 0, "charEnd": 110}, "entity": {"RL:j2Sz": {"duid": "RL:j2Sz", "attribute": [], "entityType": "Trigger", "charEnd": 165, "source": "RLIMS-P", "charStart": 151, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:PBVN": {"duid": "RL:PBVN", "attribute": [], "entityType": "Trigger", "charEnd": 392, "source": "RLIMS-P", "charStart": 380, "entityId": [], "sentenceIndex": 3, "entityText": "Phosphoserine"}, "RL:8ZhF": {"duid": "RL:8ZhF", "attribute": [], "entityType": "Trigger", "charEnd": 65, "source": "RLIMS-P", "charStart": 51, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}}, "mesh": ["Acid Phosphatase", "Animals", "Cations, Divalent", "Hydrogen-Ion Concentration", "Hydrolysis", "Kinetics", "Liver", "Metals", "Phosphotyrosine", "Rana esculenta"], "relation": {"RL:JrZR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PBVN"}], "duid": "RL:JrZR"}, "RL:cqjP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:j2Sz"}], "duid": "RL:cqjP"}, "RL:iLrp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:8ZhF"}], "duid": "RL:iLrp"}}, "type": ["Journal Article"]}
{"docId": "8216295", "sentence": [{"charStart": 0, "charEnd": 129, "index": 0}, {"index": 1, "charEnd": 252, "charStart": 131}, {"index": 2, "charEnd": 326, "charStart": 254}, {"index": 3, "charEnd": 496, "charStart": 328}, {"index": 4, "charEnd": 586, "charStart": 498}, {"index": 5, "charEnd": 746, "charStart": 588}], "text": "Anti-phosphoserine and anti-phosphothreonine antibodies modulate autophosphorylation of the insulin receptor but not EGF receptor. We examined the effect of anti-phosphothreonine and anti-phosphoserine antibodies on insulin receptor autophosphorylation. These antibodies did not affect insulin binding activity of the receptor. These antibodies, however, inhibited insulin-stimulated autophosphorylation of insulin receptor, while did not affect EGF-stimulated autophosphorylation of EGF receptor. The inhibition was reversed by adding large amounts of phosphoserine or phosphothreonine. These data suggest that phosphoserine and phosphothreonine on insulin receptor play an important role in insulin-induced conformational change of the receptor.", "title": {"charStart": 0, "charEnd": 129}, "entity": {"RL:6uag": {"duid": "RL:6uag", "attribute": [], "entityType": "Trigger", "charEnd": 251, "source": "RLIMS-P", "charStart": 233, "entityId": [], "sentenceIndex": 1, "entityText": "autophosphorylation"}, "RL:UA4H": {"duid": "RL:UA4H", "attribute": [], "entityType": "Trigger", "charEnd": 177, "source": "RLIMS-P", "charStart": 157, "entityId": [], "sentenceIndex": 1, "entityText": "anti-phosphothreonine"}, "RL:2omC": {"duid": "RL:2omC", "attribute": [], "entityType": "Trigger", "charEnd": 402, "source": "RLIMS-P", "charStart": 384, "entityId": [], "sentenceIndex": 3, "entityText": "autophosphorylation"}, "RL:xaFC": {"duid": "RL:xaFC", "attribute": [], "entityType": "Protein", "charEnd": 128, "source": "RLIMS-P", "charStart": 117, "entityId": [], "sentenceIndex": 0, "entityText": "EGF receptor"}, "RL:CPsR": {"duid": "RL:CPsR", "attribute": [], "entityType": "Protein", "charEnd": 422, "source": "RLIMS-P", "charStart": 407, "entityId": [], "sentenceIndex": 3, "entityText": "insulin receptor"}, "RL:Hy3Y": {"duid": "RL:Hy3Y", "attribute": [], "entityType": "Trigger", "charEnd": 17, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Anti-phosphoserine"}, "RL:AQPj": {"duid": "RL:AQPj", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 624, "source": "RLIMS-P", "charStart": 619, "entityId": [], "sentenceIndex": 5, "entityText": "serine"}, "RL:gdW2": {"duid": "RL:gdW2", "attribute": [], "entityType": "Protein", "charEnd": 495, "source": "RLIMS-P", "charStart": 484, "entityId": [], "sentenceIndex": 3, "entityText": "EGF receptor"}, "RL:VYat": {"duid": "RL:VYat", "attribute": [], "entityType": "Protein", "charEnd": 665, "source": "RLIMS-P", "charStart": 650, "entityId": [], "sentenceIndex": 5, "entityText": "insulin receptor"}, "RL:ie9V": {"duid": "RL:ie9V", "attribute": [], "entityType": "Protein", "charEnd": 107, "source": "RLIMS-P", "charStart": 92, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptor"}, "RL:C2jD": {"duid": "RL:C2jD", "attribute": [], "entityType": "Trigger", "charEnd": 624, "source": "RLIMS-P", "charStart": 612, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:pMv8": {"duid": "RL:pMv8", "attribute": [], "entityType": "Trigger", "charEnd": 83, "source": "RLIMS-P", "charStart": 65, "entityId": [], "sentenceIndex": 0, "entityText": "autophosphorylation"}, "RL:DUr3": {"duid": "RL:DUr3", "attribute": [], "entityType": "Trigger", "charEnd": 565, "source": "RLIMS-P", "charStart": 553, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:3Dg9": {"duid": "RL:3Dg9", "attribute": [], "entityType": "Trigger", "charEnd": 479, "source": "RLIMS-P", "charStart": 461, "entityId": [], "sentenceIndex": 3, "entityText": "autophosphorylation"}, "RL:qEFx": {"duid": "RL:qEFx", "attribute": [], "entityType": "Protein", "charEnd": 231, "source": "RLIMS-P", "charStart": 216, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}}, "mesh": ["Animals", "Antibodies", "Cells, Cultured", "ErbB Receptors", "Humans", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Receptor, Insulin"], "relation": {"RL:sBHn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:CPsR"}, {"role": "KINASE", "entity_duid": "RL:CPsR"}, {"role": "TRIGGER", "entity_duid": "RL:2omC"}], "duid": "RL:sBHn"}, "RL:Qvt8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UA4H"}], "duid": "RL:Qvt8"}, "RL:rYQS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:VYat"}, {"role": "SITE", "entity_duid": "RL:AQPj"}, {"role": "TRIGGER", "entity_duid": "RL:C2jD"}], "duid": "RL:rYQS"}, "RL:GwKb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Hy3Y"}], "duid": "RL:GwKb"}, "RL:tn7h": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:qEFx"}, {"role": "KINASE", "entity_duid": "RL:qEFx"}, {"role": "TRIGGER", "entity_duid": "RL:6uag"}], "duid": "RL:tn7h"}, "RL:kEpE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DUr3"}], "duid": "RL:kEpE"}, "RL:72qf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:xaFC"}, {"role": "KINASE", "entity_duid": "RL:ie9V"}, {"role": "TRIGGER", "entity_duid": "RL:pMv8"}], "duid": "RL:72qf"}, "RL:uJQZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:gdW2"}, {"role": "KINASE", "entity_duid": "RL:gdW2"}, {"role": "TRIGGER", "entity_duid": "RL:3Dg9"}], "duid": "RL:uJQZ"}, "RL:99cY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ie9V"}, {"role": "KINASE", "entity_duid": "RL:ie9V"}, {"role": "KINASE", "entity_duid": "RL:xaFC"}, {"role": "TRIGGER", "entity_duid": "RL:pMv8"}], "duid": "RL:99cY"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "6842186", "sentence": [{"charStart": 0, "charEnd": 101, "index": 0}, {"index": 1, "charEnd": 226, "charStart": 103}, {"index": 2, "charEnd": 384, "charStart": 228}, {"index": 3, "charEnd": 467, "charStart": 386}, {"index": 4, "charEnd": 591, "charStart": 469}, {"index": 5, "charEnd": 703, "charStart": 593}, {"index": 6, "charEnd": 867, "charStart": 705}, {"index": 7, "charEnd": 1029, "charStart": 869}, {"index": 8, "charEnd": 1198, "charStart": 1031}], "text": "Studies on the phosphorylation of the 58000 dalton early region 1B protein of human adenovirus type 5. The 58000 dalton (58K) protein coded for by early region 1B of human adenovirus type 5 (Ad5) was found to be phosphorylated. At least three major tryptic phosphopeptides were identified and the average number of phosphates per 58K molecule was estimated to be between two and three. Thus, it was possible that each phosphopeptide contained just one phosphate group. The ratio of phosphoserine to phosphothreonine was about 2 to 1 on average and essentially no phosphotyrosine was detected. No evidence was found to suggest that cAMP-dependent protein kinase was involved in the phosphorylation of 58K. Previous studies have shown that 58K was phosphorylated when immunoprecipitates containing Ad5 early region 1 proteins were incubated in vitro with [gamma-32P]ATP. Analysis of the phosphopeptides of 58K labelled under these conditions indicated a large number of phosphorylation sites which differed from those found in vivo. Thus, the action of kinases in the in vitro phosphorylation of 58K in immunoprecipitates did not mimic the enzymic activity responsible for 58K phosphorylation in vivo.", "title": {"charStart": 0, "charEnd": 101}, "entity": {"RL:5UZV": {"duid": "RL:5UZV", "attribute": [], "entityType": "Trigger", "charEnd": 271, "source": "RLIMS-P", "charStart": 257, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:XhGa": {"duid": "RL:XhGa", "attribute": [], "entityType": "Protein", "charEnd": 73, "source": "RLIMS-P", "charStart": 57, "entityId": [], "sentenceIndex": 0, "entityText": "region 1B protein"}, "RL:Nhi2": {"duid": "RL:Nhi2", "attribute": [], "entityType": "Protein", "charEnd": 702, "source": "RLIMS-P", "charStart": 700, "entityId": [], "sentenceIndex": 5, "entityText": "58K"}, "RL:cbtL": {"duid": "RL:cbtL", "attribute": [], "entityType": "Trigger", "charEnd": 982, "source": "RLIMS-P", "charStart": 968, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:Qd9i": {"duid": "RL:Qd9i", "attribute": [], "entityType": "SiteOther", "charEnd": 899, "source": "RLIMS-P", "charStart": 885, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:rBiW": {"duid": "RL:rBiW", "attribute": [], "entityType": "Trigger", "charEnd": 494, "source": "RLIMS-P", "charStart": 482, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:7pBr": {"duid": "RL:7pBr", "attribute": [], "entityType": "SiteOther", "charEnd": 431, "source": "RLIMS-P", "charStart": 418, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}, "RL:98uZ": {"duid": "RL:98uZ", "attribute": [], "entityType": "Trigger", "charEnd": 899, "source": "RLIMS-P", "charStart": 885, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:9iAo": {"duid": "RL:9iAo", "attribute": [], "entityType": "Protein", "charEnd": 740, "source": "RLIMS-P", "charStart": 738, "entityId": [], "sentenceIndex": 6, "entityText": "58K"}, "RL:haw9": {"duid": "RL:haw9", "attribute": [], "entityType": "SiteOther", "charEnd": 271, "source": "RLIMS-P", "charStart": 257, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:EwN3": {"duid": "RL:EwN3", "attribute": [], "entityType": "Trigger", "charEnd": 1089, "source": "RLIMS-P", "charStart": 1075, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:8CWR": {"duid": "RL:8CWR", "attribute": [], "entityType": "Trigger", "charEnd": 29, "source": "RLIMS-P", "charStart": 15, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:RaeV": {"duid": "RL:RaeV", "attribute": [], "entityType": "Protein", "charEnd": 1173, "source": "RLIMS-P", "charStart": 1171, "entityId": [], "sentenceIndex": 8, "entityText": "58K"}, "RL:FFBh": {"duid": "RL:FFBh", "attribute": [], "entityType": "Trigger", "charEnd": 225, "source": "RLIMS-P", "charStart": 212, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:zQPH": {"duid": "RL:zQPH", "attribute": [], "entityType": "Trigger", "charEnd": 759, "source": "RLIMS-P", "charStart": 746, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylated"}, "RL:T7vZ": {"duid": "RL:T7vZ", "attribute": [], "entityType": "Trigger", "charEnd": 695, "source": "RLIMS-P", "charStart": 681, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:fx4K": {"duid": "RL:fx4K", "attribute": [], "entityType": "SiteOther", "charEnd": 988, "source": "RLIMS-P", "charStart": 968, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation sites"}, "RL:NQAt": {"duid": "RL:NQAt", "attribute": [], "entityType": "Trigger", "charEnd": 514, "source": "RLIMS-P", "charStart": 499, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:D5rz": {"duid": "RL:D5rz", "attribute": [], "entityType": "Trigger", "charEnd": 577, "source": "RLIMS-P", "charStart": 563, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:Qitj": {"duid": "RL:Qitj", "attribute": [], "entityType": "Trigger", "charEnd": 1189, "source": "RLIMS-P", "charStart": 1175, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:uGoP": {"duid": "RL:uGoP", "attribute": [], "entityType": "Protein", "charEnd": 194, "source": "RLIMS-P", "charStart": 166, "entityId": [], "sentenceIndex": 1, "entityText": "human adenovirus type 5 (Ad5)"}, "RL:5ERm": {"duid": "RL:5ERm", "attribute": [], "entityType": "Trigger", "charEnd": 431, "source": "RLIMS-P", "charStart": 418, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}, "RL:Xa8h": {"duid": "RL:Xa8h", "attribute": [], "entityType": "Protein", "charEnd": 1096, "source": "RLIMS-P", "charStart": 1094, "entityId": [], "sentenceIndex": 8, "entityText": "58K"}}, "mesh": ["Adenoviruses, Human", "Amino Acids", "Antigens, Viral", "Electrophoresis, Polyacrylamide Gel", "Phosphates", "Phosphopeptides", "Phosphoproteins", "Phosphorylation", "Precipitin Tests", "Viral Proteins"], "relation": {"RL:8KHE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:9iAo"}, {"role": "TRIGGER", "entity_duid": "RL:zQPH"}], "duid": "RL:8KHE"}, "RL:6hhp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:haw9"}, {"role": "TRIGGER", "entity_duid": "RL:5UZV"}], "duid": "RL:6hhp"}, "RL:aszN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XhGa"}, {"role": "TRIGGER", "entity_duid": "RL:8CWR"}], "duid": "RL:aszN"}, "RL:Co7h": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Nhi2"}, {"role": "TRIGGER", "entity_duid": "RL:T7vZ"}], "duid": "RL:Co7h"}, "RL:fnNB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7pBr"}, {"role": "TRIGGER", "entity_duid": "RL:5ERm"}], "duid": "RL:fnNB"}, "RL:4wWx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NQAt"}], "duid": "RL:4wWx"}, "RL:kyEG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Xa8h"}, {"role": "TRIGGER", "entity_duid": "RL:EwN3"}], "duid": "RL:kyEG"}, "RL:wZhy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:rBiW"}], "duid": "RL:wZhy"}, "RL:84vk": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:uGoP"}, {"role": "TRIGGER", "entity_duid": "RL:FFBh"}], "duid": "RL:84vk"}, "RL:iAfD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Qd9i"}, {"role": "TRIGGER", "entity_duid": "RL:98uZ"}], "duid": "RL:iAfD"}, "RL:q4GE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:D5rz"}], "duid": "RL:q4GE"}, "RL:UnvB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:RaeV"}, {"role": "TRIGGER", "entity_duid": "RL:Qitj"}], "duid": "RL:UnvB"}, "RL:y9GW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:fx4K"}, {"role": "TRIGGER", "entity_duid": "RL:cbtL"}], "duid": "RL:y9GW"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "10536367", "sentence": [{"charStart": 0, "charEnd": 89, "index": 0}, {"index": 1, "charEnd": 202, "charStart": 91}, {"index": 2, "charEnd": 373, "charStart": 204}, {"index": 3, "charEnd": 602, "charStart": 375}, {"index": 4, "charEnd": 773, "charStart": 604}, {"index": 5, "charEnd": 850, "charStart": 775}, {"index": 6, "charEnd": 1007, "charStart": 852}, {"index": 7, "charEnd": 1203, "charStart": 1009}, {"index": 8, "charEnd": 1341, "charStart": 1205}, {"index": 9, "charEnd": 1436, "charStart": 1343}, {"index": 10, "charEnd": 1549, "charStart": 1438}], "text": "Regulation of protein phosphatase activity by regucalcin localization in rat liver nuclei. The regulatory role of regucalcin on protein phosphatase activity in isolated rat liver nuclei was investigated. Phosphatase activity toward phosphotyrosine and phosphoserine was significantly increased by the addition of CaCl(2) (10(-5) and 10(-4) M) in the enzyme reaction mixture. Trifluoperazine (25 and 50 microM), an antagonist of calmodulin, significantly inhibited protein phosphatase activity toward phosphoserine, while it had no effect on the enzyme activity toward phosphotysine and phosphothreonine. Cyclosporin A (10(-6)-10(-4) M), an inhibitor of Ca(2+)/calmodulin-dependent protein phosphatase activity toward phosphoserine, but not phosphotyrosine and phosphoserine. Thus, Ca(2+)/calmodulin-dependent phosphatases were present in liver nuclei. Regucalcin (0.25 and 0.5 microM) had an inhibitory effect on liver nuclear phosphatase activity toward phosphotyrosine, phosphoserine, and phosphothreonine. The presence of anti-regucalcin monoclonal antibody (25 and 50 ng/ml) in the enzyme reaction mixture caused a significant elevation of nuclear phosphatase activity toward three phosphoaminoacids. An analysis with sodium sulfate-polyacrylamide gel electrophoresis suggested a possibility of localization of regucalcin in liver nuclei. Moreover, regucalcin was determined in liver nuclei using enzyme-linked immunoadsorbent assay. The present study demonstrates that the endogenous regucalcin inhibits phosphatase activity in the liver nuclei.", "title": {"charStart": 0, "charEnd": 89}, "entity": {"RL:MPBF": {"duid": "RL:MPBF", "attribute": [], "entityType": "Trigger", "charEnd": 729, "source": "RLIMS-P", "charStart": 717, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:HaaG": {"duid": "RL:HaaG", "attribute": [], "entityType": "Trigger", "charEnd": 512, "source": "RLIMS-P", "charStart": 500, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:BmgM": {"duid": "RL:BmgM", "attribute": [], "entityType": "Trigger", "charEnd": 580, "source": "RLIMS-P", "charStart": 568, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotysine"}, "RL:7YcT": {"duid": "RL:7YcT", "attribute": [], "entityType": "Trigger", "charEnd": 246, "source": "RLIMS-P", "charStart": 232, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:tvbF": {"duid": "RL:tvbF", "attribute": [], "entityType": "Trigger", "charEnd": 969, "source": "RLIMS-P", "charStart": 955, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:TU7m": {"duid": "RL:TU7m", "attribute": [], "entityType": "Trigger", "charEnd": 754, "source": "RLIMS-P", "charStart": 740, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}}, "mesh": ["Animals", "Antibodies, Monoclonal", "Calcium-Binding Proteins", "Carboxylic Ester Hydrolases", "Cell Nucleus", "Enzyme Inhibitors", "In Vitro Techniques", "Intracellular Signaling Peptides and Proteins", "Liver", "Male", "Mice", "Phosphoprotein Phosphatases", "Rats", "Rats, Wistar", "Sulfotransferases"], "relation": {"RL:e5At": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tvbF"}], "duid": "RL:e5At"}, "RL:3ZYW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7YcT"}], "duid": "RL:3ZYW"}, "RL:GFnJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:MPBF"}], "duid": "RL:GFnJ"}, "RL:HLzH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:HaaG"}], "duid": "RL:HLzH"}, "RL:NxG5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TU7m"}], "duid": "RL:NxG5"}, "RL:h3i7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:BmgM"}], "duid": "RL:h3i7"}}, "type": ["Journal Article"]}
{"docId": "14678013", "sentence": [{"charStart": 0, "charEnd": 69, "index": 0}, {"index": 1, "charEnd": 197, "charStart": 71}, {"index": 2, "charEnd": 475, "charStart": 199}, {"index": 3, "charEnd": 773, "charStart": 477}, {"index": 4, "charEnd": 903, "charStart": 775}, {"index": 5, "charEnd": 1060, "charStart": 905}, {"index": 6, "charEnd": 1162, "charStart": 1062}, {"index": 7, "charEnd": 1258, "charStart": 1164}, {"index": 8, "charEnd": 1462, "charStart": 1260}, {"index": 9, "charEnd": 1684, "charStart": 1464}], "text": "Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Osteopontin (OPN) is an acidic phosphoglycoprotein that is believed to function in the prevention of soft tissue calcification. In vitro studies have shown that OPN can inhibit the formation of hydroxyapatite (HA) and other biologically relevant crystal phases, and that this inhibitory activity requires phosphorylation of the protein; however, it is not known which phosphorylated residues are involved. We have synthesized peptides corresponding to four phosphoserine-containing sequences in rat OPN: OPN7-17, containing phosphoserines 10 and 11; OPN41-52, containing phosphoserines 46 and 47; OPN248-264, containing phosphoserines 250, 257 and 262; and OPN290-301, containing phosphoserines 295-297. The abilities of these peptides to inhibit de novo HA formation were determined using a constant-composition autotitration assay. All four OPN phosphopeptides caused a dose-dependent increase in nucleation lag time, but did not significantly affect subsequent formation of the crystals. However, OPN41-52 (inhibitory constant 73.5 min/microM) and OPN290-301 (72.2 min/microM) were approx. 4 times more potent inhibitors than OPN7-17 (19.7 min/microM) and OPN247-264 (16.3 min/microM). 'Scrambling' the amino acid sequence of OPN290-301 resulted in decreased potency (45.6 min/microM), whereas omission of the phosphate groups from this peptide caused a greater decrease (5.20 min/microM). These findings have identified phosphorylated sequences that are important for the ability of rat bone OPN to inhibit HA crystal formation, and suggest that negative-charge density is an important factor in this activity.", "title": {"charStart": 0, "charEnd": 69}, "entity": {"RL:Bijt": {"duid": "RL:Bijt", "attribute": [], "entityType": "Trigger", "charEnd": 1399, "source": "RLIMS-P", "charStart": 1384, "entityId": [], "sentenceIndex": 8, "entityText": "phosphate groups"}, "RL:6aAx": {"duid": "RL:6aAx", "attribute": [], "entityType": "Trigger", "charEnd": 1508, "source": "RLIMS-P", "charStart": 1495, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylated"}, "RL:wToX": {"duid": "RL:wToX", "attribute": [], "entityType": "Trigger", "charEnd": 932, "source": "RLIMS-P", "charStart": 918, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:d6aE": {"duid": "RL:d6aE", "attribute": [], "entityType": "SiteOther", "charEnd": 1417, "source": "RLIMS-P", "charStart": 1411, "entityId": [], "sentenceIndex": 8, "entityText": "peptide"}, "RL:Vjss": {"duid": "RL:Vjss", "attribute": [], "entityType": "Trigger", "charEnd": 68, "source": "RLIMS-P", "charStart": 54, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:7WXu": {"duid": "RL:7WXu", "attribute": [], "entityType": "Trigger", "charEnd": 608, "source": "RLIMS-P", "charStart": 595, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserines"}, "RL:BnxT": {"duid": "RL:BnxT", "attribute": [], "entityType": "Trigger", "charEnd": 764, "source": "RLIMS-P", "charStart": 751, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserines"}, "RL:Ygvo": {"duid": "RL:Ygvo", "attribute": [], "entityType": "Trigger", "charEnd": 540, "source": "RLIMS-P", "charStart": 528, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:iuC9": {"duid": "RL:iuC9", "attribute": [], "entityType": "Trigger", "charEnd": 704, "source": "RLIMS-P", "charStart": 691, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserines"}, "RL:WwHs": {"duid": "RL:WwHs", "attribute": [], "entityType": "SiteOther", "charEnd": 932, "source": "RLIMS-P", "charStart": 914, "entityId": [], "sentenceIndex": 5, "entityText": "OPN phosphopeptides"}, "RL:VSZZ": {"duid": "RL:VSZZ", "attribute": [], "entityType": "Protein", "charEnd": 572, "source": "RLIMS-P", "charStart": 566, "entityId": [], "sentenceIndex": 3, "entityText": "rat OPN"}, "RL:RZW9": {"duid": "RL:RZW9", "attribute": [], "entityType": "Protein", "charEnd": 916, "source": "RLIMS-P", "charStart": 914, "entityId": [], "sentenceIndex": 5, "entityText": "OPN"}, "RL:4z78": {"duid": "RL:4z78", "attribute": [], "entityType": "Protein", "charEnd": 52, "source": "RLIMS-P", "charStart": 42, "entityId": [], "sentenceIndex": 0, "entityText": "osteopontin"}, "RL:TmaH": {"duid": "RL:TmaH", "attribute": [], "entityType": "SiteOther", "charEnd": 1295, "source": "RLIMS-P", "charStart": 1273, "entityId": [], "sentenceIndex": 8, "entityText": "the amino acid sequence"}, "RL:cAoy": {"duid": "RL:cAoy", "attribute": [], "entityType": "Protein", "charEnd": 234, "source": "RLIMS-P", "charStart": 232, "entityId": [], "sentenceIndex": 2, "entityText": "OPN"}, "RL:2Z2B": {"duid": "RL:2Z2B", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 540, "source": "RLIMS-P", "charStart": 535, "entityId": [], "sentenceIndex": 3, "entityText": "serine"}, "RL:qTHQ": {"duid": "RL:qTHQ", "attribute": [], "entityType": "Trigger", "charEnd": 452, "source": "RLIMS-P", "charStart": 439, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:LNGv": {"duid": "RL:LNGv", "attribute": [], "entityType": "SiteOther", "charEnd": 1518, "source": "RLIMS-P", "charStart": 1510, "entityId": [], "sentenceIndex": 9, "entityText": "sequences"}, "RL:T5ar": {"duid": "RL:T5ar", "attribute": [], "entityType": "Trigger", "charEnd": 655, "source": "RLIMS-P", "charStart": 642, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserines"}, "RL:6NNV": {"duid": "RL:6NNV", "attribute": [], "entityType": "Trigger", "charEnd": 390, "source": "RLIMS-P", "charStart": 376, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:9t8p": {"duid": "RL:9t8p", "attribute": [], "entityType": "Protein", "charEnd": 1309, "source": "RLIMS-P", "charStart": 1300, "entityId": [], "sentenceIndex": 8, "entityText": "OPN290-301"}, "RL:Qudo": {"duid": "RL:Qudo", "attribute": [], "entityType": "SiteOther", "charEnd": 461, "source": "RLIMS-P", "charStart": 454, "entityId": [], "sentenceIndex": 2, "entityText": "residues"}, "RL:sA5k": {"duid": "RL:sA5k", "attribute": [], "entityType": "SiteOther", "charEnd": 68, "source": "RLIMS-P", "charStart": 54, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "Hydroxyapatites", "Kinetics", "Osteopontin", "Phosphopeptides", "Sialoglycoproteins"], "relation": {"RL:rFHz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7WXu"}], "duid": "RL:rFHz"}, "RL:Ty9m": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:iuC9"}], "duid": "RL:Ty9m"}, "RL:LEtc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "INDUCER", "entity_duid": "RL:RZW9"}, {"role": "SITE_OTHER", "entity_duid": "RL:WwHs"}, {"role": "TRIGGER", "entity_duid": "RL:wToX"}], "duid": "RL:LEtc"}, "RL:hhn8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:9t8p"}, {"role": "SITE_OTHER", "entity_duid": "RL:d6aE"}, {"role": "SITE_OTHER", "entity_duid": "RL:TmaH"}, {"role": "TRIGGER", "entity_duid": "RL:Bijt"}], "duid": "RL:hhn8"}, "RL:Thop": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:cAoy"}, {"role": "TRIGGER", "entity_duid": "RL:6NNV"}], "duid": "RL:Thop"}, "RL:BFTp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:VSZZ"}, {"role": "SITE", "entity_duid": "RL:2Z2B"}, {"role": "TRIGGER", "entity_duid": "RL:Ygvo"}], "duid": "RL:BFTp"}, "RL:P7vx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "INDUCER", "entity_duid": "RL:4z78"}, {"role": "SITE_OTHER", "entity_duid": "RL:sA5k"}, {"role": "TRIGGER", "entity_duid": "RL:Vjss"}], "duid": "RL:P7vx"}, "RL:YVwZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Qudo"}, {"role": "TRIGGER", "entity_duid": "RL:qTHQ"}], "duid": "RL:YVwZ"}, "RL:vGEt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:BnxT"}], "duid": "RL:vGEt"}, "RL:GTSh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:LNGv"}, {"role": "TRIGGER", "entity_duid": "RL:6aAx"}], "duid": "RL:GTSh"}, "RL:gd9H": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:T5ar"}], "duid": "RL:gd9H"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "7635197", "sentence": [{"charStart": 0, "charEnd": 88, "index": 0}, {"index": 1, "charEnd": 361, "charStart": 90}, {"index": 2, "charEnd": 558, "charStart": 363}, {"index": 3, "charEnd": 749, "charStart": 560}, {"index": 4, "charEnd": 908, "charStart": 751}], "text": "Separation of phospho- and non-phosphopeptides using reverse phase column chromatography. Peptides containing phosphoserine, phosphothreonine or phosphotyrosine and their parent non-phosphorylated forms were chromatographed using standard C18 reverse phase chromatography in the presence of a water/acetonitrile gradient supplemented with different counter ions. We obtained the best separation of phosphorylated from non-phosphorylated peptides in the presence of heptafluorobutyric acid, with differences in retention times as large as approximately 20 min. The chromatographic method was reliable in separation of the same peptides phosphorylated at different positions, acidic or basic phospho-Ser/Thr-peptides or phospho-Tyr-containing peptides. The described separation conditions are useful in studying the kinetics of phosphorylation/dephosphorylation and in analysis of phosphorylation sites in vivo.", "title": {"charStart": 0, "charEnd": 88}, "entity": {"RL:KzMt": {"duid": "RL:KzMt", "attribute": [], "entityType": "Trigger", "charEnd": 648, "source": "RLIMS-P", "charStart": 635, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:iN45": {"duid": "RL:iN45", "attribute": [], "entityType": "Trigger", "charEnd": 858, "source": "RLIMS-P", "charStart": 826, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation/dephosphorylation"}, "RL:L6TY": {"duid": "RL:L6TY", "attribute": [], "entityType": "SiteOther", "charEnd": 45, "source": "RLIMS-P", "charStart": 27, "entityId": [], "sentenceIndex": 0, "entityText": "non-phosphopeptides"}, "RL:tx7R": {"duid": "RL:tx7R", "attribute": [], "entityType": "SiteOther", "charEnd": 899, "source": "RLIMS-P", "charStart": 879, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation sites"}, "RL:KFL9": {"duid": "RL:KFL9", "attribute": [], "entityType": "Trigger", "charEnd": 122, "source": "RLIMS-P", "charStart": 110, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:2yT4": {"duid": "RL:2yT4", "attribute": [], "entityType": "Trigger", "charEnd": 893, "source": "RLIMS-P", "charStart": 879, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:nrmx": {"duid": "RL:nrmx", "attribute": [], "entityType": "Trigger", "charEnd": 713, "source": "RLIMS-P", "charStart": 690, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-Ser/Thr-peptides"}, "RL:6C8t": {"duid": "RL:6C8t", "attribute": [], "entityType": "Trigger", "charEnd": 45, "source": "RLIMS-P", "charStart": 27, "entityId": [], "sentenceIndex": 0, "entityText": "non-phosphopeptides"}}, "mesh": ["Amino Acid Sequence", "Animals", "Cattle", "Chromatography, High Pressure Liquid", "Eye Proteins", "G-Protein-Coupled Receptor Kinase 1", "Mice", "Molecular Sequence Data", "Phosphopeptides", "Phosphorylation", "Protein Kinases", "Reproducibility of Results", "Rhodopsin"], "relation": {"RL:8fiB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:KFL9"}], "duid": "RL:8fiB"}, "RL:7cPn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:nrmx"}], "duid": "RL:7cPn"}, "RL:v6wx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:L6TY"}, {"role": "TRIGGER", "entity_duid": "RL:6C8t"}], "duid": "RL:v6wx"}, "RL:WsY2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:tx7R"}, {"role": "TRIGGER", "entity_duid": "RL:2yT4"}], "duid": "RL:WsY2"}, "RL:uyQX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:iN45"}], "duid": "RL:uyQX"}, "RL:WzEd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:KzMt"}], "duid": "RL:WzEd"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "3924662", "sentence": [{"charStart": 0, "charEnd": 78, "index": 0}, {"index": 1, "charEnd": 208, "charStart": 80}, {"index": 2, "charEnd": 358, "charStart": 210}, {"index": 3, "charEnd": 485, "charStart": 360}], "text": "Identification and quantitation of O-phosphoserine in human plasma fibronectin. O-Phosphoserine was positively identified as the phosphorylated moiety in human plasma fibronectin by 31P-NMR of intact peptides. These data correlated completely with chemical analyses which demonstrated the presence of O-phosphoserine at a concentration of 2 residues/molecule. Neither O-phosphothreonine nor O-phosphotyrosine was detected in partial acid and partial alkaline hydrolysates, respectively.", "title": {"charStart": 0, "charEnd": 78}, "entity": {"RL:Ggmk": {"duid": "RL:Ggmk", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 49, "source": "RLIMS-P", "charStart": 44, "entityId": [], "sentenceIndex": 0, "entityText": "serine"}, "RL:gsGU": {"duid": "RL:gsGU", "attribute": [], "entityType": "Protein", "charEnd": 177, "source": "RLIMS-P", "charStart": 154, "entityId": [], "sentenceIndex": 1, "entityText": "human plasma fibronectin"}, "RL:fTp7": {"duid": "RL:fTp7", "attribute": [], "entityType": "Trigger", "charEnd": 315, "source": "RLIMS-P", "charStart": 301, "entityId": [], "sentenceIndex": 2, "entityText": "O-phosphoserine"}, "RL:VtRo": {"duid": "RL:VtRo", "attribute": [], "entityType": "Trigger", "charEnd": 149, "source": "RLIMS-P", "charStart": 144, "entityId": [], "sentenceIndex": 1, "entityText": "moiety"}, "RL:ttHL": {"duid": "RL:ttHL", "attribute": [], "entityType": "Trigger", "charEnd": 94, "source": "RLIMS-P", "charStart": 80, "entityId": [], "sentenceIndex": 1, "entityText": "O-Phosphoserine"}, "RL:qvXW": {"duid": "RL:qvXW", "attribute": [], "entityType": "Protein", "charEnd": 77, "source": "RLIMS-P", "charStart": 54, "entityId": [], "sentenceIndex": 0, "entityText": "human plasma fibronectin"}, "RL:oaF6": {"duid": "RL:oaF6", "attribute": [], "entityType": "Trigger", "charEnd": 49, "source": "RLIMS-P", "charStart": 35, "entityId": [], "sentenceIndex": 0, "entityText": "O-phosphoserine"}, "RL:foKp": {"duid": "RL:foKp", "attribute": [], "entityType": "Trigger", "charEnd": 407, "source": "RLIMS-P", "charStart": 391, "entityId": [], "sentenceIndex": 3, "entityText": "O-phosphotyrosine"}, "RL:cWjF": {"duid": "RL:cWjF", "attribute": [], "entityType": "Trigger", "charEnd": 385, "source": "RLIMS-P", "charStart": 368, "entityId": [], "sentenceIndex": 3, "entityText": "O-phosphothreonine"}}, "mesh": ["Fibronectins", "Humans", "Magnetic Resonance Spectroscopy", "Peptide Fragments", "Phosphoserine", "Serine", "Thermolysin"], "relation": {"RL:NWgB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ttHL"}], "duid": "RL:NWgB"}, "RL:UGez": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:gsGU"}, {"role": "TRIGGER", "entity_duid": "RL:VtRo"}], "duid": "RL:UGez"}, "RL:jWBE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:fTp7"}], "duid": "RL:jWBE"}, "RL:7rFL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:qvXW"}, {"role": "SITE", "entity_duid": "RL:Ggmk"}, {"role": "TRIGGER", "entity_duid": "RL:oaF6"}], "duid": "RL:7rFL"}, "RL:8n2L": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:cWjF"}], "duid": "RL:8n2L"}, "RL:J7Cf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:foKp"}], "duid": "RL:J7Cf"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "2472754", "sentence": [{"charStart": 0, "charEnd": 115, "index": 0}, {"index": 1, "charEnd": 341, "charStart": 117}, {"index": 2, "charEnd": 375, "charStart": 343}, {"index": 3, "charEnd": 439, "charStart": 377}, {"index": 4, "charEnd": 591, "charStart": 441}, {"index": 5, "charEnd": 990, "charStart": 593}, {"index": 6, "charEnd": 1370, "charStart": 992}, {"index": 7, "charEnd": 1640, "charStart": 1372}], "text": "Thin-layer chromatography can resolve phosphotyrosine, phosphoserine, and phosphothreonine in a protein hydrolyzate. A solution of propionic acid, 1 M ammonium hydroxide, and isopropyl alcohol (45/17.5/17.5, v/v) was the ascending solvent in the separation of phosphotyrosine, phosphothreonine, and phosphoserine by thin-layer chromatography. The immobile phase was cellulose. The relative migrations were 0.44, 0.38, and 0.2, respectively. A previously described thin-layer system consisting of isobutyric acid and 0.5 M ammonium hydroxide (50/30, v/v) gave very similar relative migrations. To determine the usefulness of thin-layer chromatography in phosphoamino acid analysis, the propionic acid/ammonium hydroxide/isopropyl alcohol solution was used to characterize phosphorylated residues in a plasma membrane protein which is a substrate for the insulin receptor kinase, in insulin receptor phosphorylated histone H2B, and in an in vivo phosphorylated 90000-Da protein from IM9 cells. 32P-labeled proteins were separated by dodecyl sulfate-gel electrophoresis, digested with trypsin, and then hydrolyzed with 6 N HCl, 2 h, 110 degrees C. Following thin-layer chromatography of the hydrolyzates and autoradiography, phosphotyrosine was detected in insulin receptor substrates, and phosphoserine and phosphothreonine were found in the in vivo-phosphorylated protein. This study supports previous reports about the practicality of thin-layer chromatography in phosphoamino acid analysis and it demonstrates that a propionic acid, ammonium hydroxide, isoprophyl alcohol solution may be a useful ascending solvent mixture for this purpose.", "title": {"charStart": 0, "charEnd": 115}, "entity": {"RL:qXM5": {"duid": "RL:qXM5", "attribute": [], "entityType": "SiteOther", "charEnd": 793, "source": "RLIMS-P", "charStart": 786, "entityId": [], "sentenceIndex": 5, "entityText": "residues"}, "RL:3N9t": {"duid": "RL:3N9t", "attribute": [], "entityType": "Trigger", "charEnd": 1236, "source": "RLIMS-P", "charStart": 1222, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:Y9XL": {"duid": "RL:Y9XL", "attribute": [], "entityType": "Protein", "charEnd": 923, "source": "RLIMS-P", "charStart": 913, "entityId": [], "sentenceIndex": 5, "entityText": "histone H2B"}, "RL:xBoN": {"duid": "RL:xBoN", "attribute": [], "entityType": "Trigger", "charEnd": 1320, "source": "RLIMS-P", "charStart": 1305, "entityId": [], "sentenceIndex": 6, "entityText": "phosphothreonine"}, "RL:zJEg": {"duid": "RL:zJEg", "attribute": [], "entityType": "Trigger", "charEnd": 274, "source": "RLIMS-P", "charStart": 260, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:sDgt": {"duid": "RL:sDgt", "attribute": [], "entityType": "Trigger", "charEnd": 1299, "source": "RLIMS-P", "charStart": 1287, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:Qdct": {"duid": "RL:Qdct", "attribute": [], "entityType": "Trigger", "charEnd": 52, "source": "RLIMS-P", "charStart": 38, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}, "RL:Toeu": {"duid": "RL:Toeu", "attribute": [], "entityType": "Trigger", "charEnd": 957, "source": "RLIMS-P", "charStart": 944, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:PsQx": {"duid": "RL:PsQx", "attribute": [], "entityType": "Trigger", "charEnd": 1361, "source": "RLIMS-P", "charStart": 1343, "entityId": [], "sentenceIndex": 6, "entityText": "vivo-phosphorylated"}, "RL:Agq2": {"duid": "RL:Agq2", "attribute": [], "entityType": "Trigger", "charEnd": 784, "source": "RLIMS-P", "charStart": 771, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:dfrX": {"duid": "RL:dfrX", "attribute": [], "entityType": "Protein", "charEnd": 974, "source": "RLIMS-P", "charStart": 959, "entityId": [], "sentenceIndex": 5, "entityText": "90000-Da protein"}, "RL:ck2o": {"duid": "RL:ck2o", "attribute": [], "entityType": "Trigger", "charEnd": 911, "source": "RLIMS-P", "charStart": 898, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:DmZd": {"duid": "RL:DmZd", "attribute": [], "entityType": "Protein", "charEnd": 896, "source": "RLIMS-P", "charStart": 881, "entityId": [], "sentenceIndex": 5, "entityText": "insulin receptor"}}, "mesh": ["Animals", "Autoradiography", "Chromatography, Thin Layer", "Humans", "Hydrolysis", "Phosphoproteins", "Phosphorus Radioisotopes", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Rats", "Serine", "Threonine", "Tyrosine"], "relation": {"RL:iRYy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:dfrX"}, {"role": "KINASE", "entity_duid": "RL:DmZd"}, {"role": "TRIGGER", "entity_duid": "RL:Toeu"}], "duid": "RL:iRYy"}, "RL:ubFg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:3N9t"}], "duid": "RL:ubFg"}, "RL:PsrH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PsQx"}], "duid": "RL:PsrH"}, "RL:6gav": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sDgt"}], "duid": "RL:6gav"}, "RL:eSmX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Y9XL"}, {"role": "KINASE", "entity_duid": "RL:DmZd"}, {"role": "TRIGGER", "entity_duid": "RL:ck2o"}], "duid": "RL:eSmX"}, "RL:WjAu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:qXM5"}, {"role": "TRIGGER", "entity_duid": "RL:Agq2"}], "duid": "RL:WjAu"}, "RL:EzCd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zJEg"}], "duid": "RL:EzCd"}, "RL:vwNC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xBoN"}], "duid": "RL:vwNC"}, "RL:Ehyh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Qdct"}], "duid": "RL:Ehyh"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "17962309", "sentence": [{"charStart": 0, "charEnd": 61, "index": 0}, {"index": 1, "charEnd": 141, "charStart": 63}, {"index": 2, "charEnd": 242, "charStart": 143}, {"index": 3, "charEnd": 430, "charStart": 244}, {"index": 4, "charEnd": 652, "charStart": 432}, {"index": 5, "charEnd": 835, "charStart": 654}, {"index": 6, "charEnd": 1069, "charStart": 837}, {"index": 7, "charEnd": 1133, "charStart": 1071}], "text": "Phospho.ELM: a database of phosphorylation sites--update 2008. Phospho.ELM is a manually curated database of eukaryotic phosphorylation sites. The resource includes data collected from published literature as well as high-throughput data sets. The current release of Phospho.ELM (version 7.0, July 2007) contains 4078 phospho-protein sequences covering 12 025 phospho-serine, 2362 phospho-threonine and 2083 phospho-tyrosine sites. The entries provide information about the phosphorylated proteins and the exact position of known phosphorylated instances, the kinases responsible for the modification (where known) and links to bibliographic references. The database entries have hyperlinks to easily access further information from UniProt, PubMed, SMART, ELM, MSD as well as links to the protein interaction databases MINT and STRING. A new BLAST search tool, complementary to retrieval by keyword and UniProt accession number, allows users to submit a protein query (by sequence or UniProt accession) to search against the curated data set of phosphorylated peptides. Phospho.ELM is available on line at: http://phospho.elm.eu.org.", "title": {"charStart": 0, "charEnd": 61}, "entity": {"RL:G8yA": {"duid": "RL:G8yA", "attribute": [], "entityType": "Trigger", "charEnd": 397, "source": "RLIMS-P", "charStart": 381, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-threonine"}, "RL:BEoP": {"duid": "RL:BEoP", "attribute": [], "entityType": "Trigger", "charEnd": 134, "source": "RLIMS-P", "charStart": 120, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:MGCu": {"duid": "RL:MGCu", "attribute": [], "entityType": "SiteOther", "charEnd": 140, "source": "RLIMS-P", "charStart": 120, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation sites"}, "RL:fbzM": {"duid": "RL:fbzM", "attribute": [], "entityType": "Trigger", "charEnd": 429, "source": "RLIMS-P", "charStart": 408, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-tyrosine sites"}, "RL:BSm4": {"duid": "RL:BSm4", "attribute": [], "entityType": "Trigger", "charEnd": 342, "source": "RLIMS-P", "charStart": 318, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-protein sequences"}, "RL:sihR": {"duid": "RL:sihR", "attribute": [], "entityType": "Trigger", "charEnd": 1059, "source": "RLIMS-P", "charStart": 1046, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylated"}, "RL:3NP4": {"duid": "RL:3NP4", "attribute": [], "entityType": "Trigger", "charEnd": 487, "source": "RLIMS-P", "charStart": 474, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:ymbr": {"duid": "RL:ymbr", "attribute": [], "entityType": "Trigger", "charEnd": 373, "source": "RLIMS-P", "charStart": 360, "entityId": [], "sentenceIndex": 3, "entityText": "phospho-serine"}, "RL:EEwk": {"duid": "RL:EEwk", "attribute": [], "entityType": "SiteOther", "charEnd": 342, "source": "RLIMS-P", "charStart": 326, "entityId": [], "sentenceIndex": 3, "entityText": "protein sequences"}, "RL:mtjf": {"duid": "RL:mtjf", "attribute": [], "entityType": "SiteOther", "charEnd": 1068, "source": "RLIMS-P", "charStart": 1061, "entityId": [], "sentenceIndex": 6, "entityText": "peptides"}, "RL:XQT3": {"duid": "RL:XQT3", "attribute": [], "entityType": "Trigger", "charEnd": 41, "source": "RLIMS-P", "charStart": 27, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}}, "mesh": ["Databases, Protein", "Internet", "Phosphoproteins", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Protein Kinases", "Sequence Alignment", "Sequence Analysis, Protein", "Software"], "relation": {"RL:yEXT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:XQT3"}], "duid": "RL:yEXT"}, "RL:zCVU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:MGCu"}, {"role": "TRIGGER", "entity_duid": "RL:BEoP"}], "duid": "RL:zCVU"}, "RL:vJjj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:fbzM"}], "duid": "RL:vJjj"}, "RL:m6Fo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:G8yA"}], "duid": "RL:m6Fo"}, "RL:5pLV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:3NP4"}], "duid": "RL:5pLV"}, "RL:7M6m": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:EEwk"}, {"role": "TRIGGER", "entity_duid": "RL:BSm4"}], "duid": "RL:7M6m"}, "RL:FQK8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mtjf"}, {"role": "TRIGGER", "entity_duid": "RL:sihR"}], "duid": "RL:FQK8"}, "RL:JLMM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ymbr"}], "duid": "RL:JLMM"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "18522436", "sentence": [{"charStart": 0, "charEnd": 72, "index": 0}, {"index": 1, "charEnd": 178, "charStart": 74}, {"index": 2, "charEnd": 409, "charStart": 180}, {"index": 3, "charEnd": 578, "charStart": 411}, {"index": 4, "charEnd": 658, "charStart": 580}, {"index": 5, "charEnd": 804, "charStart": 660}, {"index": 6, "charEnd": 1139, "charStart": 806}, {"index": 7, "charEnd": 1377, "charStart": 1141}], "text": "Capture of phosphopeptides using alpha-zirconium phosphate nanoplatelets. Alpha-zirconium phosphate nanoplatelets (alpha-ZrPN) were studied as a binding agent for phosphopeptides. Nanoplatelets of alpha-zirconium phosphate were incubated overnight with zirconium oxychloride, followed by centrifugation, and washed twice with water followed by an aqueous solution of 80% acetonitrile to form the binding agent. Alpha-ZrPN were able specifically to capture phosphoserine-containing peptides from a tryptic digest of a complex peptide mixture in which its abundance was only 0.05%. Alpha-ZrPN also bound peptides containing phosphothreonine and phosphotyrosine. The limit of detection for phosphopeptides is approximately 2 fmol, based on using matrix-assisted laser desorption/ionization mass spectrometry. Alpha-ZrPN were applied for the analysis of tryptic digests of mouse liver and leukemia cell phosphoproteomes and succeeded in identifying 158 phosphopeptides (209 phosphorylation sites) from 101 phosphoproteins in mouse liver lysate and 78 phosphopeptides (104 phosphorylation sites) from 59 phosphoproteins in leukemia cell extract. For these two tryptic digests, the alpha-ZrPN approach is able to capture more phosphopeptides than that obtained from TiO2 particles or from Fe(3+)-IMAC beads, but each method is able to bind some phosphopeptides that the others do not.", "title": {"charStart": 0, "charEnd": 72}, "entity": {"RL:gDjZ": {"duid": "RL:gDjZ", "attribute": [], "entityType": "Trigger", "charEnd": 177, "source": "RLIMS-P", "charStart": 163, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:eJCL": {"duid": "RL:eJCL", "attribute": [], "entityType": "SiteOther", "charEnd": 963, "source": "RLIMS-P", "charStart": 949, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:Fbdc": {"duid": "RL:Fbdc", "attribute": [], "entityType": "Trigger", "charEnd": 468, "source": "RLIMS-P", "charStart": 456, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:qvEc": {"duid": "RL:qvEc", "attribute": [], "entityType": "SiteOther", "charEnd": 1061, "source": "RLIMS-P", "charStart": 1047, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:Wzhk": {"duid": "RL:Wzhk", "attribute": [], "entityType": "Trigger", "charEnd": 1113, "source": "RLIMS-P", "charStart": 1099, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoproteins"}, "RL:nr4F": {"duid": "RL:nr4F", "attribute": [], "entityType": "Trigger", "charEnd": 701, "source": "RLIMS-P", "charStart": 687, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:VzYS": {"duid": "RL:VzYS", "attribute": [], "entityType": "Trigger", "charEnd": 963, "source": "RLIMS-P", "charStart": 949, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:QqoL": {"duid": "RL:QqoL", "attribute": [], "entityType": "Trigger", "charEnd": 637, "source": "RLIMS-P", "charStart": 622, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:HsGt": {"duid": "RL:HsGt", "attribute": [], "entityType": "SiteOther", "charEnd": 1234, "source": "RLIMS-P", "charStart": 1220, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:jRNS": {"duid": "RL:jRNS", "attribute": [], "entityType": "SiteOther", "charEnd": 25, "source": "RLIMS-P", "charStart": 11, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:XD5Q": {"duid": "RL:XD5Q", "attribute": [], "entityType": "SiteOther", "charEnd": 1353, "source": "RLIMS-P", "charStart": 1339, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:fneZ": {"duid": "RL:fneZ", "attribute": [], "entityType": "Trigger", "charEnd": 1061, "source": "RLIMS-P", "charStart": 1047, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:Pqte": {"duid": "RL:Pqte", "attribute": [], "entityType": "Trigger", "charEnd": 1234, "source": "RLIMS-P", "charStart": 1220, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:hExk": {"duid": "RL:hExk", "attribute": [], "entityType": "SiteOther", "charEnd": 701, "source": "RLIMS-P", "charStart": 687, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:GTdQ": {"duid": "RL:GTdQ", "attribute": [], "entityType": "Trigger", "charEnd": 1353, "source": "RLIMS-P", "charStart": 1339, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Zxqq": {"duid": "RL:Zxqq", "attribute": [], "entityType": "Trigger", "charEnd": 1016, "source": "RLIMS-P", "charStart": 1002, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoproteins"}, "RL:qwj5": {"duid": "RL:qwj5", "attribute": [], "entityType": "Trigger", "charEnd": 25, "source": "RLIMS-P", "charStart": 11, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:A4H9": {"duid": "RL:A4H9", "attribute": [], "entityType": "SiteOther", "charEnd": 177, "source": "RLIMS-P", "charStart": 163, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}}, "mesh": ["Animals", "Cell Line, Tumor", "Humans", "Liver", "Mice", "Microscopy, Electron, Scanning", "Nanostructures", "Phosphopeptides", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization", "Zirconium"], "relation": {"RL:9rmH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:eJCL"}, {"role": "TRIGGER", "entity_duid": "RL:VzYS"}], "duid": "RL:9rmH"}, "RL:ANLW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:A4H9"}, {"role": "TRIGGER", "entity_duid": "RL:gDjZ"}], "duid": "RL:ANLW"}, "RL:wiFW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:hExk"}, {"role": "TRIGGER", "entity_duid": "RL:nr4F"}], "duid": "RL:wiFW"}, "RL:8KtJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QqoL"}], "duid": "RL:8KtJ"}, "RL:yohp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:qvEc"}, {"role": "TRIGGER", "entity_duid": "RL:fneZ"}], "duid": "RL:yohp"}, "RL:z9FB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:XD5Q"}, {"role": "TRIGGER", "entity_duid": "RL:GTdQ"}], "duid": "RL:z9FB"}, "RL:kdn3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:HsGt"}, {"role": "TRIGGER", "entity_duid": "RL:Pqte"}], "duid": "RL:kdn3"}, "RL:WFVX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Zxqq"}], "duid": "RL:WFVX"}, "RL:C4fh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:jRNS"}, {"role": "TRIGGER", "entity_duid": "RL:qwj5"}], "duid": "RL:C4fh"}, "RL:JFTp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Fbdc"}], "duid": "RL:JFTp"}, "RL:BgPW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Wzhk"}], "duid": "RL:BgPW"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}
{"docId": "22013880", "sentence": [{"charStart": 0, "charEnd": 104, "index": 0}, {"index": 1, "charEnd": 231, "charStart": 106}, {"index": 2, "charEnd": 691, "charStart": 233}, {"index": 3, "charEnd": 766, "charStart": 693}, {"index": 4, "charEnd": 921, "charStart": 768}, {"index": 5, "charEnd": 1090, "charStart": 923}, {"index": 6, "charEnd": 1165, "charStart": 1092}, {"index": 7, "charEnd": 1262, "charStart": 1167}], "text": "Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling. There are three quantitative phosphoproteomic strategies most commonly used to study receptor tyrosine kinase (RTK) signaling. These strategies quantify changes in: (1) all three forms of phosphosites (phosphoserine, phosphothreonine and phosphotyrosine) following enrichment of phosphopeptides by titanium dioxide or immobilized metal affinity chromatography; (2) phosphotyrosine sites following anti- phosphotyrosine antibody enrichment of phosphotyrosine peptides; or (3) phosphotyrosine proteins and their binding partners following anti-phosphotyrosine protein immunoprecipitation. However, it is not clear from literature which strategy is more effective. In this study, we assessed the utility of these three phosphoproteomic strategies in RTK signaling studies by using EphB receptor signaling as an example. We used all three strategies with stable isotope labeling with amino acids in cell culture (SILAC) to compare changes in phosphoproteomes upon EphB receptor activation. We used bioinformatic analysis to compare results from the three analyses. Our results show that the three strategies provide complementary information about RTK pathways.", "title": {"charStart": 0, "charEnd": 104}, "entity": {"RL:VGY5": {"duid": "RL:VGY5", "attribute": [], "entityType": "Trigger", "charEnd": 399, "source": "RLIMS-P", "charStart": 385, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:DWWw": {"duid": "RL:DWWw", "attribute": [], "entityType": "Trigger", "charEnd": 562, "source": "RLIMS-P", "charStart": 548, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:u8dT": {"duid": "RL:u8dT", "attribute": [], "entityType": "Trigger", "charEnd": 595, "source": "RLIMS-P", "charStart": 581, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:ZzwP": {"duid": "RL:ZzwP", "attribute": [], "entityType": "SiteOther", "charEnd": 399, "source": "RLIMS-P", "charStart": 385, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:QK7B": {"duid": "RL:QK7B", "attribute": [], "entityType": "Trigger", "charEnd": 662, "source": "RLIMS-P", "charStart": 643, "entityId": [], "sentenceIndex": 2, "entityText": "anti-phosphotyrosine"}, "RL:S8ZV": {"duid": "RL:S8ZV", "attribute": [], "entityType": "Trigger", "charEnd": 305, "source": "RLIMS-P", "charStart": 294, "entityId": [], "sentenceIndex": 2, "entityText": "phosphosites"}, "RL:dsKv": {"duid": "RL:dsKv", "attribute": [], "entityType": "Trigger", "charEnd": 485, "source": "RLIMS-P", "charStart": 471, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}}, "mesh": ["Animals", "Cell Line, Tumor", "Chromatography, Affinity", "Computational Biology", "Ephrin-B1", "Immunoprecipitation", "Isotope Labeling", "Mice", "Phosphoproteins", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Protein Interaction Mapping", "Protein Interaction Maps", "Proteomics", "Rats", "Receptors, Eph Family", "Signal Transduction", "Titanium"], "relation": {"RL:8jeG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QK7B"}], "duid": "RL:8jeG"}, "RL:g5zu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:u8dT"}], "duid": "RL:g5zu"}, "RL:gAbf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:dsKv"}], "duid": "RL:gAbf"}, "RL:gvv7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:S8ZV"}], "duid": "RL:gvv7"}, "RL:sfKc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ZzwP"}, {"role": "TRIGGER", "entity_duid": "RL:VGY5"}], "duid": "RL:sfKc"}, "RL:dZUQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DWWw"}], "duid": "RL:dZUQ"}}, "type": ["Comparative Study", "Journal Article", "Research Support, N.I.H., Extramural"]}
{"docId": "2506075", "sentence": [{"charStart": 0, "charEnd": 116, "index": 0}, {"index": 1, "charEnd": 398, "charStart": 118}, {"index": 2, "charEnd": 630, "charStart": 400}, {"index": 3, "charEnd": 815, "charStart": 632}, {"index": 4, "charEnd": 942, "charStart": 817}], "text": "Identification of a phosphorylation site of the rat insulin receptor catalyzed by protein kinase C in an intact cell. In two-dimensional tryptic phosphopeptide mapping, the beta-subunit of the insulin receptor phosphorylated by 12-O-tetradecanoylphorbol-13-acetate in rat hepatoma cells (H-35) was separated into one phosphothreonine-containing peptide and several phosphoserine-containing peptides. The synthetic peptide coding residues 1327-1343 in the C-terminal region of the rat insulin receptor was phosphorylated at the threonine residue by protein kinase C in a phosphatidylserine and oleoylacetylglycerol dependent manner. Tryptic digest of this phosphopeptide migrated to the same position as the phosphothreonine containing peptide obtained from the beta-subunit in two-dimensional phosphopeptide mapping. These data suggested that Thr 1336 of the insulin receptor is the site of phosphorylation by protein kinase C in intact cells.", "title": {"charStart": 0, "charEnd": 116}, "entity": {"RL:QLMc": {"duid": "RL:QLMc", "attribute": [], "entityType": "Trigger", "charEnd": 34, "source": "RLIMS-P", "charStart": 20, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:TmBq": {"duid": "RL:TmBq", "attribute": [], "entityType": "SiteOther", "charEnd": 39, "source": "RLIMS-P", "charStart": 20, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation site"}, "RL:Rhih": {"duid": "RL:Rhih", "attribute": [], "entityType": "Trigger", "charEnd": 332, "source": "RLIMS-P", "charStart": 317, "entityId": [], "sentenceIndex": 1, "entityText": "phosphothreonine"}, "RL:LHGi": {"duid": "RL:LHGi", "attribute": [], "entityType": "SiteOther", "charEnd": 471, "source": "RLIMS-P", "charStart": 455, "entityId": [], "sentenceIndex": 2, "entityText": "C-terminal region"}, "RL:zcRY": {"duid": "RL:zcRY", "attribute": [], "entityType": "Protein", "charEnd": 563, "source": "RLIMS-P", "charStart": 548, "entityId": [], "sentenceIndex": 2, "entityText": "protein kinase C"}, "RL:mgLH": {"duid": "RL:mgLH", "attribute": [], "entityType": "SiteOther", "charEnd": 886, "source": "RLIMS-P", "charStart": 883, "entityId": [], "sentenceIndex": 4, "entityText": "site"}, "RL:zGSY": {"duid": "RL:zGSY", "attribute": [], "entityType": "Protein", "charEnd": 208, "source": "RLIMS-P", "charStart": 193, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}, "RL:g7Lw": {"duid": "RL:g7Lw", "attribute": [], "entityType": "Trigger", "charEnd": 668, "source": "RLIMS-P", "charStart": 655, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}, "RL:76t4": {"duid": "RL:76t4", "attribute": [], "entityType": "Trigger", "charEnd": 377, "source": "RLIMS-P", "charStart": 365, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoserine"}, "RL:Zn5J": {"duid": "RL:Zn5J", "attribute": [{"key": "std_site", "value": "Thr-1336"}], "entityType": "Site", "charEnd": 850, "source": "RLIMS-P", "charStart": 843, "entityId": [], "sentenceIndex": 4, "entityText": "Thr 1336"}, "RL:ppH4": {"duid": "RL:ppH4", "attribute": [], "entityType": "Trigger", "charEnd": 722, "source": "RLIMS-P", "charStart": 707, "entityId": [], "sentenceIndex": 3, "entityText": "phosphothreonine"}, "RL:HhDM": {"duid": "RL:HhDM", "attribute": [], "entityType": "SiteOther", "charEnd": 446, "source": "RLIMS-P", "charStart": 400, "entityId": [], "sentenceIndex": 2, "entityText": "The synthetic peptide coding residues 1327-1343"}, "RL:oDat": {"duid": "RL:oDat", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 535, "source": "RLIMS-P", "charStart": 527, "entityId": [], "sentenceIndex": 2, "entityText": "threonine"}, "RL:EyM6": {"duid": "RL:EyM6", "attribute": [], "entityType": "Trigger", "charEnd": 905, "source": "RLIMS-P", "charStart": 891, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:pUk9": {"duid": "RL:pUk9", "attribute": [], "entityType": "Protein", "charEnd": 874, "source": "RLIMS-P", "charStart": 859, "entityId": [], "sentenceIndex": 4, "entityText": "insulin receptor"}, "RL:j6cZ": {"duid": "RL:j6cZ", "attribute": [], "entityType": "Protein", "charEnd": 499, "source": "RLIMS-P", "charStart": 484, "entityId": [], "sentenceIndex": 2, "entityText": "insulin receptor"}, "RL:FpLQ": {"duid": "RL:FpLQ", "attribute": [], "entityType": "Protein", "charEnd": 67, "source": "RLIMS-P", "charStart": 52, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptor"}, "RL:7aFJ": {"duid": "RL:7aFJ", "attribute": [], "entityType": "SiteOther", "charEnd": 668, "source": "RLIMS-P", "charStart": 655, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptide"}, "RL:LEAP": {"duid": "RL:LEAP", "attribute": [], "entityType": "Protein", "charEnd": 925, "source": "RLIMS-P", "charStart": 910, "entityId": [], "sentenceIndex": 4, "entityText": "protein kinase C"}, "RL:PNQW": {"duid": "RL:PNQW", "attribute": [], "entityType": "Trigger", "charEnd": 518, "source": "RLIMS-P", "charStart": 505, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:iowm": {"duid": "RL:iowm", "attribute": [], "entityType": "Trigger", "charEnd": 223, "source": "RLIMS-P", "charStart": 210, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}}, "mesh": ["Animals", "Binding Sites", "Cell Line", "Peptide Mapping", "Phosphoproteins", "Phosphorylation", "Phosphothreonine", "Protein Kinase C", "Rats", "Receptor, Insulin", "Threonine", "Trypsin"], "relation": {"RL:ibFT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:j6cZ"}, {"role": "SITE", "entity_duid": "RL:oDat"}, {"role": "SITE_OTHER", "entity_duid": "RL:HhDM"}, {"role": "SITE_OTHER", "entity_duid": "RL:7aFJ"}, {"role": "SITE_OTHER", "entity_duid": "RL:LHGi"}, {"role": "TRIGGER", "entity_duid": "RL:g7Lw"}], "duid": "RL:ibFT"}, "RL:ySeX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:zGSY"}, {"role": "TRIGGER", "entity_duid": "RL:iowm"}], "duid": "RL:ySeX"}, "RL:QKgb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:j6cZ"}, {"role": "KINASE", "entity_duid": "RL:zcRY"}, {"role": "SITE", "entity_duid": "RL:oDat"}, {"role": "SITE_OTHER", "entity_duid": "RL:LHGi"}, {"role": "TRIGGER", "entity_duid": "RL:PNQW"}], "duid": "RL:QKgb"}, "RL:XHBb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:pUk9"}, {"role": "KINASE", "entity_duid": "RL:LEAP"}, {"role": "SITE", "entity_duid": "RL:Zn5J"}, {"role": "SITE_OTHER", "entity_duid": "RL:mgLH"}, {"role": "TRIGGER", "entity_duid": "RL:EyM6"}], "duid": "RL:XHBb"}, "RL:PYPA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Rhih"}], "duid": "RL:PYPA"}, "RL:9z2i": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ppH4"}], "duid": "RL:9z2i"}, "RL:Dh78": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:FpLQ"}, {"role": "SITE_OTHER", "entity_duid": "RL:TmBq"}, {"role": "TRIGGER", "entity_duid": "RL:QLMc"}], "duid": "RL:Dh78"}, "RL:9PEr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:76t4"}], "duid": "RL:9PEr"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "2581963", "sentence": [{"charStart": 0, "charEnd": 116, "index": 0}, {"index": 1, "charEnd": 330, "charStart": 118}, {"index": 2, "charEnd": 518, "charStart": 332}, {"index": 3, "charEnd": 628, "charStart": 520}, {"index": 4, "charEnd": 908, "charStart": 630}, {"index": 5, "charEnd": 1051, "charStart": 910}, {"index": 6, "charEnd": 1409, "charStart": 1053}, {"index": 7, "charEnd": 1572, "charStart": 1411}, {"index": 8, "charEnd": 1882, "charStart": 1574}], "text": "Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin. Anti-phosphotyrosine antibody and anti-insulin receptor antibody were used to study insulin-stimulated phosphorylation of the beta-subunit of the insulin receptor in [32P]orthophosphate-labeled Fao hepatoma cells. Without insulin, the receptor contained both phosphoserine and phosphothreonine and could be immunoprecipitated with anti-receptor antibody but not with the anti-phosphotyrosine antibody. After incubation of these cells with insulin, both antibodies immunoprecipitated the phosphorylated receptor. The beta-subunit of the receptor precipitated with anti-phosphotyrosine antibody from cells stimulated with insulin (100 nM) for 1 min contained predominantly phosphotyrosine, whereas, after 10 min with insulin, the amounts of phosphotyrosine and phosphoserine were nearly equal. These results suggest that insulin-stimulated tyrosine phosphorylation preceded insulin-stimulated serine phosphorylation of the beta-subunit. Sequential immunoprecipitation of receptor with anti-phosphotyrosine antibody followed by precipitation of the remaining proteins with anti-receptor antibody suggests that insulin receptors which contain phosphoserine in the basal state are tyrosine phosphorylated more slowly than the dephosphorylated receptors or not at all after the addition of insulin. The beta-subunit of the insulin receptor was the major phosphorylated protein precipitated by the anti-phosphotyrosine antibody from insulin-stimulated Fao cells. These results confirm our notion that insulin initially stimulated tyrosine autophosphorylation and subsequently serine phosphorylation of the insulin receptor in intact cells and suggests that this sequence of reactions occurs faster on receptors that are dephosphorylated before the incubation with insulin.", "title": {"charStart": 0, "charEnd": 116}, "entity": {"RL:UWFF": {"duid": "RL:UWFF", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 1301, "source": "RLIMS-P", "charStart": 1294, "entityId": [], "sentenceIndex": 6, "entityText": "tyrosine"}, "RL:ypdE": {"duid": "RL:ypdE", "attribute": [], "entityType": "Trigger", "charEnd": 1668, "source": "RLIMS-P", "charStart": 1650, "entityId": [], "sentenceIndex": 8, "entityText": "autophosphorylation"}, "RL:FZ8x": {"duid": "RL:FZ8x", "attribute": [], "entityType": "Trigger", "charEnd": 871, "source": "RLIMS-P", "charStart": 857, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:4eU4": {"duid": "RL:4eU4", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 23, "source": "RLIMS-P", "charStart": 16, "entityId": [], "sentenceIndex": 0, "entityText": "tyrosine"}, "RL:2a7d": {"duid": "RL:2a7d", "attribute": [], "entityType": "Trigger", "charEnd": 1708, "source": "RLIMS-P", "charStart": 1694, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:oF8k": {"duid": "RL:oF8k", "attribute": [], "entityType": "Protein", "charEnd": 279, "source": "RLIMS-P", "charStart": 264, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}, "RL:ohqd": {"duid": "RL:ohqd", "attribute": [], "entityType": "Trigger", "charEnd": 618, "source": "RLIMS-P", "charStart": 605, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:K3D3": {"duid": "RL:K3D3", "attribute": [], "entityType": "Trigger", "charEnd": 1479, "source": "RLIMS-P", "charStart": 1466, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylated"}, "RL:wNSA": {"duid": "RL:wNSA", "attribute": [], "entityType": "Trigger", "charEnd": 803, "source": "RLIMS-P", "charStart": 789, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:ZKND": {"duid": "RL:ZKND", "attribute": [], "entityType": "Protein", "charEnd": 208, "source": "RLIMS-P", "charStart": 202, "entityId": [], "sentenceIndex": 1, "entityText": "insulin"}, "RL:VZRN": {"duid": "RL:VZRN", "attribute": [], "entityType": "Trigger", "charEnd": 1269, "source": "RLIMS-P", "charStart": 1257, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:Tdpf": {"duid": "RL:Tdpf", "attribute": [], "entityType": "Trigger", "charEnd": 1316, "source": "RLIMS-P", "charStart": 1303, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylated"}, "RL:jBBR": {"duid": "RL:jBBR", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1269, "source": "RLIMS-P", "charStart": 1264, "entityId": [], "sentenceIndex": 6, "entityText": "serine"}, "RL:G6q8": {"duid": "RL:G6q8", "attribute": [], "entityType": "Trigger", "charEnd": 389, "source": "RLIMS-P", "charStart": 377, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:sTFU": {"duid": "RL:sTFU", "attribute": [], "entityType": "Trigger", "charEnd": 39, "source": "RLIMS-P", "charStart": 25, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:8ZXR": {"duid": "RL:8ZXR", "attribute": [], "entityType": "Protein", "charEnd": 60, "source": "RLIMS-P", "charStart": 44, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptors"}, "RL:xMZP": {"duid": "RL:xMZP", "attribute": [], "entityType": "Protein", "charEnd": 1732, "source": "RLIMS-P", "charStart": 1717, "entityId": [], "sentenceIndex": 8, "entityText": "insulin receptor"}, "RL:BMFs": {"duid": "RL:BMFs", "attribute": [], "entityType": "Trigger", "charEnd": 235, "source": "RLIMS-P", "charStart": 221, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:LAwk": {"duid": "RL:LAwk", "attribute": [], "entityType": "Protein", "charEnd": 1241, "source": "RLIMS-P", "charStart": 1225, "entityId": [], "sentenceIndex": 6, "entityText": "insulin receptors"}, "RL:nZ57": {"duid": "RL:nZ57", "attribute": [], "entityType": "Trigger", "charEnd": 979, "source": "RLIMS-P", "charStart": 965, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:mLWR": {"duid": "RL:mLWR", "attribute": [], "entityType": "Protein", "charEnd": 1450, "source": "RLIMS-P", "charStart": 1435, "entityId": [], "sentenceIndex": 7, "entityText": "insulin receptor"}, "RL:7HJg": {"duid": "RL:7HJg", "attribute": [], "entityType": "Trigger", "charEnd": 1030, "source": "RLIMS-P", "charStart": 1016, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:PJvg": {"duid": "RL:PJvg", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1692, "source": "RLIMS-P", "charStart": 1687, "entityId": [], "sentenceIndex": 8, "entityText": "serine"}}, "mesh": ["Animals", "Antibodies", "Cell Line", "Dose-Response Relationship, Drug", "Immunosorbent Techniques", "Insulin", "Liver Neoplasms, Experimental", "Phosphorylation", "Phosphotyrosine", "Receptor, Insulin", "Tyrosine"], "relation": {"RL:hBHr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:nZ57"}], "duid": "RL:hBHr"}, "RL:h4zd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:oF8k"}, {"role": "INDUCER", "entity_duid": "RL:ZKND"}, {"role": "TRIGGER", "entity_duid": "RL:BMFs"}], "duid": "RL:h4zd"}, "RL:uU2C": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:G6q8"}], "duid": "RL:uU2C"}, "RL:49Ff": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:FZ8x"}], "duid": "RL:49Ff"}, "RL:MVPK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:mLWR"}, {"role": "TRIGGER", "entity_duid": "RL:K3D3"}], "duid": "RL:MVPK"}, "RL:4YVJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:LAwk"}, {"role": "SITE", "entity_duid": "RL:jBBR"}, {"role": "TRIGGER", "entity_duid": "RL:VZRN"}], "duid": "RL:4YVJ"}, "RL:scvg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wNSA"}], "duid": "RL:scvg"}, "RL:sAAf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ypdE"}], "duid": "RL:sAAf"}, "RL:cDUJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:xMZP"}, {"role": "SITE", "entity_duid": "RL:PJvg"}, {"role": "TRIGGER", "entity_duid": "RL:2a7d"}], "duid": "RL:cDUJ"}, "RL:WFEn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:oF8k"}, {"role": "TRIGGER", "entity_duid": "RL:ohqd"}], "duid": "RL:WFEn"}, "RL:QXgS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:7HJg"}], "duid": "RL:QXgS"}, "RL:BzpL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:8ZXR"}, {"role": "SITE", "entity_duid": "RL:4eU4"}, {"role": "TRIGGER", "entity_duid": "RL:sTFU"}], "duid": "RL:BzpL"}, "RL:KTYc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:LAwk"}, {"role": "SITE", "entity_duid": "RL:jBBR"}, {"role": "SITE", "entity_duid": "RL:UWFF"}, {"role": "TRIGGER", "entity_duid": "RL:Tdpf"}], "duid": "RL:KTYc"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "1652474", "sentence": [{"charStart": 0, "charEnd": 88, "index": 0}, {"index": 1, "charEnd": 198, "charStart": 90}, {"index": 2, "charEnd": 388, "charStart": 200}, {"index": 3, "charEnd": 528, "charStart": 390}, {"index": 4, "charEnd": 671, "charStart": 530}, {"index": 5, "charEnd": 801, "charStart": 673}], "text": "Multisite serine phosphorylation of the insulin and IGF-I receptors in transfected cells. Serine phosphorylation of insulin/IGF-I receptors in transfected fibroblasts was analysed by peptide mapping. PMA stimulated the phosphorylation of 5 distinct insulin receptor phosphopeptides: a single major phosphothreonine peptide containing Thr-1348, one major and 3 minor phosphoserine peptides. The major insulin-stimulated phosphoserine peptides were the same as those after PMA, with the exception of 2 minor phosphoserine peptides. PMA stimulated phosphorylation of a single major IGF-I receptor phosphoserine peptide which was phosphorylated to a lesser extent after IGF-I. We conclude that insulin/IGF-I and PMA stimulate phosphorylation of the same sites, but differ in the extents of phosphorylation.", "title": {"charStart": 0, "charEnd": 88}, "entity": {"RL:Spcp": {"duid": "RL:Spcp", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 15, "source": "RLIMS-P", "charStart": 10, "entityId": [], "sentenceIndex": 0, "entityText": "serine"}, "RL:NUZj": {"duid": "RL:NUZj", "attribute": [{"key": "std_site", "value": "Thr-1348"}], "entityType": "Site", "charEnd": 341, "source": "RLIMS-P", "charStart": 334, "entityId": [], "sentenceIndex": 2, "entityText": "Thr-1348"}, "RL:CgNZ": {"duid": "RL:CgNZ", "attribute": [], "entityType": "Protein", "charEnd": 702, "source": "RLIMS-P", "charStart": 690, "entityId": [], "sentenceIndex": 5, "entityText": "insulin/IGF-I"}, "RL:hMH5": {"duid": "RL:hMH5", "attribute": [], "entityType": "Trigger", "charEnd": 313, "source": "RLIMS-P", "charStart": 298, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:tEP4": {"duid": "RL:tEP4", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 606, "source": "RLIMS-P", "charStart": 601, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:E8pp": {"duid": "RL:E8pp", "attribute": [], "entityType": "Trigger", "charEnd": 31, "source": "RLIMS-P", "charStart": 17, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:ZTWE": {"duid": "RL:ZTWE", "attribute": [], "entityType": "Trigger", "charEnd": 233, "source": "RLIMS-P", "charStart": 219, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:J8pR": {"duid": "RL:J8pR", "attribute": [], "entityType": "Protein", "charEnd": 202, "source": "RLIMS-P", "charStart": 200, "entityId": [], "sentenceIndex": 2, "entityText": "PMA"}, "RL:RKCN": {"duid": "RL:RKCN", "attribute": [], "entityType": "Trigger", "charEnd": 800, "source": "RLIMS-P", "charStart": 786, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:FTm6": {"duid": "RL:FTm6", "attribute": [], "entityType": "Trigger", "charEnd": 111, "source": "RLIMS-P", "charStart": 97, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:SXo7": {"duid": "RL:SXo7", "attribute": [], "entityType": "Protein", "charEnd": 710, "source": "RLIMS-P", "charStart": 708, "entityId": [], "sentenceIndex": 5, "entityText": "PMA"}, "RL:QLq3": {"duid": "RL:QLq3", "attribute": [], "entityType": "Trigger", "charEnd": 606, "source": "RLIMS-P", "charStart": 594, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:4JXH": {"duid": "RL:4JXH", "attribute": [], "entityType": "Protein", "charEnd": 532, "source": "RLIMS-P", "charStart": 530, "entityId": [], "sentenceIndex": 4, "entityText": "PMA"}, "RL:GF7y": {"duid": "RL:GF7y", "attribute": [], "entityType": "Trigger", "charEnd": 431, "source": "RLIMS-P", "charStart": 419, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:XjMS": {"duid": "RL:XjMS", "attribute": [], "entityType": "Protein", "charEnd": 592, "source": "RLIMS-P", "charStart": 579, "entityId": [], "sentenceIndex": 4, "entityText": "IGF-I receptor"}, "RL:DXpi": {"duid": "RL:DXpi", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 95, "source": "RLIMS-P", "charStart": 90, "entityId": [], "sentenceIndex": 1, "entityText": "Serine"}, "RL:WC6t": {"duid": "RL:WC6t", "attribute": [], "entityType": "Trigger", "charEnd": 378, "source": "RLIMS-P", "charStart": 366, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:hZQv": {"duid": "RL:hZQv", "attribute": [], "entityType": "Trigger", "charEnd": 559, "source": "RLIMS-P", "charStart": 545, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:y6Ns": {"duid": "RL:y6Ns", "attribute": [], "entityType": "Protein", "charEnd": 46, "source": "RLIMS-P", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "insulin"}, "RL:bdgz": {"duid": "RL:bdgz", "attribute": [], "entityType": "Protein", "charEnd": 264, "source": "RLIMS-P", "charStart": 249, "entityId": [], "sentenceIndex": 2, "entityText": "insulin receptor"}, "RL:WSJX": {"duid": "RL:WSJX", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 518, "source": "RLIMS-P", "charStart": 513, "entityId": [], "sentenceIndex": 3, "entityText": "serine"}, "RL:pJsA": {"duid": "RL:pJsA", "attribute": [], "entityType": "Trigger", "charEnd": 736, "source": "RLIMS-P", "charStart": 722, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:Y4vF": {"duid": "RL:Y4vF", "attribute": [], "entityType": "Trigger", "charEnd": 280, "source": "RLIMS-P", "charStart": 266, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:VWc9": {"duid": "RL:VWc9", "attribute": [], "entityType": "SiteOther", "charEnd": 280, "source": "RLIMS-P", "charStart": 266, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:QWkm": {"duid": "RL:QWkm", "attribute": [], "entityType": "Trigger", "charEnd": 518, "source": "RLIMS-P", "charStart": 506, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:UHPA": {"duid": "RL:UHPA", "attribute": [], "entityType": "Protein", "charEnd": 138, "source": "RLIMS-P", "charStart": 116, "entityId": [], "sentenceIndex": 1, "entityText": "insulin/IGF-I receptors"}, "RL:AnTg": {"duid": "RL:AnTg", "attribute": [], "entityType": "Trigger", "charEnd": 639, "source": "RLIMS-P", "charStart": 626, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:ZUp7": {"duid": "RL:ZUp7", "attribute": [], "entityType": "SiteOther", "charEnd": 754, "source": "RLIMS-P", "charStart": 750, "entityId": [], "sentenceIndex": 5, "entityText": "sites"}}, "mesh": ["Animals", "Cell Line", "Fibroblasts", "Insulin", "Insulin-Like Growth Factor I", "Peptide Mapping", "Phosphorylation", "Receptor, Insulin", "Receptors, Cell Surface", "Receptors, Somatomedin", "Serine", "Tetradecanoylphorbol Acetate", "Threonine", "Transfection"], "relation": {"RL:p7ES": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:WC6t"}], "duid": "RL:p7ES"}, "RL:6PJf": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:bdgz"}, {"role": "INDUCER", "entity_duid": "RL:J8pR"}, {"role": "SITE", "entity_duid": "RL:NUZj"}, {"role": "SITE_OTHER", "entity_duid": "RL:VWc9"}, {"role": "TRIGGER", "entity_duid": "RL:ZTWE"}], "duid": "RL:6PJf"}, "RL:VbKX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XjMS"}, {"role": "SITE", "entity_duid": "RL:tEP4"}, {"role": "TRIGGER", "entity_duid": "RL:QLq3"}], "duid": "RL:VbKX"}, "RL:SyTy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:hMH5"}], "duid": "RL:SyTy"}, "RL:P5pg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:y6Ns"}, {"role": "SITE", "entity_duid": "RL:Spcp"}, {"role": "TRIGGER", "entity_duid": "RL:E8pp"}], "duid": "RL:P5pg"}, "RL:Jups": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:bdgz"}, {"role": "INDUCER", "entity_duid": "RL:SXo7"}, {"role": "INDUCER", "entity_duid": "RL:CgNZ"}, {"role": "SITE", "entity_duid": "RL:WSJX"}, {"role": "SITE_OTHER", "entity_duid": "RL:ZUp7"}, {"role": "TRIGGER", "entity_duid": "RL:pJsA"}], "duid": "RL:Jups"}, "RL:QCxV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "INDUCER", "entity_duid": "RL:bdgz"}, {"role": "SITE_OTHER", "entity_duid": "RL:VWc9"}, {"role": "TRIGGER", "entity_duid": "RL:Y4vF"}], "duid": "RL:QCxV"}, "RL:thQ4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:UHPA"}, {"role": "SITE", "entity_duid": "RL:DXpi"}, {"role": "TRIGGER", "entity_duid": "RL:FTm6"}], "duid": "RL:thQ4"}, "RL:vVXT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XjMS"}, {"role": "INDUCER", "entity_duid": "RL:4JXH"}, {"role": "SITE", "entity_duid": "RL:tEP4"}, {"role": "TRIGGER", "entity_duid": "RL:hZQv"}], "duid": "RL:vVXT"}, "RL:QLmV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GF7y"}], "duid": "RL:QLmV"}, "RL:sxVJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:RKCN"}], "duid": "RL:sxVJ"}, "RL:eU8Z": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QWkm"}], "duid": "RL:eU8Z"}, "RL:VWra": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XjMS"}, {"role": "TRIGGER", "entity_duid": "RL:AnTg"}], "duid": "RL:VWra"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "6185481", "sentence": [{"charStart": 0, "charEnd": 87, "index": 0}, {"index": 1, "charEnd": 539, "charStart": 89}, {"index": 2, "charEnd": 767, "charStart": 541}, {"index": 3, "charEnd": 945, "charStart": 769}, {"index": 4, "charEnd": 1145, "charStart": 947}, {"index": 5, "charEnd": 1259, "charStart": 1147}, {"index": 6, "charEnd": 1367, "charStart": 1261}, {"index": 7, "charEnd": 1450, "charStart": 1369}, {"index": 8, "charEnd": 1597, "charStart": 1452}, {"index": 9, "charEnd": 1681, "charStart": 1599}, {"index": 10, "charEnd": 1824, "charStart": 1683}, {"index": 11, "charEnd": 1986, "charStart": 1826}], "text": "Identification of multiple in vivo phosphorylation sites in rabbit myelin basic protein. Myelin basic protein of rabbit brain (Mr = 18,200) was initially freed of the bulk of the nonphosphorylated species (mainly component 1) by Cm-cellulose chromatography at high pH. The remainder of the protein was subjected to peptic digestion at pH 6.00, which resulted in specific, essentially complete cleavage at several bonds (Phe-44--Phe-45, Phe-87--Phe-88, Leu-109--Ser-110, and Leu-151--Phe-152) and partial cleavage at the Tyr-14--Leu-15 bond. Gel filtration of the digest through Sephadex G-25 (fine) yielded three fractions, the first containing primarily peptides 1-44 and 45-87, the second peptides 15-44, 88-109, and 110-151, and the third peptides 1-14 and 152-168. Each fraction was chromatographed on Cm-cellulose at pH 8.2, and the resulting subfractions and partially purified peptides were analyzed for phosphoserine and phosphothreonine. Materials containing significant amounts of the phosphoamino acids were subsequently chromatographed on Cm-cellulose at pH 4.65, and the analyses for phosphoserine and phosphothreonine were repeated. The resulting purified peptic phosphopeptides were identified by amino acid analysis and tryptic peptide mapping. Comparison of the maps with those of the unphosphorylated counterparts located the tryptic phosphopeptides. These were recovered and their identities were established by amino acid analysis. In those cases where the phosphopeptide contained 2 Ser residues, the position of the phosphoserine was established by aminopeptidase M digestion. Five phosphorylation sites were found: Ser-7, Ser-56, Thr-96, Ser-113, and Ser-163. Only a small fraction of these sites was phosphorylated in the total basic protein, with values ranging from about 2 (ser-113) to 6% (Thr-96). With the possible exception of Ser-56, these sites are not the ones that have been reported to be phosphorylated in vitro by cyclic AMP-dependent protein kinase.", "title": {"charStart": 0, "charEnd": 87}, "entity": {"RL:MRbb": {"duid": "RL:MRbb", "attribute": [{"key": "std_site", "value": "Ser-113"}], "entityType": "Site", "charEnd": 1807, "source": "RLIMS-P", "charStart": 1801, "entityId": [], "sentenceIndex": 10, "entityText": "ser-113"}, "RL:AtAV": {"duid": "RL:AtAV", "attribute": [], "entityType": "Trigger", "charEnd": 1366, "source": "RLIMS-P", "charStart": 1352, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:dsTe": {"duid": "RL:dsTe", "attribute": [], "entityType": "Protein", "charEnd": 86, "source": "RLIMS-P", "charStart": 60, "entityId": [], "sentenceIndex": 0, "entityText": "rabbit myelin basic protein"}, "RL:kWFF": {"duid": "RL:kWFF", "attribute": [], "entityType": "SiteOther", "charEnd": 1490, "source": "RLIMS-P", "charStart": 1477, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:wNRM": {"duid": "RL:wNRM", "attribute": [], "entityType": "Trigger", "charEnd": 1618, "source": "RLIMS-P", "charStart": 1604, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:bnFU": {"duid": "RL:bnFU", "attribute": [{"key": "std_site", "value": "Thr-96"}], "entityType": "Site", "charEnd": 1658, "source": "RLIMS-P", "charStart": 1653, "entityId": [], "sentenceIndex": 9, "entityText": "Thr-96"}, "RL:mRfU": {"duid": "RL:mRfU", "attribute": [], "entityType": "Trigger", "charEnd": 1490, "source": "RLIMS-P", "charStart": 1477, "entityId": [], "sentenceIndex": 8, "entityText": "phosphopeptide"}, "RL:nSYE": {"duid": "RL:nSYE", "attribute": [], "entityType": "SiteOther", "charEnd": 1718, "source": "RLIMS-P", "charStart": 1714, "entityId": [], "sentenceIndex": 10, "entityText": "sites"}, "RL:Xe4n": {"duid": "RL:Xe4n", "attribute": [], "entityType": "Protein", "charEnd": 1985, "source": "RLIMS-P", "charStart": 1958, "entityId": [], "sentenceIndex": 11, "entityText": "AMP-dependent protein kinase"}, "RL:3Rzf": {"duid": "RL:3Rzf", "attribute": [{"key": "std_site", "value": "Ser-163"}], "entityType": "Site", "charEnd": 1680, "source": "RLIMS-P", "charStart": 1674, "entityId": [], "sentenceIndex": 9, "entityText": "Ser-163"}, "RL:2Ka9": {"duid": "RL:2Ka9", "attribute": [], "entityType": "Trigger", "charEnd": 1191, "source": "RLIMS-P", "charStart": 1177, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:rHuJ": {"duid": "RL:rHuJ", "attribute": [], "entityType": "SiteOther", "charEnd": 55, "source": "RLIMS-P", "charStart": 35, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation sites"}, "RL:Rdc6": {"duid": "RL:Rdc6", "attribute": [], "entityType": "Trigger", "charEnd": 1550, "source": "RLIMS-P", "charStart": 1538, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserine"}, "RL:wwwY": {"duid": "RL:wwwY", "attribute": [], "entityType": "Protein", "charEnd": 108, "source": "RLIMS-P", "charStart": 89, "entityId": [], "sentenceIndex": 1, "entityText": "Myelin basic protein"}, "RL:F99G": {"duid": "RL:F99G", "attribute": [], "entityType": "Trigger", "charEnd": 1937, "source": "RLIMS-P", "charStart": 1924, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylated"}, "RL:ri4z": {"duid": "RL:ri4z", "attribute": [{"key": "std_site", "value": "Ser-7"}], "entityType": "Site", "charEnd": 1642, "source": "RLIMS-P", "charStart": 1638, "entityId": [], "sentenceIndex": 9, "entityText": "Ser-7"}, "RL:rNAM": {"duid": "RL:rNAM", "attribute": [], "entityType": "Trigger", "charEnd": 923, "source": "RLIMS-P", "charStart": 911, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:nVrh": {"duid": "RL:nVrh", "attribute": [], "entityType": "SiteOther", "charEnd": 1191, "source": "RLIMS-P", "charStart": 1177, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:qmPr": {"duid": "RL:qmPr", "attribute": [], "entityType": "Trigger", "charEnd": 1737, "source": "RLIMS-P", "charStart": 1724, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylated"}, "RL:K9uG": {"duid": "RL:K9uG", "attribute": [{"key": "std_site", "value": "Ser-113"}], "entityType": "Site", "charEnd": 1667, "source": "RLIMS-P", "charStart": 1661, "entityId": [], "sentenceIndex": 9, "entityText": "Ser-113"}, "RL:L2b9": {"duid": "RL:L2b9", "attribute": [], "entityType": "Trigger", "charEnd": 49, "source": "RLIMS-P", "charStart": 35, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:zLw6": {"duid": "RL:zLw6", "attribute": [], "entityType": "SiteOther", "charEnd": 1366, "source": "RLIMS-P", "charStart": 1352, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:BSy6": {"duid": "RL:BSy6", "attribute": [{"key": "std_site", "value": "Ser-56"}], "entityType": "Site", "charEnd": 1650, "source": "RLIMS-P", "charStart": 1645, "entityId": [], "sentenceIndex": 9, "entityText": "Ser-56"}, "RL:TwC7": {"duid": "RL:TwC7", "attribute": [], "entityType": "Trigger", "charEnd": 1109, "source": "RLIMS-P", "charStart": 1097, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:Zciw": {"duid": "RL:Zciw", "attribute": [], "entityType": "SiteOther", "charEnd": 1624, "source": "RLIMS-P", "charStart": 1604, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation sites"}}, "mesh": ["Amino Acid Sequence", "Animals", "Brain Chemistry", "Chromatography, Thin Layer", "Electrophoresis, Polyacrylamide Gel", "Myelin Basic Protein", "Peptide Fragments", "Phosphorylation", "Rabbits", "Trypsin"], "relation": {"RL:FBJm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Rdc6"}], "duid": "RL:FBJm"}, "RL:EbCn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kWFF"}, {"role": "TRIGGER", "entity_duid": "RL:mRfU"}], "duid": "RL:EbCn"}, "RL:4nRt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:TwC7"}], "duid": "RL:4nRt"}, "RL:H4W6": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:wwwY"}, {"role": "KINASE", "entity_duid": "RL:Xe4n"}, {"role": "SITE", "entity_duid": "RL:MRbb"}, {"role": "TRIGGER", "entity_duid": "RL:F99G"}], "duid": "RL:H4W6"}, "RL:QhGj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:rNAM"}], "duid": "RL:QhGj"}, "RL:5ZpB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:dsTe"}, {"role": "SITE_OTHER", "entity_duid": "RL:rHuJ"}, {"role": "TRIGGER", "entity_duid": "RL:L2b9"}], "duid": "RL:5ZpB"}, "RL:cJFq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nVrh"}, {"role": "TRIGGER", "entity_duid": "RL:2Ka9"}], "duid": "RL:cJFq"}, "RL:YXjV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:wwwY"}, {"role": "SITE", "entity_duid": "RL:ri4z"}, {"role": "SITE", "entity_duid": "RL:3Rzf"}, {"role": "SITE", "entity_duid": "RL:K9uG"}, {"role": "SITE", "entity_duid": "RL:bnFU"}, {"role": "SITE", "entity_duid": "RL:BSy6"}, {"role": "SITE_OTHER", "entity_duid": "RL:nSYE"}, {"role": "TRIGGER", "entity_duid": "RL:qmPr"}], "duid": "RL:YXjV"}, "RL:9JK5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:zLw6"}, {"role": "TRIGGER", "entity_duid": "RL:AtAV"}], "duid": "RL:9JK5"}, "RL:vUwz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Zciw"}, {"role": "TRIGGER", "entity_duid": "RL:wNRM"}], "duid": "RL:vUwz"}}, "type": ["Journal Article"]}
{"docId": "16372258", "sentence": [{"charStart": 0, "charEnd": 168, "index": 0}, {"index": 1, "charEnd": 278, "charStart": 170}, {"index": 2, "charEnd": 378, "charStart": 280}, {"index": 3, "charEnd": 491, "charStart": 380}, {"index": 4, "charEnd": 646, "charStart": 493}, {"index": 5, "charEnd": 876, "charStart": 648}, {"index": 6, "charEnd": 1128, "charStart": 878}, {"index": 7, "charEnd": 1343, "charStart": 1130}], "text": "Chemical derivatization of phosphoserine and phosphothreonine containing peptides to increase sensitivity for MALDI-based analysis and for selectivity of MS/MS analysis. Protein phosphorylation is one of the most important and common ways of regulating protein function in cells. However, phosphopeptides are difficult to analyse, ionising poorly under standard MALDI conditions. Several methods have been developed to deal with the low sensitivity and specificity of phosphopeptide analysis. Here, we show an approach using a simple one-step beta-elimination/Michael addition reaction for the derivatization of phosphoserine and phosphothreonine. The substitution of the negatively charged phosphate group by a positively charged S-ethylpyridyl group greatly improves the ionisation of the modified peptides, especially in MALDI MS, increasing the sensitivity of the analysis. The modification allows the formation of a unique fragment ion at m/z 106 under mild collisional activation conditions, which can be used for parent (precursor) ion scanning in order to improve both the sensitivity and the selectivity of the analysis. The optimisation of the approach is described for a standard model peptide and protein and then applied to phosphorylation analysis in two biologically derived proteins purified from different experimental systems.", "title": {"charStart": 0, "charEnd": 168}, "entity": {"RL:tsp5": {"duid": "RL:tsp5", "attribute": [], "entityType": "Trigger", "charEnd": 192, "source": "RLIMS-P", "charStart": 178, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:LeZK": {"duid": "RL:LeZK", "attribute": [], "entityType": "Trigger", "charEnd": 624, "source": "RLIMS-P", "charStart": 612, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:ZeRd": {"duid": "RL:ZeRd", "attribute": [], "entityType": "Trigger", "charEnd": 1251, "source": "RLIMS-P", "charStart": 1237, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:9ugR": {"duid": "RL:9ugR", "attribute": [], "entityType": "Trigger", "charEnd": 39, "source": "RLIMS-P", "charStart": 27, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:zqiq": {"duid": "RL:zqiq", "attribute": [], "entityType": "Trigger", "charEnd": 303, "source": "RLIMS-P", "charStart": 289, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:Gq85": {"duid": "RL:Gq85", "attribute": [], "entityType": "SiteOther", "charEnd": 303, "source": "RLIMS-P", "charStart": 289, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}}, "mesh": ["3',5'-Cyclic-AMP Phosphodiesterases", "Adipocytes", "Animals", "Caseins", "Cyclic Nucleotide Phosphodiesterases, Type 3", "Immunoprecipitation", "Male", "Peptide Mapping", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Rats", "Rats, Sprague-Dawley", "Sensitivity and Specificity", "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"], "relation": {"RL:vVmp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZeRd"}], "duid": "RL:vVmp"}, "RL:2WDL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tsp5"}], "duid": "RL:2WDL"}, "RL:EWP8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9ugR"}], "duid": "RL:EWP8"}, "RL:4XFG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LeZK"}], "duid": "RL:4XFG"}, "RL:FXXT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Gq85"}, {"role": "TRIGGER", "entity_duid": "RL:zqiq"}], "duid": "RL:FXXT"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "3848433", "sentence": [{"charStart": 0, "charEnd": 88, "index": 0}, {"index": 1, "charEnd": 343, "charStart": 90}, {"index": 2, "charEnd": 512, "charStart": 345}, {"index": 3, "charEnd": 624, "charStart": 514}, {"index": 4, "charEnd": 809, "charStart": 626}, {"index": 5, "charEnd": 939, "charStart": 811}, {"index": 6, "charEnd": 1023, "charStart": 941}, {"index": 7, "charEnd": 1361, "charStart": 1025}, {"index": 8, "charEnd": 1537, "charStart": 1363}, {"index": 9, "charEnd": 1791, "charStart": 1539}, {"index": 10, "charEnd": 1985, "charStart": 1793}, {"index": 11, "charEnd": 2186, "charStart": 1987}, {"index": 12, "charEnd": 2272, "charStart": 2188}, {"index": 13, "charEnd": 2597, "charStart": 2274}, {"index": 14, "charEnd": 2630, "charStart": 2598}], "text": "Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. Phosphorylation of the insulin receptor was studied in intact well differentiated hepatoma cells (Fao) and in a solubilized and partially purified receptor preparation obtained from these cells by affinity chromatography on wheat germ agglutinin agarose. Tryptic peptides containing the phosphorylation sites of the beta-subunit of the insulin receptor were analyzed by reverse-phase high performance liquid chromatography. Phosphoamino acid content of these peptides was determined by acid hydrolysis and high voltage electrophoresis. Separation of the phosphopeptides from unstimulated Fao cells revealed one major and two minor phosphoserine-containing peptides and a single minor phosphothreonine-containing peptide. Insulin (10(-7) M) increased the phosphorylation of the beta-subunit of the insulin receptor 3- to 4-fold in the intact Fao cell. After insulin stimulation, two phosphotyrosine-containing peptides were identified. Tyrosine phosphorylation reached a steady state within 20 s after the addition of insulin and remained nearly constant for 1 h. Under our experimental conditions, no significant change in the amount of [32P]phosphoserine or [32P]phosphothreonine associated with the beta-subunit was found during the initial response of cells to insulin. When the insulin receptor was extracted from the Fao cells and incubated in vitro with [gamma-32P]ATP and Mn2+, very little phosphorylation occurred in the absence of insulin. In this preparation, insulin rapidly stimulated autophosphorylation of the receptor on tyrosine residues only and high performance liquid chromatography analysis of the beta-subunit digested with trypsin revealed one minor and two major phosphopeptides. The elution position of the minor peptide corresponded to that of the major phosphotyrosine-containing peptide obtained from the beta-subunit of the insulin-stimulated receptor labeled in vivo. In contrast, the elution position of one of the major phosphopeptides that occurred during in vitro phosphorylation corresponded to the minor phosphotyrosine-containing peptide phosphorylated in vivo. The other major in vitro phosphotyrosine-containing peptide was not detected in vivo. Our results indicate that: tyrosine phosphorylation of the insulin receptor occurs rapidly following insulin binding to intact cells; the level of tyrosine phosphorylation remains constant for up to 1 h; the specificity of the receptor kinase or accessibility of the phosphorylation sites are different in vivo and in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)", "title": {"charStart": 0, "charEnd": 88}, "entity": {"RL:JCcD": {"duid": "RL:JCcD", "attribute": [], "entityType": "Trigger", "charEnd": 2101, "source": "RLIMS-P", "charStart": 2087, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation"}, "RL:gbfV": {"duid": "RL:gbfV", "attribute": [], "entityType": "Trigger", "charEnd": 2555, "source": "RLIMS-P", "charStart": 2541, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation"}, "RL:NstD": {"duid": "RL:NstD", "attribute": [], "entityType": "Trigger", "charEnd": 42, "source": "RLIMS-P", "charStart": 28, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:U7j8": {"duid": "RL:U7j8", "attribute": [], "entityType": "Protein", "charEnd": 2348, "source": "RLIMS-P", "charStart": 2333, "entityId": [], "sentenceIndex": 13, "entityText": "insulin receptor"}, "RL:V2Gq": {"duid": "RL:V2Gq", "attribute": [], "entityType": "Trigger", "charEnd": 733, "source": "RLIMS-P", "charStart": 721, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:ovaC": {"duid": "RL:ovaC", "attribute": [], "entityType": "SiteOther", "charEnd": 1790, "source": "RLIMS-P", "charStart": 1776, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:tTtR": {"duid": "RL:tTtR", "attribute": [], "entityType": "Trigger", "charEnd": 2143, "source": "RLIMS-P", "charStart": 2129, "entityId": [], "sentenceIndex": 11, "entityText": "phosphotyrosine"}, "RL:c5FT": {"duid": "RL:c5FT", "attribute": [], "entityType": "Trigger", "charEnd": 1501, "source": "RLIMS-P", "charStart": 1487, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:cNjT": {"duid": "RL:cNjT", "attribute": [], "entityType": "Trigger", "charEnd": 789, "source": "RLIMS-P", "charStart": 774, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:VNJb": {"duid": "RL:VNJb", "attribute": [], "entityType": "SiteOther", "charEnd": 658, "source": "RLIMS-P", "charStart": 644, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:AgRM": {"duid": "RL:AgRM", "attribute": [], "entityType": "Trigger", "charEnd": 1605, "source": "RLIMS-P", "charStart": 1587, "entityId": [], "sentenceIndex": 9, "entityText": "autophosphorylation"}, "RL:65zF": {"duid": "RL:65zF", "attribute": [], "entityType": "Trigger", "charEnd": 2444, "source": "RLIMS-P", "charStart": 2430, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation"}, "RL:5CTg": {"duid": "RL:5CTg", "attribute": [], "entityType": "Trigger", "charEnd": 2055, "source": "RLIMS-P", "charStart": 2041, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:er38": {"duid": "RL:er38", "attribute": [], "entityType": "SiteOther", "charEnd": 397, "source": "RLIMS-P", "charStart": 377, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation sites"}, "RL:e48p": {"duid": "RL:e48p", "attribute": [], "entityType": "Trigger", "charEnd": 2227, "source": "RLIMS-P", "charStart": 2213, "entityId": [], "sentenceIndex": 12, "entityText": "phosphotyrosine"}, "RL:79xc": {"duid": "RL:79xc", "attribute": [], "entityType": "Trigger", "charEnd": 658, "source": "RLIMS-P", "charStart": 644, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:bcSS": {"duid": "RL:bcSS", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 2308, "source": "RLIMS-P", "charStart": 2301, "entityId": [], "sentenceIndex": 13, "entityText": "tyrosine"}, "RL:VLdQ": {"duid": "RL:VLdQ", "attribute": [], "entityType": "SiteOther", "charEnd": 23, "source": "RLIMS-P", "charStart": 19, "entityId": [], "sentenceIndex": 0, "entityText": "sites"}, "RL:zYQV": {"duid": "RL:zYQV", "attribute": [], "entityType": "Trigger", "charEnd": 2324, "source": "RLIMS-P", "charStart": 2310, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation"}, "RL:Nxni": {"duid": "RL:Nxni", "attribute": [], "entityType": "SiteOther", "charEnd": 2561, "source": "RLIMS-P", "charStart": 2541, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation sites"}, "RL:pp6P": {"duid": "RL:pp6P", "attribute": [], "entityType": "Protein", "charEnd": 904, "source": "RLIMS-P", "charStart": 887, "entityId": [], "sentenceIndex": 5, "entityText": "insulin receptor 3"}, "RL:X2XM": {"duid": "RL:X2XM", "attribute": [], "entityType": "Protein", "charEnd": 128, "source": "RLIMS-P", "charStart": 113, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}, "RL:smWL": {"duid": "RL:smWL", "attribute": [], "entityType": "Trigger", "charEnd": 391, "source": "RLIMS-P", "charStart": 377, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:sBon": {"duid": "RL:sBon", "attribute": [], "entityType": "Trigger", "charEnd": 2177, "source": "RLIMS-P", "charStart": 2164, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylated"}, "RL:3CgQ": {"duid": "RL:3CgQ", "attribute": [], "entityType": "Trigger", "charEnd": 1790, "source": "RLIMS-P", "charStart": 1776, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptides"}, "RL:iRD7": {"duid": "RL:iRD7", "attribute": [], "entityType": "Protein", "charEnd": 827, "source": "RLIMS-P", "charStart": 820, "entityId": [], "sentenceIndex": 5, "entityText": "10(-7) M"}, "RL:Boqv": {"duid": "RL:Boqv", "attribute": [], "entityType": "Trigger", "charEnd": 104, "source": "RLIMS-P", "charStart": 90, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphorylation"}, "RL:75M4": {"duid": "RL:75M4", "attribute": [], "entityType": "Trigger", "charEnd": 1244, "source": "RLIMS-P", "charStart": 1232, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}, "RL:Hvgo": {"duid": "RL:Hvgo", "attribute": [], "entityType": "Trigger", "charEnd": 1883, "source": "RLIMS-P", "charStart": 1869, "entityId": [], "sentenceIndex": 10, "entityText": "phosphotyrosine"}, "RL:oHa5": {"duid": "RL:oHa5", "attribute": [], "entityType": "Trigger", "charEnd": 1048, "source": "RLIMS-P", "charStart": 1034, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:4oMY": {"duid": "RL:4oMY", "attribute": [], "entityType": "Trigger", "charEnd": 986, "source": "RLIMS-P", "charStart": 972, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:j9ha": {"duid": "RL:j9ha", "attribute": [], "entityType": "Protein", "charEnd": 66, "source": "RLIMS-P", "charStart": 51, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptor"}, "RL:agT9": {"duid": "RL:agT9", "attribute": [], "entityType": "Protein", "charEnd": 817, "source": "RLIMS-P", "charStart": 811, "entityId": [], "sentenceIndex": 5, "entityText": "Insulin"}, "RL:uiWm": {"duid": "RL:uiWm", "attribute": [], "entityType": "SiteOther", "charEnd": 2055, "source": "RLIMS-P", "charStart": 2031, "entityId": [], "sentenceIndex": 11, "entityText": "the major phosphopeptides"}, "RL:benr": {"duid": "RL:benr", "attribute": [], "entityType": "Protein", "charEnd": 441, "source": "RLIMS-P", "charStart": 426, "entityId": [], "sentenceIndex": 2, "entityText": "insulin receptor"}, "RL:deYa": {"duid": "RL:deYa", "attribute": [], "entityType": "SiteOther", "charEnd": 2055, "source": "RLIMS-P", "charStart": 2041, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:y57s": {"duid": "RL:y57s", "attribute": [], "entityType": "Trigger", "charEnd": 858, "source": "RLIMS-P", "charStart": 844, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}}, "mesh": ["Amino Acids", "Animals", "Cell Line", "Kinetics", "Liver Neoplasms, Experimental", "Peptide Fragments", "Phosphorus Radioisotopes", "Phosphorylation", "Rats", "Receptor, Insulin", "Trypsin", "Vanadates", "Vanadium"], "relation": {"RL:GP3w": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:V2Gq"}], "duid": "RL:GP3w"}, "RL:JQXC": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:e48p"}], "duid": "RL:JQXC"}, "RL:iLkY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:cNjT"}], "duid": "RL:iLkY"}, "RL:8yT7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:75M4"}], "duid": "RL:8yT7"}, "RL:K4jH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sBon"}], "duid": "RL:K4jH"}, "RL:WSnU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ovaC"}, {"role": "TRIGGER", "entity_duid": "RL:3CgQ"}], "duid": "RL:WSnU"}, "RL:C5JW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:X2XM"}, {"role": "TRIGGER", "entity_duid": "RL:Boqv"}], "duid": "RL:C5JW"}, "RL:fnS7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:deYa"}, {"role": "TRIGGER", "entity_duid": "RL:5CTg"}], "duid": "RL:fnS7"}, "RL:Zixa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:benr"}, {"role": "SITE_OTHER", "entity_duid": "RL:er38"}, {"role": "TRIGGER", "entity_duid": "RL:smWL"}], "duid": "RL:Zixa"}, "RL:k9yR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:tTtR"}], "duid": "RL:k9yR"}, "RL:BSXT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JCcD"}], "duid": "RL:BSXT"}, "RL:BiVv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:VNJb"}, {"role": "TRIGGER", "entity_duid": "RL:79xc"}], "duid": "RL:BiVv"}, "RL:YrLi": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:j9ha"}, {"role": "SITE_OTHER", "entity_duid": "RL:VLdQ"}, {"role": "TRIGGER", "entity_duid": "RL:NstD"}], "duid": "RL:YrLi"}, "RL:xvtM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:AgRM"}], "duid": "RL:xvtM"}, "RL:LHP5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:uiWm"}, {"role": "SITE_OTHER", "entity_duid": "RL:Nxni"}, {"role": "TRIGGER", "entity_duid": "RL:gbfV"}], "duid": "RL:LHP5"}, "RL:pWoE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:c5FT"}], "duid": "RL:pWoE"}, "RL:MvSW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4oMY"}], "duid": "RL:MvSW"}, "RL:qaes": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:pp6P"}, {"role": "INDUCER", "entity_duid": "RL:agT9"}, {"role": "INDUCER", "entity_duid": "RL:iRD7"}, {"role": "TRIGGER", "entity_duid": "RL:y57s"}], "duid": "RL:qaes"}, "RL:b7SQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:oHa5"}], "duid": "RL:b7SQ"}, "RL:jqyK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Hvgo"}], "duid": "RL:jqyK"}, "RL:s6F8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:U7j8"}, {"role": "SITE", "entity_duid": "RL:bcSS"}, {"role": "TRIGGER", "entity_duid": "RL:zYQV"}], "duid": "RL:s6F8"}, "RL:37wW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:65zF"}], "duid": "RL:37wW"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "16242953", "sentence": [{"charStart": 0, "charEnd": 162, "index": 0}, {"index": 1, "charEnd": 290, "charStart": 164}, {"index": 2, "charEnd": 521, "charStart": 292}, {"index": 3, "charEnd": 613, "charStart": 523}, {"index": 4, "charEnd": 799, "charStart": 615}, {"index": 5, "charEnd": 889, "charStart": 801}, {"index": 6, "charEnd": 1059, "charStart": 891}, {"index": 7, "charEnd": 1189, "charStart": 1061}], "text": "Manipulating the fragmentation patterns of phosphopeptides via gas-phase boron derivatization: determining phosphorylation sites in peptides with multiple serines. Trivalent boron species readily react with protonated phosphopeptides to give addition products with the loss of boron ligands. In the present study, trimethoxyborane (TMB), diisopropoxymethylborane (DIPM), and diethylmethoxyborane (DEMB) were allowed to react with four phosphopeptides, VsSF, LSsF, LsGASA, and VSGAsA (lower-case s indicates phosphoserine). Each of the phosphopeptides contains one serine that is phosphorylated and one that is not. Under collision-activated dissociation (CAD) conditions, the boron-derivatized peptides give fragmentation patterns that differ significantly from that of the protonated phosphopeptide. The patterns vary, depending on the number of labile (i.e., alkoxy) ligands on the boron. In general, boron derivatization increases the yield of phosphate-containing sequence ions, but dramatic effects are only seen with certain reagent/peptide combinations. However, the suite of reagents provides a means of altering and increasing the information content of phosphopeptide CAD spectra.", "title": {"charStart": 0, "charEnd": 162}, "entity": {"RL:7PjM": {"duid": "RL:7PjM", "attribute": [], "entityType": "SiteOther", "charEnd": 139, "source": "RLIMS-P", "charStart": 132, "entityId": [], "sentenceIndex": 0, "entityText": "peptides"}, "RL:9ybN": {"duid": "RL:9ybN", "attribute": [], "entityType": "Trigger", "charEnd": 549, "source": "RLIMS-P", "charStart": 535, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:LNZm": {"duid": "RL:LNZm", "attribute": [], "entityType": "Trigger", "charEnd": 519, "source": "RLIMS-P", "charStart": 507, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:Ertm": {"duid": "RL:Ertm", "attribute": [], "entityType": "SiteOther", "charEnd": 549, "source": "RLIMS-P", "charStart": 535, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:pAgC": {"duid": "RL:pAgC", "attribute": [], "entityType": "Trigger", "charEnd": 57, "source": "RLIMS-P", "charStart": 43, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}, "RL:5pTf": {"duid": "RL:5pTf", "attribute": [], "entityType": "Trigger", "charEnd": 592, "source": "RLIMS-P", "charStart": 579, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:GCw2": {"duid": "RL:GCw2", "attribute": [], "entityType": "SiteOther", "charEnd": 127, "source": "RLIMS-P", "charStart": 107, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation sites"}, "RL:dGEH": {"duid": "RL:dGEH", "attribute": [], "entityType": "SiteOther", "charEnd": 798, "source": "RLIMS-P", "charStart": 785, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:8kVQ": {"duid": "RL:8kVQ", "attribute": [], "entityType": "SiteOther", "charEnd": 232, "source": "RLIMS-P", "charStart": 218, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:7kxi": {"duid": "RL:7kxi", "attribute": [], "entityType": "Trigger", "charEnd": 121, "source": "RLIMS-P", "charStart": 107, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:apTN": {"duid": "RL:apTN", "attribute": [], "entityType": "Trigger", "charEnd": 798, "source": "RLIMS-P", "charStart": 785, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptide"}, "RL:3RR4": {"duid": "RL:3RR4", "attribute": [], "entityType": "Trigger", "charEnd": 232, "source": "RLIMS-P", "charStart": 218, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:c7uy": {"duid": "RL:c7uy", "attribute": [], "entityType": "SiteOther", "charEnd": 57, "source": "RLIMS-P", "charStart": 43, "entityId": [], "sentenceIndex": 0, "entityText": "phosphopeptides"}}, "mesh": ["Algorithms", "Binding Sites", "Boron Compounds", "Gas Chromatography-Mass Spectrometry", "Gases", "Peptide Fragments", "Phase Transition", "Phosphopeptides", "Phosphorylation", "Protein Binding", "Serine", "Spectrometry, Mass, Electrospray Ionization"], "relation": {"RL:6ujd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:dGEH"}, {"role": "TRIGGER", "entity_duid": "RL:apTN"}], "duid": "RL:6ujd"}, "RL:zGNs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8kVQ"}, {"role": "TRIGGER", "entity_duid": "RL:3RR4"}], "duid": "RL:zGNs"}, "RL:tsuQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:GCw2"}, {"role": "SITE_OTHER", "entity_duid": "RL:7PjM"}, {"role": "TRIGGER", "entity_duid": "RL:7kxi"}], "duid": "RL:tsuQ"}, "RL:NRsw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LNZm"}], "duid": "RL:NRsw"}, "RL:igLS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:c7uy"}, {"role": "TRIGGER", "entity_duid": "RL:pAgC"}], "duid": "RL:igLS"}, "RL:DJB3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:5pTf"}], "duid": "RL:DJB3"}, "RL:R2YJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Ertm"}, {"role": "TRIGGER", "entity_duid": "RL:9ybN"}], "duid": "RL:R2YJ"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural"]}
{"docId": "16738478", "sentence": [{"charStart": 0, "charEnd": 75, "index": 0}, {"index": 1, "charEnd": 239, "charStart": 77}, {"index": 2, "charEnd": 412, "charStart": 241}, {"index": 3, "charEnd": 692, "charStart": 414}, {"index": 4, "charEnd": 824, "charStart": 694}, {"index": 5, "charEnd": 1075, "charStart": 826}], "text": "Simultaneous detection of tau phospho-epitopes with haptenylated antibodies. Neurofibrillary tangles as a neuropathological hallmark of Alzheimer's disease are mainly composed of abnormally phosphorylated microtubule-associated protein tau. The present work was primarily focused on the immunohistochemical characterization of recently developed monoclonal antibodies directed against disease-associated epitopes. Anti-phospho-threonine 212/phospho-serine 214 (HPT-1), anti-phospho-threonine 231/phospho-serine 235 (HPT-101) and their biotinylated derivatives were shown to be sensitive markers for the immunohistochemical detection of neuropathological alterations during Alzheimer's disease. Triple carbocyanine immunofluorescence labelling was based on digoxigenylated, fluoresceinated and biotinylated primary antibodies. AT8-immunolabelling of phospho-serine 202 and phospho-threonine 205 combined with HPT-1 and HPT-101-staining revealed similar distribution patterns of the three double-phosphorylated tau epitopes in the neocortex of patients with Alzheimer's disease.", "title": {"charStart": 0, "charEnd": 75}, "entity": {"RL:cJEC": {"duid": "RL:cJEC", "attribute": [], "entityType": "Trigger", "charEnd": 1007, "source": "RLIMS-P", "charStart": 987, "entityId": [], "sentenceIndex": 5, "entityText": "double-phosphorylated"}, "RL:vdZJ": {"duid": "RL:vdZJ", "attribute": [{"key": "std_site", "value": "Ser-202"}], "entityType": "Site", "charEnd": 866, "source": "RLIMS-P", "charStart": 857, "entityId": [], "sentenceIndex": 5, "entityText": "serine 202"}, "RL:mNrY": {"duid": "RL:mNrY", "attribute": [], "entityType": "Trigger", "charEnd": 203, "source": "RLIMS-P", "charStart": 190, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:HdgX": {"duid": "RL:HdgX", "attribute": [{"key": "std_site", "value": "Thr-212"}], "entityType": "Site", "charEnd": 439, "source": "RLIMS-P", "charStart": 427, "entityId": [], "sentenceIndex": 3, "entityText": "threonine 212"}, "RL:gQGF": {"duid": "RL:gQGF", "attribute": [{"key": "std_site", "value": "Thr-205"}], "entityType": "Site", "charEnd": 892, "source": "RLIMS-P", "charStart": 880, "entityId": [], "sentenceIndex": 5, "entityText": "threonine 205"}, "RL:ui6r": {"duid": "RL:ui6r", "attribute": [], "entityType": "Protein", "charEnd": 1011, "source": "RLIMS-P", "charStart": 1009, "entityId": [], "sentenceIndex": 5, "entityText": "tau"}, "RL:mvVU": {"duid": "RL:mvVU", "attribute": [], "entityType": "Trigger", "charEnd": 866, "source": "RLIMS-P", "charStart": 849, "entityId": [], "sentenceIndex": 5, "entityText": "phospho-serine 202"}, "RL:WzMg": {"duid": "RL:WzMg", "attribute": [], "entityType": "Trigger", "charEnd": 439, "source": "RLIMS-P", "charStart": 414, "entityId": [], "sentenceIndex": 3, "entityText": "Anti-phospho-threonine 212"}}, "mesh": ["Alzheimer Disease", "Antibodies, Monoclonal", "Antibody Specificity", "Epitopes", "Humans", "Immunohistochemistry", "Neocortex", "Nerve Tissue Proteins", "Phosphorylation", "Serine", "Threonine", "tau Proteins"], "relation": {"RL:cpCj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:vdZJ"}, {"role": "TRIGGER", "entity_duid": "RL:mvVU"}], "duid": "RL:cpCj"}, "RL:7JWp": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ui6r"}, {"role": "SITE", "entity_duid": "RL:gQGF"}, {"role": "SITE", "entity_duid": "RL:vdZJ"}, {"role": "TRIGGER", "entity_duid": "RL:cJEC"}], "duid": "RL:7JWp"}, "RL:uNSv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:HdgX"}, {"role": "TRIGGER", "entity_duid": "RL:WzMg"}], "duid": "RL:uNSv"}, "RL:GHeP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:mNrY"}], "duid": "RL:GHeP"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "19002654", "sentence": [{"charStart": 0, "charEnd": 125, "index": 0}, {"index": 1, "charEnd": 287, "charStart": 127}, {"index": 2, "charEnd": 535, "charStart": 289}, {"index": 3, "charEnd": 832, "charStart": 537}, {"index": 4, "charEnd": 970, "charStart": 834}, {"index": 5, "charEnd": 1142, "charStart": 972}], "text": "Detection and assignment of phosphoserine and phosphothreonine residues by (13)C- (31)P spin-echo difference NMR spectroscopy. A simple NMR method is presented for the identification and assignment of phosphorylated serine and threonine residues in (13)C- or (13)C/(15)N-labeled proteins. By exploiting modest (~5 Hz) 2- and 3-bond (13)C-(31)P scalar couplings, the aliphatic (1)H-(13)C signals from phosphoserines and phosphothreonines can be detected selectively in a (31)P spin-echo difference constant time (1)H-(13)C HSQC spectrum. Inclusion of the same (31)P spin-echo element within the (13)C frequency editing period of an intraHNCA or HN(CO)CA experiment allows identification of the amide (1)H(N) and (15)N signals of residues (i) for which( 13)C(alpha)(i) or ( 13)C(alpha)(i - 1), respectively, are coupled to a phosphate. Furthermore, (31)P resonance assignments can be obtained by applying selective low power cw (31)P decoupling during the spin-echo period. The approach is demonstrated using a PNT domain containing fragment of the transcription factor Ets-1, phosphorylated in vitro at Thr38 and Ser41 with the MAP kinase ERK2.", "title": {"charStart": 0, "charEnd": 125}, "entity": {"RL:2bhu": {"duid": "RL:2bhu", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 235, "source": "RLIMS-P", "charStart": 227, "entityId": [], "sentenceIndex": 1, "entityText": "threonine"}, "RL:mDjm": {"duid": "RL:mDjm", "attribute": [], "entityType": "Protein", "charEnd": 286, "source": "RLIMS-P", "charStart": 269, "entityId": [], "sentenceIndex": 1, "entityText": "N-labeled proteins"}, "RL:Zaxo": {"duid": "RL:Zaxo", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 221, "source": "RLIMS-P", "charStart": 216, "entityId": [], "sentenceIndex": 1, "entityText": "serine"}, "RL:jXD5": {"duid": "RL:jXD5", "attribute": [], "entityType": "Trigger", "charEnd": 40, "source": "RLIMS-P", "charStart": 28, "entityId": [], "sentenceIndex": 0, "entityText": "phosphoserine"}, "RL:9Uzo": {"duid": "RL:9Uzo", "attribute": [], "entityType": "Trigger", "charEnd": 1088, "source": "RLIMS-P", "charStart": 1075, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:b6f4": {"duid": "RL:b6f4", "attribute": [], "entityType": "Trigger", "charEnd": 413, "source": "RLIMS-P", "charStart": 400, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserines"}, "RL:CchF": {"duid": "RL:CchF", "attribute": [{"key": "std_site", "value": "Thr-38"}], "entityType": "Site", "charEnd": 1106, "source": "RLIMS-P", "charStart": 1102, "entityId": [], "sentenceIndex": 5, "entityText": "Thr38"}, "RL:sgyh": {"duid": "RL:sgyh", "attribute": [], "entityType": "Trigger", "charEnd": 214, "source": "RLIMS-P", "charStart": 201, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:gyuU": {"duid": "RL:gyuU", "attribute": [{"key": "std_site", "value": "Ser-41"}], "entityType": "Site", "charEnd": 1116, "source": "RLIMS-P", "charStart": 1112, "entityId": [], "sentenceIndex": 5, "entityText": "Ser41"}}, "mesh": ["Carbon Isotopes", "Escherichia coli", "Nitrogen Isotopes", "Nuclear Magnetic Resonance, Biomolecular", "Phosphoproteins", "Phosphorus Isotopes", "Phosphoserine", "Phosphothreonine", "Proteins", "Proto-Oncogene Protein c-ets-1"], "relation": {"RL:imKT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jXD5"}], "duid": "RL:imKT"}, "RL:Lgyw": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:mDjm"}, {"role": "SITE", "entity_duid": "RL:Zaxo"}, {"role": "SITE", "entity_duid": "RL:2bhu"}, {"role": "TRIGGER", "entity_duid": "RL:sgyh"}], "duid": "RL:Lgyw"}, "RL:wcJU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:mDjm"}, {"role": "SITE", "entity_duid": "RL:gyuU"}, {"role": "SITE", "entity_duid": "RL:CchF"}, {"role": "TRIGGER", "entity_duid": "RL:9Uzo"}], "duid": "RL:wcJU"}, "RL:3cX8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:b6f4"}], "duid": "RL:3cX8"}}, "type": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}
{"docId": "11440136", "sentence": [{"charStart": 0, "charEnd": 111, "index": 0}, {"index": 1, "charEnd": 350, "charStart": 113}, {"index": 2, "charEnd": 539, "charStart": 352}, {"index": 3, "charEnd": 680, "charStart": 541}], "text": "Phosphopeptides derived from hen egg yolk phosvitin: effect of molecular size on the calcium-binding properties. Two different phosphopeptide (PPP) fragments derived from partially dephosphorylated hen egg yolk phosvitin were prepared by tryptic digestion, and their Ca2+ binding property compared with that of commercial casein phosphopeptides (CPP). The smaller fragment of less than 1 kDa and O-phospho-1-serine did not bind Ca2+ to any significant extend, while PPP of 1-3 kDa showed a higher ability than CPP to render soluble calcium. The results show that not only the phosphoserine residues are critical for Ca2+ binding, but also the molecular size of the phosphopeptides.", "title": {"charStart": 0, "charEnd": 111}, "entity": {"RL:yKSz": {"duid": "RL:yKSz", "attribute": [], "entityType": "SiteOther", "charEnd": 14, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptides"}, "RL:mTbD": {"duid": "RL:mTbD", "attribute": [], "entityType": "SiteOther", "charEnd": 679, "source": "RLIMS-P", "charStart": 665, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:h9bM": {"duid": "RL:h9bM", "attribute": [], "entityType": "Protein", "charEnd": 50, "source": "RLIMS-P", "charStart": 42, "entityId": [], "sentenceIndex": 0, "entityText": "phosvitin"}, "RL:FHLR": {"duid": "RL:FHLR", "attribute": [], "entityType": "Trigger", "charEnd": 588, "source": "RLIMS-P", "charStart": 576, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:giVE": {"duid": "RL:giVE", "attribute": [], "entityType": "Trigger", "charEnd": 679, "source": "RLIMS-P", "charStart": 665, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:XHMw": {"duid": "RL:XHMw", "attribute": [], "entityType": "Protein", "charEnd": 219, "source": "RLIMS-P", "charStart": 211, "entityId": [], "sentenceIndex": 1, "entityText": "phosvitin"}, "RL:8RJd": {"duid": "RL:8RJd", "attribute": [], "entityType": "SiteOther", "charEnd": 349, "source": "RLIMS-P", "charStart": 322, "entityId": [], "sentenceIndex": 1, "entityText": "casein phosphopeptides (CPP)"}, "RL:2Hvo": {"duid": "RL:2Hvo", "attribute": [], "entityType": "Trigger", "charEnd": 343, "source": "RLIMS-P", "charStart": 329, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptides"}, "RL:42Kb": {"duid": "RL:42Kb", "attribute": [], "entityType": "SiteOther", "charEnd": 156, "source": "RLIMS-P", "charStart": 127, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide (PPP) fragments"}, "RL:7Wg2": {"duid": "RL:7Wg2", "attribute": [], "entityType": "Trigger", "charEnd": 140, "source": "RLIMS-P", "charStart": 127, "entityId": [], "sentenceIndex": 1, "entityText": "phosphopeptide"}, "RL:yrWy": {"duid": "RL:yrWy", "attribute": [], "entityType": "Trigger", "charEnd": 14, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphopeptides"}}, "mesh": ["Animals", "Calcium", "Chickens", "Egg Yolk", "Female", "Molecular Weight", "Phosphopeptides", "Phosvitin", "Protein Binding"], "relation": {"RL:vgoc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:h9bM"}, {"role": "SITE_OTHER", "entity_duid": "RL:yKSz"}, {"role": "TRIGGER", "entity_duid": "RL:yrWy"}], "duid": "RL:vgoc"}, "RL:Ds5q": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mTbD"}, {"role": "TRIGGER", "entity_duid": "RL:giVE"}], "duid": "RL:Ds5q"}, "RL:HyYN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8RJd"}, {"role": "TRIGGER", "entity_duid": "RL:2Hvo"}], "duid": "RL:HyYN"}, "RL:P7co": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:FHLR"}], "duid": "RL:P7co"}, "RL:En5B": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:XHMw"}, {"role": "SITE_OTHER", "entity_duid": "RL:42Kb"}, {"role": "TRIGGER", "entity_duid": "RL:7Wg2"}], "duid": "RL:En5B"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "8922284", "sentence": [{"charStart": 0, "charEnd": 41, "index": 0}, {"index": 1, "charEnd": 306, "charStart": 43}, {"index": 2, "charEnd": 568, "charStart": 308}, {"index": 3, "charEnd": 742, "charStart": 570}, {"index": 4, "charEnd": 850, "charStart": 744}, {"index": 5, "charEnd": 979, "charStart": 852}, {"index": 6, "charEnd": 1180, "charStart": 981}], "text": "Phosphoamino acids in proteasome subunits. Proteasomes, the major catalysts of the non-lysosomal proteolytic pathway in eukaryotic cells, were analyzed for their content of phosphoamino acids using polyacrylamide gel electrophoresis and subsequent detection on Western blots by phosphoamino acid antibodies. No specific binding to proteasome subunits was observed with phosphoserine or phosphothreonine antibodies, whereas phosphotyrosine antibodies were bound by a single proteasome subunit, which was identified in rat as well as in human proteasomes as subunit C7-1. Since dephosphorylation of the subunit by phosphatases was not possible, analysis of phosphoamino acid content of all proteasome subunits was performed using another method. All proteasome subunits were isolated from 2D-polyacrylamide gels and subjected to partial acid hydrolysis. Phosphoamino acids were subsequently detected by capillary electrophoresis after their derivatization with phenylisothiocyanate. This analysis revealed no phosphorylated amino acid in subunit C7-1, however, subunit C3 contained phosphotyrosine and phosphothreonine, and phosphoserine was detected in subunits zeta, C5, C8 and C9.", "title": {"charStart": 0, "charEnd": 41}, "entity": {"RL:LizT": {"duid": "RL:LizT", "attribute": [], "entityType": "Trigger", "charEnd": 11, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphoamino"}, "RL:PSJK": {"duid": "RL:PSJK", "attribute": [], "entityType": "Trigger", "charEnd": 289, "source": "RLIMS-P", "charStart": 278, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoamino"}, "RL:5Hnb": {"duid": "RL:5Hnb", "attribute": [], "entityType": "Protein", "charEnd": 1047, "source": "RLIMS-P", "charStart": 1036, "entityId": [], "sentenceIndex": 6, "entityText": "subunit C7-1"}, "RL:E2Uw": {"duid": "RL:E2Uw", "attribute": [], "entityType": "Trigger", "charEnd": 381, "source": "RLIMS-P", "charStart": 369, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:MhTd": {"duid": "RL:MhTd", "attribute": [], "entityType": "Protein", "charEnd": 1172, "source": "RLIMS-P", "charStart": 1171, "entityId": [], "sentenceIndex": 6, "entityText": "C8"}, "RL:zbfw": {"duid": "RL:zbfw", "attribute": [], "entityType": "Trigger", "charEnd": 1134, "source": "RLIMS-P", "charStart": 1122, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:oBQ2": {"duid": "RL:oBQ2", "attribute": [], "entityType": "Protein", "charEnd": 1164, "source": "RLIMS-P", "charStart": 1152, "entityId": [], "sentenceIndex": 6, "entityText": "subunits zeta"}, "RL:Zrjo": {"duid": "RL:Zrjo", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1134, "source": "RLIMS-P", "charStart": 1129, "entityId": [], "sentenceIndex": 6, "entityText": "serine"}, "RL:cP8M": {"duid": "RL:cP8M", "attribute": [], "entityType": "Trigger", "charEnd": 1094, "source": "RLIMS-P", "charStart": 1080, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:kBhH": {"duid": "RL:kBhH", "attribute": [], "entityType": "Protein", "charEnd": 1168, "source": "RLIMS-P", "charStart": 1167, "entityId": [], "sentenceIndex": 6, "entityText": "C5"}, "RL:WRLb": {"duid": "RL:WRLb", "attribute": [], "entityType": "SiteOther", "charEnd": 1031, "source": "RLIMS-P", "charStart": 1022, "entityId": [], "sentenceIndex": 6, "entityText": "amino acid"}, "RL:riwB": {"duid": "RL:riwB", "attribute": [], "entityType": "Protein", "charEnd": 1179, "source": "RLIMS-P", "charStart": 1178, "entityId": [], "sentenceIndex": 6, "entityText": "C9"}, "RL:Ne7x": {"duid": "RL:Ne7x", "attribute": [], "entityType": "Trigger", "charEnd": 1020, "source": "RLIMS-P", "charStart": 1007, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylated"}}, "mesh": ["Amino Acids", "Animals", "Cysteine Endopeptidases", "Electrophoresis, Gel, Two-Dimensional", "Humans", "Liver", "Multienzyme Complexes", "Peptide Mapping", "Proteasome Endopeptidase Complex", "Rats", "Rats, Wistar"], "relation": {"RL:Lx7j": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:5Hnb"}, {"role": "SITE_OTHER", "entity_duid": "RL:WRLb"}, {"role": "TRIGGER", "entity_duid": "RL:Ne7x"}], "duid": "RL:Lx7j"}, "RL:A8j3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:MhTd"}, {"role": "SITE", "entity_duid": "RL:Zrjo"}, {"role": "TRIGGER", "entity_duid": "RL:zbfw"}], "duid": "RL:A8j3"}, "RL:tP6J": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:cP8M"}], "duid": "RL:tP6J"}, "RL:v9ny": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:LizT"}], "duid": "RL:v9ny"}, "RL:n2hy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PSJK"}], "duid": "RL:n2hy"}, "RL:z5ED": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:riwB"}, {"role": "SITE", "entity_duid": "RL:Zrjo"}, {"role": "TRIGGER", "entity_duid": "RL:zbfw"}], "duid": "RL:z5ED"}, "RL:ZgoA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:kBhH"}, {"role": "SITE", "entity_duid": "RL:Zrjo"}, {"role": "TRIGGER", "entity_duid": "RL:zbfw"}], "duid": "RL:ZgoA"}, "RL:M7h2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:E2Uw"}], "duid": "RL:M7h2"}, "RL:3CdW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:oBQ2"}, {"role": "SITE", "entity_duid": "RL:Zrjo"}, {"role": "TRIGGER", "entity_duid": "RL:zbfw"}], "duid": "RL:3CdW"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "2482717", "sentence": [{"charStart": 0, "charEnd": 72, "index": 0}, {"index": 1, "charEnd": 170, "charStart": 74}, {"index": 2, "charEnd": 439, "charStart": 172}, {"index": 3, "charEnd": 539, "charStart": 441}, {"index": 4, "charEnd": 721, "charStart": 541}, {"index": 5, "charEnd": 889, "charStart": 723}], "text": "Phosphoamino acid phosphatases in human normal and leukaemic lymphocytes. The activities of phosphoamino acid phosphatases were measured in lymphocytes from normal adults. For cells from white individuals the mean value (+/- SD) for phosphotyrosine phosphatase activity was 342 +/- 120 mU/mg protein; mean values for phosphothreonine and phosphoserine phosphatase activities were 35.6 +/- 17.1 and 21.6 +/- 10.2 mU/mg protein, respectively. The corresponding activities were similar to these for both the Indian and Bantu population groups. The activity of phosphotyrosine phosphatase was significantly lower in lymphocytes from white children with acute lymphocytic leukaemia than in cells from normal children or adults. For phosphothreonine and phosphoserine phosphatases, there was no significant difference between activities obtained in lymphocytes from normal and leukaemic children.", "title": {"charStart": 0, "charEnd": 72}, "entity": {"RL:3hr5": {"duid": "RL:3hr5", "attribute": [], "entityType": "Trigger", "charEnd": 103, "source": "RLIMS-P", "charStart": 92, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoamino"}, "RL:PF52": {"duid": "RL:PF52", "attribute": [], "entityType": "Trigger", "charEnd": 247, "source": "RLIMS-P", "charStart": 233, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:kwyr": {"duid": "RL:kwyr", "attribute": [], "entityType": "Trigger", "charEnd": 332, "source": "RLIMS-P", "charStart": 317, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:qNgG": {"duid": "RL:qNgG", "attribute": [], "entityType": "Trigger", "charEnd": 571, "source": "RLIMS-P", "charStart": 557, "entityId": [], "sentenceIndex": 4, "entityText": "phosphotyrosine"}, "RL:R5VP": {"duid": "RL:R5VP", "attribute": [], "entityType": "Trigger", "charEnd": 11, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphoamino"}, "RL:6mAW": {"duid": "RL:6mAW", "attribute": [], "entityType": "Protein", "charEnd": 29, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Phosphoamino acid phosphatases"}, "RL:NZuH": {"duid": "RL:NZuH", "attribute": [], "entityType": "Protein", "charEnd": 121, "source": "RLIMS-P", "charStart": 92, "entityId": [], "sentenceIndex": 1, "entityText": "phosphoamino acid phosphatases"}, "RL:QDqP": {"duid": "RL:QDqP", "attribute": [], "entityType": "Trigger", "charEnd": 742, "source": "RLIMS-P", "charStart": 727, "entityId": [], "sentenceIndex": 5, "entityText": "phosphothreonine"}}, "mesh": ["Adult", "Humans", "Kinetics", "Leukemia, Lymphoid", "Lymphocytes", "Male", "Phosphoric Monoester Hydrolases"], "relation": {"RL:TBRP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kwyr"}], "duid": "RL:TBRP"}, "RL:C32H": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:6mAW"}, {"role": "TRIGGER", "entity_duid": "RL:R5VP"}], "duid": "RL:C32H"}, "RL:HgXS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:qNgG"}], "duid": "RL:HgXS"}, "RL:5aE7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PF52"}], "duid": "RL:5aE7"}, "RL:eHzd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:NZuH"}, {"role": "TRIGGER", "entity_duid": "RL:3hr5"}], "duid": "RL:eHzd"}, "RL:aWPm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:QDqP"}], "duid": "RL:aWPm"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "10341292", "sentence": [{"charStart": 0, "charEnd": 110, "index": 0}, {"index": 1, "charEnd": 227, "charStart": 112}, {"index": 2, "charEnd": 388, "charStart": 229}, {"index": 3, "charEnd": 560, "charStart": 390}, {"index": 4, "charEnd": 737, "charStart": 562}, {"index": 5, "charEnd": 801, "charStart": 739}, {"index": 6, "charEnd": 1046, "charStart": 803}, {"index": 7, "charEnd": 1175, "charStart": 1048}, {"index": 8, "charEnd": 1313, "charStart": 1177}, {"index": 9, "charEnd": 1575, "charStart": 1315}, {"index": 10, "charEnd": 1738, "charStart": 1577}], "text": "Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent protein phosphatase activity in rat brain cytosol. The effect of Ca2+-binding protein regucalcin on neutral phosphatase activity in rat brain cytosol was investigated. Phosphatase activity was assayed in a reaction mixture containing the cytosolic protein in the presence of phosphotyrosine, phosphoserine, and phosphothreonine. The presence of calcium chloride (10(-5) and 10(-4) M) in the enzyme reaction mixture caused a significant increase in phosphatase activity toward three phosphoaminoacids. The enzyme activity toward phosphoserine and phosphothreonine was significantly enhanced by the addition of calmodulin (1 or 5 microg/ml) in the presence of calcium (10(-5) M). Such an effect was not seen in the presence of phosphotyrosine. Trifluoperazine (2x10(-5) M), an antagonist of calmodulin, completely inhibited calcium (10(-5) M)-increased phosphatase activity toward phosphoserine and phosphothreonine, whereas it had no effect on the enzyme activity toward phosphotyrosine. Regucalcin (10(-9) M) significantly inhibited phosphatase activity toward three phosphoaminoacids without or with Ca2+ addition. The inhibitory effect of regucalcin (10(-10) and 10(-9) M) was also seen in the presence of Ca2+ (10(-5) M) and calmodulin (5 microg/ml). The presence of anti-regucalcin monoclonal antibody (20 or 50 ng/ml) in the enzyme reaction mixture caused a significant elevation of phosphatase activity toward three phosphoaminoacids; this effect was completely abolished by addition of regucalcin (10(-9) M). The present study suggests that the endogenous regucalcin has an inhibitory effect on Ca2+/calmodulin-dependent protein phosphatase activity in rat brain cytosol.", "title": {"charStart": 0, "charEnd": 110}, "entity": {"RL:2HBK": {"duid": "RL:2HBK", "attribute": [], "entityType": "Trigger", "charEnd": 601, "source": "RLIMS-P", "charStart": 589, "entityId": [], "sentenceIndex": 4, "entityText": "phosphoserine"}, "RL:ewHX": {"duid": "RL:ewHX", "attribute": [], "entityType": "Trigger", "charEnd": 800, "source": "RLIMS-P", "charStart": 786, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:NYpD": {"duid": "RL:NYpD", "attribute": [], "entityType": "Trigger", "charEnd": 952, "source": "RLIMS-P", "charStart": 940, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:Jfye": {"duid": "RL:Jfye", "attribute": [], "entityType": "Trigger", "charEnd": 1045, "source": "RLIMS-P", "charStart": 1031, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:uMiQ": {"duid": "RL:uMiQ", "attribute": [], "entityType": "Trigger", "charEnd": 350, "source": "RLIMS-P", "charStart": 336, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}}, "mesh": ["Animals", "Antibodies, Monoclonal", "Biomarkers", "Brain", "Calbindins", "Calcineurin", "Calcium", "Calcium-Binding Proteins", "Calmodulin", "Carboxylic Ester Hydrolases", "Cytosol", "Enzyme Activation", "Female", "Intracellular Signaling Peptides and Proteins", "Liver", "Phosphoserine", "Phosphothreonine", "Phosphotyrosine", "Rats", "Rats, Wistar", "S100 Calcium Binding Protein G", "S100 Proteins", "Sulfotransferases", "Trifluoperazine"], "relation": {"RL:Dy3G": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:uMiQ"}], "duid": "RL:Dy3G"}, "RL:NnyN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ewHX"}], "duid": "RL:NnyN"}, "RL:ZKpJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Jfye"}], "duid": "RL:ZKpJ"}, "RL:KnV8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:NYpD"}], "duid": "RL:KnV8"}, "RL:zWHu": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2HBK"}], "duid": "RL:zWHu"}}, "type": ["Journal Article"]}
{"docId": "2452204", "sentence": [{"charStart": 0, "charEnd": 40, "index": 0}, {"index": 1, "charEnd": 161, "charStart": 42}, {"index": 2, "charEnd": 251, "charStart": 163}, {"index": 3, "charEnd": 391, "charStart": 253}, {"index": 4, "charEnd": 509, "charStart": 393}, {"index": 5, "charEnd": 687, "charStart": 511}, {"index": 6, "charEnd": 832, "charStart": 689}, {"index": 7, "charEnd": 992, "charStart": 834}, {"index": 8, "charEnd": 1162, "charStart": 994}], "text": "Monoclonal antibodies to phosphotyrosine. Phosphotyrosine coupled to KLH, BSA, and OVA was used for the production and screening of antibodies to phosphotyrosine. 800 hybridomas secreting antibodies that bound to phosphotyrosine were detected by ELISA. The most reactive 100 of these 800 were tested subsequently for their ability to bind phosphotyrosine-containing proteins on Western blots. Eight stable hybridoma cell lines were selected for further study, cloned by limiting dilution, and grown as ascites. These antibodies were purified by three different methods, and it was found that affinity chromatography on phosphotyrosine-affigel provided the most rapid and effective method. Many phosphotyrosine-containing proteins were detected by using these antibodies in Western blotting and immunoaffinity purification procedures. Binding of anti-phosphotyrosine antibody could be competed by phosphotyrosine or phenylphosphate but not by phosphoserine, phosphothreonine, or free phosphate. These antibodies should be useful for the identification and purification of proteins phosphorylated on tyrosine residues in transformed and growth factor-treated cells.", "title": {"charStart": 0, "charEnd": 40}, "entity": {"RL:4bxA": {"duid": "RL:4bxA", "attribute": [], "entityType": "Trigger", "charEnd": 1093, "source": "RLIMS-P", "charStart": 1080, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylated"}, "RL:JkCj": {"duid": "RL:JkCj", "attribute": [], "entityType": "Trigger", "charEnd": 353, "source": "RLIMS-P", "charStart": 339, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:GyZf": {"duid": "RL:GyZf", "attribute": [], "entityType": "Trigger", "charEnd": 160, "source": "RLIMS-P", "charStart": 146, "entityId": [], "sentenceIndex": 1, "entityText": "phosphotyrosine"}, "RL:Py3c": {"duid": "RL:Py3c", "attribute": [], "entityType": "Trigger", "charEnd": 39, "source": "RLIMS-P", "charStart": 25, "entityId": [], "sentenceIndex": 0, "entityText": "phosphotyrosine"}, "RL:9Hjt": {"duid": "RL:9Hjt", "attribute": [], "entityType": "Trigger", "charEnd": 708, "source": "RLIMS-P", "charStart": 694, "entityId": [], "sentenceIndex": 6, "entityText": "phosphotyrosine"}, "RL:2GPM": {"duid": "RL:2GPM", "attribute": [], "entityType": "Trigger", "charEnd": 227, "source": "RLIMS-P", "charStart": 213, "entityId": [], "sentenceIndex": 2, "entityText": "phosphotyrosine"}, "RL:Piuy": {"duid": "RL:Piuy", "attribute": [], "entityType": "Trigger", "charEnd": 929, "source": "RLIMS-P", "charStart": 915, "entityId": [], "sentenceIndex": 7, "entityText": "phenylphosphate"}, "RL:AzvG": {"duid": "RL:AzvG", "attribute": [], "entityType": "Trigger", "charEnd": 56, "source": "RLIMS-P", "charStart": 42, "entityId": [], "sentenceIndex": 1, "entityText": "Phosphotyrosine"}, "RL:e5yw": {"duid": "RL:e5yw", "attribute": [], "entityType": "Trigger", "charEnd": 633, "source": "RLIMS-P", "charStart": 619, "entityId": [], "sentenceIndex": 5, "entityText": "phosphotyrosine"}, "RL:Cuya": {"duid": "RL:Cuya", "attribute": [], "entityType": "Trigger", "charEnd": 954, "source": "RLIMS-P", "charStart": 942, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}}, "mesh": ["Animals", "Antibodies, Monoclonal", "Antibody Specificity", "Cell Fusion", "Cell Line", "Enzyme-Linked Immunosorbent Assay", "Humans", "Phosphotyrosine", "Tyrosine"], "relation": {"RL:QRjY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:JkCj"}], "duid": "RL:QRjY"}, "RL:aZSx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Piuy"}], "duid": "RL:aZSx"}, "RL:Lvsr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Py3c"}], "duid": "RL:Lvsr"}, "RL:yPwx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:9Hjt"}], "duid": "RL:yPwx"}, "RL:VHcK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:AzvG"}], "duid": "RL:VHcK"}, "RL:XVKz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GyZf"}], "duid": "RL:XVKz"}, "RL:ySTR": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Cuya"}], "duid": "RL:ySTR"}, "RL:XFto": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:4bxA"}], "duid": "RL:XFto"}, "RL:ZotW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:e5yw"}], "duid": "RL:ZotW"}, "RL:iGwE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:2GPM"}], "duid": "RL:iGwE"}}, "type": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "25890253", "sentence": [{"charStart": 0, "charEnd": 84, "index": 0}, {"index": 1, "charEnd": 259, "charStart": 86}, {"index": 2, "charEnd": 327, "charStart": 261}, {"index": 3, "charEnd": 434, "charStart": 329}, {"index": 4, "charEnd": 655, "charStart": 436}, {"index": 5, "charEnd": 720, "charStart": 657}, {"index": 6, "charEnd": 880, "charStart": 722}, {"index": 7, "charEnd": 1010, "charStart": 882}, {"index": 8, "charEnd": 1102, "charStart": 1012}, {"index": 9, "charEnd": 1156, "charStart": 1104}, {"index": 10, "charEnd": 1245, "charStart": 1158}, {"index": 11, "charEnd": 1349, "charStart": 1247}, {"index": 12, "charEnd": 1508, "charStart": 1351}, {"index": 13, "charEnd": 1655, "charStart": 1510}, {"index": 14, "charEnd": 1819, "charStart": 1657}, {"index": 15, "charEnd": 1894, "charStart": 1821}, {"index": 16, "charEnd": 2005, "charStart": 1896}, {"index": 17, "charEnd": 2132, "charStart": 2007}, {"index": 18, "charEnd": 2218, "charStart": 2134}, {"index": 19, "charEnd": 2424, "charStart": 2220}, {"index": 20, "charEnd": 2513, "charStart": 2426}, {"index": 21, "charEnd": 2738, "charStart": 2515}, {"index": 22, "charEnd": 2799, "charStart": 2740}], "text": "Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics. BACKGROUND: Mass spectrometry based phosphoproteomics emerged as advantageous approach for the analysis of tyrosine phosphorylation on proteins and tyrosine kinase signaling. Immunoaffinity purification is required for comprehensive analysis. Here we compared the performance of two antibodies for label-free phosphotyrosine-based phosphoproteomics. METHODS: Phosphopeptide immunoprecipitation of six technical replicates corresponding to 10mg protein from HCT116 cells was performed using agarose bead-coupled phosphotyrosine antibodies P-Tyr-1000 (N=3) and 4G10 (N=3). NanoLC-MS/MS was performed using a Q Exactive mass spectrometer. For relative quantitation of protein phosphorylation, spectral counts of phosphoproteins and ion intensities of phosphopeptides were determined using MaxQuant. RESULTS: From the 3 samples incubated with P-Tyr-1000 a total of 689 phosphopeptides were identified with 60% ID reproducibility. The phosphopeptide capture using 4G10 resulted in a total of 421 at 46% ID reproducibility. The P-Tyr-1000 was applied to EGFR mutated U87 cells. Erlotinib reduced EGFR phosphorylation with 59% at y978, y1125, y1138, y1172, and y1197. EGFR inhibition was accompanied by enhanced phosphorylation of FYN, MET, PTK2, DYRK1A, MAPK1 and EPHA2. CONCLUSION: The P-Tyr-1000 phosphotyrosine antibody performs superiorly when compared to 4G10 antibody for label-free phosphotyrosine-based phosphoproteomics. This workflow allows evaluation of drug target phosphorylation and may give insights in the pharmacodynamic effects of tyrosine kinase inhibitors. CLINICAL SIGNIFICANCE: In the past decade multiple tyrosine kinase inhibitors (TKIs) have been implemented in standard treatment regimens for patients with cancer. Unfortunately the majority of patients develops resistance to these drugs. Reliable tools for analysis of pharmacodynamic effects and drug resistance mechanisms are therefore warranted. Phosphoproteomic analyses have meanwhile emerged as a sophisticated approach for the determination of protein phosphorylation. These analyses rely on antibodies for enrichment of tyrosine-phosphorylated peptides. Here we compared two commercially available phosphotyrosine antibodies and show that P-Tyr-1000 yields 64% more phosphopeptides than 4G10 antibody, while including almost all 4G10 captured phosphopeptides. The workflow can be reproducibly performed at intermediate protein input levels of 10mg. Furthermore, application of the P-Tyr-1000 antibody in a standardized phosphoproteomics workflow allows relative quantitation of drug target inhibition and provides insights in alternative signaling pathways in cancer cells. This article is part of a Special Issue entitled: HUPO 2014.", "title": {"charStart": 0, "charEnd": 84}, "entity": {"RL:gCzc": {"duid": "RL:gCzc", "attribute": [], "entityType": "Trigger", "charEnd": 965, "source": "RLIMS-P", "charStart": 951, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:2oun": {"duid": "RL:2oun", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 2193, "source": "RLIMS-P", "charStart": 2186, "entityId": [], "sentenceIndex": 18, "entityText": "tyrosine"}, "RL:uyF3": {"duid": "RL:uyF3", "attribute": [], "entityType": "Trigger", "charEnd": 848, "source": "RLIMS-P", "charStart": 834, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:bRcm": {"duid": "RL:bRcm", "attribute": [], "entityType": "Trigger", "charEnd": 1392, "source": "RLIMS-P", "charStart": 1378, "entityId": [], "sentenceIndex": 12, "entityText": "phosphotyrosine"}, "RL:gvjG": {"duid": "RL:gvjG", "attribute": [], "entityType": "Trigger", "charEnd": 1555, "source": "RLIMS-P", "charStart": 1550, "entityId": [], "sentenceIndex": 13, "entityText": "target"}, "RL:cBgK": {"duid": "RL:cBgK", "attribute": [], "entityType": "SiteOther", "charEnd": 965, "source": "RLIMS-P", "charStart": 951, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Him2": {"duid": "RL:Him2", "attribute": [], "entityType": "SiteOther", "charEnd": 848, "source": "RLIMS-P", "charStart": 834, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptides"}, "RL:GYDh": {"duid": "RL:GYDh", "attribute": [], "entityType": "Protein", "charEnd": 1338, "source": "RLIMS-P", "charStart": 1334, "entityId": [], "sentenceIndex": 11, "entityText": "MAPK1"}, "RL:e4iR": {"duid": "RL:e4iR", "attribute": [], "entityType": "Trigger", "charEnd": 2346, "source": "RLIMS-P", "charStart": 2332, "entityId": [], "sentenceIndex": 19, "entityText": "phosphopeptides"}, "RL:8cqY": {"duid": "RL:8cqY", "attribute": [], "entityType": "SiteOther", "charEnd": 2423, "source": "RLIMS-P", "charStart": 2409, "entityId": [], "sentenceIndex": 19, "entityText": "phosphopeptides"}, "RL:p5qq": {"duid": "RL:p5qq", "attribute": [], "entityType": "Trigger", "charEnd": 50, "source": "RLIMS-P", "charStart": 24, "entityId": [], "sentenceIndex": 0, "entityText": "phospho-tyrosine antibodies"}, "RL:N6Dc": {"duid": "RL:N6Dc", "attribute": [], "entityType": "Trigger", "charEnd": 2423, "source": "RLIMS-P", "charStart": 2409, "entityId": [], "sentenceIndex": 19, "entityText": "phosphopeptides"}, "RL:hjMQ": {"duid": "RL:hjMQ", "attribute": [], "entityType": "Trigger", "charEnd": 1305, "source": "RLIMS-P", "charStart": 1291, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation"}, "RL:rxiA": {"duid": "RL:rxiA", "attribute": [], "entityType": "Trigger", "charEnd": 809, "source": "RLIMS-P", "charStart": 795, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoproteins"}, "RL:Qgys": {"duid": "RL:Qgys", "attribute": [], "entityType": "Protein", "charEnd": 1179, "source": "RLIMS-P", "charStart": 1176, "entityId": [], "sentenceIndex": 10, "entityText": "EGFR"}, "RL:yUtr": {"duid": "RL:yUtr", "attribute": [], "entityType": "Trigger", "charEnd": 1483, "source": "RLIMS-P", "charStart": 1469, "entityId": [], "sentenceIndex": 12, "entityText": "phosphotyrosine"}, "RL:fMQG": {"duid": "RL:fMQG", "attribute": [], "entityType": "Trigger", "charEnd": 2208, "source": "RLIMS-P", "charStart": 2195, "entityId": [], "sentenceIndex": 18, "entityText": "phosphorylated"}, "RL:sqJQ": {"duid": "RL:sqJQ", "attribute": [], "entityType": "Protein", "charEnd": 1312, "source": "RLIMS-P", "charStart": 1310, "entityId": [], "sentenceIndex": 11, "entityText": "FYN"}, "RL:W5ko": {"duid": "RL:W5ko", "attribute": [], "entityType": "Protein", "charEnd": 1348, "source": "RLIMS-P", "charStart": 1344, "entityId": [], "sentenceIndex": 11, "entityText": "EPHA2"}, "RL:hDWt": {"duid": "RL:hDWt", "attribute": [], "entityType": "Protein", "charEnd": 1323, "source": "RLIMS-P", "charStart": 1320, "entityId": [], "sentenceIndex": 11, "entityText": "PTK2"}, "RL:UtNx": {"duid": "RL:UtNx", "attribute": [], "entityType": "Trigger", "charEnd": 1195, "source": "RLIMS-P", "charStart": 1181, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:BKcM": {"duid": "RL:BKcM", "attribute": [], "entityType": "Trigger", "charEnd": 409, "source": "RLIMS-P", "charStart": 395, "entityId": [], "sentenceIndex": 3, "entityText": "phosphotyrosine"}, "RL:84Uo": {"duid": "RL:84Uo", "attribute": [], "entityType": "Trigger", "charEnd": 2131, "source": "RLIMS-P", "charStart": 2117, "entityId": [], "sentenceIndex": 17, "entityText": "phosphorylation"}, "RL:egY9": {"duid": "RL:egY9", "attribute": [{"key": "std_site", "value": "Tyr-1000"}], "entityType": "Site", "charEnd": 2314, "source": "RLIMS-P", "charStart": 2307, "entityId": [], "sentenceIndex": 19, "entityText": "Tyr-1000"}, "RL:w3n2": {"duid": "RL:w3n2", "attribute": [], "entityType": "Trigger", "charEnd": 216, "source": "RLIMS-P", "charStart": 202, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:43zb": {"duid": "RL:43zb", "attribute": [], "entityType": "Protein", "charEnd": 1331, "source": "RLIMS-P", "charStart": 1326, "entityId": [], "sentenceIndex": 11, "entityText": "DYRK1A"}, "RL:Jupd": {"duid": "RL:Jupd", "attribute": [], "entityType": "Trigger", "charEnd": 773, "source": "RLIMS-P", "charStart": 759, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}}, "mesh": ["Antibodies, Neoplasm", "Cell Line, Tumor", "ErbB Receptors", "Erlotinib Hydrochloride", "Humans", "Mass Spectrometry", "Phosphoproteins", "Phosphotyrosine"], "relation": {"RL:qR95": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Qgys"}, {"role": "TRIGGER", "entity_duid": "RL:UtNx"}], "duid": "RL:qR95"}, "RL:k5m2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:84Uo"}], "duid": "RL:k5m2"}, "RL:QKcv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:43zb"}, {"role": "TRIGGER", "entity_duid": "RL:hjMQ"}], "duid": "RL:QKcv"}, "RL:zQHx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Him2"}, {"role": "TRIGGER", "entity_duid": "RL:rxiA"}], "duid": "RL:zQHx"}, "RL:UDEG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:w3n2"}], "duid": "RL:UDEG"}, "RL:gkWe": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:sqJQ"}, {"role": "SUBSTRATE", "entity_duid": "RL:W5ko"}, {"role": "SUBSTRATE", "entity_duid": "RL:hDWt"}, {"role": "SUBSTRATE", "entity_duid": "RL:43zb"}, {"role": "SUBSTRATE", "entity_duid": "RL:GYDh"}, {"role": "SITE", "entity_duid": "RL:2oun"}, {"role": "TRIGGER", "entity_duid": "RL:fMQG"}], "duid": "RL:gkWe"}, "RL:Zrjq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Jupd"}], "duid": "RL:Zrjq"}, "RL:Wzsj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Him2"}, {"role": "TRIGGER", "entity_duid": "RL:uyF3"}], "duid": "RL:Wzsj"}, "RL:gaxQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:p5qq"}], "duid": "RL:gaxQ"}, "RL:Q4RV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:yUtr"}], "duid": "RL:Q4RV"}, "RL:EJ2E": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:gvjG"}], "duid": "RL:EJ2E"}, "RL:p6ww": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:W5ko"}, {"role": "TRIGGER", "entity_duid": "RL:hjMQ"}], "duid": "RL:p6ww"}, "RL:Sdpq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:cBgK"}, {"role": "TRIGGER", "entity_duid": "RL:gCzc"}], "duid": "RL:Sdpq"}, "RL:Q9GJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:GYDh"}, {"role": "TRIGGER", "entity_duid": "RL:hjMQ"}], "duid": "RL:Q9GJ"}, "RL:v3bL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:8cqY"}, {"role": "TRIGGER", "entity_duid": "RL:N6Dc"}], "duid": "RL:v3bL"}, "RL:EHzd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:hDWt"}, {"role": "TRIGGER", "entity_duid": "RL:hjMQ"}], "duid": "RL:EHzd"}, "RL:wfgj": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:sqJQ"}, {"role": "TRIGGER", "entity_duid": "RL:hjMQ"}], "duid": "RL:wfgj"}, "RL:AGfY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:bRcm"}], "duid": "RL:AGfY"}, "RL:9iKQ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:egY9"}, {"role": "TRIGGER", "entity_duid": "RL:e4iR"}], "duid": "RL:9iKQ"}, "RL:DaEb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:BKcM"}], "duid": "RL:DaEb"}}, "type": ["Evaluation Study", "Journal Article"]}
{"docId": "1654905", "sentence": [{"charStart": 0, "charEnd": 202, "index": 0}, {"index": 1, "charEnd": 451, "charStart": 204}, {"index": 2, "charEnd": 615, "charStart": 453}, {"index": 3, "charEnd": 715, "charStart": 617}, {"index": 4, "charEnd": 923, "charStart": 717}], "text": "Insulin-stimulated serine/threonine phosphorylation of the insulin receptor: paucity of threonine 1348 phosphorylation in vitro indicates the involvement of more than one serine/threonine kinase in vivo. Immunoaffinity-purified insulin receptors were used to analyse and compare the serine/threonine sites phosphorylated on the insulin receptor in vitro (isolated receptor) with the insulin-stimulated phosphorylation in vivo (intact cells in culture). In vivo, insulin-stimulation resulted in the appearance of three phosphoserine-containing phosphopeptides and a distinct phosphothreonine peptide (threonine 1348). In vitro, similar phosphoserine peptides were observed but the phosphothreonine peptide was absent. These results indicate that multiple serine sites are phosphorylated in vivo and in vitro and that an additional protein kinase mediates insulin-stimulated insulin receptor threonine phosphorylation in vivo.", "title": {"charStart": 0, "charEnd": 202}, "entity": {"RL:ptQf": {"duid": "RL:ptQf", "attribute": [], "entityType": "Protein", "charEnd": 888, "source": "RLIMS-P", "charStart": 873, "entityId": [], "sentenceIndex": 4, "entityText": "insulin receptor"}, "RL:rrkM": {"duid": "RL:rrkM", "attribute": [], "entityType": "Protein", "charEnd": 74, "source": "RLIMS-P", "charStart": 59, "entityId": [], "sentenceIndex": 0, "entityText": "insulin receptor"}, "RL:YbZT": {"duid": "RL:YbZT", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 898, "source": "RLIMS-P", "charStart": 890, "entityId": [], "sentenceIndex": 4, "entityText": "threonine"}, "RL:Mxfw": {"duid": "RL:Mxfw", "attribute": [], "entityType": "Trigger", "charEnd": 50, "source": "RLIMS-P", "charStart": 36, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:ujdh": {"duid": "RL:ujdh", "attribute": [], "entityType": "Protein", "charEnd": 343, "source": "RLIMS-P", "charStart": 328, "entityId": [], "sentenceIndex": 1, "entityText": "insulin receptor"}, "RL:y5Ft": {"duid": "RL:y5Ft", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 34, "source": "RLIMS-P", "charStart": 26, "entityId": [], "sentenceIndex": 0, "entityText": "threonine"}, "RL:8Zsv": {"duid": "RL:8Zsv", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 759, "source": "RLIMS-P", "charStart": 754, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:PAUg": {"duid": "RL:PAUg", "attribute": [], "entityType": "Trigger", "charEnd": 416, "source": "RLIMS-P", "charStart": 402, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:DshC": {"duid": "RL:DshC", "attribute": [], "entityType": "Trigger", "charEnd": 117, "source": "RLIMS-P", "charStart": 103, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:BAKD": {"duid": "RL:BAKD", "attribute": [], "entityType": "Trigger", "charEnd": 914, "source": "RLIMS-P", "charStart": 900, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:4QPt": {"duid": "RL:4QPt", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 298, "source": "RLIMS-P", "charStart": 290, "entityId": [], "sentenceIndex": 1, "entityText": "threonine"}, "RL:htiW": {"duid": "RL:htiW", "attribute": [], "entityType": "Trigger", "charEnd": 530, "source": "RLIMS-P", "charStart": 518, "entityId": [], "sentenceIndex": 2, "entityText": "phosphoserine"}, "RL:fzUr": {"duid": "RL:fzUr", "attribute": [], "entityType": "Trigger", "charEnd": 647, "source": "RLIMS-P", "charStart": 635, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:NFMg": {"duid": "RL:NFMg", "attribute": [], "entityType": "Trigger", "charEnd": 319, "source": "RLIMS-P", "charStart": 306, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:zReP": {"duid": "RL:zReP", "attribute": [], "entityType": "Trigger", "charEnd": 695, "source": "RLIMS-P", "charStart": 680, "entityId": [], "sentenceIndex": 3, "entityText": "phosphothreonine"}, "RL:KEUa": {"duid": "RL:KEUa", "attribute": [{"key": "std_site", "value": "Thr-1348"}], "entityType": "Site", "charEnd": 101, "source": "RLIMS-P", "charStart": 88, "entityId": [], "sentenceIndex": 0, "entityText": "threonine 1348"}, "RL:ssBu": {"duid": "RL:ssBu", "attribute": [], "entityType": "Trigger", "charEnd": 784, "source": "RLIMS-P", "charStart": 771, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:jMEP": {"duid": "RL:jMEP", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 288, "source": "RLIMS-P", "charStart": 283, "entityId": [], "sentenceIndex": 1, "entityText": "serine"}, "RL:GaMN": {"duid": "RL:GaMN", "attribute": [], "entityType": "Trigger", "charEnd": 589, "source": "RLIMS-P", "charStart": 574, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:i6uH": {"duid": "RL:i6uH", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 24, "source": "RLIMS-P", "charStart": 19, "entityId": [], "sentenceIndex": 0, "entityText": "serine"}}, "mesh": ["Animals", "Cell Line", "Electrophoresis, Gel, Two-Dimensional", "Insulin", "Peptide Mapping", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Protein Kinases", "Protein-Serine-Threonine Kinases", "Protein-Tyrosine Kinases", "Receptor, Insulin", "Threonine", "Transfection"], "relation": {"RL:jym4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GaMN"}], "duid": "RL:jym4"}, "RL:VBbK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:zReP"}], "duid": "RL:VBbK"}, "RL:Pwm4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:rrkM"}, {"role": "SITE", "entity_duid": "RL:i6uH"}, {"role": "SITE", "entity_duid": "RL:y5Ft"}, {"role": "TRIGGER", "entity_duid": "RL:Mxfw"}], "duid": "RL:Pwm4"}, "RL:LVpS": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:fzUr"}], "duid": "RL:LVpS"}, "RL:vCYX": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ptQf"}, {"role": "SITE", "entity_duid": "RL:YbZT"}, {"role": "TRIGGER", "entity_duid": "RL:BAKD"}], "duid": "RL:vCYX"}, "RL:JWak": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ujdh"}, {"role": "SITE", "entity_duid": "RL:4QPt"}, {"role": "SITE", "entity_duid": "RL:jMEP"}, {"role": "TRIGGER", "entity_duid": "RL:NFMg"}], "duid": "RL:JWak"}, "RL:An5E": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:KEUa"}, {"role": "TRIGGER", "entity_duid": "RL:DshC"}], "duid": "RL:An5E"}, "RL:PfXG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:htiW"}], "duid": "RL:PfXG"}, "RL:xize": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:ptQf"}, {"role": "SITE", "entity_duid": "RL:8Zsv"}, {"role": "TRIGGER", "entity_duid": "RL:ssBu"}], "duid": "RL:xize"}, "RL:Q3AN": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:PAUg"}], "duid": "RL:Q3AN"}}, "type": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "1517236", "sentence": [{"charStart": 0, "charEnd": 91, "index": 0}, {"index": 1, "charEnd": 210, "charStart": 93}, {"index": 2, "charEnd": 398, "charStart": 212}, {"index": 3, "charEnd": 578, "charStart": 400}, {"index": 4, "charEnd": 818, "charStart": 580}, {"index": 5, "charEnd": 994, "charStart": 820}, {"index": 6, "charEnd": 1152, "charStart": 996}, {"index": 7, "charEnd": 1337, "charStart": 1154}, {"index": 8, "charEnd": 1449, "charStart": 1339}, {"index": 9, "charEnd": 1615, "charStart": 1451}, {"index": 10, "charEnd": 1761, "charStart": 1617}, {"index": 11, "charEnd": 2039, "charStart": 1763}, {"index": 12, "charEnd": 2141, "charStart": 2041}], "text": "Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. The Xenopus cdk2 gene encodes a 32-kDa protein kinase with sequence similarity to the 34-kDa product of the cdc2 gene. Previous studies have shown that the kinase activity of the protein product of the cdk2 gene oscillates in the Xenopus embryonic cell cycle with a high in M-phase and a low in interphase. In the present study cdk2 was found not to be associated with any newly synthesized proteins during the cell cycle, but the enzyme did undergo periodic changes in phosphorylation. Upon exit from metaphase, cdk2 became increasingly phosphorylated on both tyrosine and serine residues, and labeling on these residues increased progressively until entry into mitosis, when tyrosine residues were markedly dephosphorylated. Phosphopeptide mapping of cdk2 demonstrated the major sites of phosphorylation were in a phosphopeptide with a pI of 3.7 that contained both phosphoserine and phosphotyrosine. This phosphopeptide accumulated in egg extracts blocked in S-phase with aphidicolin and was not evident in cdc2 immunoprecipitated under the same conditions. Under the same conditions cdc2 was phosphorylated primarily on a phosphopeptide containing both phosphothreonine and phosphotyrosine residues, most likely threonine 14 and tyrosine 15. Affinity-purified human GST-cdc25 was able to dephosphorylate and activate cdk2 isolated from interphase cells. Phosphopeptide mapping demonstrated that the phosphate was specifically removed from the same phosphopeptide identified as the major in vivo site of phosphorylation. These results demonstrate that cdk2 is regulated in the cell cycle by phosphorylation and dephosphorylation on both serine and tyrosine residues. Moreover, the increased phosphorylation of cdk2 in aphidicolin-blocked extracts and the ability of cdc25 to mediate cdk2 dephosphorylation in vitro suggest the possibility that cdk2 is part of the mechanism ensuring mitosis is not initiated until completion of DNA replication. It also implies cdc25 may have other functions in addition to the regulation of cdc2 kinase activity.", "title": {"charStart": 0, "charEnd": 91}, "entity": {"RL:v4E5": {"duid": "RL:v4E5", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1265, "source": "RLIMS-P", "charStart": 1257, "entityId": [], "sentenceIndex": 7, "entityText": "threonine"}, "RL:d2sT": {"duid": "RL:d2sT", "attribute": [], "entityType": "SiteOther", "charEnd": 1232, "source": "RLIMS-P", "charStart": 1219, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptide"}, "RL:s6WP": {"duid": "RL:s6WP", "attribute": [], "entityType": "Trigger", "charEnd": 577, "source": "RLIMS-P", "charStart": 563, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:q6M7": {"duid": "RL:q6M7", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 672, "source": "RLIMS-P", "charStart": 667, "entityId": [], "sentenceIndex": 4, "entityText": "serine"}, "RL:UD9D": {"duid": "RL:UD9D", "attribute": [], "entityType": "Trigger", "charEnd": 973, "source": "RLIMS-P", "charStart": 961, "entityId": [], "sentenceIndex": 5, "entityText": "phosphoserine"}, "RL:rfAx": {"duid": "RL:rfAx", "attribute": [], "entityType": "SiteOther", "charEnd": 1014, "source": "RLIMS-P", "charStart": 1001, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide"}, "RL:7MFT": {"duid": "RL:7MFT", "attribute": [], "entityType": "Trigger", "charEnd": 922, "source": "RLIMS-P", "charStart": 909, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptide"}, "RL:avgS": {"duid": "RL:avgS", "attribute": [], "entityType": "Trigger", "charEnd": 897, "source": "RLIMS-P", "charStart": 883, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:C6no": {"duid": "RL:C6no", "attribute": [], "entityType": "Trigger", "charEnd": 1801, "source": "RLIMS-P", "charStart": 1787, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation"}, "RL:Hdst": {"duid": "RL:Hdst", "attribute": [], "entityType": "Protein", "charEnd": 609, "source": "RLIMS-P", "charStart": 606, "entityId": [], "sentenceIndex": 4, "entityText": "cdk2"}, "RL:js5V": {"duid": "RL:js5V", "attribute": [], "entityType": "SiteOther", "charEnd": 922, "source": "RLIMS-P", "charStart": 907, "entityId": [], "sentenceIndex": 5, "entityText": "a phosphopeptide"}, "RL:5uBq": {"duid": "RL:5uBq", "attribute": [{"key": "std_site", "value": "Thr-14"}], "entityType": "Site", "charEnd": 1320, "source": "RLIMS-P", "charStart": 1309, "entityId": [], "sentenceIndex": 7, "entityText": "threonine 14"}, "RL:jxFN": {"duid": "RL:jxFN", "attribute": [], "entityType": "SiteOther", "charEnd": 1558, "source": "RLIMS-P", "charStart": 1545, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptide"}, "RL:LAmd": {"duid": "RL:LAmd", "attribute": [], "entityType": "Protein", "charEnd": 1183, "source": "RLIMS-P", "charStart": 1180, "entityId": [], "sentenceIndex": 7, "entityText": "cdc2"}, "RL:npTh": {"duid": "RL:npTh", "attribute": [], "entityType": "Trigger", "charEnd": 1202, "source": "RLIMS-P", "charStart": 1189, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylated"}, "RL:biZK": {"duid": "RL:biZK", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 661, "source": "RLIMS-P", "charStart": 654, "entityId": [], "sentenceIndex": 4, "entityText": "tyrosine"}, "RL:hpSd": {"duid": "RL:hpSd", "attribute": [], "entityType": "Trigger", "charEnd": 1723, "source": "RLIMS-P", "charStart": 1687, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation and dephosphorylation"}, "RL:vYF6": {"duid": "RL:vYF6", "attribute": [{"key": "std_site", "value": "Tyr-15"}], "entityType": "Site", "charEnd": 1336, "source": "RLIMS-P", "charStart": 1326, "entityId": [], "sentenceIndex": 7, "entityText": "tyrosine 15"}, "RL:FVei": {"duid": "RL:FVei", "attribute": [], "entityType": "Trigger", "charEnd": 1232, "source": "RLIMS-P", "charStart": 1219, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptide"}, "RL:n5fE": {"duid": "RL:n5fE", "attribute": [], "entityType": "Trigger", "charEnd": 1265, "source": "RLIMS-P", "charStart": 1250, "entityId": [], "sentenceIndex": 7, "entityText": "phosphothreonine"}, "RL:fXoQ": {"duid": "RL:fXoQ", "attribute": [], "entityType": "SiteOther", "charEnd": 878, "source": "RLIMS-P", "charStart": 874, "entityId": [], "sentenceIndex": 5, "entityText": "sites"}, "RL:sf5c": {"duid": "RL:sf5c", "attribute": [], "entityType": "Trigger", "charEnd": 1900, "source": "RLIMS-P", "charStart": 1884, "entityId": [], "sentenceIndex": 11, "entityText": "dephosphorylation"}, "RL:yCeK": {"duid": "RL:yCeK", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1738, "source": "RLIMS-P", "charStart": 1733, "entityId": [], "sentenceIndex": 10, "entityText": "serine"}, "RL:SXpv": {"duid": "RL:SXpv", "attribute": [{"key": "std_site", "value": "Tyr"}], "entityType": "Site", "charEnd": 1751, "source": "RLIMS-P", "charStart": 1744, "entityId": [], "sentenceIndex": 10, "entityText": "tyrosine"}, "RL:UyZw": {"duid": "RL:UyZw", "attribute": [], "entityType": "Trigger", "charEnd": 34, "source": "RLIMS-P", "charStart": 20, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylation"}, "RL:CmFN": {"duid": "RL:CmFN", "attribute": [], "entityType": "Protein", "charEnd": 90, "source": "RLIMS-P", "charStart": 56, "entityId": [], "sentenceIndex": 0, "entityText": "Xenopus cdk2 protein kinase complex"}, "RL:iFCS": {"duid": "RL:iFCS", "attribute": [], "entityType": "Trigger", "charEnd": 1014, "source": "RLIMS-P", "charStart": 1001, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide"}, "RL:rPgq": {"duid": "RL:rPgq", "attribute": [], "entityType": "Trigger", "charEnd": 644, "source": "RLIMS-P", "charStart": 631, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:Jw6s": {"duid": "RL:Jw6s", "attribute": [], "entityType": "Trigger", "charEnd": 1614, "source": "RLIMS-P", "charStart": 1600, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:8eiA": {"duid": "RL:8eiA", "attribute": [], "entityType": "Protein", "charEnd": 1809, "source": "RLIMS-P", "charStart": 1806, "entityId": [], "sentenceIndex": 11, "entityText": "cdk2"}, "RL:PQCE": {"duid": "RL:PQCE", "attribute": [], "entityType": "Trigger", "charEnd": 1558, "source": "RLIMS-P", "charStart": 1545, "entityId": [], "sentenceIndex": 9, "entityText": "phosphopeptide"}, "RL:uf63": {"duid": "RL:uf63", "attribute": [], "entityType": "SiteOther", "charEnd": 1232, "source": "RLIMS-P", "charStart": 1217, "entityId": [], "sentenceIndex": 7, "entityText": "a phosphopeptide"}, "RL:cWtD": {"duid": "RL:cWtD", "attribute": [], "entityType": "SiteOther", "charEnd": 1595, "source": "RLIMS-P", "charStart": 1592, "entityId": [], "sentenceIndex": 9, "entityText": "site"}, "RL:xkLR": {"duid": "RL:xkLR", "attribute": [], "entityType": "Protein", "charEnd": 4, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Cdc25"}}, "mesh": ["Animals", "Aphidicolin", "Base Sequence", "CDC2 Protein Kinase", "CDC2-CDC28 Kinases", "Cell Cycle", "Cell Nucleus", "Cyclin-Dependent Kinase 2", "Cyclin-Dependent Kinases", "DNA Replication", "Embryo, Nonmammalian", "Glutathione Transferase", "Humans", "Kinetics", "Male", "Molecular Sequence Data", "Oligodeoxyribonucleotides", "Peptide Mapping", "Phosphopeptides", "Phosphorylation", "Protein Kinases", "Protein-Serine-Threonine Kinases", "Proteins", "Recombinant Fusion Proteins", "Spermatozoa", "Xenopus", "Xenopus Proteins", "cdc25 Phosphatases"], "relation": {"RL:X4Gs": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:js5V"}, {"role": "TRIGGER", "entity_duid": "RL:7MFT"}], "duid": "RL:X4Gs"}, "RL:WHwF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:rfAx"}, {"role": "TRIGGER", "entity_duid": "RL:iFCS"}], "duid": "RL:WHwF"}, "RL:eQpU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:jxFN"}, {"role": "TRIGGER", "entity_duid": "RL:PQCE"}], "duid": "RL:eQpU"}, "RL:Bvxy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:LAmd"}, {"role": "SITE_OTHER", "entity_duid": "RL:uf63"}, {"role": "TRIGGER", "entity_duid": "RL:FVei"}], "duid": "RL:Bvxy"}, "RL:het4": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Hdst"}, {"role": "SITE", "entity_duid": "RL:vYF6"}, {"role": "SITE", "entity_duid": "RL:v4E5"}, {"role": "SITE", "entity_duid": "RL:5uBq"}, {"role": "TRIGGER", "entity_duid": "RL:n5fE"}], "duid": "RL:het4"}, "RL:swjd": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UD9D"}], "duid": "RL:swjd"}, "RL:UCza": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:cWtD"}, {"role": "TRIGGER", "entity_duid": "RL:Jw6s"}], "duid": "RL:UCza"}, "RL:FBmv": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:js5V"}, {"role": "SITE_OTHER", "entity_duid": "RL:fXoQ"}, {"role": "TRIGGER", "entity_duid": "RL:avgS"}], "duid": "RL:FBmv"}, "RL:wUVo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:s6WP"}], "duid": "RL:wUVo"}, "RL:wzDa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:LAmd"}, {"role": "SITE_OTHER", "entity_duid": "RL:uf63"}, {"role": "TRIGGER", "entity_duid": "RL:npTh"}], "duid": "RL:wzDa"}, "RL:Fyg9": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sf5c"}], "duid": "RL:Fyg9"}, "RL:UtxA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:8eiA"}, {"role": "TRIGGER", "entity_duid": "RL:C6no"}], "duid": "RL:UtxA"}, "RL:hYU5": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:CmFN"}, {"role": "INDUCER", "entity_duid": "RL:xkLR"}, {"role": "TRIGGER", "entity_duid": "RL:UyZw"}], "duid": "RL:hYU5"}, "RL:QrAW": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Hdst"}, {"role": "SITE", "entity_duid": "RL:biZK"}, {"role": "SITE", "entity_duid": "RL:q6M7"}, {"role": "TRIGGER", "entity_duid": "RL:rPgq"}], "duid": "RL:QrAW"}, "RL:PSRt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:LAmd"}, {"role": "SITE", "entity_duid": "RL:vYF6"}, {"role": "SITE", "entity_duid": "RL:5uBq"}, {"role": "SITE", "entity_duid": "RL:SXpv"}, {"role": "SITE", "entity_duid": "RL:yCeK"}, {"role": "SITE_OTHER", "entity_duid": "RL:d2sT"}, {"role": "TRIGGER", "entity_duid": "RL:hpSd"}], "duid": "RL:PSRt"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}
{"docId": "6292479", "sentence": [{"charStart": 0, "charEnd": 101, "index": 0}, {"index": 1, "charEnd": 224, "charStart": 103}, {"index": 2, "charEnd": 423, "charStart": 226}, {"index": 3, "charEnd": 641, "charStart": 425}, {"index": 4, "charEnd": 746, "charStart": 643}, {"index": 5, "charEnd": 963, "charStart": 748}, {"index": 6, "charEnd": 1139, "charStart": 965}, {"index": 7, "charEnd": 1276, "charStart": 1141}, {"index": 8, "charEnd": 1332, "charStart": 1278}, {"index": 9, "charEnd": 1500, "charStart": 1334}, {"index": 10, "charEnd": 1667, "charStart": 1502}, {"index": 11, "charEnd": 1821, "charStart": 1669}, {"index": 12, "charEnd": 1936, "charStart": 1823}, {"index": 13, "charEnd": 2006, "charStart": 1938}, {"index": 14, "charEnd": 2163, "charStart": 2008}, {"index": 15, "charEnd": 2286, "charStart": 2165}, {"index": 16, "charEnd": 2355, "charStart": 2288}, {"index": 17, "charEnd": 2472, "charStart": 2357}], "text": "Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. The phosphorylation sites of simian virus 40 large T antigen were determined within the primary structure of the molecule. Exhaustive digestion of (32)P-labeled large T antigen with trypsin generated six major phosphopeptides which could be separated in a newly developed isobutyric acid-containing chromatography system. By partial tryptic digestion, large T antigen was cleaved into an amino-terminal fragment of 17,000 daltons and overlapping fragments from the carboxy-terminal region ranging in size between 71,000 and 13,000 daltons. The location of the phosphopeptides was then determined by fingerprint analyses of individual fragments. Their physical properties were analyzed by sizing on polyacrylamide gels and by sequential digestion and peptide mapping; their amino acid composition was determined by differential labeling with various amino acids. The amino-terminal 17,000-dalton fragment gave rise to only one phosphopeptide (phosphopeptide 3) that contained half of the phosphate label incorporated into large T antigen. It contained phosphoserine and phosphothreonine sites, all of which were clustered within a small segment between Cys(105) and Lys(127). This segment contained five serines and two threonines. Among these, Ser(106), Ser(123), and Thr(124) were identified as phosphorylated residues; in addition, either one or both of Ser(111) and Ser(112) were phosphorylated. The neighboring residues, Ser(123) and Thr(124), were found in three different phosphorylation states in that either Ser(123) or Thr(124) or both were phosphorylated. Phosphopeptides 1, 2, 4, 5, and 6 were all derived from a single fragment extending 26,000 daltons upstream from the carboxy terminus of large T antigen. Phosphopeptide 6 was identical with the previously determined phosphothreonine peptide phosphorylated at Thr(701). Phosphopeptides 1, 2, 4, and 5 contained only serine-bound phosphate. Phosphopeptides 1, 2, and 4 represented overlapping peptides, all of which were phosphorylated at Ser(639) located next to a cluster of six acidic residues. In phosphopeptide 5, a large peptide ranging from Asn(653) to Arg(691), at least two of seven serines were phosphorylated. Thus, large T antigen contains at least eight phosphorylation sites. Their clustering within two separate regions might correlate with structural and functional domains of this protein.", "title": {"charStart": 0, "charEnd": 101}, "entity": {"RL:THJK": {"duid": "RL:THJK", "attribute": [], "entityType": "Trigger", "charEnd": 1061, "source": "RLIMS-P", "charStart": 1020, "entityId": [], "sentenceIndex": 6, "entityText": "only one phosphopeptide (phosphopeptide 3)"}, "RL:BQh8": {"duid": "RL:BQh8", "attribute": [], "entityType": "Trigger", "charEnd": 1952, "source": "RLIMS-P", "charStart": 1938, "entityId": [], "sentenceIndex": 13, "entityText": "Phosphopeptides"}, "RL:jvSo": {"duid": "RL:jvSo", "attribute": [{"key": "std_site", "value": "Thr-124"}], "entityType": "Site", "charEnd": 1378, "source": "RLIMS-P", "charStart": 1371, "entityId": [], "sentenceIndex": 9, "entityText": "Thr(124)"}, "RL:zfAX": {"duid": "RL:zfAX", "attribute": [], "entityType": "SiteOther", "charEnd": 1701, "source": "RLIMS-P", "charStart": 1669, "entityId": [], "sentenceIndex": 11, "entityText": "Phosphopeptides 1, 2, 4, 5, and 6"}, "RL:LCP6": {"duid": "RL:LCP6", "attribute": [{"key": "std_site", "value": "Ser-106"}], "entityType": "Site", "charEnd": 1354, "source": "RLIMS-P", "charStart": 1347, "entityId": [], "sentenceIndex": 9, "entityText": "Ser(106)"}, "RL:UUBT": {"duid": "RL:UUBT", "attribute": [], "entityType": "Trigger", "charEnd": 1166, "source": "RLIMS-P", "charStart": 1154, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}, "RL:QJcG": {"duid": "RL:QJcG", "attribute": [], "entityType": "Trigger", "charEnd": 1836, "source": "RLIMS-P", "charStart": 1823, "entityId": [], "sentenceIndex": 12, "entityText": "Phosphopeptide"}, "RL:6QHe": {"duid": "RL:6QHe", "attribute": [], "entityType": "Trigger", "charEnd": 2022, "source": "RLIMS-P", "charStart": 2008, "entityId": [], "sentenceIndex": 14, "entityText": "Phosphopeptides"}, "RL:DPVs": {"duid": "RL:DPVs", "attribute": [], "entityType": "SiteOther", "charEnd": 2183, "source": "RLIMS-P", "charStart": 2168, "entityId": [], "sentenceIndex": 15, "entityText": "phosphopeptide 5"}, "RL:B86G": {"duid": "RL:B86G", "attribute": [], "entityType": "Trigger", "charEnd": 48, "source": "RLIMS-P", "charStart": 35, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:3v27": {"duid": "RL:3v27", "attribute": [], "entityType": "SiteOther", "charEnd": 327, "source": "RLIMS-P", "charStart": 313, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:pYNv": {"duid": "RL:pYNv", "attribute": [], "entityType": "SiteOther", "charEnd": 2067, "source": "RLIMS-P", "charStart": 2048, "entityId": [], "sentenceIndex": 14, "entityText": "overlapping peptides"}, "RL:KrPd": {"duid": "RL:KrPd", "attribute": [{"key": "std_site", "value": "Ser-112"}], "entityType": "Site", "charEnd": 1479, "source": "RLIMS-P", "charStart": 1472, "entityId": [], "sentenceIndex": 9, "entityText": "Ser(112)"}, "RL:FaRd": {"duid": "RL:FaRd", "attribute": [{"key": "std_site", "value": "Ser-111"}], "entityType": "Site", "charEnd": 1466, "source": "RLIMS-P", "charStart": 1459, "entityId": [], "sentenceIndex": 9, "entityText": "Ser(111)"}, "RL:GYoG": {"duid": "RL:GYoG", "attribute": [{"key": "std_site", "value": "Ser-639"}], "entityType": "Site", "charEnd": 2113, "source": "RLIMS-P", "charStart": 2106, "entityId": [], "sentenceIndex": 14, "entityText": "Ser(639)"}, "RL:Gs6w": {"duid": "RL:Gs6w", "attribute": [], "entityType": "Trigger", "charEnd": 1412, "source": "RLIMS-P", "charStart": 1399, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylated"}, "RL:Yeuv": {"duid": "RL:Yeuv", "attribute": [], "entityType": "Trigger", "charEnd": 2285, "source": "RLIMS-P", "charStart": 2272, "entityId": [], "sentenceIndex": 15, "entityText": "phosphorylated"}, "RL:qXft": {"duid": "RL:qXft", "attribute": [], "entityType": "Trigger", "charEnd": 677, "source": "RLIMS-P", "charStart": 663, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:KDhz": {"duid": "RL:KDhz", "attribute": [], "entityType": "Trigger", "charEnd": 1923, "source": "RLIMS-P", "charStart": 1910, "entityId": [], "sentenceIndex": 12, "entityText": "phosphorylated"}, "RL:tbdQ": {"duid": "RL:tbdQ", "attribute": [], "entityType": "Trigger", "charEnd": 2181, "source": "RLIMS-P", "charStart": 2168, "entityId": [], "sentenceIndex": 15, "entityText": "phosphopeptide"}, "RL:is6C": {"duid": "RL:is6C", "attribute": [], "entityType": "Trigger", "charEnd": 327, "source": "RLIMS-P", "charStart": 313, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:fk79": {"duid": "RL:fk79", "attribute": [], "entityType": "SiteOther", "charEnd": 1967, "source": "RLIMS-P", "charStart": 1938, "entityId": [], "sentenceIndex": 13, "entityText": "Phosphopeptides 1, 2, 4, and 5"}, "RL:cHS4": {"duid": "RL:cHS4", "attribute": [{"key": "std_site", "value": "Ser-123"}], "entityType": "Site", "charEnd": 1364, "source": "RLIMS-P", "charStart": 1357, "entityId": [], "sentenceIndex": 9, "entityText": "Ser(123)"}, "RL:YTh7": {"duid": "RL:YTh7", "attribute": [], "entityType": "SiteOther", "charEnd": 127, "source": "RLIMS-P", "charStart": 107, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation sites"}, "RL:mPiD": {"duid": "RL:mPiD", "attribute": [], "entityType": "SiteOther", "charEnd": 1061, "source": "RLIMS-P", "charStart": 1029, "entityId": [], "sentenceIndex": 6, "entityText": "phosphopeptide (phosphopeptide 3)"}, "RL:WoY8": {"duid": "RL:WoY8", "attribute": [], "entityType": "SiteOther", "charEnd": 677, "source": "RLIMS-P", "charStart": 663, "entityId": [], "sentenceIndex": 4, "entityText": "phosphopeptides"}, "RL:asS3": {"duid": "RL:asS3", "attribute": [], "entityType": "SiteOther", "charEnd": 2354, "source": "RLIMS-P", "charStart": 2334, "entityId": [], "sentenceIndex": 16, "entityText": "phosphorylation sites"}, "RL:ZhAe": {"duid": "RL:ZhAe", "attribute": [], "entityType": "Trigger", "charEnd": 121, "source": "RLIMS-P", "charStart": 107, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:2fXb": {"duid": "RL:2fXb", "attribute": [{"key": "std_site", "value": "Thr-701"}], "entityType": "Site", "charEnd": 1935, "source": "RLIMS-P", "charStart": 1928, "entityId": [], "sentenceIndex": 12, "entityText": "Thr(701)"}, "RL:Zm2Y": {"duid": "RL:Zm2Y", "attribute": [], "entityType": "Trigger", "charEnd": 1683, "source": "RLIMS-P", "charStart": 1669, "entityId": [], "sentenceIndex": 11, "entityText": "Phosphopeptides"}, "RL:iwAC": {"duid": "RL:iwAC", "attribute": [], "entityType": "SiteOther", "charEnd": 1838, "source": "RLIMS-P", "charStart": 1823, "entityId": [], "sentenceIndex": 12, "entityText": "Phosphopeptide 6"}, "RL:aSup": {"duid": "RL:aSup", "attribute": [], "entityType": "Trigger", "charEnd": 1900, "source": "RLIMS-P", "charStart": 1885, "entityId": [], "sentenceIndex": 12, "entityText": "phosphothreonine"}, "RL:GW6V": {"duid": "RL:GW6V", "attribute": [], "entityType": "SiteOther", "charEnd": 2034, "source": "RLIMS-P", "charStart": 2008, "entityId": [], "sentenceIndex": 14, "entityText": "Phosphopeptides 1, 2, and 4"}, "RL:MMFs": {"duid": "RL:MMFs", "attribute": [], "entityType": "SiteOther", "charEnd": 1421, "source": "RLIMS-P", "charStart": 1414, "entityId": [], "sentenceIndex": 9, "entityText": "residues"}, "RL:e6ea": {"duid": "RL:e6ea", "attribute": [], "entityType": "Trigger", "charEnd": 1499, "source": "RLIMS-P", "charStart": 1486, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylated"}, "RL:kBd9": {"duid": "RL:kBd9", "attribute": [], "entityType": "Trigger", "charEnd": 1666, "source": "RLIMS-P", "charStart": 1653, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylated"}, "RL:hzCZ": {"duid": "RL:hzCZ", "attribute": [], "entityType": "Protein", "charEnd": 30, "source": "RLIMS-P", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "T antigen"}, "RL:RTha": {"duid": "RL:RTha", "attribute": [], "entityType": "SiteOther", "charEnd": 66, "source": "RLIMS-P", "charStart": 62, "entityId": [], "sentenceIndex": 0, "entityText": "sites"}, "RL:jg69": {"duid": "RL:jg69", "attribute": [], "entityType": "Trigger", "charEnd": 1595, "source": "RLIMS-P", "charStart": 1581, "entityId": [], "sentenceIndex": 10, "entityText": "phosphorylation"}, "RL:D5Lk": {"duid": "RL:D5Lk", "attribute": [], "entityType": "Trigger", "charEnd": 2348, "source": "RLIMS-P", "charStart": 2334, "entityId": [], "sentenceIndex": 16, "entityText": "phosphorylation"}, "RL:NY7w": {"duid": "RL:NY7w", "attribute": [], "entityType": "Trigger", "charEnd": 2101, "source": "RLIMS-P", "charStart": 2088, "entityId": [], "sentenceIndex": 14, "entityText": "phosphorylated"}}, "mesh": ["Adenosine Diphosphate Ribose", "Animals", "Antigens, Viral", "Antigens, Viral, Tumor", "Cell Line", "Chlorocebus aethiops", "Electrophoresis, Polyacrylamide Gel", "Peptide Hydrolases", "Phosphopeptides", "Phosphorylation", "Phosphoserine", "Phosphothreonine", "Simian virus 40"], "relation": {"RL:YmQc": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aSup"}], "duid": "RL:YmQc"}, "RL:tyPE": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:mPiD"}, {"role": "TRIGGER", "entity_duid": "RL:THJK"}], "duid": "RL:tyPE"}, "RL:yLwy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jg69"}], "duid": "RL:yLwy"}, "RL:7pM8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:GW6V"}, {"role": "SITE_OTHER", "entity_duid": "RL:pYNv"}, {"role": "TRIGGER", "entity_duid": "RL:6QHe"}], "duid": "RL:7pM8"}, "RL:CUFn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:2fXb"}, {"role": "TRIGGER", "entity_duid": "RL:KDhz"}], "duid": "RL:CUFn"}, "RL:imMq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:zfAX"}, {"role": "TRIGGER", "entity_duid": "RL:Zm2Y"}], "duid": "RL:imMq"}, "RL:Z6Ss": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:fk79"}, {"role": "TRIGGER", "entity_duid": "RL:BQh8"}], "duid": "RL:Z6Ss"}, "RL:UTpZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:GYoG"}, {"role": "TRIGGER", "entity_duid": "RL:NY7w"}], "duid": "RL:UTpZ"}, "RL:cuKY": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:Yeuv"}], "duid": "RL:cuKY"}, "RL:AaJr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:kBd9"}], "duid": "RL:AaJr"}, "RL:yX58": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:iwAC"}, {"role": "TRIGGER", "entity_duid": "RL:QJcG"}], "duid": "RL:yX58"}, "RL:f8c7": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:WoY8"}, {"role": "TRIGGER", "entity_duid": "RL:qXft"}], "duid": "RL:f8c7"}, "RL:DaCz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:KrPd"}, {"role": "SITE", "entity_duid": "RL:FaRd"}, {"role": "TRIGGER", "entity_duid": "RL:e6ea"}], "duid": "RL:DaCz"}, "RL:2PQm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:UUBT"}], "duid": "RL:2PQm"}, "RL:2bXZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE", "entity_duid": "RL:LCP6"}, {"role": "SITE", "entity_duid": "RL:cHS4"}, {"role": "SITE", "entity_duid": "RL:jvSo"}, {"role": "SITE_OTHER", "entity_duid": "RL:MMFs"}, {"role": "TRIGGER", "entity_duid": "RL:Gs6w"}], "duid": "RL:2bXZ"}, "RL:qz6W": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:YTh7"}, {"role": "TRIGGER", "entity_duid": "RL:ZhAe"}], "duid": "RL:qz6W"}, "RL:PCiH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:hzCZ"}, {"role": "SITE_OTHER", "entity_duid": "RL:RTha"}, {"role": "TRIGGER", "entity_duid": "RL:B86G"}], "duid": "RL:PCiH"}, "RL:CFAK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:asS3"}, {"role": "TRIGGER", "entity_duid": "RL:D5Lk"}], "duid": "RL:CFAK"}, "RL:pxHn": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:DPVs"}, {"role": "TRIGGER", "entity_duid": "RL:tbdQ"}], "duid": "RL:pxHn"}, "RL:BtKZ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:3v27"}, {"role": "TRIGGER", "entity_duid": "RL:is6C"}], "duid": "RL:BtKZ"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "7787767", "sentence": [{"charStart": 0, "charEnd": 117, "index": 0}, {"index": 1, "charEnd": 247, "charStart": 119}, {"index": 2, "charEnd": 477, "charStart": 249}, {"index": 3, "charEnd": 755, "charStart": 479}, {"index": 4, "charEnd": 919, "charStart": 757}, {"index": 5, "charEnd": 1142, "charStart": 921}, {"index": 6, "charEnd": 1319, "charStart": 1144}, {"index": 7, "charEnd": 1491, "charStart": 1321}, {"index": 8, "charEnd": 1659, "charStart": 1493}, {"index": 9, "charEnd": 1783, "charStart": 1661}, {"index": 10, "charEnd": 1935, "charStart": 1785}, {"index": 11, "charEnd": 2198, "charStart": 1937}], "text": "Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease. The abnormally phosphorylated forms of tau factor are major constituents of neurofibrillary tangles in Alzheimer's disease brain. In order to investigate protein phosphatases which are related to dephosphorylation of abnormal phosphorylation sites, we examined the dephosphorylation of tau factor phosphorylated by three proline-directed type protein kinases. Tau factor phosphorylated by cdc2 kinase and tau protein kinase II was dephosphorylated by the holoenzyme of protein phosphatase 2A and calcineurin, while either the catalytic subunit of protein phosphatase 2A or protein phosphatase 2C could not catalyze the dephosphorylation. From the kinetic analysis, we concluded that tau factors phosphorylated by the protein kinases serve as good substrates for protein phosphatase 2A and calcineurin. On the other hand, tau factor phosphorylated by glycogen synthase kinase 3 alpha was dephosphorylated by the catalytic subunit of protein phosphatases 2A as well as the holoenzyme of protein phosphatase 2A and calcineurin. It has been reported that serines 199, 202 and 396 according to the numbering of the longest human tau isoform are among the major abnormal phosphorylation sites of tau factor. We synthesized two phosphopeptides which contained phosphoserines 199 and 202 or phosphoserine 396 and prepared the polyclonal antibodies specific for the phosphopeptides. Using these antibodies, we confirmed that the holoenzyme of protein phosphatase 2A and calcineurin could dephosphorylate phosphoserines 199, 202 and 396 in tau factor. The catalytic subunit of protein phosphatase 2A could dephosphorylate phosphoserine 396 but not phosphoserines 199 and 202. Neurofibrillary tangles in Alzheimer's disease brain were immunostained with both antibodies but the normal neurons in the normal aged brains were not. The results suggest that protein phosphatase 2A and calcineurin can be involved in the dephosphorylation of abnormal phosphorylation sites in tau factor and that the dephosphorylation of phosphoserine 396 is differently regulated from phosphoserines 199 and 202.", "title": {"charStart": 0, "charEnd": 117}, "entity": {"RL:LAg9": {"duid": "RL:LAg9", "attribute": [], "entityType": "Trigger", "charEnd": 147, "source": "RLIMS-P", "charStart": 134, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylated"}, "RL:sQyf": {"duid": "RL:sQyf", "attribute": [], "entityType": "Trigger", "charEnd": 1770, "source": "RLIMS-P", "charStart": 1757, "entityId": [], "sentenceIndex": 9, "entityText": "phosphoserines"}, "RL:rn7q": {"duid": "RL:rn7q", "attribute": [], "entityType": "Trigger", "charEnd": 503, "source": "RLIMS-P", "charStart": 490, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:CYuN": {"duid": "RL:CYuN", "attribute": [], "entityType": "Trigger", "charEnd": 1385, "source": "RLIMS-P", "charStart": 1372, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserines"}, "RL:79fB": {"duid": "RL:79fB", "attribute": [{"key": "std_site", "value": "Ser-199"}], "entityType": "Site", "charEnd": 1193, "source": "RLIMS-P", "charStart": 1170, "entityId": [], "sentenceIndex": 6, "entityText": "serines 199, 202 and 396"}, "RL:QTY5": {"duid": "RL:QTY5", "attribute": [], "entityType": "Protein", "charEnd": 949, "source": "RLIMS-P", "charStart": 940, "entityId": [], "sentenceIndex": 5, "entityText": "tau factor"}, "RL:ukcJ": {"duid": "RL:ukcJ", "attribute": [], "entityType": "SiteOther", "charEnd": 1354, "source": "RLIMS-P", "charStart": 1340, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:3Kgo": {"duid": "RL:3Kgo", "attribute": [{"key": "std_site", "value": "Ser-202"}], "entityType": "Site", "charEnd": 1193, "source": "RLIMS-P", "charStart": 1170, "entityId": [], "sentenceIndex": 6, "entityText": "serines 199, 202 and 396"}, "RL:smka": {"duid": "RL:smka", "attribute": [], "entityType": "Trigger", "charEnd": 2185, "source": "RLIMS-P", "charStart": 2172, "entityId": [], "sentenceIndex": 11, "entityText": "phosphoserines"}, "RL:pmnt": {"duid": "RL:pmnt", "attribute": [], "entityType": "Protein", "charEnd": 476, "source": "RLIMS-P", "charStart": 457, "entityId": [], "sentenceIndex": 2, "entityText": "type protein kinases"}, "RL:xhs7": {"duid": "RL:xhs7", "attribute": [], "entityType": "Trigger", "charEnd": 1627, "source": "RLIMS-P", "charStart": 1614, "entityId": [], "sentenceIndex": 8, "entityText": "phosphoserines"}, "RL:6qam": {"duid": "RL:6qam", "attribute": [], "entityType": "Trigger", "charEnd": 1490, "source": "RLIMS-P", "charStart": 1476, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Y5Nt": {"duid": "RL:Y5Nt", "attribute": [], "entityType": "Trigger", "charEnd": 964, "source": "RLIMS-P", "charStart": 951, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylated"}, "RL:vdzN": {"duid": "RL:vdzN", "attribute": [], "entityType": "Protein", "charEnd": 1318, "source": "RLIMS-P", "charStart": 1309, "entityId": [], "sentenceIndex": 6, "entityText": "tau factor"}, "RL:YfXx": {"duid": "RL:YfXx", "attribute": [], "entityType": "Trigger", "charEnd": 827, "source": "RLIMS-P", "charStart": 814, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylated"}, "RL:a5AE": {"duid": "RL:a5AE", "attribute": [], "entityType": "Protein", "charEnd": 1000, "source": "RLIMS-P", "charStart": 969, "entityId": [], "sentenceIndex": 5, "entityText": "glycogen synthase kinase 3 alpha"}, "RL:Ncrx": {"duid": "RL:Ncrx", "attribute": [], "entityType": "Protein", "charEnd": 812, "source": "RLIMS-P", "charStart": 802, "entityId": [], "sentenceIndex": 4, "entityText": "tau factors"}, "RL:5WHz": {"duid": "RL:5WHz", "attribute": [], "entityType": "Trigger", "charEnd": 2068, "source": "RLIMS-P", "charStart": 2054, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation"}, "RL:gbtz": {"duid": "RL:gbtz", "attribute": [], "entityType": "SiteOther", "charEnd": 1304, "source": "RLIMS-P", "charStart": 1284, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation sites"}, "RL:rhxA": {"duid": "RL:rhxA", "attribute": [{"key": "std_site", "value": "Ser-202"}], "entityType": "Site", "charEnd": 2197, "source": "RLIMS-P", "charStart": 2179, "entityId": [], "sentenceIndex": 11, "entityText": "serines 199 and 202"}, "RL:4snJ": {"duid": "RL:4snJ", "attribute": [], "entityType": "Trigger", "charEnd": 1298, "source": "RLIMS-P", "charStart": 1284, "entityId": [], "sentenceIndex": 6, "entityText": "phosphorylation"}, "RL:JiWd": {"duid": "RL:JiWd", "attribute": [], "entityType": "SiteOther", "charEnd": 2074, "source": "RLIMS-P", "charStart": 2054, "entityId": [], "sentenceIndex": 11, "entityText": "phosphorylation sites"}, "RL:XwYi": {"duid": "RL:XwYi", "attribute": [], "entityType": "Trigger", "charEnd": 359, "source": "RLIMS-P", "charStart": 345, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:LxC7": {"duid": "RL:LxC7", "attribute": [], "entityType": "Trigger", "charEnd": 1354, "source": "RLIMS-P", "charStart": 1340, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:Pa9r": {"duid": "RL:Pa9r", "attribute": [], "entityType": "Protein", "charEnd": 518, "source": "RLIMS-P", "charStart": 508, "entityId": [], "sentenceIndex": 3, "entityText": "cdc2 kinase"}, "RL:cecs": {"duid": "RL:cecs", "attribute": [], "entityType": "Trigger", "charEnd": 1743, "source": "RLIMS-P", "charStart": 1731, "entityId": [], "sentenceIndex": 9, "entityText": "phosphoserine"}, "RL:u9Xd": {"duid": "RL:u9Xd", "attribute": [], "entityType": "Protein", "charEnd": 488, "source": "RLIMS-P", "charStart": 479, "entityId": [], "sentenceIndex": 3, "entityText": "Tau factor"}, "RL:sD7Y": {"duid": "RL:sD7Y", "attribute": [{"key": "std_site", "value": "Ser-396"}], "entityType": "Site", "charEnd": 2140, "source": "RLIMS-P", "charStart": 2131, "entityId": [], "sentenceIndex": 11, "entityText": "serine 396"}, "RL:GSBt": {"duid": "RL:GSBt", "attribute": [], "entityType": "Protein", "charEnd": 2088, "source": "RLIMS-P", "charStart": 2079, "entityId": [], "sentenceIndex": 11, "entityText": "tau factor"}, "RL:ZhdX": {"duid": "RL:ZhdX", "attribute": [], "entityType": "Trigger", "charEnd": 1414, "source": "RLIMS-P", "charStart": 1402, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoserine"}, "RL:a65a": {"duid": "RL:a65a", "attribute": [], "entityType": "Trigger", "charEnd": 2136, "source": "RLIMS-P", "charStart": 2124, "entityId": [], "sentenceIndex": 11, "entityText": "phosphoserine"}, "RL:StxX": {"duid": "RL:StxX", "attribute": [], "entityType": "SiteOther", "charEnd": 1490, "source": "RLIMS-P", "charStart": 1476, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:TLo6": {"duid": "RL:TLo6", "attribute": [{"key": "std_site", "value": "Ser-199"}], "entityType": "Site", "charEnd": 2197, "source": "RLIMS-P", "charStart": 2179, "entityId": [], "sentenceIndex": 11, "entityText": "serines 199 and 202"}, "RL:aCAY": {"duid": "RL:aCAY", "attribute": [], "entityType": "Trigger", "charEnd": 16, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Dephosphorylation"}, "RL:tmFf": {"duid": "RL:tmFf", "attribute": [], "entityType": "Protein", "charEnd": 167, "source": "RLIMS-P", "charStart": 158, "entityId": [], "sentenceIndex": 1, "entityText": "tau factor"}, "RL:gFoL": {"duid": "RL:gFoL", "attribute": [], "entityType": "SiteOther", "charEnd": 365, "source": "RLIMS-P", "charStart": 345, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation sites"}, "RL:hzCB": {"duid": "RL:hzCB", "attribute": [], "entityType": "Protein", "charEnd": 544, "source": "RLIMS-P", "charStart": 524, "entityId": [], "sentenceIndex": 3, "entityText": "tau protein kinase II"}, "RL:9Bb2": {"duid": "RL:9Bb2", "attribute": [], "entityType": "Trigger", "charEnd": 429, "source": "RLIMS-P", "charStart": 416, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylated"}, "RL:DsuW": {"duid": "RL:DsuW", "attribute": [{"key": "std_site", "value": "Ser-396"}], "entityType": "Site", "charEnd": 1193, "source": "RLIMS-P", "charStart": 1170, "entityId": [], "sentenceIndex": 6, "entityText": "serines 199, 202 and 396"}}, "mesh": ["Aged", "Alzheimer Disease", "Animals", "CDC2 Protein Kinase", "Calcium-Calmodulin-Dependent Protein Kinases", "Cattle", "Cyclin-Dependent Kinase 5", "DNA Polymerase III", "Glycogen Synthase Kinase 3", "Glycogen Synthase Kinases", "Humans", "Immunohistochemistry", "Microtubule-Associated Proteins", "Middle Aged", "Neurofibrillary Tangles", "Peptide Mapping", "Phosphopeptides", "Phosphoprotein Phosphatases", "Phosphorylation", "Protein Phosphatase 2", "Protein-Serine-Threonine Kinases", "Transcription Factors"], "relation": {"RL:Gui3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:Ncrx"}, {"role": "TRIGGER", "entity_duid": "RL:YfXx"}], "duid": "RL:Gui3"}, "RL:CbpP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:CYuN"}], "duid": "RL:CbpP"}, "RL:tXGM": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:QTY5"}, {"role": "KINASE", "entity_duid": "RL:a5AE"}, {"role": "TRIGGER", "entity_duid": "RL:Y5Nt"}], "duid": "RL:tXGM"}, "RL:KA4d": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:vdzN"}, {"role": "SITE", "entity_duid": "RL:3Kgo"}, {"role": "SITE", "entity_duid": "RL:79fB"}, {"role": "SITE", "entity_duid": "RL:DsuW"}, {"role": "SITE_OTHER", "entity_duid": "RL:gbtz"}, {"role": "TRIGGER", "entity_duid": "RL:4snJ"}], "duid": "RL:KA4d"}, "RL:UJ8b": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "KINASE", "entity_duid": "RL:pmnt"}, {"role": "TRIGGER", "entity_duid": "RL:9Bb2"}], "duid": "RL:UJ8b"}, "RL:zgn2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:cecs"}], "duid": "RL:zgn2"}, "RL:Bff8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:tmFf"}, {"role": "TRIGGER", "entity_duid": "RL:LAg9"}], "duid": "RL:Bff8"}, "RL:Rtwy": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ZhdX"}], "duid": "RL:Rtwy"}, "RL:NxjL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:a65a"}], "duid": "RL:NxjL"}, "RL:i3AF": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:aCAY"}], "duid": "RL:i3AF"}, "RL:Q5cH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:smka"}], "duid": "RL:Q5cH"}, "RL:eQY3": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:StxX"}, {"role": "TRIGGER", "entity_duid": "RL:6qam"}], "duid": "RL:eQY3"}, "RL:Kcyt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:xhs7"}], "duid": "RL:Kcyt"}, "RL:7ryP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:gFoL"}, {"role": "TRIGGER", "entity_duid": "RL:XwYi"}], "duid": "RL:7ryP"}, "RL:skaz": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:GSBt"}, {"role": "SITE", "entity_duid": "RL:sD7Y"}, {"role": "SITE", "entity_duid": "RL:rhxA"}, {"role": "SITE", "entity_duid": "RL:TLo6"}, {"role": "SITE_OTHER", "entity_duid": "RL:JiWd"}, {"role": "TRIGGER", "entity_duid": "RL:5WHz"}], "duid": "RL:skaz"}, "RL:NZsx": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sQyf"}], "duid": "RL:NZsx"}, "RL:Cxsh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:u9Xd"}, {"role": "KINASE", "entity_duid": "RL:hzCB"}, {"role": "KINASE", "entity_duid": "RL:Pa9r"}, {"role": "TRIGGER", "entity_duid": "RL:rn7q"}], "duid": "RL:Cxsh"}, "RL:oiMo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ukcJ"}, {"role": "TRIGGER", "entity_duid": "RL:LxC7"}], "duid": "RL:oiMo"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "3138233", "sentence": [{"charStart": 0, "charEnd": 85, "index": 0}, {"index": 1, "charEnd": 312, "charStart": 87}, {"index": 2, "charEnd": 523, "charStart": 314}, {"index": 3, "charEnd": 617, "charStart": 525}, {"index": 4, "charEnd": 706, "charStart": 619}, {"index": 5, "charEnd": 795, "charStart": 708}, {"index": 6, "charEnd": 965, "charStart": 797}, {"index": 7, "charEnd": 1145, "charStart": 967}, {"index": 8, "charEnd": 1282, "charStart": 1147}, {"index": 9, "charEnd": 1361, "charStart": 1284}, {"index": 10, "charEnd": 1431, "charStart": 1363}, {"index": 11, "charEnd": 1493, "charStart": 1433}, {"index": 12, "charEnd": 1598, "charStart": 1495}, {"index": 13, "charEnd": 1727, "charStart": 1600}], "text": "Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo. The epidermal growth factor (EGF) receptor is regulated by EGF-stimulated autophosphorylation and by phorbol ester-stimulated, protein kinase C (Ca2+/phospholipid-dependent enzyme) mediated phosphorylation at identified sites. The EGF receptor contains additional phosphorylation sites including a prominent phosphothreonine and several phosphoserines which account for the majority of phosphate covalently bound to the receptor in vivo. We have identified three of these sites in EGF receptor purified from 32P-labeled A431 cells. The major phosphothreonine was identified as threonine 669 in the EGF receptor sequence. Phosphoserine residues were identified as serines 671 and 1046/1047 of the EGF receptor. Two other phosphoserine residues were localized to tryptic peptides containing multiple serine residues located carboxyl-terminal to the conserved protein kinase domain. The amino acid sequences surrounding the three identified phosphorylation sites are highly conserved in the EGF receptor and the protein products of the v-erb B and neu oncogenes. Analysis of predicted secondary structure of the EGF receptor reveals that all of the phosphorylation sites are located near beta turns. In A431 cells phosphorylation of the serine residues was dependent upon serum. In mouse B82 L cells transfected with a wild type human EGF receptor. EGF increased the 32P content in all tryptic phosphopeptides. A mutant EGF receptor lacking protein tyrosine kinase activity was phosphorylated only at threonine 669. Regulated phosphorylation of the EGF receptor at these threonine and serine residues may influence aspects of receptor function.", "title": {"charStart": 0, "charEnd": 85}, "entity": {"RL:sUUt": {"duid": "RL:sUUt", "attribute": [], "entityType": "Trigger", "charEnd": 410, "source": "RLIMS-P", "charStart": 395, "entityId": [], "sentenceIndex": 2, "entityText": "phosphothreonine"}, "RL:6gGK": {"duid": "RL:6gGK", "attribute": [], "entityType": "Trigger", "charEnd": 1247, "source": "RLIMS-P", "charStart": 1233, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:BrXL": {"duid": "RL:BrXL", "attribute": [], "entityType": "Protein", "charEnd": 1644, "source": "RLIMS-P", "charStart": 1633, "entityId": [], "sentenceIndex": 13, "entityText": "EGF receptor"}, "RL:UGXM": {"duid": "RL:UGXM", "attribute": [], "entityType": "Trigger", "charEnd": 76, "source": "RLIMS-P", "charStart": 63, "entityId": [], "sentenceIndex": 0, "entityText": "phosphorylated"}, "RL:JEx9": {"duid": "RL:JEx9", "attribute": [{"key": "std_site", "value": "Thr-669"}], "entityType": "Site", "charEnd": 1597, "source": "RLIMS-P", "charStart": 1585, "entityId": [], "sentenceIndex": 12, "entityText": "threonine 669"}, "RL:zgbi": {"duid": "RL:zgbi", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 41, "source": "RLIMS-P", "charStart": 33, "entityId": [], "sentenceIndex": 0, "entityText": "threonine"}, "RL:BkDx": {"duid": "RL:BkDx", "attribute": [], "entityType": "Protein", "charEnd": 579, "source": "RLIMS-P", "charStart": 568, "entityId": [], "sentenceIndex": 3, "entityText": "EGF receptor"}, "RL:8Ydy": {"duid": "RL:8Ydy", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1326, "source": "RLIMS-P", "charStart": 1321, "entityId": [], "sentenceIndex": 9, "entityText": "serine"}, "RL:GHJG": {"duid": "RL:GHJG", "attribute": [], "entityType": "Trigger", "charEnd": 644, "source": "RLIMS-P", "charStart": 629, "entityId": [], "sentenceIndex": 4, "entityText": "phosphothreonine"}, "RL:RZBu": {"duid": "RL:RZBu", "attribute": [], "entityType": "Trigger", "charEnd": 1312, "source": "RLIMS-P", "charStart": 1298, "entityId": [], "sentenceIndex": 9, "entityText": "phosphorylation"}, "RL:LCpu": {"duid": "RL:LCpu", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 1674, "source": "RLIMS-P", "charStart": 1669, "entityId": [], "sentenceIndex": 13, "entityText": "serine"}, "RL:fuEq": {"duid": "RL:fuEq", "attribute": [], "entityType": "Protein", "charEnd": 1207, "source": "RLIMS-P", "charStart": 1196, "entityId": [], "sentenceIndex": 8, "entityText": "EGF receptor"}, "RL:jci2": {"duid": "RL:jci2", "attribute": [], "entityType": "Trigger", "charEnd": 819, "source": "RLIMS-P", "charStart": 807, "entityId": [], "sentenceIndex": 6, "entityText": "phosphoserine"}, "RL:w5Hw": {"duid": "RL:w5Hw", "attribute": [], "entityType": "SiteOther", "charEnd": 1253, "source": "RLIMS-P", "charStart": 1233, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation sites"}, "RL:KgSU": {"duid": "RL:KgSU", "attribute": [], "entityType": "Trigger", "charEnd": 179, "source": "RLIMS-P", "charStart": 161, "entityId": [], "sentenceIndex": 1, "entityText": "autophosphorylation"}, "RL:DJxr": {"duid": "RL:DJxr", "attribute": [], "entityType": "Trigger", "charEnd": 481, "source": "RLIMS-P", "charStart": 473, "entityId": [], "sentenceIndex": 2, "entityText": "phosphate"}, "RL:tEQd": {"duid": "RL:tEQd", "attribute": [], "entityType": "Protein", "charEnd": 696, "source": "RLIMS-P", "charStart": 685, "entityId": [], "sentenceIndex": 4, "entityText": "EGF receptor"}, "RL:zUTv": {"duid": "RL:zUTv", "attribute": [{"key": "std_site", "value": "Thr"}], "entityType": "Site", "charEnd": 1663, "source": "RLIMS-P", "charStart": 1655, "entityId": [], "sentenceIndex": 13, "entityText": "threonine"}, "RL:zpFR": {"duid": "RL:zpFR", "attribute": [], "entityType": "Trigger", "charEnd": 1575, "source": "RLIMS-P", "charStart": 1562, "entityId": [], "sentenceIndex": 12, "entityText": "phosphorylated"}, "RL:P8aA": {"duid": "RL:P8aA", "attribute": [], "entityType": "Trigger", "charEnd": 291, "source": "RLIMS-P", "charStart": 277, "entityId": [], "sentenceIndex": 1, "entityText": "phosphorylation"}, "RL:pYtr": {"duid": "RL:pYtr", "attribute": [], "entityType": "SiteOther", "charEnd": 563, "source": "RLIMS-P", "charStart": 553, "entityId": [], "sentenceIndex": 3, "entityText": "these sites"}, "RL:7ptm": {"duid": "RL:7ptm", "attribute": [], "entityType": "Protein", "charEnd": 31, "source": "RLIMS-P", "charStart": 0, "entityId": [], "sentenceIndex": 0, "entityText": "Epidermal growth factor receptor"}, "RL:PK5M": {"duid": "RL:PK5M", "attribute": [], "entityType": "SiteOther", "charEnd": 1045, "source": "RLIMS-P", "charStart": 1025, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation sites"}, "RL:bt7v": {"duid": "RL:bt7v", "attribute": [], "entityType": "Trigger", "charEnd": 1039, "source": "RLIMS-P", "charStart": 1025, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}, "RL:hC4U": {"duid": "RL:hC4U", "attribute": [], "entityType": "Trigger", "charEnd": 365, "source": "RLIMS-P", "charStart": 351, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation"}, "RL:Mco6": {"duid": "RL:Mco6", "attribute": [], "entityType": "Trigger", "charEnd": 1492, "source": "RLIMS-P", "charStart": 1478, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:qGgB": {"duid": "RL:qGgB", "attribute": [], "entityType": "SiteOther", "charEnd": 311, "source": "RLIMS-P", "charStart": 307, "entityId": [], "sentenceIndex": 1, "entityText": "sites"}, "RL:ArPy": {"duid": "RL:ArPy", "attribute": [], "entityType": "SiteOther", "charEnd": 371, "source": "RLIMS-P", "charStart": 351, "entityId": [], "sentenceIndex": 2, "entityText": "phosphorylation sites"}, "RL:VARR": {"duid": "RL:VARR", "attribute": [], "entityType": "SiteOther", "charEnd": 1045, "source": "RLIMS-P", "charStart": 1004, "entityId": [], "sentenceIndex": 7, "entityText": "the three identified phosphorylation sites"}, "RL:AQqo": {"duid": "RL:AQqo", "attribute": [], "entityType": "SiteOther", "charEnd": 1492, "source": "RLIMS-P", "charStart": 1478, "entityId": [], "sentenceIndex": 11, "entityText": "phosphopeptides"}, "RL:87MP": {"duid": "RL:87MP", "attribute": [], "entityType": "Protein", "charEnd": 266, "source": "RLIMS-P", "charStart": 214, "entityId": [], "sentenceIndex": 1, "entityText": "protein kinase C (Ca2+/phospholipid-dependent enzyme)"}, "RL:Q2A2": {"duid": "RL:Q2A2", "attribute": [], "entityType": "Trigger", "charEnd": 1624, "source": "RLIMS-P", "charStart": 1610, "entityId": [], "sentenceIndex": 13, "entityText": "phosphorylation"}, "RL:MwBr": {"duid": "RL:MwBr", "attribute": [], "entityType": "Protein", "charEnd": 128, "source": "RLIMS-P", "charStart": 91, "entityId": [], "sentenceIndex": 1, "entityText": "epidermal growth factor (EGF) receptor"}, "RL:Ru6X": {"duid": "RL:Ru6X", "attribute": [{"key": "std_site", "value": "Ser"}], "entityType": "Site", "charEnd": 52, "source": "RLIMS-P", "charStart": 47, "entityId": [], "sentenceIndex": 0, "entityText": "serine"}, "RL:8bvL": {"duid": "RL:8bvL", "attribute": [], "entityType": "Trigger", "charEnd": 720, "source": "RLIMS-P", "charStart": 708, "entityId": [], "sentenceIndex": 5, "entityText": "Phosphoserine"}}, "mesh": ["Amino Acid Sequence", "Animals", "Blood", "Cell Line", "Chromatography, High Pressure Liquid", "ErbB Receptors", "Peptide Mapping", "Phosphorylation", "Serine", "Threonine"], "relation": {"RL:jhev": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:AQqo"}, {"role": "TRIGGER", "entity_duid": "RL:Mco6"}], "duid": "RL:jhev"}, "RL:EmqL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:MwBr"}, {"role": "KINASE", "entity_duid": "RL:MwBr"}, {"role": "TRIGGER", "entity_duid": "RL:KgSU"}], "duid": "RL:EmqL"}, "RL:GQeK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:BkDx"}, {"role": "SITE", "entity_duid": "RL:Ru6X"}, {"role": "SITE", "entity_duid": "RL:zgbi"}, {"role": "SITE_OTHER", "entity_duid": "RL:PK5M"}, {"role": "SITE_OTHER", "entity_duid": "RL:pYtr"}, {"role": "TRIGGER", "entity_duid": "RL:bt7v"}], "duid": "RL:GQeK"}, "RL:JfUJ": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:DJxr"}], "duid": "RL:JfUJ"}, "RL:UAGT": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:BrXL"}, {"role": "SITE", "entity_duid": "RL:LCpu"}, {"role": "SITE", "entity_duid": "RL:zUTv"}, {"role": "TRIGGER", "entity_duid": "RL:Q2A2"}], "duid": "RL:UAGT"}, "RL:AHZ8": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:GHJG"}], "duid": "RL:AHZ8"}, "RL:sbWb": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:tEQd"}, {"role": "SITE", "entity_duid": "RL:JEx9"}, {"role": "TRIGGER", "entity_duid": "RL:zpFR"}], "duid": "RL:sbWb"}, "RL:8odL": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:ArPy"}, {"role": "TRIGGER", "entity_duid": "RL:hC4U"}], "duid": "RL:8odL"}, "RL:cmaV": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "INDUCER", "entity_duid": "RL:87MP"}, {"role": "SITE_OTHER", "entity_duid": "RL:qGgB"}, {"role": "TRIGGER", "entity_duid": "RL:P8aA"}], "duid": "RL:cmaV"}, "RL:XpgP": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:7ptm"}, {"role": "SITE", "entity_duid": "RL:Ru6X"}, {"role": "SITE", "entity_duid": "RL:zgbi"}, {"role": "TRIGGER", "entity_duid": "RL:UGXM"}], "duid": "RL:XpgP"}, "RL:wzHA": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:sUUt"}], "duid": "RL:wzHA"}, "RL:gFGt": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:fuEq"}, {"role": "SITE", "entity_duid": "RL:8Ydy"}, {"role": "TRIGGER", "entity_duid": "RL:RZBu"}], "duid": "RL:gFGt"}, "RL:RR2S": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:jci2"}], "duid": "RL:RR2S"}, "RL:MR7g": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:8bvL"}], "duid": "RL:MR7g"}, "RL:KVUa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SUBSTRATE", "entity_duid": "RL:BkDx"}, {"role": "SITE", "entity_duid": "RL:Ru6X"}, {"role": "SITE", "entity_duid": "RL:zgbi"}, {"role": "SITE_OTHER", "entity_duid": "RL:VARR"}, {"role": "SITE_OTHER", "entity_duid": "RL:w5Hw"}, {"role": "SITE_OTHER", "entity_duid": "RL:pYtr"}, {"role": "TRIGGER", "entity_duid": "RL:6gGK"}], "duid": "RL:KVUa"}}, "type": ["Journal Article", "Research Support, Non-U.S. Gov't"]}
{"docId": "17372656", "sentence": [{"charStart": 0, "charEnd": 158, "index": 0}, {"index": 1, "charEnd": 229, "charStart": 160}, {"index": 2, "charEnd": 333, "charStart": 231}, {"index": 3, "charEnd": 805, "charStart": 335}, {"index": 4, "charEnd": 946, "charStart": 807}, {"index": 5, "charEnd": 1165, "charStart": 948}, {"index": 6, "charEnd": 1295, "charStart": 1167}, {"index": 7, "charEnd": 1565, "charStart": 1297}, {"index": 8, "charEnd": 1767, "charStart": 1567}], "text": "An integrated chemical, mass spectrometric and computational strategy for (quantitative) phosphoproteomics: application to Drosophila melanogaster Kc167 cells. Current methods for phosphoproteome analysis have several limitations. First, most methods for phosphopeptide enrichment lack the specificity to truly purify phosphopeptides. Second, fragmentation spectra of phosphopeptides, in particular those of phosphoserine and phosphothreonine containing peptides, are often dominated by the loss of the phosphate group(s) and therefore lack the information required to identify the peptide sequence and the site of phosphorylation, and third, sequence database search engines and statistical models for data validation are not optimized for the specific fragmentation properties of phosphorylated peptides. Consequently, phosphoproteomic data are characterized by large and unknown rates of false positive and false negative phosphorylation sites. Here we present an integrated chemical, mass spectrometric and computational strategy to improve the efficiency, specificity and confidence in the identification of phosphopeptides and their site(s) of phosphorylation. Phosphopeptides were isolated with high specificity through a simple derivatization procedure based on phosphoramidate chemistry. Identification of phosphopeptides, their site(s) of phosphorylation and the corresponding phosphoproteins was achieved by the optimization of the mass spectrometric data acquisition procedure, the computational tools for database searching and the data post processing. The strategy was applied to the mapping of phosphorylation sites of a purified transcription factor, dFOXO and for the global analysis of protein phosphorylation of Drosophila melanogaster Kc167 cells.", "title": {"charStart": 0, "charEnd": 158}, "entity": {"RL:vVbk": {"duid": "RL:vVbk", "attribute": [], "entityType": "Trigger", "charEnd": 332, "source": "RLIMS-P", "charStart": 318, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:Mc9x": {"duid": "RL:Mc9x", "attribute": [], "entityType": "SiteOther", "charEnd": 1181, "source": "RLIMS-P", "charStart": 1167, "entityId": [], "sentenceIndex": 6, "entityText": "Phosphopeptides"}, "RL:suTc": {"duid": "RL:suTc", "attribute": [], "entityType": "Trigger", "charEnd": 1164, "source": "RLIMS-P", "charStart": 1150, "entityId": [], "sentenceIndex": 5, "entityText": "phosphorylation"}, "RL:7xbv": {"duid": "RL:7xbv", "attribute": [], "entityType": "SiteOther", "charEnd": 945, "source": "RLIMS-P", "charStart": 925, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation sites"}, "RL:RGJP": {"duid": "RL:RGJP", "attribute": [], "entityType": "SiteOther", "charEnd": 1329, "source": "RLIMS-P", "charStart": 1315, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:XR72": {"duid": "RL:XR72", "attribute": [], "entityType": "SiteOther", "charEnd": 610, "source": "RLIMS-P", "charStart": 607, "entityId": [], "sentenceIndex": 3, "entityText": "site"}, "RL:vrxe": {"duid": "RL:vrxe", "attribute": [], "entityType": "Trigger", "charEnd": 420, "source": "RLIMS-P", "charStart": 408, "entityId": [], "sentenceIndex": 3, "entityText": "phosphoserine"}, "RL:nPXd": {"duid": "RL:nPXd", "attribute": [], "entityType": "SiteOther", "charEnd": 1127, "source": "RLIMS-P", "charStart": 1113, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:G6Rs": {"duid": "RL:G6Rs", "attribute": [], "entityType": "Trigger", "charEnd": 1181, "source": "RLIMS-P", "charStart": 1167, "entityId": [], "sentenceIndex": 6, "entityText": "Phosphopeptides"}, "RL:LEHL": {"duid": "RL:LEHL", "attribute": [], "entityType": "SiteOther", "charEnd": 382, "source": "RLIMS-P", "charStart": 368, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:9oio": {"duid": "RL:9oio", "attribute": [], "entityType": "Trigger", "charEnd": 1127, "source": "RLIMS-P", "charStart": 1113, "entityId": [], "sentenceIndex": 5, "entityText": "phosphopeptides"}, "RL:mJmo": {"duid": "RL:mJmo", "attribute": [], "entityType": "Trigger", "charEnd": 382, "source": "RLIMS-P", "charStart": 368, "entityId": [], "sentenceIndex": 3, "entityText": "phosphopeptides"}, "RL:jXwM": {"duid": "RL:jXwM", "attribute": [], "entityType": "Trigger", "charEnd": 1624, "source": "RLIMS-P", "charStart": 1610, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:WWMj": {"duid": "RL:WWMj", "attribute": [], "entityType": "Trigger", "charEnd": 1727, "source": "RLIMS-P", "charStart": 1713, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation"}, "RL:KZGH": {"duid": "RL:KZGH", "attribute": [], "entityType": "SiteOther", "charEnd": 1630, "source": "RLIMS-P", "charStart": 1610, "entityId": [], "sentenceIndex": 8, "entityText": "phosphorylation sites"}, "RL:h6nX": {"duid": "RL:h6nX", "attribute": [], "entityType": "SiteOther", "charEnd": 804, "source": "RLIMS-P", "charStart": 797, "entityId": [], "sentenceIndex": 3, "entityText": "peptides"}, "RL:5H2r": {"duid": "RL:5H2r", "attribute": [], "entityType": "Trigger", "charEnd": 939, "source": "RLIMS-P", "charStart": 925, "entityId": [], "sentenceIndex": 4, "entityText": "phosphorylation"}, "RL:L582": {"duid": "RL:L582", "attribute": [], "entityType": "Trigger", "charEnd": 629, "source": "RLIMS-P", "charStart": 615, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylation"}, "RL:kRxo": {"duid": "RL:kRxo", "attribute": [], "entityType": "SiteOther", "charEnd": 332, "source": "RLIMS-P", "charStart": 318, "entityId": [], "sentenceIndex": 2, "entityText": "phosphopeptides"}, "RL:ma3i": {"duid": "RL:ma3i", "attribute": [], "entityType": "Trigger", "charEnd": 1401, "source": "RLIMS-P", "charStart": 1387, "entityId": [], "sentenceIndex": 7, "entityText": "phosphoproteins"}, "RL:NKMd": {"duid": "RL:NKMd", "attribute": [], "entityType": "Trigger", "charEnd": 1329, "source": "RLIMS-P", "charStart": 1315, "entityId": [], "sentenceIndex": 7, "entityText": "phosphopeptides"}, "RL:ZDPa": {"duid": "RL:ZDPa", "attribute": [], "entityType": "Trigger", "charEnd": 795, "source": "RLIMS-P", "charStart": 782, "entityId": [], "sentenceIndex": 3, "entityText": "phosphorylated"}, "RL:wp9c": {"duid": "RL:wp9c", "attribute": [], "entityType": "Trigger", "charEnd": 1363, "source": "RLIMS-P", "charStart": 1349, "entityId": [], "sentenceIndex": 7, "entityText": "phosphorylation"}}, "mesh": ["Animals", "Binding Sites", "Cell Line", "Chromatography, Liquid", "Computational Biology", "Drosophila Proteins", "Drosophila melanogaster", "Forkhead Transcription Factors", "Mass Spectrometry", "Models, Chemical", "Molecular Structure", "Phosphopeptides", "Phosphorylation", "Proteomics"], "relation": {"RL:NzAH": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:ma3i"}], "duid": "RL:NzAH"}, "RL:bqNK": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KZGH"}, {"role": "TRIGGER", "entity_duid": "RL:WWMj"}], "duid": "RL:bqNK"}, "RL:x6iB": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:LEHL"}, {"role": "TRIGGER", "entity_duid": "RL:mJmo"}], "duid": "RL:x6iB"}, "RL:cVjm": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:Mc9x"}, {"role": "TRIGGER", "entity_duid": "RL:G6Rs"}], "duid": "RL:cVjm"}, "RL:7VKh": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:RGJP"}, {"role": "TRIGGER", "entity_duid": "RL:NKMd"}], "duid": "RL:7VKh"}, "RL:PDjr": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:KZGH"}, {"role": "TRIGGER", "entity_duid": "RL:jXwM"}], "duid": "RL:PDjr"}, "RL:tzJq": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:XR72"}, {"role": "TRIGGER", "entity_duid": "RL:L582"}], "duid": "RL:tzJq"}, "RL:hyJG": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:h6nX"}, {"role": "TRIGGER", "entity_duid": "RL:ZDPa"}], "duid": "RL:hyJG"}, "RL:NTWD": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:vrxe"}], "duid": "RL:NTWD"}, "RL:bzSo": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:kRxo"}, {"role": "TRIGGER", "entity_duid": "RL:vVbk"}], "duid": "RL:bzSo"}, "RL:DAGa": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:wp9c"}], "duid": "RL:DAGa"}, "RL:2FXg": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:nPXd"}, {"role": "TRIGGER", "entity_duid": "RL:9oio"}], "duid": "RL:2FXg"}, "RL:FuQ2": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "SITE_OTHER", "entity_duid": "RL:7xbv"}, {"role": "TRIGGER", "entity_duid": "RL:5H2r"}], "duid": "RL:FuQ2"}, "RL:QPAU": {"relationType": "PHOSPHORYLATION", "source": "RLIMS-P", "argument": [{"role": "TRIGGER", "entity_duid": "RL:suTc"}], "duid": "RL:QPAU"}}, "type": ["Evaluation Study", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}
